aspirin has been researched along with Complication, Postoperative in 1107 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Among patients undergoing hip or knee arthroplasty for osteoarthritis, aspirin compared with enoxaparin resulted in a significantly higher rate of symptomatic VTE within 90 days, defined as below- or above-knee DVT or pulmonary embolism." | 9.51 | Effect of Aspirin vs Enoxaparin on Symptomatic Venous Thromboembolism in Patients Undergoing Hip or Knee Arthroplasty: The CRISTAL Randomized Trial. ( Ackerman, I; Adie, S; Bastiras, D; Brighton, R; Buchbinder, R; Burns, AWR; Cashman, K; Chong, BH; Clavisi, O; Cripps, M; de Steiger, R; Dekkers, M; Dixon, M; Ellis, A; Graves, SE; Griffith, EC; Hale, D; Hansen, A; Harris, A; Harris, IA; Hau, R; Horsley, M; James, D; Kelly, TL; Khorshid, O; Kuo, L; Lewis, P; Lieu, D; Lorimer, M; MacDessi, S; McCombe, P; McDougall, C; Mulford, J; Naylor, JM; Page, RS; Pratt, N; Radovanovic, J; Sidhu, VS; Solomon, M; Sorial, R; Summersell, P; Tran, P; Walter, WL; Webb, S; Wilson, C; Wysocki, D, 2022) |
| "Adding clopidogrel to aspirin for 3 months after transcatheter atrial septal defect (ASD) closure results in a lower incidence of new-onset migraine attacks." | 9.41 | Effect of Clopidogrel and Aspirin vs Aspirin Alone on Migraine Headaches After Transcatheter Atrial Septal Defect Closure: One-Year Results of the CANOA Randomized Clinical Trial. ( Cheema, AN; Côté, M; Horlick, E; Houde, C; Ibrahim, R; Labinaz, M; Marrero, A; Marsal, JR; Nadeem, N; Osten, M; Rivest, D; Rodés-Cabau, J; Wintzer-Wehekind, J, 2021) |
| "The aspirin for metal stents in malignant distal common bile duct obstruction (AIMS) study should determine the efficacy of aspirin in maintaining metal-stent patency in patients with malignant distal CBD obstructive." | 9.34 | Aspirin for metal stent in malignant distal common bile duct obstruction (AIMS): study protocol for a multicenter randomized controlled trial. ( Choi, JH; Choi, YH; Kim, YT; Lee, KJ; Lee, SH; Paik, WH; Ryu, JK; Shin, BS; You, MS, 2020) |
| "Compared with ticagrelor plus aspirin, the effect of ticagrelor monotherapy in reducing the risk of clinically relevant bleeding without any increase in ischemic events was consistent among patients with or without DM undergoing PCI." | 9.34 | Ticagrelor With or Without Aspirin in High-Risk Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention. ( Angiolillo, DJ; Baber, U; Briguori, C; Chandiramani, R; Cohen, DJ; Collier, T; Dangas, G; Dudek, D; Escaned, J; Gibson, CM; Huber, K; Kaul, U; Kornowski, R; Kunadian, V; Mehran, R; Mehta, SR; Oldroyd, KG; Pocock, S; Sardella, G; Sartori, S; Sharma, S; Shlofmitz, RA; Weisz, G; Witzenbichler, B; Ya-Ling, H, 2020) |
| " Whether aspirin may reduce the risk for CVD, death, and kidney failure outcomes is uncertain." | 9.22 | Aspirin Use and Incident Cardiovascular Disease, Kidney Failure, and Death in Stable Kidney Transplant Recipients: A Post Hoc Analysis of the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial. ( Bostom, A; Carpenter, M; Dad, T; Hunsicker, L; Joseph, A; Kusek, JW; Levey, AS; Pfeffer, M; Tighiouart, H; Weiner, DE, 2016) |
| "ᅟ: We investigated the occurrence of bleeding complications in patients who underwent skin tumor surgery and compared it between Aspirin users and a placebo control group." | 9.22 | Aspirin use and bleeding volume in skin cancer patients undergoing surgery: a randomized controlled trial. ( Atri, A; Engheta, A; Hadadi Abianeh, S; Sanatkarfar, M, 2016) |
| "There is insufficient data on the efficacy of prasugrel and ticagrelor in Korean patients with ST-segment elevation myocardial infarction (STEMI)." | 9.20 | Comparison of Prasugrel and Ticagrelor Antiplatelet Effects in Korean Patients Presenting With ST-Segment Elevation Myocardial Infarction. ( Cho, YR; Guo, LZ; Jin, CD; Kim, MH; Kim, YD; Lee, YS; Park, JS; Park, K; Park, TH, 2015) |
| "Prior aspirin treatment is considered a risk factor for adverse outcomes in acute coronary syndrome (ACS) patients." | 9.20 | Effect of Prior Aspirin Treatment on Patients With Acute Coronary Syndromes: Insights From the PROSPECT Study. ( Brener, SJ; de Bruyne, B; Maehara, A; Mintz, GS; Serruys, PW; Stone, GW; Weisz, G, 2015) |
| "To determine whether aspirin compared with placebo, and clonidine compared with placebo, alters the risk of perioperative acute kidney injury." | 9.19 | Perioperative aspirin and clonidine and risk of acute kidney injury: a randomized clinical trial. ( Acedillo, R; Amir, M; Bergese, S; Biccard, B; Bidgoli, SJ; Cata, JP; Cegarra, V; Chan, MT; Chan, V; Clanchet, Mde N; Cuerden, M; Devereaux, PJ; Dresser, G; Fleischmann, E; Font, A; Forget, P; Garg, AX; Gomez, MF; Jones, PM; Kumar, P; Kurz, A; Leslie, K; Malaga, G; Martinsen, K; Mehra, B; Meyhoff, CS; Mizera, R; Mrkobrada, M; Myles, P; Painter, T; Parikh, CR; Parlow, J; Pasin, L; Robinson, A; Roshanov, PS; Sessler, DI; Srinathan, S; Tiboni, M; Torres, D; VanHelder, T; Villar, JC; Walsh, M; Whitlock, R; Wijeysundera, DN; Yusuf, S, 2014) |
| "The safety and efficacy of combined low dose aspirin and warfarin therapy in patients with atrial fibrillation after mechanical heart valve replacement were evaluated." | 9.19 | Combined low-dose aspirin and warfarin anticoagulant therapy of postoperative atrial fibrillation following mechanical heart valve replacement. ( Dong, MF; Ma, SJ; Ma, ZS; Song, GM; Wang, JT, 2014) |
| "To evaluates the efficacy and safety of rivaroxaban versus aspirin in prevention of venous thromboembolism (VTE) following total hip (THA) or knee arthroplasty (TKA) or hip fracture surgery." | 9.12 | Rivaroxaban versus aspirin in prevention of venous thromboembolism following total joint arthroplasty or hip fracture surgery: a meta-analysis. ( Dai, Z; Hu, B; Hu, M; Jiang, L; Tang, H; Yu, J, 2021) |
| "In this analysis, we aimed to compare the efficacy and safety of dual therapy (DT) with a non-vitamin K oral anticoagulant (NOAC) and an adenosine diphosphate receptor antagonist (P2Y12 inhibitor) vs triple therapy (TT) with aspirin, a P2Y12 inhibitor and a vitamin K antagonist for the treatment of diabetes mellitus (DM) patients with co-existing atrial fibrillation (AF) following percutaneous coronary intervention (PCI)." | 9.12 | Dual therapy with an oral non-vitamin K antagonist and a P2Y12 inhibitor vs triple therapy with aspirin, a P2Y12 inhibitor and a vitamin K antagonist for the treatment of diabetes mellitus patients with co-existing atrial fibrillation following percutaneo ( Wang, Q; Yang, K, 2021) |
| "Among the patients with hip fracture, allocation to aspirin produced proportional reductions in pulmonary embolism of 43% (95% CI 18-60; p=0." | 9.09 | Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. ( , 2000) |
| "The study objective was to determine the relative efficacy and safety of a low-molecular-weight heparinoid (Orgaran) compared with aspirin for the prevention of postoperative venous thromboembolism in patients undergoing surgery for fractured hips." | 9.08 | Low-molecular-weight heparinoid orgaran is more effective than aspirin in the prevention of venous thromboembolism after surgery for hip fracture. ( Geerts, WH; Gent, M; Ginsberg, JS; Hirsh, J; Jay, RM; Leclerc, J; Levine, MN; Neemeh, JA; Powers, PJ; Turpie, AG, 1996) |
| "It has been suggested that desmopressin acetate has been effective in reducing hemorrhage after coronary artery bypass grafting in patients receiving aspirin before operation." | 9.07 | The effect of desmopressin acetate on postoperative hemorrhage in patients receiving aspirin therapy before coronary artery bypass operations. ( Ablaza, SG; Afshar, M; DeCastro, N; Gratz, I; Koehler, J; Larijani, GE; Olsen, D; Spagna, PM, 1992) |
| " The computer-based searches combined terms and combinations of keywords related to the population (eg, hip replacement, knee replacement, hip arthroplasty, and knee arthroplasty), drug intervention (eg, aspirin, heparin, clexane, dabigatran, rivaroxaban, and warfarin), and outcome (eg, venous thromboembolism, deep vein thrombosis, pulmonary embolism, and bleeding) in humans." | 9.05 | Clinical Effectiveness and Safety of Aspirin for Venous Thromboembolism Prophylaxis After Total Hip and Knee Replacement: A Systematic Review and Meta-analysis of Randomized Clinical Trials. ( Blom, AW; Judge, A; Kunutsor, SK; Matharu, GS; Whitehouse, MR, 2020) |
| "In a prospective, randomized, parallel study, two regimens of platelet-suppressant therapy (PST)--dipyridamole-aspirin and pentoxifylline-aspirin--were compared with standard oral anticoagulation with warfarin in the prevention of prosthetic heart valve thromboembolism." | 9.05 | Warfarin versus dipyridamole-aspirin and pentoxifylline-aspirin for the prevention of prosthetic heart valve thromboembolism: a prospective randomized clinical trial. ( Boey, J; Chan, TK; Cheung, KL; Chow, J; Lee, PK; Mok, CK; Ng, RP; Tse, TF; Wang, R, 1985) |
| "While aspirin is acceptable for venous thromboembolism (VTE) prophylaxis following total joint arthroplasty in most patients, more potent agents are used in patients considered higher risk for VTE." | 8.31 | Comparison of 90-Day Adverse Events Associated With Aspirin and Potent Anticoagulation Use for Venous Thromboembolism Prophylaxis: A Cohort Study of 72,288 Total Knee and 35,142 Total Hip Arthroplasty Patients. ( Kroger, EW; Prentice, HA; Singh, G; Winston, BA, 2023) |
| "Patient-reported allergies to aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) may preclude certain patients from receiving aspirin as venous thromboembolism (VTE) prophylaxis after total joint arthroplasty (TJA)." | 8.12 | Patients Who Do Not Receive Aspirin Because of Allergy Have an Increased Risk of Venous Thromboembolism Following Total Joint Arthroplasty. ( Goh, GS; Kozaily, E; Parvizi, J; Tan, TL, 2022) |
| " Therefore, we investigated the risk of discontinuing aspirin concerning thrombotic complications in laparoscopic colorectal cancer surgery." | 8.12 | Impact of aspirin discontinuation on thrombotic complications in laparoscopic colorectal cancer surgery. ( Dono, K; Hamabe, A; Harino, T; Noura, S; Ogino, T; Suzuki, Y; Takeyama, H; Tanida, T; Tomita, N, 2022) |
| "In recent years, aspirin has become a popular agent for venous thromboembolism (VTE) prophylaxis following total joint arthroplasty (TJA)." | 8.12 | Aspirin May Be a Suitable Prophylaxis for Patients with a History of Venous Thromboembolism Undergoing Total Joint Arthroplasty. ( Ledesma, J; Ludwick, L; Paladino, J; Parvizi, J; Shohat, N; Van Nest, D, 2022) |
| "To evaluate whether a daily full-dose aspirin regimen after anterior cruciate ligament (ACL) reconstruction reduces the risk of postoperative symptomatic deep-venous thrombosis (DVT)." | 8.02 | Aspirin for Deep-Venous Thrombosis Prophylaxis After Anterior Cruciate Ligament Reconstruction. ( Bernstein, EM; Briggs, AM; Ferris, WJ; Hurvitz, AP; McDonald, LS; McIntire, SC; Renninger, CH; Tompane, TM, 2021) |
| " The purpose of this study is to evaluate a weight-based aspirin dosing regimen for prevention of venous thromboembolism (VTE) following TJA." | 8.02 | Weight-Based Aspirin Dosing May Further Reduce the Incidence of Venous Thromboembolism Following Primary Total Joint Arthroplasty. ( Brown, TS; Gulbrandsen, TR; Halbur, CR; Noiseux, NO; West, CR, 2021) |
| "Based on this single institutional study, addressing preoperative anemia and considering the implementation of aspirin for venous thromboembolism prophylaxis may be 2 targets to potentially reduce readmission after aseptic revision TJA." | 7.96 | Highlighting the Roles of Anemia and Aspirin in Predicting Ninety-Day Readmission Following Aseptic Revision Total Joint Arthroplasty. ( Foltz, C; Klement, MR; Li, WT; Parvizi, J; Sinensky, A; Yazdi, H, 2020) |
| "To test the hypothesis that preoperative aspirin administered within 24 hours before coronary artery bypass grafting (CABG) could reduce the incidence of postoperative acute kidney injury (AKI) following CABG." | 7.96 | Association between preoperative aspirin and acute kidney injury following coronary artery bypass grafting. ( Aboul-Hassan, SS; Cichon, R; Marczak, J; Nawotka, M; Peksa, M; Stanislawski, R; Stankowski, T, 2020) |
| " Nevertheless, external validation of these RSs it has not yet been performed in ACS (acute coronary syndrome) patients treated with prasugrel or ticagrelor in a real- world scenario." | 7.96 | Comparative external validation of the PRECISE-DAPT and PARIS risk scores in 4424 acute coronary syndrome patients treated with prasugrel or ticagrelor. ( Alexopoulos, D; Ariza-Solé, A; Assi, EA; Autelli, M; Bernardi, A; Bianco, M; Blanco, PF; Boccuzzi, G; Cequier, A; Cerrato, E; D'ascenzo, F; Destefanis, P; Dominguez-Rodriguez, A; Durante, A; Fernández, MC; Gallo, D; Garay, A; Gili, S; Giustetto, C; Gravinese, C; Grosso, A; Iñiguez-Romo, A; Kinnaird, T; Lopez-Cuenca, Á; Luciano, A; Magnani, G; Manzano-Fernández, S; Montabone, A; Morbiducci, U; Omedè, P; Paz, RC; Peyracchia, M; Pousa, IM; Pozzi, R; Quadri, G; Queija, BC; Raposeiras Roubin, S; Rinaldi, M; Rognoni, A; Rossini, R; Srdanovic, I; Taha, S; Templin, C; Valgimigli, M; Varbella, F; Velicki, L; Xanthopoulou, I, 2020) |
| "To evaluate the safety of phacoemulsification cataract surgery in the patients undergoing dual antiplatelet therapy with aspirin and clopidogrel." | 7.96 | Combined aspirin and clopidogrel therapy in phacoemulsification cataract surgery: a risk factor for ocular hemorrhage? ( Jiang, J; Li, Q; Qian, Y; Shen, X; Su, T; Wang, S; Wang, Z; Yan, K; Zhang, P; Zhang, Y, 2020) |
| "To determine using a simplified risk-stratified protocol to select candidates for aspirin therapy have similar death and postoperative complications as universal warfarin therapy in patients undergoing total joint replacement (TJR)." | 7.96 | Evaluation of a Simplified Risk Stratification Twice-Daily Aspirin Protocol for Venous Thromboembolism Prophylaxis After Total Joint Replacement. ( Adams, W; Davis, ES; Ng, C; Pinzur, MS; Zavala, S, 2020) |
| " Aspirin has been considered a safe and cost-effective prophylaxis for venous thromboembolism (VTE), and there have been some reports about the incidence of PTE (0%-0." | 7.96 | Clinical efficacy of risk-stratified prophylaxis with low-dose aspirin for the management of symptomatic venous thromboembolism after total hip arthroplasty. ( Hirakawa, K; Mihara, M; Nakura, N; Ochiai, S; Saito, A; Takayanagi, S; Tamaki, Y, 2020) |
| "To compare the efficacy and safety of aspirin with rivaroxaban following treatment with enoxaparin for prevention of venous thromboembolism (VTE) after hip fracture surgery (HFS)." | 7.91 | Comparison of the Efficacy and Safety of Aspirin and Rivaroxaban Following Enoxaparin Treatment for Prevention of Venous Thromboembolism after Hip Fracture Surgery. ( Huang, Q; Shen, B; Si, HB; Xing, SX; Zeng, Y; Zhou, ZK, 2019) |
| "The use of aspirin as prophylaxis against venous thromboembolism (VTE) following total joint arthroplasty (TJA) has increased in popularity; however, the potential cardioprotective effects of aspirin when administered as VTE prophylaxis remain unknown." | 7.91 | The Use of Aspirin for Prophylaxis Against Venous Thromboembolism Decreases Mortality Following Primary Total Joint Arthroplasty. ( Goswami, K; Huang, RC; Parvizi, J; Rondon, AJ; Shohat, N; Tan, TL, 2019) |
| "The risks of venous thromboembolism (VTE) and bleeding with direct oral anticoagulants (DOACs) and aspirin for thromboprophylaxis after orthopedic surgery were studied." | 7.91 | Direct oral anticoagulants versus aspirin for venous thromboembolism prophylaxis after orthopedic surgery. ( Muntz, J; Murillo, M; Putney, D; Vadhariya, A; Wilson, A; Yang, T, 2019) |
| "We investigated whether the use of aspirin (irreversible COX1 inhibitor) in the preoperative period may prevent non-valvular atrial fibrillation, which is the most common rhythm problem in the postoperative period." | 7.91 | The Effect of Aspirin as an Irreversible COX1 Inhibitor in Preventing Non-Valvular Atrial Fibrillation After Coronary Bypass Surgery. ( Ates, A; Erkut, B, 2019) |
| "Although guidelines now allow the use of aspirin as an alternative to anticoagulants for venous thromboembolism prophylaxis after knee or hip arthroplasty, there is limited data on contemporary use and outcomes with aspirin." | 7.91 | Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study. ( Auerbach, AD; Baumgartner, C; Fang, MC; Maselli, J, 2019) |
| "Aspirin is an effective prophylaxis for venous thromboembolism (VTE) after total knee arthroplasty (TKA)." | 7.88 | Low-Dose Aspirin Is Safe and Effective for Venous Thromboembolism Prophylaxis Following Total Knee Arthroplasty. ( Barsoum, WK; Brigati, DP; Faour, M; Higuera, CA; Klika, AK; Mont, MA; Piuzzi, NS, 2018) |
| "Recent guidelines include aspirin as an option to prevent venous thromboembolism (VTE) in selected patients undergoing hip or knee replacement surgery." | 7.85 | The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty. ( Auerbach, AD; Chu, JN; Fang, MC; Maselli, J, 2017) |
| "Aspirin is a safe and effective prophylaxis for the prevention of venous thromboembolism following total joint arthroplasty." | 7.85 | Low-Dose Aspirin Is Effective Chemoprophylaxis Against Clinically Important Venous Thromboembolism Following Total Joint Arthroplasty: A Preliminary Analysis. ( Austin, MS; Chen, AF; Hozack, WJ; Huang, R; Lonner, JH; Parvizi, J; Restrepo, C, 2017) |
| " She had discontinued Phenprocoumon-treatment in the 5+4 week of pregnancy by herself." | 7.83 | [Mechanic valve prosthesis and pregnancy: Is Phenprocoumon replaceable?]. ( Gawaz, M; Klee, K; Meyer-Zürn, CS, 2016) |
| "We aim to investigate the safety profile of aspirin continuation in the perioperative period in patients undergoing elective primary inguinal hernia repair." | 7.83 | Is preoperative withdrawal of aspirin necessary in patients undergoing elective inguinal hernia repair? ( Lomanto, D; Ong, W; Shen, T; Tan, WB, 2016) |
| "The effects of dual antiplatelet therapy with aspirin and clopidogrel on the progression of native coronary artery disease after coronary artery bypass grafting are unknown." | 7.80 | Impact of clopidogrel plus aspirin versus aspirin alone on the progression of native coronary artery disease after bypass surgery: analysis from the Clopidogrel After Surgery for Coronary Artery DiseasE (CASCADE) randomized trial. ( Al-Atassi, T; Kulik, A; Le May, M; Ruel, M; Une, D; Voisine, P, 2014) |
| "Aspirin resistance is common in the population of patients with hemodynamic cerebral ischemia scheduled for cerebral revascularization." | 7.79 | Aspirin resistance in patients with hemodynamic cerebral ischemia undergoing extracranial-intracranial bypass surgery. ( Horn, P; Jussen, D; Vajkoczy, P, 2013) |
| "The objectives of this study were to compare the risk of venous thromboembolism (VTE), bleeding, surgical site infection, and mortality in patients receiving aspirin or guideline-approved VTE prophylactic therapies (warfarin, low-molecular-weight heparins, synthetic pentasaccharides) in total knee arthroplasty (TKA)." | 7.76 | Does aspirin have a role in venous thromboembolism prophylaxis in total knee arthroplasty patients? ( Auerbach, AD; Bozic, KJ; Lindenauer, PK; Maselli, JH; Pekow, PS; Vail, TP, 2010) |
| "The aim of this study was to compare the incidence of postoperative nausea and vomiting (PONV) in propofol-anesthetized patients receiving either fentanyl or pentazocine as opioid supplement." | 7.74 | [Postoperative nausea and vomiting after laparoscopic cholecystectomy under total intravenous anesthesia using propofol combined with fentanyl or pentazocine]. ( Abe, F; Furuya, A; Nagamine, N; Nonaka, A; Suzuki, S, 2007) |
| "Aspirin-sensitivity, asthma, and nasal polyposis (NP) comprise the clinical entity of Samter's triad." | 7.74 | Sinonasal outcomes after endoscopic sinus surgery in asthmatic patients with nasal polyps: a difference between aspirin-tolerant and aspirin-induced asthma? ( Awad, OG; Fasano, MB; Graham, SM; Lee, JH, 2008) |
| "The combination of clopidogrel for four weeks and aspirin for six months is superior to aspirin alone for six months for preventing migraine with aura after transcatheter closure of an atrial shunt." | 7.73 | Clopidogrel reduces migraine with aura after transcatheter closure of persistent foramen ovale and atrial septal defects. ( Morrison, WL; Nightingale, S; Walsh, KP; Wilmshurst, PT, 2005) |
| "We studied 30 patients with postsurgical ulcer and aspirin abuse." | 7.70 | Intractable upper gastrointestinal ulceration due to aspirin in patients who have undergone surgery for peptic ulcer. ( Hirschowitz, BI; Lanas, A, 1998) |
| "A case of acute subdural haematoma originating spontaneously from an angiomatous meningioma in a patient receiving prophylactic aspirin therapy is presented." | 7.69 | Intracranial haemorrhage from a meningioma in a patient receiving aspirin prophylaxis: a case report. ( Ashkenazi, E; Israel, Z; Spektor, S, 1995) |
| "Aspirin and nonsteroidal antiinflammatory drugs (NSAIDs) inhibit platelet cyclooxygenase activity, resulting in altered platelet function and thus potentially enhanced bleeding." | 7.69 | Effect of aspirin and nonsteroidal antiinflammatory drug therapy on bleeding complications in dermatologic surgical patients. ( Lawrence, C; Sakuntabhai, A; Tiling-Grosse, S, 1994) |
| "An 11-year retrospective study was conducted to evaluate the surgical treatment of sinusitis in aspirin-triad patients." | 7.68 | Surgery for sinusitis and aspirin triad. ( Fink, JN; Kany, RJ; McFadden, EA; Toohill, RJ, 1990) |
| "Although this study was performed on a relatively small number of patients undergoing total hip arthroplasty in conjunction with aspirin prophylaxis for postoperative pulmonary embolism, several important points are noted: the use of pre- and postoperative lung perfusion scanning can eliminate a 15% rate of false-positive diagnosis of pulmonary embolism, and pulmonary embolism occurred in approximately 8% of patients undergoing total hip arthroplasty in conjunction with aspirin prophylaxis, without fatality." | 7.66 | Aspirin prophylaxis for pulmonary embolism following total hip arthroplasty. An incidence study. ( Dorr, LD; Ranawat, CS; Schneider, R; Stulberg, BN, 1982) |
| "The efficacy of two antithrombotic regimens, combined dextran and aspirin and combined dextran and warfarin, was analyzed by comparing the incidence of thromboembolism following total hip replacement in two groups of similar patients." | 7.65 | Thromboembolism following total hip-replacement arthroplasty. The efficicy of dextran-aspirin and dextran-warfarin in prophylaxis. ( Lachiewicz, P; Salvati, EA, 1976) |
| "Both aspirin and dextran were well tolerated." | 6.69 | Prophylaxis for deep vein thrombosis with aspirin or low molecular weight dextran in Korean patients undergoing total hip replacement. A randomized controlled trial. ( Cho, JL; Choi, IY; Kim, YH; Park, MR; Park, TS, 1998) |
| " Conditions characterized by a reduction in platelet survival and where dipyridamole has been used include heart valve replacement, arterial grafting, cerebrovascular disorders, and disorders of peripheral circulation." | 6.15 | Dipyridamole: a critical evaluation. ( Alexander, MR; Rivey, MP; Taylor, JW, 1984) |
| "Aspirin has been convincingly shown to reduce stroke and death in men with transient ischemic attacks (it may possibly be beneficial to women also), myocardial infarction and death in patients with unstable angina, thromboembolic complications associated with artificial heart valves in patients receiving oral anticoagulants (although gastrointestinal bleeding is prohibitive with this combination), and thrombotic occlusion of silicone rubber arteriovenous cannulae in uremic patients undergoing hemodialysis." | 6.15 | Clinical trials evaluating platelet-modifying drugs in patients with atherosclerotic cardiovascular disease and thrombosis. ( Harker, LA, 1986) |
| " The aim of this study was to determine whether a protocol of 81-mg aspirin (ASA) bis in die (BID) is safe and/or sufficient in preventing VTE in patients undergoing rTKAs versus 325-mg ASA BID." | 5.72 | Low-Dose Aspirin is Safe and Effective for Venous Thromboembolism Prevention in Patients Undergoing Revision Total Knee Arthroplasty: A Retrospective Cohort Study. ( Bosco, JA; Iorio, R; Schwarzkopf, R; Slover, JD; Tang, A; Waren, D; Zak, SG, 2022) |
| " The aim of this study is to determine if discontinued use of outpatient IPCDs is safe and does not increase the rate of VTE or any other related complications in patients following TKA." | 5.72 | Discontinued Use of Outpatient Portable Intermittent Pneumatic Compression Devices May Be Safe for Venous Thromboembolism Prophylaxis in Primary Total Knee Arthroplasty Using Low-Dose Aspirin. ( Lajam, C; Lygrisse, K; Macaulay, W; Meftah, M; Schwarzkopf, R; Slover, J; Tang, A; Zak, S, 2022) |
| "ASA is safe for VTE prophylaxis after total joint arthroplasty in patients with history of GI issues and is not associated with an increased risk of postoperative GI bleeds." | 5.62 | Aspirin Is Safe for Venous Thromboembolism Prophylaxis for Patients With a History of Gastrointestinal Issues. ( Austin, MS; Grosso, MJ; Kozaily, E; Parvizi, J, 2021) |
| "The aspirin group was older (73 ± 7." | 5.62 | No Increased Risk of Venous Thromboembolism in High-Risk Patients Continuing Their Dose of 75 mg Aspirin Compared to Healthier Patients Given Low-Molecular-Weight Heparin. ( Amlie, EJ; Hovik, O; Jenssen, KK, 2021) |
| "Among patients undergoing hip or knee arthroplasty for osteoarthritis, aspirin compared with enoxaparin resulted in a significantly higher rate of symptomatic VTE within 90 days, defined as below- or above-knee DVT or pulmonary embolism." | 5.51 | Effect of Aspirin vs Enoxaparin on Symptomatic Venous Thromboembolism in Patients Undergoing Hip or Knee Arthroplasty: The CRISTAL Randomized Trial. ( Ackerman, I; Adie, S; Bastiras, D; Brighton, R; Buchbinder, R; Burns, AWR; Cashman, K; Chong, BH; Clavisi, O; Cripps, M; de Steiger, R; Dekkers, M; Dixon, M; Ellis, A; Graves, SE; Griffith, EC; Hale, D; Hansen, A; Harris, A; Harris, IA; Hau, R; Horsley, M; James, D; Kelly, TL; Khorshid, O; Kuo, L; Lewis, P; Lieu, D; Lorimer, M; MacDessi, S; McCombe, P; McDougall, C; Mulford, J; Naylor, JM; Page, RS; Pratt, N; Radovanovic, J; Sidhu, VS; Solomon, M; Sorial, R; Summersell, P; Tran, P; Walter, WL; Webb, S; Wilson, C; Wysocki, D, 2022) |
| "The rate of surgical site infection was similar between the aspirin group and the warfarin group (1." | 5.43 | Aspirin Can Be Used as Prophylaxis for Prevention of Venous Thromboembolism After Revision Hip and Knee Arthroplasty. ( Chen, AF; Deirmengian, GK; Heller, S; Maltenfort, M; Parvizi, J; Smith, EB, 2016) |
| "Aspirin was not significantly associated with bleeding complications during or after surgery (p = 0." | 5.42 | A case-control study to assess aspirin as a risk factor of bleeding in rhegmatogenous retinal detachment surgery. ( Albaladejo, P; Aptel, F; Bernheim, D; Brillat, E; Chiquet, C; Palombi, K; Quesada, JL; Romanet, JP; Rouberol, F, 2015) |
| "Adding clopidogrel to aspirin for 3 months after transcatheter atrial septal defect (ASD) closure results in a lower incidence of new-onset migraine attacks." | 5.41 | Effect of Clopidogrel and Aspirin vs Aspirin Alone on Migraine Headaches After Transcatheter Atrial Septal Defect Closure: One-Year Results of the CANOA Randomized Clinical Trial. ( Cheema, AN; Côté, M; Horlick, E; Houde, C; Ibrahim, R; Labinaz, M; Marrero, A; Marsal, JR; Nadeem, N; Osten, M; Rivest, D; Rodés-Cabau, J; Wintzer-Wehekind, J, 2021) |
| " However, it is unclear whether antiplatelet monotherapy with ticagrelor alone versus ticagrelor plus aspirin reduces the incidence of clinically relevant bleeding without increasing the risk of major adverse cardiovascular and cerebrovascular events (MACCEs) in ACS patients undergoing percutaneous coronary intervention (PCI) with DES implantation guided by either intravascular ultrasound (IVUS) or angiography who have completed a 1-month course of DAPT with aspirin plus ticagrelor." | 5.41 | Comparison of one-month versus twelve-month dual antiplatelet therapy after implantation of drug-eluting stents guided by either intravascular ultrasound or angiography in patients with acute coronary syndrome: rationale and design of prospective, multice ( Chen, F; Chen, SL; Gao, DS; Gao, XF; Ge, Z; Han, YL; He, YQ; Kan, J; Kong, XQ; Li, F; Lin, S; Liu, ZZ; Qian, XS; Qu, H; Shao, YB; Tao, L; Tian, NL; Wang, Y; Wang, ZZ; Wen, SY; Xia, Y; Xiao, PX; Yang, Q; Yang, S; Ye, F; Zeng, HS; Zhang, JJ; Zuo, GF, 2021) |
| "Switching warfarin to aspirin 3 months after successful RFCA of AF could be as safe and efficacious as long-term anticoagulation even in patients with CHA₂DS₂-VASc score≥2." | 5.40 | Safety and efficacy of switching anticoagulation to aspirin three months after successful radiofrequency catheter ablation of atrial fibrillation. ( Choi, KJ; Joung, B; Kim, YH; Lee, MH; Nam, GB; Pak, HN; Uhm, JS; Won, H, 2014) |
| "The aspirin for metal stents in malignant distal common bile duct obstruction (AIMS) study should determine the efficacy of aspirin in maintaining metal-stent patency in patients with malignant distal CBD obstructive." | 5.34 | Aspirin for metal stent in malignant distal common bile duct obstruction (AIMS): study protocol for a multicenter randomized controlled trial. ( Choi, JH; Choi, YH; Kim, YT; Lee, KJ; Lee, SH; Paik, WH; Ryu, JK; Shin, BS; You, MS, 2020) |
| "The authors previously reported that perioperative aspirin and/or clonidine does not prevent a composite of death or myocardial infarction 30 days after noncardiac surgery." | 5.34 | One-year Results of a Factorial Randomized Trial of Aspirin versus Placebo and Clonidine versus Placebo in Patients Having Noncardiac Surgery. ( Amir, M; Balasubramanian, K; Berwanger, O; Biccard, BM; Chan, MTV; Conen, D; Devereaux, PJ; Fleischmann, E; Forget, P; Gilron, I; Graham, M; Guyatt, G; Kumar, PA; Kurz, A; Lamy, A; Landoni, G; Leslie, K; Malaga, G; Manach, YL; Meyhoff, CS; Mrkobrada, M; Paniagua, P; Parlow, JL; Pettit, S; Popova, E; Sessler, DI; Sigamani, A; Srinathan, S; Torres, D; Turan, A; Villar, JC; Wang, CY; Whitlock, R; Xavier, D; Yusuf, S, 2020) |
| "Compared with ticagrelor plus aspirin, the effect of ticagrelor monotherapy in reducing the risk of clinically relevant bleeding without any increase in ischemic events was consistent among patients with or without DM undergoing PCI." | 5.34 | Ticagrelor With or Without Aspirin in High-Risk Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention. ( Angiolillo, DJ; Baber, U; Briguori, C; Chandiramani, R; Cohen, DJ; Collier, T; Dangas, G; Dudek, D; Escaned, J; Gibson, CM; Huber, K; Kaul, U; Kornowski, R; Kunadian, V; Mehran, R; Mehta, SR; Oldroyd, KG; Pocock, S; Sardella, G; Sartori, S; Sharma, S; Shlofmitz, RA; Weisz, G; Witzenbichler, B; Ya-Ling, H, 2020) |
| " Compared to ticagrelor plus aspirin, ticagrelor plus placebo resulted in significantly lower rates of Bleeding Academic Research Consortium (BARC) type 2, 3, or 5 bleeding (4." | 5.34 | Ticagrelor With or Without Aspirin After Complex PCI. ( Angiolillo, DJ; Baber, U; Briguori, C; Chandiramani, R; Cohen, DJ; Collier, T; Dangas, G; Dudek, D; Escaned, J; Gibson, CM; Giustino, G; Huber, K; Kaul, U; Kornowski, R; Kunadian, V; Mehran, R; Mehta, S; Oldroyd, K; Pocock, S; Sardella, G; Sartori, S; Sharma, S; Shlofmitz, R; Witzenbichler, B; Ya-Ling, H, 2020) |
| "However, systemic study of thrombus formation in vein grafts is still lacking, and few effective techniques are available to prevent this event." | 5.32 | Thrombosis and neointima formation in vein grafts are inhibited by locally applied aspirin through endothelial protection. ( Hu, Y; Mayr, U; Thompson, WD; Torsney, E; Xu, Q; Zou, Y, 2004) |
| "Aspirin was not administered to the remaining 175 patients." | 5.30 | Low-dose aspirin therapy is associated with few side effects but does not prevent hepatic artery thrombosis in liver transplant recipients. ( Birnbaum, A; Boccagni, P; Bodenheimer, HC; Chodoff, L; Freni, MA; Miller, CM; Mor, E; Schwartz, ME; Wolf, DC, 1997) |
| "Aspirin (650 mg) was given the night prior to surgery and continued at that dose twice per day." | 5.28 | Aspirin prophylaxis and surveillance of pulmonary embolism and deep vein thrombosis in total hip arthroplasty. ( Jones, K; Lachiewicz, PF; McCardel, BR, 1990) |
| "Clinical trials and meta-analyses have suggested that aspirin may be effective for the prevention of venous thromboembolism (proximal deep-vein thrombosis or pulmonary embolism) after total hip or total knee arthroplasty, but comparisons with direct oral anticoagulants are lacking for prophylaxis beyond hospital discharge." | 5.27 | Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthroplasty. ( Abianui, A; Anderson, DR; Andreou, P; Belzile, E; Bohm, E; Carrier, M; Coyle, D; Crowther, M; Dolan, S; Doucette, S; Dunbar, M; Fisher, W; Forsythe, M; Gofton, W; Gross, P; Kahn, SR; Kim, P; Kovacs, MJ; MacDonald, SJ; Murnaghan, J; Pelet, S; Pleasance, S; Rodger, MA; Theriault, C; Vendittoli, PA; Wells, PS; Zukor, D, 2018) |
| "Aspirin was administered in the recovery room and continued 600 mg twice a day until discharge." | 5.27 | Activity, air boots, and aspirin as thromboembolism prophylaxis in knee arthroplasty. A multiple regimen approach. ( Clayton, ML; Thompson, TR, 1987) |
| "Tranexamic acid reduces the risk of bleeding among patients undergoing cardiac surgery, but it is unclear whether this leads to improved outcomes." | 5.24 | Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery. ( Bussières, JS; Byrne, K; Chan, MT; Cooper, DJ; Forbes, A; Jayarajah, M; Landoni, G; Marasco, S; McGuinness, S; McNeil, J; Myles, PS; Painter, T; Silbert, B; Smith, JA; Wallace, S, 2017) |
| "Our results suggest that aspirin might be equally effective as warfarin in preventing thromboembolic events after BAVR, but with less major bleedings." | 5.24 | Antithrombotic therapy after bioprosthetic aortic valve implantation: Warfarin versus aspirin, a randomized controlled trial. ( Køber, L; Lilleør, NB; Lund, JT; Møller, CH; Olsen, PS; Rafiq, S; Steinbrüchel, DA; Thiis, JJ, 2017) |
| "In the PRODIGY trial, prolonging clopidogrel-based DAPT beyond six months in elderly patients increased the risk of bleeding, without affording a significant prevention of ischaemic events." | 5.24 | Ischaemic and bleeding outcomes in elderly patients undergoing a prolonged versus shortened duration of dual antiplatelet therapy after percutaneous coronary intervention: insights from the PRODIGY randomised trial. ( Ariotti, S; Franzone, A; Gargiulo, G; Heg, D; Magnani, G; Marino, M; Piccolo, R; Santucci, A; Tebaldi, M; Valgimigli, M; Windecker, S, 2017) |
| " Whether aspirin may reduce the risk for CVD, death, and kidney failure outcomes is uncertain." | 5.22 | Aspirin Use and Incident Cardiovascular Disease, Kidney Failure, and Death in Stable Kidney Transplant Recipients: A Post Hoc Analysis of the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial. ( Bostom, A; Carpenter, M; Dad, T; Hunsicker, L; Joseph, A; Kusek, JW; Levey, AS; Pfeffer, M; Tighiouart, H; Weiner, DE, 2016) |
| "ᅟ: We investigated the occurrence of bleeding complications in patients who underwent skin tumor surgery and compared it between Aspirin users and a placebo control group." | 5.22 | Aspirin use and bleeding volume in skin cancer patients undergoing surgery: a randomized controlled trial. ( Atri, A; Engheta, A; Hadadi Abianeh, S; Sanatkarfar, M, 2016) |
| "Rates of bleeding and thrombotic events were not significantly different according to 6- versus 24-month DAPT after PCI with new-generation DES in good aspirin responders." | 5.20 | 6- versus 24-month dual antiplatelet therapy after implantation of drug-eluting stents in patients nonresistant to aspirin: the randomized, multicenter ITALIC trial. ( Armengaud, J; Barragan, P; Benamer, H; Berland, J; Blanchard, D; Boschat, J; Bressolette, E; Carrie, D; Cassat, C; Castellant, P; Cazaux, P; Champagnac, D; Darremont, O; Dauphin, R; Delarche, N; Druelles, P; Dupouy, P; Endresen, K; Furber, A; Gilard, M; Gommeaux, A; Hovasse, T; Jouve, B; Kermarrec, A; Kiss, RG; Le Breton, H; Levy, G; Lyuycx-Bore, A; Maillard, L; Majwal, T; Morice, MC; Noor, HA; Noryani, AAL; Ohlmann, P; Ormezzano, O; Paganelli, F; Sainsous, J; Schneeberger, M; Ungi, I; Wojcik, J, 2015) |
| " Between 12 and 30 months, continued thienopyridine reduced stent thrombosis compared with placebo in patients with and without MI at presentation (MI group, 0." | 5.20 | Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI in Patients With and Without Acute Myocardial Infarction. ( Cohen, DJ; Cutlip, DE; Gershlick, AH; Iancu, AC; Jacobs, A; Kereiakes, DJ; Massaro, JM; Mauri, L; Rinaldi, MJ; Steg, PG; Tanguay, JF; Windecker, S; Wiviott, SD; Yeh, RW, 2015) |
| "There is insufficient data on the efficacy of prasugrel and ticagrelor in Korean patients with ST-segment elevation myocardial infarction (STEMI)." | 5.20 | Comparison of Prasugrel and Ticagrelor Antiplatelet Effects in Korean Patients Presenting With ST-Segment Elevation Myocardial Infarction. ( Cho, YR; Guo, LZ; Jin, CD; Kim, MH; Kim, YD; Lee, YS; Park, JS; Park, K; Park, TH, 2015) |
| "Prior aspirin treatment is considered a risk factor for adverse outcomes in acute coronary syndrome (ACS) patients." | 5.20 | Effect of Prior Aspirin Treatment on Patients With Acute Coronary Syndromes: Insights From the PROSPECT Study. ( Brener, SJ; de Bruyne, B; Maehara, A; Mintz, GS; Serruys, PW; Stone, GW; Weisz, G, 2015) |
| "Administration of aspirin before surgery and throughout the early postsurgical period had no significant effect on the rate of a composite of death or nonfatal myocardial infarction but increased the risk of major bleeding." | 5.19 | Aspirin in patients undergoing noncardiac surgery. ( Alonso-Coello, P; Amir, M; Baigent, C; Berwanger, O; Biccard, BM; Botto, F; Chan, MT; Chow, C; Chrolavicius, S; Cook, D; Devereaux, PJ; Eikelboom, J; Fleischmann, E; Forget, P; Gao, P; Garg, AX; Graham, M; Guyatt, G; Kearon, C; Kumar, PA; Kurz, A; Lamy, A; Le Manach, Y; Leslie, K; Lurati Buse, G; Malaga, G; Meyhoff, CS; Mizera, R; Mrkobrada, M; Paniagua, P; Parlow, JL; Pasin, L; Pettit, S; Pogue, J; Robinson, A; Rodseth, RN; Sessler, DI; Sigamani, A; Srinathan, S; Tiboni, M; Torres, D; VanHelder, T; Villar, JC; Wang, CY; Whitlock, R; Xavier, D; Yusuf, S, 2014) |
| "To determine whether aspirin compared with placebo, and clonidine compared with placebo, alters the risk of perioperative acute kidney injury." | 5.19 | Perioperative aspirin and clonidine and risk of acute kidney injury: a randomized clinical trial. ( Acedillo, R; Amir, M; Bergese, S; Biccard, B; Bidgoli, SJ; Cata, JP; Cegarra, V; Chan, MT; Chan, V; Clanchet, Mde N; Cuerden, M; Devereaux, PJ; Dresser, G; Fleischmann, E; Font, A; Forget, P; Garg, AX; Gomez, MF; Jones, PM; Kumar, P; Kurz, A; Leslie, K; Malaga, G; Martinsen, K; Mehra, B; Meyhoff, CS; Mizera, R; Mrkobrada, M; Myles, P; Painter, T; Parikh, CR; Parlow, J; Pasin, L; Robinson, A; Roshanov, PS; Sessler, DI; Srinathan, S; Tiboni, M; Torres, D; VanHelder, T; Villar, JC; Walsh, M; Whitlock, R; Wijeysundera, DN; Yusuf, S, 2014) |
| "The safety and efficacy of combined low dose aspirin and warfarin therapy in patients with atrial fibrillation after mechanical heart valve replacement were evaluated." | 5.19 | Combined low-dose aspirin and warfarin anticoagulant therapy of postoperative atrial fibrillation following mechanical heart valve replacement. ( Dong, MF; Ma, SJ; Ma, ZS; Song, GM; Wang, JT, 2014) |
| "More favorable thromboprophylaxis strategies are needed in light of the difficulties in controlling warfarin therapy and the high prevalence of thrombosis in this population." | 5.17 | Factors associated with thrombotic complications after the Fontan procedure: a secondary analysis of a multicenter, randomized trial of primary thromboprophylaxis for 2 years after the Fontan procedure. ( Andrew, M; Cochrane, A; Hughes, M; Manlhiot, C; McCrindle, BW; Monagle, P; Roberts, R; Szechtman, B; Weintraub, R, 2013) |
| "The study reports higher risks of venous thromboembolism, pulmonary embolism, and overall mortality for the patients receiving aspirin before undergoing." | 5.12 | Comparison between use of direct oral anticoagulants and aspirin for risk of thromboembolism complications in patients undergoing total knee and hip arthroplasty: a systematic review and meta-analysis. ( Cai, JY; Cao, YQ; Cui, CM; Min, JK; Zhang, LY, 2021) |
| "To evaluates the efficacy and safety of rivaroxaban versus aspirin in prevention of venous thromboembolism (VTE) following total hip (THA) or knee arthroplasty (TKA) or hip fracture surgery." | 5.12 | Rivaroxaban versus aspirin in prevention of venous thromboembolism following total joint arthroplasty or hip fracture surgery: a meta-analysis. ( Dai, Z; Hu, B; Hu, M; Jiang, L; Tang, H; Yu, J, 2021) |
| "In this analysis, we aimed to compare the efficacy and safety of dual therapy (DT) with a non-vitamin K oral anticoagulant (NOAC) and an adenosine diphosphate receptor antagonist (P2Y12 inhibitor) vs triple therapy (TT) with aspirin, a P2Y12 inhibitor and a vitamin K antagonist for the treatment of diabetes mellitus (DM) patients with co-existing atrial fibrillation (AF) following percutaneous coronary intervention (PCI)." | 5.12 | Dual therapy with an oral non-vitamin K antagonist and a P2Y12 inhibitor vs triple therapy with aspirin, a P2Y12 inhibitor and a vitamin K antagonist for the treatment of diabetes mellitus patients with co-existing atrial fibrillation following percutaneo ( Wang, Q; Yang, K, 2021) |
| "Five previously suspected risk factors (valve surgery, prior protamine exposure, history of pulmonary hypertension, fish allergy, and vasectomy), aspirin ingestion within 7 days of surgery, and demographic information were recorded." | 5.10 | Effect of site of venous protamine administration, previously alleged risk factors, and preoperative use of aspirin on acute protamine-induced pulmonary vasoconstriction. ( Comunale, ME; Haering, JM; Lowenstein, E; Mashikian, JS; Maslow, A; Robertson, LK, 2003) |
| "We studied stent thrombosis in 4,607 patients with acute coronary syndromes who received a coronary stent as part of routine care during 2 trials of aspirin versus sibrafiban for secondary prevention." | 5.10 | Frequency of stent thrombosis after acute coronary syndromes (from the SYMPHONY and 2nd SYMPHONY trials). ( Berger, PB; Bhapkar, MV; Califf, RM; Harrington, RA; Moliterno, DJ; Newby, LK; Ohman, EM; Tolleson, TR; Topol, EJ; Van de Werf, F; Verheugt, FW; White, HD, 2003) |
| " Furthermore, the simpler dosing regimen, the absence of neutropenia, and the lower frequency of other side effects make it a safe alternative to ticlopidine." | 5.09 | Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin in preventing stent thrombosis after coronary stent implantation. ( Collins, M; Colombo, A; Iyer, S; Kreps, E; Maida, R; Moses, JW; Moussa, I; Oetgen, M; Roubin, G; Wang, X, 1999) |
| "A multicenter randomized clinical trial designed to assess the effect of photocoagulation and aspirin in patients with mild to severe nonproliferative or early proliferative diabetic retinopathy and/or macular edema." | 5.09 | Results after lens extraction in patients with diabetic retinopathy: early treatment diabetic retinopathy study report number 25. ( Benson, WE; Burton, TC; Chew, EY; Csaky, K; Ferris, FL; Lindley, AA; Remaley, NA; Williams, GA, 1999) |
| "Among the patients with hip fracture, allocation to aspirin produced proportional reductions in pulmonary embolism of 43% (95% CI 18-60; p=0." | 5.09 | Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. ( , 2000) |
| "The study objective was to determine the relative efficacy and safety of a low-molecular-weight heparinoid (Orgaran) compared with aspirin for the prevention of postoperative venous thromboembolism in patients undergoing surgery for fractured hips." | 5.08 | Low-molecular-weight heparinoid orgaran is more effective than aspirin in the prevention of venous thromboembolism after surgery for hip fracture. ( Geerts, WH; Gent, M; Ginsberg, JS; Hirsh, J; Jay, RM; Leclerc, J; Levine, MN; Neemeh, JA; Powers, PJ; Turpie, AG, 1996) |
| "Previous studies have shown that stents can be inserted in coronary arteries of patients who are subsequently treated safely with antiplatelet therapy only (ticlopidine and/or aspirin) with a low incidence of stent thrombosis, provided that stent expansion is adequate and there are no other flow-limiting lesions present." | 5.08 | Results of a consecutive series of patients receiving only antiplatelet therapy after optimized stent implantation. Comparison of aspirin alone versus combined ticlopidine and aspirin therapy. ( Albiero, R; Blengino, S; Colombo, A; Ferraro, M; Hall, P; Itoh, A; Martini, G; Nakamura, S, 1997) |
| "Perioperative anticoagulation therapy with heparin increases the incidence rate of wound hematomas, but long-term anticoagulation therapy with warfarin improves the patency rate of autogenous vein infrainguinal bypass grafts and the limb salvage rate for patients at high risk for graft failure." | 5.08 | Warfarin improves the outcome of infrainguinal vein bypass grafting at high risk for failure. ( Back, MR; Carlton, LM; Flynn, TC; Huber, TS; Ozaki, CK; Sarac, TP; Seeger, JM, 1998) |
| "Patients with heart disease are frequently maintained on a regimen of aspirin because of its ability to decrease thrombotic complications and reduce the prevalence of unstable angina and myocardial infarction." | 5.07 | Aprotinin significantly decreases bleeding and transfusion requirements in patients receiving aspirin and undergoing cardiac operations. ( Guiraudon, GM; Lux, J; McKenzie, FN; Menkis, AH; Murkin, JM; Novick, RJ; Shannon, NA, 1994) |
| "It has been suggested that desmopressin acetate has been effective in reducing hemorrhage after coronary artery bypass grafting in patients receiving aspirin before operation." | 5.07 | The effect of desmopressin acetate on postoperative hemorrhage in patients receiving aspirin therapy before coronary artery bypass operations. ( Ablaza, SG; Afshar, M; DeCastro, N; Gratz, I; Koehler, J; Larijani, GE; Olsen, D; Spagna, PM, 1992) |
| "We undertook a randomized controlled trial designed to compare the effects of carotid endarterectomy with medical treatment using low-dose aspirin in patients with asymptomatic carotid stenosis." | 5.07 | Results of a randomized controlled trial of carotid endarterectomy for asymptomatic carotid stenosis. Mayo Asymptomatic Carotid Endarterectomy Study Group. ( , 1992) |
| " The computer-based searches combined terms and combinations of keywords related to the population (eg, hip replacement, knee replacement, hip arthroplasty, and knee arthroplasty), drug intervention (eg, aspirin, heparin, clexane, dabigatran, rivaroxaban, and warfarin), and outcome (eg, venous thromboembolism, deep vein thrombosis, pulmonary embolism, and bleeding) in humans." | 5.05 | Clinical Effectiveness and Safety of Aspirin for Venous Thromboembolism Prophylaxis After Total Hip and Knee Replacement: A Systematic Review and Meta-analysis of Randomized Clinical Trials. ( Blom, AW; Judge, A; Kunutsor, SK; Matharu, GS; Whitehouse, MR, 2020) |
| "The safety and effectiveness of dual therapy (direct oral anticoagulant [DOAC] plus P2Y12 inhibitor) versus triple therapy (vitamin K antagonist plus aspirin and P2Y12 inhibitor) in patients with nonvalvular atrial fibrillation (AF) after percutaneous coronary intervention (PCI) is unclear." | 5.05 | Dual Versus Triple Therapy for Atrial Fibrillation After Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis. ( Al-Abdouh, A; Hasan, RK; Khan, MS; Khan, MU; Khan, SU; Mamas, MA; Michos, ED; Osman, M; Savji, N; Zhao, D, 2020) |
| "In a prospective, randomized, parallel study, two regimens of platelet-suppressant therapy (PST)--dipyridamole-aspirin and pentoxifylline-aspirin--were compared with standard oral anticoagulation with warfarin in the prevention of prosthetic heart valve thromboembolism." | 5.05 | Warfarin versus dipyridamole-aspirin and pentoxifylline-aspirin for the prevention of prosthetic heart valve thromboembolism: a prospective randomized clinical trial. ( Boey, J; Chan, TK; Cheung, KL; Chow, J; Lee, PK; Mok, CK; Ng, RP; Tse, TF; Wang, R, 1985) |
| " The cluster ranking of major outcomes indicated that FXI-ASO, ardeparin, aspirin, and apixaban were ideal for preventing all-cause VTE and avoiding all bleeding events." | 4.95 | Effectiveness and Tolerability of Anticoagulants for Thromboprophylaxis after Major Joint Surgery: a Network Meta-Analysis. ( Chen, X; Jin, Y; Wang, Z; Xiang, Y; Zhao, Y; Zheng, J, 2017) |
| " The question addressed was whether continuation of administration of preoperative aspirin until the day of coronary artery bypass grafting (CABG) could minimize postoperative mortality, prevalence of postoperative myocardial infarction (MI) with or without influence on postoperative bleeding, packed red blood cell (PRBC) transfusion and reoperation for bleeding." | 4.95 | What is the impact of preoperative aspirin administration on patients undergoing coronary artery bypass grafting? ( Aboul-Hassan, SS; Cichon, R; Marczak, J; Stankowski, T, 2017) |
| "In patients with acute coronary syndromes undergoing percutaneous coronary intervention, the combination of aspirin and clopidogrel, a P2Y12 adenosine diphosphate (ADP) receptor antagonist, is the gold standard of antiplatelet therapy." | 4.88 | Latest evidence in personalized antiplatelet therapy in patients with acute coronary syndromes undergoing percutaneous coronary intervention. ( Bessereau, J; Bonello, L; Camoin-Jau, L; Paganelli, F; Uhry, S, 2012) |
| "Dual antiplatelet therapy with acetylsalicylic acid (aspirin) and clopidogrel is a guideline-recommended standard of care for patients with acute coronary syndromes (ACS) and those who undergo percutaneous coronary intervention (PCI)." | 4.88 | Clopidogrel: the data, the experience, and the controversies. ( Sadanandan, S; Singh, IM, 2012) |
| " However, recently there has been some progress in elucidating the etiology of nasal polyposis, especially regarding tissue eosinophilia as well as the role of aspirin intolerance and eicosanoid mediators." | 4.82 | Current concepts in therapy of chronic rhinosinusitis and nasal polyposis. ( Gosepath, J; Mann, WJ, 2005) |
| "Randomized trials of aspirin have been conducted in three main populations: patients with evolving acute myocardial infarction (MI), patients with a history of cardiovascular disease and apparently healthy subjects." | 4.80 | Aspirin in the treatment and prevention of cardiovascular disease. ( Buring, JE; Gaziano, JM; Skerrett, PJ, 2000) |
| "The following criteria were used to select studies for inclusion: study design--randomized clinical trial; study population--patients undergoing elective total hip replacement; interventions--aspirin, warfarin, dextran, heparin, low-molecular-weight heparin, compression stockings; and outcomes--venous thromboembolism, major hemorrhage." | 4.79 | A meta-analysis of methods to prevent venous thromboembolism following total hip replacement. ( Imperiale, TF; Speroff, T, 1994) |
| " The recent clinical reports suggest that there is a narrower window of safety with recombinant hirudin than initially thought particularly when it is used in conjunction with thrombolytic agents and aspirin in acute myocardial infarction." | 4.79 | Advances in antithrombotic therapy: novel agents. ( Hirsh, J; Turpie, AG; Weitz, JI, 1995) |
| "While aspirin is acceptable for venous thromboembolism (VTE) prophylaxis following total joint arthroplasty in most patients, more potent agents are used in patients considered higher risk for VTE." | 4.31 | Comparison of 90-Day Adverse Events Associated With Aspirin and Potent Anticoagulation Use for Venous Thromboembolism Prophylaxis: A Cohort Study of 72,288 Total Knee and 35,142 Total Hip Arthroplasty Patients. ( Kroger, EW; Prentice, HA; Singh, G; Winston, BA, 2023) |
| "Our study is based on the largest open-access all-payer inpatient database, revealing a noteworthy finding of aspirin's protective and adverse impact on different postoperative complications in the US population, such as acute cardiovascular disease, and stroke, etc." | 4.31 | The impact of long-term aspirin use on the patients undergoing shoulder arthroplasty. ( Cui, Y; Li, X; Liang, C; Liang, F; Mao, X; Shi, D; Xie, H; Yang, Q, 2023) |
| "Patient-reported allergies to aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) may preclude certain patients from receiving aspirin as venous thromboembolism (VTE) prophylaxis after total joint arthroplasty (TJA)." | 4.12 | Patients Who Do Not Receive Aspirin Because of Allergy Have an Increased Risk of Venous Thromboembolism Following Total Joint Arthroplasty. ( Goh, GS; Kozaily, E; Parvizi, J; Tan, TL, 2022) |
| " Therefore, we investigated the risk of discontinuing aspirin concerning thrombotic complications in laparoscopic colorectal cancer surgery." | 4.12 | Impact of aspirin discontinuation on thrombotic complications in laparoscopic colorectal cancer surgery. ( Dono, K; Hamabe, A; Harino, T; Noura, S; Ogino, T; Suzuki, Y; Takeyama, H; Tanida, T; Tomita, N, 2022) |
| "In recent years, aspirin has become a popular agent for venous thromboembolism (VTE) prophylaxis following total joint arthroplasty (TJA)." | 4.12 | Aspirin May Be a Suitable Prophylaxis for Patients with a History of Venous Thromboembolism Undergoing Total Joint Arthroplasty. ( Ledesma, J; Ludwick, L; Paladino, J; Parvizi, J; Shohat, N; Van Nest, D, 2022) |
| " To investigate the safety of aspirin continuation, patients who continued taking aspirin perioperatively (Group C) were matched to other patients (Group O), using a propensity score, and bleeding outcomes were compared." | 4.02 | Continuation of aspirin perioperatively for lung resection: a propensity matched analysis. ( Aokage, K; Katsumata, S; Miyoshi, T; Sakai, T; Tane, K; Tsuboi, M, 2021) |
| "To evaluate whether a daily full-dose aspirin regimen after anterior cruciate ligament (ACL) reconstruction reduces the risk of postoperative symptomatic deep-venous thrombosis (DVT)." | 4.02 | Aspirin for Deep-Venous Thrombosis Prophylaxis After Anterior Cruciate Ligament Reconstruction. ( Bernstein, EM; Briggs, AM; Ferris, WJ; Hurvitz, AP; McDonald, LS; McIntire, SC; Renninger, CH; Tompane, TM, 2021) |
| " Bleeding (n = 100) and quality of life (n = 90) were assessed using validated questionnaires: Warfarin and Aspirin Bleeding assessment tool and Pediatric Quality of Life Inventory, respectively." | 4.02 | Long-term outcomes of warfarin versus aspirin after Fontan surgery. ( Attard, C; Briody, J; Cordina, R; d'Udekem, Y; Hassan, EB; Ignjatovic, V; Mackay, MT; Monagle, PT; Rice, K; Simm, P, 2021) |
| " The purpose of this study is to evaluate a weight-based aspirin dosing regimen for prevention of venous thromboembolism (VTE) following TJA." | 4.02 | Weight-Based Aspirin Dosing May Further Reduce the Incidence of Venous Thromboembolism Following Primary Total Joint Arthroplasty. ( Brown, TS; Gulbrandsen, TR; Halbur, CR; Noiseux, NO; West, CR, 2021) |
| " Additionally, he had undergone an aortic root dilatation and aortic valve replacement at the age of 10 because of progression of aortic and supra-aortic stenosis and had received chronic anticoagulation and antiplatelet therapy with warfarin and aspirin, respectively." | 4.02 | Spontaneous Spinal Epidural Hematoma in an Adult Patient with Complex Congenital Heart Disease. ( Ifuku, T; Nishiguchi, T, 2021) |
| "Based on this single institutional study, addressing preoperative anemia and considering the implementation of aspirin for venous thromboembolism prophylaxis may be 2 targets to potentially reduce readmission after aseptic revision TJA." | 3.96 | Highlighting the Roles of Anemia and Aspirin in Predicting Ninety-Day Readmission Following Aseptic Revision Total Joint Arthroplasty. ( Foltz, C; Klement, MR; Li, WT; Parvizi, J; Sinensky, A; Yazdi, H, 2020) |
| "To test the hypothesis that preoperative aspirin administered within 24 hours before coronary artery bypass grafting (CABG) could reduce the incidence of postoperative acute kidney injury (AKI) following CABG." | 3.96 | Association between preoperative aspirin and acute kidney injury following coronary artery bypass grafting. ( Aboul-Hassan, SS; Cichon, R; Marczak, J; Nawotka, M; Peksa, M; Stanislawski, R; Stankowski, T, 2020) |
| " Nevertheless, external validation of these RSs it has not yet been performed in ACS (acute coronary syndrome) patients treated with prasugrel or ticagrelor in a real- world scenario." | 3.96 | Comparative external validation of the PRECISE-DAPT and PARIS risk scores in 4424 acute coronary syndrome patients treated with prasugrel or ticagrelor. ( Alexopoulos, D; Ariza-Solé, A; Assi, EA; Autelli, M; Bernardi, A; Bianco, M; Blanco, PF; Boccuzzi, G; Cequier, A; Cerrato, E; D'ascenzo, F; Destefanis, P; Dominguez-Rodriguez, A; Durante, A; Fernández, MC; Gallo, D; Garay, A; Gili, S; Giustetto, C; Gravinese, C; Grosso, A; Iñiguez-Romo, A; Kinnaird, T; Lopez-Cuenca, Á; Luciano, A; Magnani, G; Manzano-Fernández, S; Montabone, A; Morbiducci, U; Omedè, P; Paz, RC; Peyracchia, M; Pousa, IM; Pozzi, R; Quadri, G; Queija, BC; Raposeiras Roubin, S; Rinaldi, M; Rognoni, A; Rossini, R; Srdanovic, I; Taha, S; Templin, C; Valgimigli, M; Varbella, F; Velicki, L; Xanthopoulou, I, 2020) |
| "We therefore examined the rate of all perioperative hemorrhages and separately the rate of only severe bleedings during vitrectomy, scleral buckling with or without drainage of subretinal fluid (SRD), or combined procedures due to retinal detachment in patients undergoing different types of perioperative anticoagulation including acetylsalicylic acetate (ASA), clopidogrel, heparin, low molecular weight heparin, and phenprocoumon." | 3.96 | Risk of perioperative bleeding complications in rhegmatogenous retinal detachment surgery: a retrospective single-center study. ( Affeldt, J; Bemme, S; Bertelmann, T; Callizo, J; Feltgen, N; Hoerauf, H; Khattab, MH; Lauermann, P; Pfeiffer, S; Striebe, NA, 2020) |
| "To evaluate the safety of phacoemulsification cataract surgery in the patients undergoing dual antiplatelet therapy with aspirin and clopidogrel." | 3.96 | Combined aspirin and clopidogrel therapy in phacoemulsification cataract surgery: a risk factor for ocular hemorrhage? ( Jiang, J; Li, Q; Qian, Y; Shen, X; Su, T; Wang, S; Wang, Z; Yan, K; Zhang, P; Zhang, Y, 2020) |
| " The aim of this study is to identify the rates of PWD among THA and TKA patients who received aspirin (ASA) or Coumadin for postoperative venous thromboembolism (VTE) prophylaxis." | 3.96 | Persistent Wound Drainage among Total Joint Arthroplasty Patients Receiving Aspirin vs Coumadin. ( Oliashirazi, A; Saleh, U; Shahi, A; Singh, V; Tarabichi, S, 2020) |
| "To determine using a simplified risk-stratified protocol to select candidates for aspirin therapy have similar death and postoperative complications as universal warfarin therapy in patients undergoing total joint replacement (TJR)." | 3.96 | Evaluation of a Simplified Risk Stratification Twice-Daily Aspirin Protocol for Venous Thromboembolism Prophylaxis After Total Joint Replacement. ( Adams, W; Davis, ES; Ng, C; Pinzur, MS; Zavala, S, 2020) |
| " Aspirin has been considered a safe and cost-effective prophylaxis for venous thromboembolism (VTE), and there have been some reports about the incidence of PTE (0%-0." | 3.96 | Clinical efficacy of risk-stratified prophylaxis with low-dose aspirin for the management of symptomatic venous thromboembolism after total hip arthroplasty. ( Hirakawa, K; Mihara, M; Nakura, N; Ochiai, S; Saito, A; Takayanagi, S; Tamaki, Y, 2020) |
| " For patients with MINS who are not at high risk of bleeding, physicians should consider initiating dabigatran 110 mg twice daily and low-dose aspirin." | 3.96 | Myocardial injury after non-cardiac surgery: diagnosis and management. ( Devereaux, PJ; Szczeklik, W, 2020) |
| "Although several studies now support the use of aspirin for venous thromboembolism (VTE) prophylaxis in primary total hip arthroplasty (THA) and total knee arthroplasty (TKA), the optimal chemoprophylactic agent in revision THA and TKA is not clear." | 3.91 | Anticoagulation in Revision Total Joint Arthroplasty: A Retrospective Review of 1917 Cases. ( Batko, BD; Courtney, PM; Edmiston, TA; Hannon, CP; Levine, BR; Manista, GC; Sexton, AC, 2019) |
| "To compare the efficacy and safety of aspirin with rivaroxaban following treatment with enoxaparin for prevention of venous thromboembolism (VTE) after hip fracture surgery (HFS)." | 3.91 | Comparison of the Efficacy and Safety of Aspirin and Rivaroxaban Following Enoxaparin Treatment for Prevention of Venous Thromboembolism after Hip Fracture Surgery. ( Huang, Q; Shen, B; Si, HB; Xing, SX; Zeng, Y; Zhou, ZK, 2019) |
| "The use of aspirin as prophylaxis against venous thromboembolism (VTE) following total joint arthroplasty (TJA) has increased in popularity; however, the potential cardioprotective effects of aspirin when administered as VTE prophylaxis remain unknown." | 3.91 | The Use of Aspirin for Prophylaxis Against Venous Thromboembolism Decreases Mortality Following Primary Total Joint Arthroplasty. ( Goswami, K; Huang, RC; Parvizi, J; Rondon, AJ; Shohat, N; Tan, TL, 2019) |
| "Aspirin prophylaxis demonstrated a lower rate of deep vein thrombosis, pulmonary embolism, and venous thromboembolism than warfarin and low-molecular-weight heparin alone throughout all risk scores." | 3.91 | Potent Anticoagulation Does Not Reduce Venous Thromboembolism in High-Risk Patients. ( Chen, AF; Foltz, C; Hansen, EN; Higuera, C; Huang, R; Parvizi, J; Sing, DC; Siqueira, M; Tan, TL, 2019) |
| "The risks of venous thromboembolism (VTE) and bleeding with direct oral anticoagulants (DOACs) and aspirin for thromboprophylaxis after orthopedic surgery were studied." | 3.91 | Direct oral anticoagulants versus aspirin for venous thromboembolism prophylaxis after orthopedic surgery. ( Muntz, J; Murillo, M; Putney, D; Vadhariya, A; Wilson, A; Yang, T, 2019) |
| "We investigated whether the use of aspirin (irreversible COX1 inhibitor) in the preoperative period may prevent non-valvular atrial fibrillation, which is the most common rhythm problem in the postoperative period." | 3.91 | The Effect of Aspirin as an Irreversible COX1 Inhibitor in Preventing Non-Valvular Atrial Fibrillation After Coronary Bypass Surgery. ( Ates, A; Erkut, B, 2019) |
| " There was no difference in hematoma formation (aspirin, 1." | 3.91 | The Perioperative Continuation of Aspirin in Patients Undergoing Arthroscopic Surgery of the Knee. ( Bogunovic, L; Brophy, RH; Haas, AK; Matava, MJ; Smith, MV; Wright, RW, 2019) |
| "Although guidelines now allow the use of aspirin as an alternative to anticoagulants for venous thromboembolism prophylaxis after knee or hip arthroplasty, there is limited data on contemporary use and outcomes with aspirin." | 3.91 | Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study. ( Auerbach, AD; Baumgartner, C; Fang, MC; Maselli, J, 2019) |
| "The aims of this study were to compare the efficacy of two agents, aspirin and warfarin, for the prevention of venous thromboembolism (VTE) after simultaneous bilateral total knee arthroplasty (SBTKA), and to elucidate the risk of VTE conferred by this procedure compared with unilateral TKA (UTKA)." | 3.88 | Venous thromboembolic prophylaxis after simultaneous bilateral total knee arthroplasty: aspirin ( Fleischman, AN; Goel, R; Higuera, C; Huang, R; Parvizi, J; Rothman, RH; Sterbis, E; Tan, T, 2018) |
| "Aspirin is an effective prophylaxis for venous thromboembolism (VTE) after total knee arthroplasty (TKA)." | 3.88 | Low-Dose Aspirin Is Safe and Effective for Venous Thromboembolism Prophylaxis Following Total Knee Arthroplasty. ( Barsoum, WK; Brigati, DP; Faour, M; Higuera, CA; Klika, AK; Mont, MA; Piuzzi, NS, 2018) |
| "AC and/or AP therapy with clopidogrel appears to increase the risk for hematoma following S-ICD implantation." | 3.88 | Perioperative hematoma with subcutaneous ICD implantation: Impact of anticoagulation and antiplatelet therapies. ( Atkins, D; Berenbom, LD; Cunnane, R; Dendi, R; Emert, MP; Lakkireddy, DR; Lavu, M; Parikh, V; Pimentel, R; Reddy, YM; Sheldon, SH, 2018) |
| "Recent guidelines include aspirin as an option to prevent venous thromboembolism (VTE) in selected patients undergoing hip or knee replacement surgery." | 3.85 | The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty. ( Auerbach, AD; Chu, JN; Fang, MC; Maselli, J, 2017) |
| "Suboptimal platelet response to aspirin was detected in 64 of 430 patients (15%) and thrombosis was detected in 11 patients (2." | 3.85 | Platelet testing to guide aspirin dose adjustment in pediatric patients after cardiac surgery. ( DiNardo, JA; Emani, S; Emani, SM; Mulone, M; Trenor, CC; Zurakowski, D, 2017) |
| "Aspirin is a safe and effective prophylaxis for the prevention of venous thromboembolism following total joint arthroplasty." | 3.85 | Low-Dose Aspirin Is Effective Chemoprophylaxis Against Clinically Important Venous Thromboembolism Following Total Joint Arthroplasty: A Preliminary Analysis. ( Austin, MS; Chen, AF; Hozack, WJ; Huang, R; Lonner, JH; Parvizi, J; Restrepo, C, 2017) |
| " The individual duration of either VKAs (acenocoumarol) or aspirin was determined and related to thrombotic and bleeding events." | 3.83 | Antithrombotic strategy after bioprosthetic aortic valve replacement in patients in sinus rhythm: evaluation of guideline implementation. ( Huisman, MV; Jansen, EK; Keijzers, M; Schotten, J; Umans, VA; van der Wall, SJ; Vonk, AB; Wolterbeek, R, 2016) |
| " She had discontinued Phenprocoumon-treatment in the 5+4 week of pregnancy by herself." | 3.83 | [Mechanic valve prosthesis and pregnancy: Is Phenprocoumon replaceable?]. ( Gawaz, M; Klee, K; Meyer-Zürn, CS, 2016) |
| "We aim to investigate the safety profile of aspirin continuation in the perioperative period in patients undergoing elective primary inguinal hernia repair." | 3.83 | Is preoperative withdrawal of aspirin necessary in patients undergoing elective inguinal hernia repair? ( Lomanto, D; Ong, W; Shen, T; Tan, WB, 2016) |
| " We compared the incidence of fatal pulmonary embolism in patients undergoing elective primary total hip arthroplasty (THA) between those receiving aspirin, warfarin and low molecular weight heparin (LMWH) for the chemical component of a multi-modal thromboprophylaxis regime." | 3.83 | Fatal pulmonary embolism following elective total hip arthroplasty: a 12-year study. ( Bayley, E; Bhamber, NS; Brown, S; Howard, PW, 2016) |
| "To characterize platelet function and responsiveness to aspirin in relation to thrombogenesis, systemic inflammation, and markers of endothelial function in adults with Fontan circulation (FC)." | 3.81 | Aspirin resistance in adult patients after Fontan surgery. ( Chłopicki, S; Komar, M; Musiałek, P; Olszowska, M; Pajak, J; Podolec, J; Podolec, P; Rubis, P; Sitek, B; Tomkiewicz-Pajak, L; Wojcik, T, 2015) |
| "The effects of dual antiplatelet therapy with aspirin and clopidogrel on the progression of native coronary artery disease after coronary artery bypass grafting are unknown." | 3.80 | Impact of clopidogrel plus aspirin versus aspirin alone on the progression of native coronary artery disease after bypass surgery: analysis from the Clopidogrel After Surgery for Coronary Artery DiseasE (CASCADE) randomized trial. ( Al-Atassi, T; Kulik, A; Le May, M; Ruel, M; Une, D; Voisine, P, 2014) |
| "Aspirin resistance is common in the population of patients with hemodynamic cerebral ischemia scheduled for cerebral revascularization." | 3.79 | Aspirin resistance in patients with hemodynamic cerebral ischemia undergoing extracranial-intracranial bypass surgery. ( Horn, P; Jussen, D; Vajkoczy, P, 2013) |
| "We aimed to identify the risk factors for acute kidney injury in infants who have received ketorolac after a cardiac surgical procedure by identifying patients with a > or = 50% increase in serum creatinine from baseline and matching them by age with three controls that had < 50% increase in serum creatinine." | 3.79 | Ketorolac-associated renal morbidity: risk factors in cardiac surgical infants. ( Cabrera, A; Moffett, BS, 2013) |
| " In patients with patent foramen ovale (PFO) and stroke or transient ischemic attack, we recommend initial aspirin therapy (Grade 1B) and suggest substitution of VKA if recurrence (Grade 2C)." | 3.78 | Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. ( Fremes, SE; Rubens, FD; Sun, JC; Teoh, KH; Whitlock, RP, 2012) |
| "Our institution has used a thromboprophylaxis regimen consisting of inpatient enoxaparin and outpatient aspirin for patients at standard risk for venous thrombosis after hip and knee arthroplasty." | 3.78 | Inpatient enoxaparin and outpatient aspirin chemoprophylaxis regimen after primary hip and knee arthroplasty: a preliminary study. ( Anderson, BJ; Bradbury, TL; Erens, GA; Hamilton, SC; Roberson, JR; Whang, WW, 2012) |
| " Deep vein thrombosis prophylaxis consisted of oral enteric-coated aspirin, pneumatic calf compression pumps, and early ambulation in all patients unless medically contraindicated." | 3.77 | Thromboembolic events are uncommon after open treatment of proximal humerus fractures using aspirin and compression devices. ( Abboud, JA; Bassora, R; Warrender, WJ; Widmer, BJ, 2011) |
| "The objectives of this study were to compare the risk of venous thromboembolism (VTE), bleeding, surgical site infection, and mortality in patients receiving aspirin or guideline-approved VTE prophylactic therapies (warfarin, low-molecular-weight heparins, synthetic pentasaccharides) in total knee arthroplasty (TKA)." | 3.76 | Does aspirin have a role in venous thromboembolism prophylaxis in total knee arthroplasty patients? ( Auerbach, AD; Bozic, KJ; Lindenauer, PK; Maselli, JH; Pekow, PS; Vail, TP, 2010) |
| "In patients receiving the HeartMate II LVAD who were directly transitioned to warfarin and aspirin therapy without intravenous heparin there was no short-term increase in risk of thrombotic or thromboembolic events, and bleeding requiring transfusion was significantly reduced." | 3.76 | Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy. ( Aaronson, KD; Boyle, A; Conte, JV; Farrar, DJ; John, R; Naka, Y; Pagani, FD; Russell, SD; Slaughter, MS; Sundareswaran, KS, 2010) |
| "To study the prevention of occlusion of aortocoronary-artery bypass grafts, we conducted a prospective, randomized, double-blind trial comparing long-term administration of dipyridamole (begun 2 days before operation) plus aspirin (begun 7 hr after operation) with placebo in 407 patients." | 3.76 | Role of platelets and platelet inhibitors in aortocoronary artery vein-graft disease. ( Chesebro, JH; Fuster, V, 1986) |
| "The P2Y12 receptor has proven to be a key target in the prevention of complications associated with atherosclerotic vascular disease especially in the context of acute coronary syndrome and percutaneous coronary intervention in addition to aspirin." | 3.75 | P2Y12 inhibitors: thienopyridines and direct oral inhibitors. ( Collet, JP; Montalescot, G, 2009) |
| "Our objective of the study was to address the question: "What is the efficacy of a deep venous thrombosis (DVT) and pulmonary embolus prophylaxis protocol after total knee arthroplasty (TKA) in which low-risk patients had only aspirin and mechanical devices for prophylaxis?" A multimodal approach to DVT prophylaxis using aspirin as the primary mode of chemoprophylaxis was successful in preventing DVT-related morbidity and mortality in 312 consecutive TKAs performed in low-risk patients." | 3.74 | Evaluation of deep venous thrombosis prophylaxis in low-risk patients undergoing total knee arthroplasty. ( Callaghan, JJ; Hoballah, JJ; Liu, SS; Warth, LC; Wells, CW, 2008) |
| " Patients who received low-molecular-weight heparin for prophylaxis against deep venous thrombosis had a longer time until the postoperative wound was dry than did those treated with aspirin and mechanical foot compression or those who received Coumadin (warfarin); this difference was significant on the fifth postoperative day (p = 0." | 3.74 | Factors associated with prolonged wound drainage after primary total hip and knee arthroplasty. ( DeWal, H; Di Cesare, PE; Patel, VP; Preston, C; Sehgal, B; Walsh, M, 2007) |
| "The aim of this study was to compare the incidence of postoperative nausea and vomiting (PONV) in propofol-anesthetized patients receiving either fentanyl or pentazocine as opioid supplement." | 3.74 | [Postoperative nausea and vomiting after laparoscopic cholecystectomy under total intravenous anesthesia using propofol combined with fentanyl or pentazocine]. ( Abe, F; Furuya, A; Nagamine, N; Nonaka, A; Suzuki, S, 2007) |
| "Aspirin-sensitivity, asthma, and nasal polyposis (NP) comprise the clinical entity of Samter's triad." | 3.74 | Sinonasal outcomes after endoscopic sinus surgery in asthmatic patients with nasal polyps: a difference between aspirin-tolerant and aspirin-induced asthma? ( Awad, OG; Fasano, MB; Graham, SM; Lee, JH, 2008) |
| "The combination of clopidogrel for four weeks and aspirin for six months is superior to aspirin alone for six months for preventing migraine with aura after transcatheter closure of an atrial shunt." | 3.73 | Clopidogrel reduces migraine with aura after transcatheter closure of persistent foramen ovale and atrial septal defects. ( Morrison, WL; Nightingale, S; Walsh, KP; Wilmshurst, PT, 2005) |
| "Arachidonic acid (AA)-induced light-transmittance platelet aggregation (LTA) and thrombelastography (TEG) platelet mapping were performed on the blood of healthy subjects (n = 6) before and 24 h after receiving 325 mg aspirin, and on 223 patients reporting compliance with long-term daily aspirin treatment (n = 203 undergoing percutaneous intervention [PCI] and n = 20 with a history of stent thrombosis)." | 3.73 | Overestimation of platelet aspirin resistance detection by thrombelastograph platelet mapping and validation by conventional aggregometry using arachidonic acid stimulation. ( Bliden, KP; Gurbel, PA; Tantry, US, 2005) |
| "We studied 30 patients with postsurgical ulcer and aspirin abuse." | 3.70 | Intractable upper gastrointestinal ulceration due to aspirin in patients who have undergone surgery for peptic ulcer. ( Hirschowitz, BI; Lanas, A, 1998) |
| "Post-anesthesia anaphylactic reactions or those seen during drug provocation tests with a systemic clinical reaction may be confirmed by the sequential release into blood of plasma histamine, tryptase and leukotriene C4 and into urine of urinary methylhistamine and leukotriene E4." | 3.70 | [Importance of the urinary leukotriene E4 level. Preliminary study]. ( Drouet, M; el Founini, M; Sabbah, A, 1998) |
| "This retrospective study was performed to examine the influence of aspirin on the incidence of RVT in cadaveric and living-related renal transplant recipients receiving cyclosporin-based triple immunosuppression." | 3.70 | Low dose aspirin as prophylaxis against renal-vein thrombosis in renal-transplant recipients. ( Gray, DW; Morris, PJ; Nargund, V; Robertson, AJ, 2000) |
| "A case of acute subdural haematoma originating spontaneously from an angiomatous meningioma in a patient receiving prophylactic aspirin therapy is presented." | 3.69 | Intracranial haemorrhage from a meningioma in a patient receiving aspirin prophylaxis: a case report. ( Ashkenazi, E; Israel, Z; Spektor, S, 1995) |
| "Hirulog, a thrombin-specific inhibitor, has shown efficacy in reducing arterial thrombosis in patients treated with aspirin who require angioplasty or have unstable angina." | 3.69 | Inhibition of platelet deposition by combined hirulog and aspirin in a rat carotid endarterectomy model. ( Alving, BM; Barr, CF; Gomez, ER; Hamelink, JK; Jackson, MR; Reid, TJ; Tang, DB, 1995) |
| "Aspirin and nonsteroidal antiinflammatory drugs (NSAIDs) inhibit platelet cyclooxygenase activity, resulting in altered platelet function and thus potentially enhanced bleeding." | 3.69 | Effect of aspirin and nonsteroidal antiinflammatory drug therapy on bleeding complications in dermatologic surgical patients. ( Lawrence, C; Sakuntabhai, A; Tiling-Grosse, S, 1994) |
| " Using a described model of microarterial thrombosis, the antithrombotic effects of oral aspirin (ASA) were assessed in rats." | 3.69 | The role of various antithrombotic agents in microvascular surgery. ( Buckley, RC; Das, SK; Davidson, SF, 1994) |
| " There were 12 independent significant predictors for readmission: clinical history (a previous history of either congestive heart failure or myocardial infarction, or CABG); acute operation; postoperative complications (time in intensive care unit greater than two days, neurological complications); clinical findings four to seven days after the operation (arrhythmia, systolic murmur equivalent to mitral regurgitation); medication four to seven days after the operation (antidiabetics, diuretics for heart failure, other antiarrhythmics (other than beta blockers, calcium antagonists, and digitalis), and lack of treatment with aspirin)." | 3.69 | Predictors of hospital readmission two years after coronary artery bypass grafting. ( Albertsson, P; Brandrup-Wognsen, G; Emanuelsson, H; Haglid, M; Hartford, M; Herlitz, J; Hjalmarson, A; Karlson, BW; Karlsson, T; Sandén, W, 1997) |
| "Low-dose aspirin is widely used in patients operated on for coronary disease as secondary prevention of coronary artery occlusion." | 3.68 | Gastric changes in coronary-operated patients with low-dose aspirin. ( Kivilaakso, E; Leivonen, M; Sipponen, P, 1992) |
| "An 11-year retrospective study was conducted to evaluate the surgical treatment of sinusitis in aspirin-triad patients." | 3.68 | Surgery for sinusitis and aspirin triad. ( Fink, JN; Kany, RJ; McFadden, EA; Toohill, RJ, 1990) |
| "Although this study was performed on a relatively small number of patients undergoing total hip arthroplasty in conjunction with aspirin prophylaxis for postoperative pulmonary embolism, several important points are noted: the use of pre- and postoperative lung perfusion scanning can eliminate a 15% rate of false-positive diagnosis of pulmonary embolism, and pulmonary embolism occurred in approximately 8% of patients undergoing total hip arthroplasty in conjunction with aspirin prophylaxis, without fatality." | 3.66 | Aspirin prophylaxis for pulmonary embolism following total hip arthroplasty. An incidence study. ( Dorr, LD; Ranawat, CS; Schneider, R; Stulberg, BN, 1982) |
| " Twenty-four hours after an uncomplicated procedure she had a severe bleeding diathesis following the ingestion of a small amount of aspirin." | 3.66 | Salicylate-induced bleeding problem in ophthalmic plastic surgery. ( Paris, GL; Waltuch, GF, 1982) |
| "To evaluate the potential effect of aspirin, a platelet inhibitory agent, on postoperative bleeding complications after coronary artery bypass graft surgery, we compared each of nine patients who had taken aspirin within 7 days prior to operation to one or two control subjects (total 16 patients) matched for age, sex, extent of coronary disease, number of grafts placed total operative time, bypass time, and preoperative use of propranolol." | 3.66 | Relation of preoperative use of aspirin to increased mediastinal blood loss after coronary artery bypass graft surgery. ( Mac Vaugh, H; Michelson, EL; Morganroth, J; Torosian, M, 1978) |
| "Two patients are reported in whom repeated postoperative hematomas appeared to be secondary to aspirin-induced platelet defect." | 3.66 | Surgical postoperative bleeding associated with aspirin ingestion. Report of two cases. ( Bell, W; Long, DM; Merriman, E, 1979) |
| " In the presence of thrombophlebitis, phenylbutazone (Butazolidin) is used." | 3.65 | A multifaceted approach to prevention of thromboembolism: a report of 529 cases. ( Brady, LP, 1977) |
| "The efficacy of two antithrombotic regimens, combined dextran and aspirin and combined dextran and warfarin, was analyzed by comparing the incidence of thromboembolism following total hip replacement in two groups of similar patients." | 3.65 | Thromboembolism following total hip-replacement arthroplasty. The efficicy of dextran-aspirin and dextran-warfarin in prophylaxis. ( Lachiewicz, P; Salvati, EA, 1976) |
| " In nine patients who took aspirin regularly the incidence of thromboembolism was 11 per cent, while in the eight who did not take aspirin or any other antiplatelet drug the incidence was 88 per cent, a difference which was highly significant (p = 0." | 3.65 | Thromboembolic disease in patients undergoing total knee replacement. ( Bachmann, F; Galante, JO; Kaushal, SP; McKenna, R, 1976) |
| " There were five chronic alcoholics, one aspirin abuser, one severely burned patient, and one patient with sepsis." | 3.65 | Gastric devascularization: an alternate approach to the surgical treatment of massive, diffuse hemorrhage from gastritis. ( Aust, JB; McFee, AS; Rittenhouse, M, 1976) |
| " There was no lysozymuria with severe uraemic heart failure, aspirin and paracetamol poisoning, or severe jaundice, nor in two cases of acute glomerulonephritis." | 3.65 | Lysozymuria and acute disorders of renal function. ( De Silva, KL; Harrison, JF; Parker, RW, 1973) |
| "The primary endpoint was thrombus size at the post-randomization visit with platelet reactivity following stimuli to arachidonic acid, collagen, adenosine diphosphate, and thrombin as secondary endpoints." | 2.94 | Ticagrelor With or Without Aspirin After PCI: The TWILIGHT Platelet Substudy. ( Angiolillo, DJ; Baber, U; Badimon, JJ; Dangas, G; Escolar, G; Farhan, S; Fuster, V; Gibson, CM; Gurbel, P; Joyce, L; Kini, AS; Mehran, R; Sartori, S; Sharma, SK; Vogel, B; Zafar, MU, 2020) |
| "For patients with inguinal hernias, laparoscopic TAPP repair is completely safe to be performed on those taking low-dose acetylsalicylic acid when it was only ceased on the operation day, with intravenous salvianolate given after the operation instead." | 2.90 | Continuation of low-dose acetylsalicylic acid during perioperative period of laparoscopic inguinal hernia repair is safe: results of a prospective clinical trial. ( Han, H; Liu, Y; Ruze, R; Wang, M; Xiong, Y; Yan, Z; Zhan, H; Zhang, G, 2019) |
| "Warfarin treatment was associated with better liver function protection and renal function improvement than aspirin treatment." | 2.90 | Warfarin versus aspirin prevents portal vein thrombosis after laparoscopic splenectomy and azygoportal disconnection: A randomized clinical trial. ( Bai, DS; Jiang, GQ; Jin, SJ; Qian, JJ; Xia, BL; Ye, J; Zhang, C, 2019) |
| " In Part A, rivaroxaban pharmacokinetics, pharmacodynamics, safety, and tolerability are assessed to validate the pediatric dosing selected." | 2.90 | Rivaroxaban, a direct Factor Xa inhibitor, versus acetylsalicylic acid as thromboprophylaxis in children post-Fontan procedure: Rationale and design of a prospective, randomized trial (the UNIVERSE study). ( Bonnet, D; Dong, X; Harris, KC; Jefferies, J; Justino, H; Li, JS; McCrindle, BW; Michelson, AD; Pina, LM; Samtani, MN; Zhang, L, 2019) |
| "Myocardial infarction was assessed using the third universal definition." | 2.82 | Effectiveness of platelet inhibition on major adverse cardiac events in non-cardiac surgery after percutaneous coronary intervention: a prospective cohort study. ( Beattie, WS; Carroll, J; Grewal, D; Harsha, P; Karkouti, K; Ragoonanan, T; Starzyk, Ł; Syed, S; Travis, G; Wąsowicz, M; Wijeysundera, DN, 2016) |
| "A cause other than paradoxical embolism was usually apparent in patients with recurrent neurologic events." | 2.77 | Closure or medical therapy for cryptogenic stroke with patent foramen ovale. ( Adams, H; Albers, GW; Felberg, R; Furlan, AJ; Herrmann, H; Kar, S; Landzberg, M; Massaro, J; Mauri, L; Raizner, A; Reisman, M; Wechsler, L, 2012) |
| "Transplant renal artery stenosis is a major complication that requires a therapeutic approach involving surgery or angioplasty." | 2.77 | Angioplasty and stent treatment of transplant renal artery stenosis. ( Ballarín, J; Canal, C; de la Torre, P; Del Pozo, M; Díaz, JM; Facundo, C; Guirado, L; Martí, J, 2012) |
| "Treatment with aspirin resulted in a 7." | 2.75 | To continue or discontinue aspirin in the perioperative period: a randomized, controlled clinical trial. ( Darvish, B; Eintrei, C; Fredrikson, M; Gupta, A; Järhult, J; Krook, H; Nyström, M; Oscarsson, A; Pettersson, E; Swahn, E, 2010) |
| "Graft thrombosis is a well-recognised complication of solid organ transplantation and is one of the leading causes of graft failure." | 2.72 | Interventions for preventing thrombosis in solid organ transplant recipients. ( Hanley, J; Hoather, TJ; Surianarayanan, V; Thompson, ER; Tingle, SJ; Wilson, CH, 2021) |
| "Oral aspirin was also associated with a >or=99." | 2.72 | Biological efficacy of low against medium dose aspirin regimen after coronary surgery: analysis of platelet function. ( Bellm, S; Cornelissen, J; Goddard, M; Kirtland, S; Large, S; Lim, E; Sheridan, K; Vuylsteke, A, 2006) |
| "Aspirin therapy was associated with a 48 percent reduction in the incidence of myocardial infarction (2." | 2.70 | Aspirin and mortality from coronary bypass surgery. ( Mangano, DT, 2002) |
| "Probucol is a lipid-lowering drug that has an antioxidant effect." | 2.70 | Effect of antioxidant probucol for preventing stent restenosis. ( Cha, KS; Han, JY; Kim, HJ; Kim, JS; Kim, MH, 2002) |
| "The benefits of the long-term administration of oral anticoagulant therapy remain unclear in patients with lower extremity arterial bypass surgery." | 2.70 | Benefits, morbidity, and mortality associated with long-term administration of oral anticoagulant therapy to patients with peripheral arterial bypass procedures: a prospective randomized study. ( Johnson, WC; Williford, WO, 2002) |
| "Both aspirin and dextran were well tolerated." | 2.69 | Prophylaxis for deep vein thrombosis with aspirin or low molecular weight dextran in Korean patients undergoing total hip replacement. A randomized controlled trial. ( Cho, JL; Choi, IY; Kim, YH; Park, MR; Park, TS, 1998) |
| "Aspirin use was defined by identification of ingestion within 7 days before the operation." | 2.69 | Effect of preoperative aspirin use on mortality in coronary artery bypass grafting patients. ( Birkmeyer, JD; Dacey, LJ; Johnson, ER; Leavitt, BJ; Maloney, CT; Morton, JR; Munoz, JJ; O'Connor, GT; Olmstead, EM, 2000) |
| "The aspirin and warfarin treatment groups were compared by size and location of venographically revealed clots and changes in ventilation perfusion scans." | 2.68 | Aspirin and warfarin for thromboembolic disease after total joint arthroplasty. ( Ecker, ML; Keenan, AM; Kelley, MA; Lotke, PA; Meranze, S; Palevsky, H; Steinberg, ME, 1996) |
| "In addition, 6 transient ischemic attacks and 3 myocardial infarctions could be directly linked to CEA, for a total CEA event rate of 2." | 2.68 | An analysis of perioperative surgical mortality and morbidity in the asymptomatic carotid atherosclerosis study. ACAS Investigators. Asymptomatic Carotid Atherosclerosis Study. ( Broderick, JP; Cohen, SN; Dempsey, RJ; Ernst, CB; Hosking, JD; Moore, WS; Robertson, JT; Toole, JF; Young, B, 1996) |
| "Aspirin has an established benefit in reducing the incidence of coronary events and vein graft occlusion." | 2.67 | Pre-operative aspirin decreases platelet aggregation and increases post-operative blood loss--a prospective, randomised, placebo controlled, double-blind clinical trial in 100 patients with chronic stable angina. ( Bevan, DH; Cowans, D; Kallis, P; Talbot, S; Tooze, JA; Treasure, T, 1994) |
| "Carotid stenosis was confirmed by arteriography, which demonstrated at least 50% stenosis, measured by comparing the least transverse diameter of the stenosis on lateral arteriography." | 2.67 | 4. Current status of operative treatment for asymptomatic carotid stenosis. ( Hobson, RW; Towne, JB, 1994) |
| "Q-wave myocardial infarctions were increased in the aprotinin subgroups (17." | 2.67 | Aprotinin therapy for reoperative myocardial revascularization: a placebo-controlled study. ( Cosgrove, DM; Golding, LA; Heric, B; Loop, FD; Lytle, BW; McCarthy, PM; Novoa, R; Stewart, RW; Taylor, PC, 1992) |
| "The efficacy of aspirin for prevention of thrombotic graft occlusion after coronary artery bypass grafting (CABG) depends both on the dosage and time window of administration." | 2.67 | Immediate postoperative aspirin improves vein graft patency early and late after coronary artery bypass graft surgery. A placebo-controlled, randomized study. ( Baron, DW; Gavaghan, TP; Gebski, V, 1991) |
| "The incidence of pulmonary embolism (PE) in all trials combined was low, with seven cases in 3818 participants." | 2.66 | Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy. ( Badariotti, G; Chahla, J; Perrotta, C; Ramos, J, 2020) |
| "Proximal vein thrombosis or pulmonary embolism occurred in 6 patients (9." | 2.66 | A randomized trial of less intense postoperative warfarin or aspirin therapy in the prevention of venous thromboembolism after surgery for fractured hip. ( Gent, M; Hirsh, J; Jay, RM; Julian, DH; Levine, M; Powers, PJ; Turpie, AG, 1989) |
| "A considerable degree of trismus was demonstrated in most of the tonsillectomized patients." | 2.66 | Relief of pain and trismus in patients treated with naproxen or acetylsalicylic acid after tonsillectomy. ( Hein, P; Kristensen, S; Outzen, KE; Poulsen, HB; Tveteraas, K, 1988) |
| "To study the prevention of occlusion of aortocoronary-artery bypass grafts, we concluded a prospective, randomized, double-blind trial comparing long-term administration of dipyridamole (begun two days before operation) plus aspirin (begun seven hours after operation) with placebo in 407 patients." | 2.65 | Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations. ( Bardsley, WT; Chesebro, JH; Clements, IP; Elveback, LR; Fuster, V; Holmes, DR; Pluth, JR; Puga, FJ; Smith, HC; Wallace, RB, 1984) |
| "In a double-blind crossover study acetylsalicylic acid (ASA) in low (2 g daily) or high (4 g daily) dosage was tested against placebo in two groups of 20 patients who each underwent identical oral surgical procedures on two separate occasions." | 2.65 | The effects of acetylsalicylic acid on swelling, pain and other events after surgery. ( Skjelbred, P, 1984) |
| "Aspirin has been demonstrated to be an effective prophylactic agent against postoperative venous thromboembolic disease, but the optimum dosage is unknown." | 2.65 | High and low-dose aspirin prophylaxis against venous thromboembolic disease in total hip replacement. ( Athanasoulis, CA; Harris, WH; Salzman, EW; Waltman, AC, 1982) |
| " Increasing the heparin dosage postoperatively to 3 X 7500 IU/24 h effectively prevented the incidence of thrombosis by reducing it to 11% in these high-risk patients." | 2.64 | [Heparin in the prevention of thromboembolism after elective hip-joint operations (author's transl)]. ( Schöndorf, TH, 1978) |
| "The frequency in letal pulmonary embolism at the I." | 2.64 | [Thrombosis, embolism and aggregation inhibitors in surgery]. ( Zekert, F, 1976) |
| "Treatment with aspirin reduced urinary excretion of 5-hydroxy indole acetic acid--presumably by inhibiting in vivo platelet release of serotonin, reduced postoperative consumption of platelets, and reduced the mean corpuscular volume of the platelet population." | 2.64 | The influence of aspirin on postoperative platelet kinetics and venous thrombosis. ( Clagett, GP; Rosoff, CB; Salzman, EW; Schneider, P, 1975) |
| "Myxomas are slowly growing benign neoplasms and represent the most common tumor of the heart." | 2.61 | Delayed intracranial aneurysm formation after cardiac myxoma resection: Report of two cases and review of the literature. ( Knopman, J; Patsalides, A; Pierre Gobin, Y; Santillan, A, 2019) |
| "Treatment with aspirin alone ranked with high values both for primary and secondary endpoints (surface under the cumulative ranking curve of 70% and 82%, respectively)." | 2.61 | Medical and endovascular treatments of symptomatic intracranial stenosis. A Bayesian network meta-analysis. ( Agostoni, E; Consoli, A; Consoli, D; Grampa, G; Vidale, S, 2019) |
| "The authors present a case of delayed acute subdural hematoma and review all reported cases in the literature." | 2.53 | Case Report and Review of Literature of Delayed Acute Subdural Hematoma. ( Baisden, JL; Doan, N; Nguyen, HS; Shabani, S, 2016) |
| "Venous thromboembolic disease (VTED) (deep venous thrombosis and pulmonary embolism) is a considerable source of morbidity and mortality following lower extremity total joint arthroplasty." | 2.52 | What's New in Venous Thromboembolic Prophylaxis Following Total Knee and Total Hip Arthroplasty? An Update. ( Cherian, JJ; Elmallah, RK; Jauregui, JJ; Mont, MA; Pierce, TP, 2015) |
| " However, before these agents are recommended for general use, large multicenter trials should be done exploring not only efficacy but also dose-response relationships and side effects." | 2.50 | Novel preoperative pharmacologic methods of preventing postoperative sore throat due to tracheal intubation. ( Austin, PN; Kalil, DM; Silvestro, LS, 2014) |
| "Deep Venous Thrombosis is a common disease with fatal and serious long term burdensome complications." | 2.45 | Deep vein thrombosis: risk factors and prevention in surgical patients. ( Adekoya-Cole, TO; Enweluzo, GO; Giwa, SO; Obalum, DC; Ogo, CN, 2009) |
| "Fatal pulmonary embolism is estimated to occur in nearly 1% of these women." | 2.44 | WITHDRAWN: Anticoagulant and aspirin prophylaxis for preventing thromboembolism after major gynaecological surgery. ( D'Angelo, A; Mol, B; Oates-Whitehead, RM, 2007) |
| "Fatal pulmonary embolism is estimated to occur in nearly 1% of these women." | 2.42 | Anticoagulant and aspirin prophylaxis for preventing thromboembolism after major gynaecological surgery. ( D'Angelo, A; Mol, B; Oates-Whitehead, RM, 2003) |
| " The choice of topical corticosteroid is important because long-term use is necessary; the least absorbed should be used." | 2.41 | Comparison of medical and surgical treatment of nasal polyposis. ( Scadding, GK, 2002) |
| "Triflusal is an antiplatelet agent structurally related to the salicylate group of compounds, but it is not derived from aspirin (acetylsalicylic acid)." | 2.40 | Triflusal. ( Goa, KL; McNeely, W, 1998) |
| "Aspirin was first synthesised 100 years ago and its preparation and marketing is generally reckoned to have been the foundation of the pharmaceutical industry." | 2.40 | Platelets, aspirin, and cardiovascular disease. ( Elwood, PC; Hughes, C; O'Brien, JR, 1998) |
| " A low (100 mg) to medium (325 mg) daily aspirin dosage was more effective than a high dose (975 mg)." | 2.38 | Optimal antithrombotic therapy following aortocoronary bypass: a meta-analysis. ( Chen, E; Christakis, GT; Fremes, SE; Goldman, BS; Levinton, C; Naylor, CD, 1993) |
| " The dosage of ASA in the majority of works has been about 1,000 mg daily while isolated investigations have shown good effect from doses as low as 60 mg daily." | 2.38 | [Acetylsalicylic acid in the treatment of arterial thromboembolytic diseases. 2. Clinical documentation]. ( Faergeman, O; Fasting, H; Husted, SE; Krusell, LR; Nielsen, HK, 1989) |
| "Transient ischemic attacks are associated with a 30 to 35 percent risk of stroke within five years of the initial episode." | 2.37 | Carotid surgery in stroke prevention. ( Busuttil, RW; Sheng, FC, 1986) |
| "The incidence of deep vein thrombosis (DVT) and pulmonary embolism (PE) after total joint arthroplasty (TJA) procedures are lower in Asian populations than in Caucasian populations." | 1.91 | Combination of enoxaparin and low-dose aspirin for thromboprophylaxis in selective patients after primary total joint arthroplasty in a Taiwanese population. ( Chang, WL; Chen, CF; Chen, WM; Chou, TA; Pai, FY; Tsai, SW; Wu, PK, 2023) |
| "Aspirin 81 mg was cost-effective if the initial symptomatic VTE rates decreased by an absolute risk reduction (ARR) of 0." | 1.72 | Cost-Effective Modeling of Thromboembolic Chemoprophylaxis for Total Ankle Arthroplasty. ( Aynardi, MC; Bonaddio, V; Kirchner, GJ; Koroneos, Z; Lorenz, FJ; Manto, KM; Martinazzi, BJ; Stauch, CM, 2022) |
| " The aim of this study was to determine whether a protocol of 81-mg aspirin (ASA) bis in die (BID) is safe and/or sufficient in preventing VTE in patients undergoing rTKAs versus 325-mg ASA BID." | 1.72 | Low-Dose Aspirin is Safe and Effective for Venous Thromboembolism Prevention in Patients Undergoing Revision Total Knee Arthroplasty: A Retrospective Cohort Study. ( Bosco, JA; Iorio, R; Schwarzkopf, R; Slover, JD; Tang, A; Waren, D; Zak, SG, 2022) |
| " The aim of this study is to determine if discontinued use of outpatient IPCDs is safe and does not increase the rate of VTE or any other related complications in patients following TKA." | 1.72 | Discontinued Use of Outpatient Portable Intermittent Pneumatic Compression Devices May Be Safe for Venous Thromboembolism Prophylaxis in Primary Total Knee Arthroplasty Using Low-Dose Aspirin. ( Lajam, C; Lygrisse, K; Macaulay, W; Meftah, M; Schwarzkopf, R; Slover, J; Tang, A; Zak, S, 2022) |
| "ASA is safe for VTE prophylaxis after total joint arthroplasty in patients with history of GI issues and is not associated with an increased risk of postoperative GI bleeds." | 1.62 | Aspirin Is Safe for Venous Thromboembolism Prophylaxis for Patients With a History of Gastrointestinal Issues. ( Austin, MS; Grosso, MJ; Kozaily, E; Parvizi, J, 2021) |
| "The aspirin group was older (73 ± 7." | 1.62 | No Increased Risk of Venous Thromboembolism in High-Risk Patients Continuing Their Dose of 75 mg Aspirin Compared to Healthier Patients Given Low-Molecular-Weight Heparin. ( Amlie, EJ; Hovik, O; Jenssen, KK, 2021) |
| "The current rates of deep vein thrombosis (DVT) and pulmonary embolism (PE) at our institution following hip or knee arthroplasty or hip fracture surgery are 1." | 1.56 | Incidence of venous thromboembolism after total hip, total knee and hip fracture surgery at Waitemata District Health Board following a peer-reviewed audit. ( Andrew, P; Farrington, B; Lawes, CM; Merriman, E; Millar, JS; Misur, P; Walker, M, 2020) |
| " Postoperative outcomes of patients receiving ASA prior to TJA, dosing of ASA (81 mg or 325 mg) preoperatively and postoperatively, and the time of preoperative discontinuation (no ASA, <4 days, <7 days, and 7 or more days) were compared." | 1.51 | Effect of Acetylsalicylic Acid Dose and Time Discontinued Preoperatively on Outcomes After Total Knee and Hip Arthroplasty. ( Charters, M; Kadri, OM; Les, CM; Shaw, JH, 2019) |
| "Aspirin resistance was defined as platelet inhibition below 50%." | 1.51 | Prevalence of aspirin resistance by thromboelastography plus platelet mapping in children with CHD: a single-centre experience. ( Bartakian, S; Berganza, FM; Brownlee, J; Egbe, AC; Gonzalez de Alba, C, 2019) |
| " A randomised trial is needed to determine appropriate acetylsalicylic acid dosing in infants with modified Blalock-Taussig." | 1.51 | High acetylsalicylic acid dosing in infants after modified Blalock-Taussig shunt. ( Allen, J; Boston, US; Cowan, KM; Jones, T; Joshi, AD; Knott-Craig, CJ; Kumar, STK; Nouer, SS; Saini, A; Shah, SH; Wayne Gatewood, C, 2019) |
| "Aspirin has both the anti-platelet and anti-inflammatory effects, and decreases several cytokines production." | 1.51 | Suppressive Effects of Aspirin for Postthoracotomy Pleural Adhesion in Rats. ( Inoue, M; Ishihara, S; Ito, K; Okada, S; Shimada, J; Shimomura, M; Yamaguchi, T, 2019) |
| "The aspirin group was older (66 vs 52 years), included more tobacco users (58." | 1.48 | The Effect of Continued Low Dose Aspirin Therapy in Patients Undergoing Percutaneous Nephrolithotomy. ( Bird, VG; Gupta, M; Hamann, HC; Lutfi, FG; Otto, BJ; Syed, JS; Terry, RS, 2018) |
| "Recent studies suggested protruding thrombus and atheroma after stent placement could be a substrate for subsequent adverse ischemic events." | 1.48 | Potent effect of prasugrel on acute phase resolution of intra-stent athero-thrombotic burden after percutaneous intervention to acute coronary syndrome. ( Hirata, KI; Kijima, Y; Kozuki, A; Masano, T; Nagoshi, R; Otake, H; Shibata, H; Shinke, T; Shite, J; Takeshige, R; Tsukiyama, Y; Yanaka, KI, 2018) |
| "Head and neck skin cancer surgery using a full thickness skin graft is a common procedure." | 1.48 | Antithrombotic treatment and risk of complications after head and neck full thickness skin graft surgery. ( Ekström, M; Hasselgren, M; Janson, P; Runer, T, 2018) |
| "Aspirin consumption was associated with increased long-term mortality and MACE." | 1.48 | Are Prior Aspirin Users With ST-Elevation Myocardial Infarction at Increased Risk of Adverse Events and Worse Angiographic Features? ( Geraiely, B; Mortazavi, SH; Poorhosseini, H; Sadeghian, S; Sattarzadeh Badkoubeh, R, 2018) |
| "EHIT can lead to deep vein thrombosis/pulmonary embolism, which cause significant disability and, rarely, death." | 1.46 | Outcomes of a single-center experience with classification and treatment of endothermal heat-induced thrombosis after endovenous ablation. ( Chambers, CM; Cuff, RF; Korepta, LM; Mansour, MA; Slaikeu, JD; Watson, JJ; Wong, PY, 2017) |
| "The rate of postoperative complications has significantly increased annually only in HFS: VTE (P=0." | 1.46 | Trends of thromboprophylaxis and complications after major lower limb orthopaedic surgeries in Korea: National Health Insurance Claim Data. ( Ahn, H; Kim, S; Park, JH; Shin, SA; Won, CW, 2017) |
| "Aspirin has been implicated in the postoperative management of moyamoya disease (MMD) in order to avoid bypass failure and decrease the incidence of subsequent stroke." | 1.46 | Effect of Aspirin in Postoperative Management of Adult Ischemic Moyamoya Disease. ( Zhang, D; Zhang, Q; Zhao, Y, 2017) |
| "Aspirin was continued in 25% of the cases." | 1.46 | Impact of Anticoagulant and Antiplatelet Drugs on Perioperative Outcomes of Robotic-assisted Partial Nephrectomy. ( Bensalah, K; Khene, Z; Mathieu, R; Peyronnet, B; Pradere, B; Roupret, M; Ruggiero, M; Seisen, T; Vaessen, C; Verhoest, G, 2017) |
| "Although frequent, hemoptysis is usually transient and minor." | 1.43 | Late Major Hemoptysis After Lung Volume Reduction With Coils Induced by Dual Antiaggregation Therapy. ( Casutt, A; Koutsokera, A; Krueger, T; Lovis, A; Nicod, LP; Noetzli, J; Perentes, JY; Pons, M; Valenti, A, 2016) |
| "Procedure-related thromboembolism is a major limitation of coil embolization, but the relationship between thromboembolic infarction and antiplatelet resistance is poorly understood." | 1.43 | Association between Postprocedural Infarction and Antiplatelet Drug Resistance after Coiling for Unruptured Intracranial Aneurysms. ( Hong, SC; Jeon, P; Jo, KI; Kim, JS; Kim, KH; Kim, MS; Yeon, JY, 2016) |
| "The rate of surgical site infection was similar between the aspirin group and the warfarin group (1." | 1.43 | Aspirin Can Be Used as Prophylaxis for Prevention of Venous Thromboembolism After Revision Hip and Knee Arthroplasty. ( Chen, AF; Deirmengian, GK; Heller, S; Maltenfort, M; Parvizi, J; Smith, EB, 2016) |
| "Six cases (6." | 1.43 | Complication of Stenting in Intracranial Arterial Stenosis. ( Liu, L; Zhang, F, 2016) |
| " The primary efficacy endpoint was major adverse cardiac events (MACE), defined as the composite of cardiac death, myocardial infarction, or stent thrombosis." | 1.43 | Efficacy and Safety of Dual Antiplatelet Therapy After Complex PCI. ( Abizaid, A; Bhatt, DL; Chieffo, A; Colombo, A; Costa, RA; Feres, F; Genereux, P; Gilard, M; Giustino, G; Hong, MK; Jang, Y; Kim, BK; Kim, HS; Leon, MB; Morice, MC; Palmerini, T; Park, KW; Redfors, B; Sardella, G; Sawaya, F; Stone, GW; Valgimigli, M, 2016) |
| "Thrombosis is a devastating complication after repair of traumatic vascular injury." | 1.43 | Do Antiplatelet and Anticoagulation Agents Matter after Repair of Traumatic Arterial Injuries? ( Benjamin, E; Byerly, S; Cho, J; Demetriades, D; Inaba, K; Lam, L; Rowe, V; Wang, E, 2016) |
| " However, data are lacking regarding optimal timing and dosing of ASA." | 1.42 | Association Between Preoperative Aspirin-dosing Strategy and Mortality After Coronary Artery Bypass Graft Surgery. ( Collard, CD; Coselli, J; Deng, Y; Elayda, MA; Lee, VV; Pan, W; Pisklak, PV; Tolpin, DA, 2015) |
| "Aspirin was not significantly associated with bleeding complications during or after surgery (p = 0." | 1.42 | A case-control study to assess aspirin as a risk factor of bleeding in rhegmatogenous retinal detachment surgery. ( Albaladejo, P; Aptel, F; Bernheim, D; Brillat, E; Chiquet, C; Palombi, K; Quesada, JL; Romanet, JP; Rouberol, F, 2015) |
| "Aspirin was prescribed from discharge until 6 weeks following surgery." | 1.42 | Staged venous thromboemolic events prophylaxis with low-molecular-weight heparin followed by aspirin is safe and effective after arthroplasty. ( Asopa, V; Bauze, A; Cobain, W; Keene, G; Martin, D, 2015) |
| "Despite recent advances in stent design and constantly improving protective pharmacological strategies, complications and adverse events following percutaneous coronary interventions (PCI) are still major factors influencing morbidity and mortality." | 1.42 | Independent Predictors of Major Adverse Events following Coronary Stenting over 28 Months of Follow-Up. ( Bulaeva, NI; Fortmann, S; Golukhova, EZ; Grigorian, MV; Ryabinina, MN; Serebruany, VL, 2015) |
| "Aspirin fills were more common in younger veterans, Blacks, Hispanics, males, hypertensive veterans, mentally ill patients, those with no co-pay and those prescribed antiplatelets/anticoagulants in addition to aspirin postoperatively." | 1.42 | Use of Health Care System-Supplied Aspirin by Veterans With Postoperative Heart Attack or Unstable Angina. ( Copeland, LA; MacCarthy, DJ; McNeal, CJ; Mortensen, EM; Pugh, MJ; Rivera, CM, 2015) |
| "Incidences of symptomatic deep vein thrombosis (DVT) and PE, and major or minor bleeding complications were evaluated." | 1.42 | Clinical Performance of the 1st American Academy of Orthopaedic Surgeons Clinical Guideline on Prevention of Symptomatic Pulmonary Embolism after Total Knee Arthroplasty in Korean Patients. ( Cho, KJ; Fang, R; Kim, TK; Kim, YH; Na, YG, 2015) |
| "Rivaroxaban has a higher incidence of bleeding complication and further clinical trials are required to be conducted to assess the safety of rivaroxaban in clinical." | 1.42 | [Case-control study on three antithrombotic agents for the prevention of venous thromboembolism after unilateral total knee arthroplasty]. ( Lu, JH; Lu, N; Miao, SG; Yang, Y; Zhang, XG, 2015) |
| "Clopidogrel and ticlopidine, sometimes in combination with ASA, are associated with a low risk of bleeding during renal transplantation and does not seem to be a contraindication for renal transplant surgery." | 1.40 | Ticlopidine and clopidogrel, sometimes combined with aspirin, only minimally increase the surgical risk in renal transplantation: a case-control study. ( Abramowicz, D; Benahmed, A; Broeders, N; Donckier, V; Ghisdal, L; Hoang, AD; Kianda, M; Le Moine, A; Lemy, A; Madhoun, P; Massart, A; Mikhalski, D; Racapé, J; Sadis, C; Wissing, M, 2014) |
| "Cangrelor is an intravenous ATP analog that directly, selectively and reversibly inhibits P2Y12 receptors on platelets." | 1.40 | Cangrelor for treatment during percutaneous coronary intervention. ( Dobesh, PP; Oestreich, JH, 2014) |
| "Switching warfarin to aspirin 3 months after successful RFCA of AF could be as safe and efficacious as long-term anticoagulation even in patients with CHA₂DS₂-VASc score≥2." | 1.40 | Safety and efficacy of switching anticoagulation to aspirin three months after successful radiofrequency catheter ablation of atrial fibrillation. ( Choi, KJ; Joung, B; Kim, YH; Lee, MH; Nam, GB; Pak, HN; Uhm, JS; Won, H, 2014) |
| "Liver fibrosis was assessed by histological evaluation." | 1.40 | Aspirin may reduce liver fibrosis progression: Evidence from a multicenter retrospective study of recurrent hepatitis C after liver transplantation. ( Boëlle, PY; Chazouillères, O; Conti, F; Corpechot, C; Durand, F; Duvoux, C; Mackiewicz, V; Paradis, V; Poujol-Robert, A; Poupon, R; Wendum, D, 2014) |
| "Medical records of patients operated for abdominal hernia were analysed." | 1.40 | Anticoagulants as a risk factor in patients operated on for abdominal hernia. ( Piątek, B; Piwnik, M; Podgórski, M; Strzelczyk, J, 2014) |
| "Pocket hematoma is a troublesome complication associated with the implantation of cardiac implantable electronic devices (CIEDs)." | 1.39 | Thrombocytopenia, dual antiplatelet therapy, and heparin bridging strategy increase pocket hematoma complications in patients undergoing cardiac rhythm device implantation. ( Chang, JP; Chen, HC; Chen, MC; Chen, YL; Guo, BF; Lin, YS; Pan, KL; Tsai, TH, 2013) |
| " The aim of this retrospective study was to measure the therapeutic response to standard dosing with LMWH (using anti-Xa) in patients after ablative and reconstructive surgery for head and neck cancer, and to review the associated risk of bleeding." | 1.39 | Low molecular weight heparin in patients undergoing free tissue transfer following head and neck ablative surgery: review of efficacy and associated complications. ( Eley, KA; Parker, RJ; Watt-Smith, SR, 2013) |
| "In selected low TE risk patients undergoing ablation for AF, a short period of periprocedural therapeutic anticoagulation with LMWH together with aspirin is an effective and safe strategy to prevent TE events." | 1.39 | Catheter ablation of atrial fibrillation in patients at low thrombo-embolic risk: efficacy and safety of a simplified periprocedural anticoagulation strategy. ( Acena, M; Berte, B; Bun, SS; De Meyer, G; Duytschaever, M; Tavernier, R; Van Heuverswyn, F; Vandekerckhove, Y, 2013) |
| "Though dextran 40 did not result in any significant adverse local or systemic complications, it is not useful as a postoperative antithrombotic agent in head and neck oncologic reconstruction with free tissue transfer." | 1.39 | Safety and efficacy of low molecular weight dextran (dextran 40) in head and neck free flap reconstruction. ( Duraisamy, S; Iyer, S; Jayaprasad, K; Mathew, J; Paul, J; Rajan, S; Sharma, M; Thankappan, K, 2013) |
| " We evaluated preoperative and perioperative parameters, functional outcomes, and adverse events up to 12 months postoperatively of patients on oral anticoagulation therapy undergoing PVP, and compared the results with patients who did not take anticoagulation therapy." | 1.39 | The safety and efficacy of aspirin intake in photoselective vaporization laser treatment of benign prostate hyperplasia. ( Chang, PL; Chen, CL; Chen, SM; Hou, CP; Lin, YH; Shao, IH; Tsui, KH, 2013) |
| "Onyx HD-500 is a liquid embolic used to treat intracranial aneurysms." | 1.39 | Continued concern about parent vessel steno-occlusive progression with Onyx HD-500 and the utility of quantitative magnetic resonance imaging in serial assessment. ( Alaraj, A; Aletich, VA; Amin-Hanjani, S; Carlson, AP; Charbel, FT, 2013) |
| "Unilateral vertebral artery dissection has been described in fewer than 40% of cases of RCVS." | 1.39 | Reversible cerebral vasoconstriction syndrome and bilateral vertebral artery dissection presenting in a patient after cesarean section. ( Do, HM; Mitchell, LA; Santarelli, JG; Singh, IP, 2013) |
| "Vasoplegia was defined as persistent low systemic vascular resistance, despite multiple intravenous pressor drugs at high dose, between 6 and 48 hours after surgery." | 1.38 | Pre-operative risk factors and clinical outcomes associated with vasoplegia in recipients of orthotopic heart transplantation in the contemporary era. ( Patarroyo, M; Shrestha, K; Simbaqueba, C; Smedira, N; Starling, RC; Tang, WH; Taylor, DO, 2012) |
| "Aspirin (100 mg/day) was used <3 days before surgery in 240 patients and was discontinued >3 days before surgery in 619 patients." | 1.38 | Timing of preoperative aspirin discontinuation and outcome after elective coronary artery bypass graft surgery. ( Airaksinen, J; Biancari, F; Gunn, J; Heikkinen, J; Juvonen, T; Kuttila, K; Lahtinen, J; Mikkola, R; Teittinen, K; Wistbacka, JO, 2012) |
| "Aspirin has been shown to decrease postoperative CABG mortality and ischemic events." | 1.38 | Effect of timing of chronic preoperative aspirin discontinuation on morbidity and mortality in patients having combined coronary artery bypass grafting and valve surgery. ( Blackstone, E; Cho, L; Jacob, M; Smedira, N; Williams, S, 2012) |
| "Stent thrombosis is not unusual in a post-operative setting." | 1.38 | Successful use of glycoprotein IIb/IIIa inhibitor, heparin, and IABP during PCI in a post-neurosurgical patient with STEMI and cardiogenic shock due to very late bare-metal stent thrombosis. ( Agnani, S; Akkus, NI; Rajpal, S, 2012) |
| "The aspirin-treated group was significantly older, with higher weight and poorer health state (higher incidence of ischemic heart disease, cerebral ischemia and diabetes)." | 1.38 | [Low-dose aspirin doesn't increase surgical bleeding nor transfusion rate in total knee arthroplasty]. ( Bisbe Vives, E; Castillo Monsegur, J; López Bosque, R; Ruiz, A; Santiveri Papiol, X, 2012) |
| "The rate of VTE, pulmonary embolism, proximal deep vein thrombosis (DVT) and distal DVT was 1." | 1.38 | Aspirin for elective hip and knee arthroplasty: a multimodal thromboprophylaxis protocol. ( Esposito, A; Gesell, M; Gonzalez Della Valle, A; Ma, Y; Memtsoudis, SG; Vulcano, E, 2012) |
| "Aspirin was restarted on the first postoperative day and clopidogrel was restarted on the second postoperative day." | 1.38 | Perioperative management of a neurosurgical patient requiring antiplatelet therapy. ( Gregory Thompson, B; Rohatgi, P; Than, KD; Wilson, TJ, 2012) |
| "Aspirin (ASA) has been shown to reduce postoperative coronary artery bypass grafting (CABG) mortality and ischemic events; however, the timing of chronic ASA discontinuation before surgery is controversial because of concern about postoperative bleeding." | 1.37 | Effect of timing of chronic preoperative aspirin discontinuation on morbidity and mortality in coronary artery bypass surgery. ( Blackstone, E; Cho, L; Jacob, M; Smedira, N; Williams, S, 2011) |
| "None experienced strokes or transient ischemic attacks." | 1.35 | Low incidence of neurologic events during long-term support with the HeartMate XVE left ventricular assist device. ( Dia, M; Gallagher, C; Silver, MA; Slaughter, MS; Sobieski, MA, 2008) |
| "Aspirin intake was associated with reduced risk for sinusoidal lesions (P = ." | 1.35 | Risk factors for chemotherapy-associated liver injuries: A multivariate analysis of a group of 146 patients with colorectal metastases. ( Beauchet, A; Benoist, S; Brouquet, A; Julie, C; Nordlinger, B; Penna, C; Rougier, P, 2009) |
| "Deep venous thrombosis (DVT) and pulmonary embolism (PE) cause significant morbidity and mortality in orthopaedic surgical practice, although the incidence following surgery to the lumbosacral spine is less than following lower limb surgery." | 1.35 | Incidence of thromboembolic complications in lumbar spinal surgery in 1,111 patients. ( Craig, N; Nicol, M; Sun, Y; Wardlaw, D, 2009) |
| "The patient had developed anterior spinal artery syndrome due to ischaemia of the lower thoracic myelum." | 1.35 | [Paraplegia following a transurethral prostate resection: the anterior spinal artery syndrome]. ( Stienstra, R; van Poorten, F; Vermin, B, 2009) |
| "Twenty patients in each group had deep venous thrombosis (7% and 5." | 1.34 | Symptomatic thromboembolism after one-stage bilateral THA with a multimodal prophylaxis protocol. ( Anderson, J; Beksaç, B; González Della Valle, A; Salvato, EA; Sculco, TP; Sharrock, NE, 2007) |
| "Aspirin is an antiplatelet agent that acetylates cyclo-oxygenase and decreases the products of arachidonic acid metabolism, including thromboxane and prostacyclin." | 1.33 | Effects of clopidogrel and high dose aspirin on survival of skin flaps in rats. ( Akan, M; Aköz, T; Cakir, B; Misirlioğlu, A; Taylan, G; Yildirim, S, 2005) |
| "Nonfatal pulmonary embolisms were diagnosed in 17 (0." | 1.33 | Thromboembolic disease prophylaxis in total hip arthroplasty. ( Goswami, A; Sarmiento, A, 2005) |
| "Aspirin was the sole antithrombotic agent used during the study." | 1.33 | Endothelial injury and acquired aspirin resistance as promoters of regional thrombin formation and early vein graft failure after coronary artery bypass grafting. ( Brown, JM; Gammie, JS; Griffith, BP; Gu, J; Nie, L; Pierson, RN; Poston, RS; White, C, 2006) |
| "Their mitral regurgitation (MR) is a result of left ventricular (LV) geometrical distortion." | 1.33 | Flexible versus nonflexible mitral valve rings for congestive heart failure: differential durability of repair. ( Bolling, SF; Geltz, A; Spoor, MT, 2006) |
| "Diagnoses included dilated cardiomyopathy (n = 15), myocarditis (n = 2), and postcardiotomy ventricular failure (n = 1)." | 1.33 | Ventricular assist device support in children and adolescents as a bridge to heart transplantation. ( Buchanan, JR; Gandhi, SK; Kormos, RL; Morell, VO; Sharma, MS; Wearden, PD; Webber, SA, 2006) |
| "Data indicate that deep venous thrombosis (DVT) occurs at the time of knee arthroplasty." | 1.32 | A multimodality regimen for deep venous thrombosis prophylaxis in total knee arthroplasty. ( Emerson, RH; Higgins, LL; Reitman, RD; Tarbox, TR, 2003) |
| "The average postoperative blood loss (845 mL versus 775 mL; p = 0." | 1.32 | Effect of preoperative aspirin use in off-pump coronary artery bypass operations. ( Dihmis, WC; Fabri, BM; Grayson, AD; Pullan, DM; Srinivasan, AK, 2003) |
| "However, systemic study of thrombus formation in vein grafts is still lacking, and few effective techniques are available to prevent this event." | 1.32 | Thrombosis and neointima formation in vein grafts are inhibited by locally applied aspirin through endothelial protection. ( Hu, Y; Mayr, U; Thompson, WD; Torsney, E; Xu, Q; Zou, Y, 2004) |
| "Stroke is a devastating complication in patients with prosthetic valves, but characterization of its late occurrence from a large cohort is lacking." | 1.32 | Late incidence and determinants of stroke after aortic and mitral valve replacement. ( Bédard, PJ; Goldstein, WG; Hendry, PJ; Masters, RG; Mesana, TG; Pipe, AL; Rubens, FD; Ruel, M, 2004) |
| "Aspirin treatment has an undoubted beneficial impact on the progression of cardiovascular diseases." | 1.32 | Low-dose aspirin therapy is associated with improved allograft function and prolonged allograft survival after kidney transplantation. ( Grotz, W; Olschewski, M; Peter, K; Siebig, S; Strey, CW, 2004) |
| "Bioprosthetic valve thrombosis is a rare complication, supporting this approach." | 1.31 | Early bioprosthetic mitral valve "pseudostenosis" after complete preservation of the native mitral apparatus. ( Korkolis, DP; Koullias, GJ; Marshalko, SJ; Passik, CS, 2002) |
| "Aspirin treatment significantly increased activity during the first and second dark cycles after surgery, whereas buprenorphine significantly increased activity during the second dark cycle only." | 1.31 | Oral buprenorphine and aspirin analgesia in rats undergoing liver transplantation. ( Howden, BO; Jablonski, P, 2002) |
| "Reduced anticoagulation with antiplatelet therapy alone after coronary stenting, despite infrequent use of intravascular ultrasound, is an effective and safe strategy with a low rate of vascular complications, a relatively short hospital stay and a low incidence of clinical manifestations of stent thrombosis." | 1.30 | Antiplatelet therapy alone is safe and effective after coronary stenting: observations of a transition in practice. ( Buller, CE; Chauhan, A; Moscovich, MD; Penn, IM; Ricci, DR; Zubaid, M, 1997) |
| "Aspirin was not administered to the remaining 175 patients." | 1.30 | Low-dose aspirin therapy is associated with few side effects but does not prevent hepatic artery thrombosis in liver transplant recipients. ( Birnbaum, A; Boccagni, P; Bodenheimer, HC; Chodoff, L; Freni, MA; Miller, CM; Mor, E; Schwartz, ME; Wolf, DC, 1997) |
| "Hemorrhage was present in 9 cases of group B (21." | 1.30 | [Comparative study of 2 antithrombotic regimens in 75 patients with coronary endoprostheses]. ( Azaceta, G; Civeira, E; Cornudella, R; Iturbe, T; Moreno, JA; Olave, T; Peleato, J; Sánchez, C; Varo, MJ, 1997) |
| "Lesions with thrombus formation were found in four animals in the heparin/aspirin group and in nine animals in the control group." | 1.29 | Power and temperature guided radiofrequency catheter ablation of the right atrium in pigs. ( Aass, H; Amlie, JP; Foerster, A; Kongsgaard, E; Madsen, S, 1994) |
| "Aspirin was administered during the entire course, low molecular weight heparin (LMWH) preoperatively and as of the fourth postoperative (pOP) day and unfractionated heparin (UH) upon surgery and three days thereafter." | 1.29 | Platelet response to vascular surgery--a preliminary study on the effect of aspirin and heparin. ( Greinacher, A; Lasser, R; Reininger, AJ; Reininger, CB; Schweiberer, L; Steckmeier, B, 1994) |
| "Acute myocardial infarctions were registered in group 1 in 25% (11." | 1.29 | [Emergency intracoronary stent implantation: complications and experiences with 124 patients]. ( Arens, R; Heuer, H; Krakau, I; Müller, T; Rissel, U; Schulze-Waltrup, N; Willgeroth, W, 1994) |
| "Of practical implication in traumatology is the finding that, for both paracetamol and glucocorticoids, almost the same reductions were recorded in swelling and pain whether the drug was administered prior to surgery or 2-3 hours afterwards." | 1.29 | [Anti-inflammatory agents in acute tissue trauma. Choice and effects]. ( Løkken, P; Skjelbred, P, 1993) |
| "This difference in asymptomatic pulmonary embolism between the two groups was statistically significant." | 1.29 | Pneumatic compression or aspirin prophylaxis against thromboembolism in total hip arthroplasty. ( Holleman, JB; Kelley, S; Klein, JA; Lachiewicz, PF, 1996) |
| "The risk of death from pulmonary embolism was similarly diminished in the group that received warfarin." | 1.28 | Venous thromboembolism associated with hip and knee arthroplasty: current prophylactic practices and outcomes. ( Heit, JA; Ilstrup, DM; Mohr, DN; Morrey, BF; Silverstein, MD, 1992) |
| "The dicloxacillin-treated patients had an increase in creatinine and beta 2-microglobulin in serum that was not seen in the cloxacillin group." | 1.28 | Renal function after hip arthroplasty and isoxazolylpenicillin prophylaxis. ( Djerf, K; Ivarsson, I; Maller, R; Wahlström, O, 1992) |
| "Symptomatic pulmonary embolism occurred in 1." | 1.28 | The significance of calf thrombi after total knee arthroplasty. ( Becker, MW; Haas, SB; Insall, JN; Tribus, CB; Windsor, RE, 1992) |
| "It is concluded that aspirin does affect the platelet response to shear forces, but this requires higher dosage (greater than 300 mg/day), suggesting a mechanism probably different from that of interference with thromboxane formation." | 1.28 | High-dose aspirin inhibits shear-induced platelet reaction involving thrombin generation. ( Edmondson, SF; Kovacs, IB; Ratnatunga, CP; Rees, GM, 1992) |
| "Aspirin (650 mg) was given the night prior to surgery and continued at that dose twice per day." | 1.28 | Aspirin prophylaxis and surveillance of pulmonary embolism and deep vein thrombosis in total hip arthroplasty. ( Jones, K; Lachiewicz, PF; McCardel, BR, 1990) |
| "Heparin-associated thrombocytopenia is mediated through IgG or IgM immunoglobulin fractions and is believed to be an immune phenomenon, with heparin acting as a hapten." | 1.27 | Plasmapheresis in the management of heparin-associated thrombocytopenia with thrombosis. ( Nand, S; Robinson, JA, 1988) |
| "In 8 patients with liver cirrhosis who underwent hepatectomy, one patient with a prolonged T2 (260 secs) and a normal skin BT bled postoperatively, however, 3 patients with a prolonged skin BT (greater than 15 min) and a normal T2 had no hemorrhagic complications." | 1.27 | Clinical application of a new in vitro bleeding time device on surgical patients. ( Itoh, T; Kambayashi, J; Mori, T; Sakon, M; Tsujinaka, T; Uemura, Y, 1988) |
| " A prevention of thromboembolic disease by individual dosage of heparin must be considered in patients at high risk for thromboembolic disease." | 1.27 | [Mortality and morbidity of thromboembolism in drug prevention--5-year analysis]. ( Hopp, A; Hopp, H; Knispel, J, 1988) |
| "Aspirin was administered in the recovery room and continued 600 mg twice a day until discharge." | 1.27 | Activity, air boots, and aspirin as thromboembolism prophylaxis in knee arthroplasty. A multiple regimen approach. ( Clayton, ML; Thompson, TR, 1987) |
| "Thromboembolism was prospectively studied in 215 patients who survived aortic valve replacement with porcine bioprostheses." | 1.27 | Thromboembolism in patients with aortic porcine bioprostheses. ( Christakis, GT; David, TE; Ho, WI, 1985) |
| " There was no significant difference in the AUC-value between the two routes of administration, but a slower rate of absorption with no clear peak effect was found after rectal administration." | 1.26 | Bioavailability of rectal aspirin in neurosurgical patients. ( Kanto, J; Klossner, J; Mäntylä, R; Yrjänä, T, 1981) |
| "Aspirin treatment did not influence patency." | 1.26 | Delayed thrombosis of synthetic microvascular bypass grafts. ( Brittain, F; Reinert, RL; Weinstein, PR, 1981) |
| "Both indomethacin and aspirin were shown to prodcue a significant reduction in the acute ocular hypertension which can be expected to follow 6 hours after routine cataract surgery." | 1.26 | Prevention of postoperative ocular hypertension by prostaglandin inhibitors. ( Rich, WJ, 1977) |
| "It should also be of use in treating other fevers." | 1.26 | Rectal aspirin--absorption and antipyretic effect. ( Connolly, K; Lam, L; Ward, OC, 1979) |
| "Although thrombocytosis is a very common finding after splenectomy, the thromboembolic risk of postsplenectomy thrombocytosis has not been clarified." | 1.26 | Thromboembolic risk of postsplenectomy thrombocytosis. ( Boxer, MA; Braun, J; Ellman, L, 1978) |
| "Pretreatment with aspirin and intraoperative heparin irrigation of the vessel lumen were not beneficial in altering the quantity of thrombus." | 1.26 | Thrombus formation and endothelial alterations in microarterial anastomoses. ( Rosenbaum, TJ; Sundt, TM, 1977) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 314 (28.36) | 18.7374 |
| 1990's | 159 (14.36) | 18.2507 |
| 2000's | 188 (16.98) | 29.6817 |
| 2010's | 354 (31.98) | 24.3611 |
| 2020's | 92 (8.31) | 2.80 |
| Authors | Studies |
|---|---|
| Yashima, F | 1 |
| Inohara, T | 1 |
| Nishida, H | 1 |
| Shimoji, K | 1 |
| Ueno, K | 1 |
| Noma, S | 1 |
| Yamaji, K | 1 |
| Ishii, H | 1 |
| Tanaka, N | 1 |
| Kohsaka, S | 1 |
| Amano, T | 1 |
| Ikari, Y | 2 |
| Albisinni, S | 1 |
| Diamand, R | 1 |
| Mjaess, G | 1 |
| Assenmacher, G | 1 |
| Assenmacher, C | 1 |
| Loos, S | 1 |
| Verhoest, G | 2 |
| Holz, S | 1 |
| Naudin, M | 1 |
| Ploussard, G | 1 |
| Mari, A | 1 |
| Di Maida, F | 1 |
| Minervini, A | 1 |
| Aoun, F | 1 |
| Tay, A | 1 |
| Issa, R | 1 |
| Roumiguié, M | 1 |
| Bajeot, AS | 1 |
| Simone, G | 1 |
| Anceschi, U | 1 |
| Umari, P | 1 |
| Sridhar, A | 1 |
| Kelly, J | 1 |
| Hendricksen, K | 1 |
| Einerhand, S | 1 |
| Sanchez-Salas, R | 1 |
| Colomer, A | 1 |
| Quackels, T | 1 |
| Peltier, A | 1 |
| Montorsi, F | 1 |
| Briganti, A | 1 |
| Pradere, B | 2 |
| Moschini, M | 1 |
| Roumeguère, T | 1 |
| Cai, JY | 1 |
| Cui, CM | 1 |
| Min, JK | 1 |
| Cao, YQ | 1 |
| Zhang, LY | 1 |
| Goh, GS | 1 |
| Kozaily, E | 2 |
| Tan, TL | 3 |
| Parvizi, J | 12 |
| Søgaard, M | 1 |
| Nielsen, PB | 1 |
| Skjøth, F | 1 |
| Larsen, TB | 1 |
| Eldrup, N | 1 |
| Harino, T | 1 |
| Noura, S | 1 |
| Hamabe, A | 1 |
| Ogino, T | 1 |
| Takeyama, H | 1 |
| Suzuki, Y | 1 |
| Tanida, T | 1 |
| Tomita, N | 1 |
| Dono, K | 1 |
| Rothweiler, R | 1 |
| Gerlach, V | 1 |
| Voss, P | 1 |
| Poxleitner, P | 1 |
| Ermer, M | 1 |
| Gross, C | 1 |
| Schwer, C | 1 |
| Vach, K | 1 |
| Kalbhenn, J | 1 |
| Metzger, M | 1 |
| Jenny, JY | 1 |
| Didier, A | 1 |
| De Ladoucette, A | 1 |
| Ludwick, L | 1 |
| Shohat, N | 2 |
| Van Nest, D | 1 |
| Paladino, J | 1 |
| Ledesma, J | 1 |
| Mittal, A | 1 |
| Tamer, P | 1 |
| Shah, I | 1 |
| Cortes, A | 1 |
| Hinman, AD | 1 |
| Martinazzi, BJ | 1 |
| Kirchner, GJ | 1 |
| Stauch, CM | 1 |
| Lorenz, FJ | 1 |
| Manto, KM | 1 |
| Bonaddio, V | 1 |
| Koroneos, Z | 1 |
| Aynardi, MC | 1 |
| Sidhu, VS | 4 |
| Kelly, TL | 2 |
| Pratt, N | 1 |
| Graves, SE | 2 |
| Buchbinder, R | 2 |
| Adie, S | 3 |
| Cashman, K | 1 |
| Ackerman, I | 1 |
| Bastiras, D | 1 |
| Brighton, R | 1 |
| Burns, AWR | 1 |
| Chong, BH | 2 |
| Clavisi, O | 2 |
| Cripps, M | 2 |
| Dekkers, M | 1 |
| de Steiger, R | 1 |
| Dixon, M | 1 |
| Ellis, A | 1 |
| Griffith, EC | 2 |
| Hale, D | 1 |
| Hansen, A | 2 |
| Harris, A | 3 |
| Hau, R | 1 |
| Horsley, M | 2 |
| James, D | 1 |
| Khorshid, O | 1 |
| Kuo, L | 1 |
| Lewis, P | 1 |
| Lieu, D | 2 |
| Lorimer, M | 2 |
| MacDessi, S | 1 |
| McCombe, P | 1 |
| McDougall, C | 1 |
| Mulford, J | 1 |
| Naylor, JM | 3 |
| Page, RS | 1 |
| Radovanovic, J | 1 |
| Solomon, M | 1 |
| Sorial, R | 1 |
| Summersell, P | 1 |
| Tran, P | 1 |
| Walter, WL | 1 |
| Webb, S | 2 |
| Wilson, C | 1 |
| Wysocki, D | 1 |
| Harris, IA | 5 |
| Beltrán de Heredia, S | 1 |
| Mases, A | 1 |
| Recasens, L | 1 |
| Sabaté, S | 2 |
| Núñez, M | 1 |
| Bosch, L | 1 |
| Roman, L | 1 |
| Rueda, M | 1 |
| Alonso, E | 1 |
| Gallart, L | 1 |
| Hsu, CH | 1 |
| Chen, CH | 1 |
| Hsu, NC | 1 |
| Hsu, CC | 1 |
| Hsu, CJ | 1 |
| Wei, JC | 1 |
| DeMik, DE | 1 |
| Mont, MA | 3 |
| Dunbar, M | 2 |
| Walker, R | 1 |
| Kim, RG | 1 |
| Agarwal, AR | 1 |
| Das, A | 1 |
| Campbell, JC | 1 |
| Golladay, GJ | 1 |
| Thakkar, SC | 1 |
| Kulkarni, NS | 1 |
| Singh, G | 1 |
| Prentice, HA | 1 |
| Winston, BA | 1 |
| Kroger, EW | 1 |
| Liu, FC | 1 |
| Miller, TJ | 1 |
| Henn, D | 1 |
| Nguyen, D | 1 |
| Momeni, A | 1 |
| Poacher, AT | 1 |
| Hoskins, HC | 1 |
| Protty, MB | 1 |
| Pettit, R | 1 |
| Johansen, A | 1 |
| Tsai, SW | 1 |
| Chang, WL | 1 |
| Pai, FY | 1 |
| Chou, TA | 1 |
| Chen, CF | 1 |
| Wu, PK | 1 |
| Chen, WM | 1 |
| Rychen, J | 1 |
| Weiger, VF | 1 |
| Halbeisen, FS | 1 |
| Ebel, F | 1 |
| Ullmann, M | 1 |
| Mariani, L | 2 |
| Guzman, R | 1 |
| Soleman, J | 1 |
| Mao, X | 1 |
| Liang, C | 1 |
| Li, X | 2 |
| Shi, D | 1 |
| Yang, Q | 2 |
| Xie, H | 1 |
| Liang, F | 1 |
| Cui, Y | 1 |
| Liu, H | 3 |
| Li, J | 1 |
| Chen, M | 1 |
| Yang, T | 3 |
| Ruan, Z | 1 |
| Su, J | 1 |
| Xing, Y | 1 |
| Shaw, JH | 1 |
| Kadri, OM | 1 |
| Les, CM | 1 |
| Charters, M | 1 |
| Samama, CM | 1 |
| Fan, KL | 1 |
| Black, CK | 1 |
| Abbate, O | 1 |
| Lu, K | 1 |
| Camden, RC | 1 |
| Evans, KK | 1 |
| Yan, Z | 1 |
| Liu, Y | 1 |
| Ruze, R | 1 |
| Xiong, Y | 1 |
| Han, H | 1 |
| Zhan, H | 1 |
| Wang, M | 1 |
| Zhang, G | 1 |
| Manista, GC | 1 |
| Batko, BD | 1 |
| Sexton, AC | 1 |
| Edmiston, TA | 1 |
| Courtney, PM | 1 |
| Hannon, CP | 1 |
| Levine, BR | 1 |
| Watari, J | 1 |
| Tomita, T | 1 |
| Tozawa, K | 1 |
| Oshima, T | 1 |
| Fukui, H | 1 |
| Miwa, H | 1 |
| Watanabe, H | 1 |
| Domei, T | 1 |
| Morimoto, T | 1 |
| Natsuaki, M | 1 |
| Shiomi, H | 1 |
| Toyota, T | 1 |
| Ohya, M | 1 |
| Suwa, S | 1 |
| Takagi, K | 1 |
| Nanasato, M | 1 |
| Hata, Y | 1 |
| Yagi, M | 1 |
| Suematsu, N | 1 |
| Yokomatsu, T | 1 |
| Takamisawa, I | 1 |
| Doi, M | 1 |
| Noda, T | 1 |
| Okayama, H | 1 |
| Seino, Y | 1 |
| Tada, T | 1 |
| Sakamoto, H | 1 |
| Hibi, K | 1 |
| Abe, M | 1 |
| Kawai, K | 1 |
| Nakao, K | 1 |
| Ando, K | 1 |
| Tanabe, K | 1 |
| Hanaoka, KI | 1 |
| Morino, Y | 1 |
| Kozuma, K | 1 |
| Kadota, K | 1 |
| Furukawa, Y | 1 |
| Nakagawa, Y | 1 |
| Kimura, T | 1 |
| Jastifer, J | 1 |
| Manson, W | 1 |
| Smith, B | 1 |
| Cooper, MT | 1 |
| Brigido, SA | 1 |
| Li, WT | 1 |
| Klement, MR | 1 |
| Foltz, C | 2 |
| Sinensky, A | 1 |
| Yazdi, H | 1 |
| Aboul-Hassan, SS | 4 |
| Stankowski, T | 4 |
| Marczak, J | 4 |
| Peksa, M | 3 |
| Nawotka, M | 3 |
| Stanislawski, R | 3 |
| Cichon, R | 4 |
| Huang, Q | 1 |
| Xing, SX | 1 |
| Zeng, Y | 1 |
| Si, HB | 1 |
| Zhou, ZK | 1 |
| Shen, B | 1 |
| Davis, BH | 1 |
| DeFrank, G | 1 |
| Limdi, NA | 1 |
| Harada, S | 1 |
| Pratt, NL | 1 |
| de Steiger, RS | 1 |
| Ackerman, IN | 1 |
| Anandan, D | 1 |
| O'Donohue, G | 1 |
| Bianco, M | 1 |
| D'ascenzo, F | 1 |
| Raposeiras Roubin, S | 1 |
| Kinnaird, T | 1 |
| Peyracchia, M | 1 |
| Ariza-Solé, A | 1 |
| Cerrato, E | 1 |
| Manzano-Fernández, S | 1 |
| Gravinese, C | 1 |
| Templin, C | 1 |
| Destefanis, P | 1 |
| Velicki, L | 1 |
| Luciano, A | 1 |
| Xanthopoulou, I | 1 |
| Rinaldi, M | 1 |
| Rognoni, A | 1 |
| Varbella, F | 1 |
| Boccuzzi, G | 1 |
| Omedè, P | 1 |
| Montabone, A | 1 |
| Bernardi, A | 1 |
| Taha, S | 1 |
| Rossini, R | 2 |
| Durante, A | 1 |
| Gili, S | 1 |
| Magnani, G | 2 |
| Autelli, M | 1 |
| Grosso, A | 1 |
| Blanco, PF | 1 |
| Giustetto, C | 1 |
| Garay, A | 1 |
| Quadri, G | 1 |
| Queija, BC | 1 |
| Srdanovic, I | 1 |
| Paz, RC | 1 |
| Fernández, MC | 1 |
| Pousa, IM | 1 |
| Gallo, D | 1 |
| Morbiducci, U | 1 |
| Dominguez-Rodriguez, A | 1 |
| Lopez-Cuenca, Á | 1 |
| Cequier, A | 1 |
| Alexopoulos, D | 1 |
| Iñiguez-Romo, A | 1 |
| Pozzi, R | 1 |
| Assi, EA | 1 |
| Valgimigli, M | 7 |
| Lazar, HL | 2 |
| Pellegrini, VD | 1 |
| Eikelboom, J | 2 |
| McCollister Evarts, C | 1 |
| Franklin, PD | 1 |
| Goldhaber, SZ | 1 |
| Iorio, R | 3 |
| Lambourne, CA | 1 |
| Magaziner, JS | 1 |
| Magder, LS | 1 |
| Kashou, AH | 1 |
| May, AM | 1 |
| Noseworthy, PA | 1 |
| Bemme, S | 1 |
| Lauermann, P | 1 |
| Striebe, NA | 1 |
| Khattab, MH | 1 |
| Affeldt, J | 1 |
| Callizo, J | 1 |
| Bertelmann, T | 1 |
| Pfeiffer, S | 1 |
| Hoerauf, H | 1 |
| Feltgen, N | 1 |
| Choi, JH | 1 |
| Paik, WH | 1 |
| You, MS | 1 |
| Lee, KJ | 1 |
| Choi, YH | 1 |
| Shin, BS | 1 |
| Lee, SH | 1 |
| Ryu, JK | 1 |
| Kim, YT | 1 |
| Murphy, RF | 1 |
| Williams, D | 1 |
| Hogue, GD | 1 |
| Spence, DD | 1 |
| Epps, H | 1 |
| Chambers, HG | 1 |
| Shore, BJ | 1 |
| Matharu, GS | 1 |
| Kunutsor, SK | 1 |
| Judge, A | 1 |
| Blom, AW | 2 |
| Whitehouse, MR | 1 |
| Sessler, DI | 7 |
| Conen, D | 1 |
| Leslie, K | 6 |
| Yusuf, S | 5 |
| Popova, E | 4 |
| Graham, M | 2 |
| Kurz, A | 6 |
| Villar, JC | 5 |
| Mrkobrada, M | 6 |
| Sigamani, A | 4 |
| Biccard, BM | 5 |
| Meyhoff, CS | 6 |
| Parlow, JL | 3 |
| Guyatt, G | 5 |
| Xavier, D | 3 |
| Chan, MTV | 3 |
| Kumar, PA | 3 |
| Forget, P | 3 |
| Malaga, G | 4 |
| Fleischmann, E | 5 |
| Amir, M | 5 |
| Torres, D | 4 |
| Wang, CY | 2 |
| Paniagua, P | 2 |
| Berwanger, O | 2 |
| Srinathan, S | 4 |
| Landoni, G | 3 |
| Manach, YL | 1 |
| Whitlock, R | 5 |
| Lamy, A | 3 |
| Balasubramanian, K | 3 |
| Gilron, I | 1 |
| Turan, A | 1 |
| Pettit, S | 2 |
| Devereaux, PJ | 10 |
| Kuthiah, N | 1 |
| Er, C | 1 |
| Baber, U | 3 |
| Zafar, MU | 1 |
| Dangas, G | 4 |
| Escolar, G | 1 |
| Angiolillo, DJ | 5 |
| Sharma, SK | 1 |
| Kini, AS | 1 |
| Sartori, S | 3 |
| Joyce, L | 1 |
| Vogel, B | 1 |
| Farhan, S | 1 |
| Gurbel, P | 1 |
| Gibson, CM | 3 |
| Fuster, V | 8 |
| Mehran, R | 5 |
| Badimon, JJ | 1 |
| Beller, JP | 1 |
| Chancellor, WZ | 1 |
| Mehaffey, JH | 1 |
| Hawkins, RB | 1 |
| Byler, MR | 1 |
| Speir, AM | 1 |
| Quader, MA | 1 |
| Kiser, AC | 1 |
| Yarboro, LT | 1 |
| Ailawadi, G | 1 |
| Teman, NR | 1 |
| Millar, JS | 1 |
| Lawes, CM | 1 |
| Farrington, B | 1 |
| Andrew, P | 1 |
| Misur, P | 1 |
| Merriman, E | 2 |
| Walker, M | 1 |
| Khan, SU | 1 |
| Osman, M | 2 |
| Khan, MU | 1 |
| Khan, MS | 1 |
| Zhao, D | 2 |
| Mamas, MA | 1 |
| Savji, N | 1 |
| Al-Abdouh, A | 1 |
| Hasan, RK | 1 |
| Michos, ED | 1 |
| Naito, S | 1 |
| Fujikawa, T | 3 |
| Hasegawa, S | 1 |
| Briguori, C | 3 |
| Cohen, DJ | 4 |
| Mehta, SR | 1 |
| Chandiramani, R | 2 |
| Huber, K | 4 |
| Kornowski, R | 2 |
| Weisz, G | 3 |
| Kunadian, V | 2 |
| Oldroyd, KG | 1 |
| Ya-Ling, H | 2 |
| Kaul, U | 2 |
| Witzenbichler, B | 4 |
| Dudek, D | 3 |
| Sardella, G | 3 |
| Escaned, J | 2 |
| Sharma, S | 3 |
| Shlofmitz, RA | 1 |
| Collier, T | 2 |
| Pocock, S | 2 |
| Giustino, G | 2 |
| Mehta, S | 1 |
| Oldroyd, K | 1 |
| Shlofmitz, R | 1 |
| Ní Cheallaigh, S | 1 |
| Fleming, A | 1 |
| Dahly, D | 1 |
| Kehoe, E | 1 |
| O'Byrne, JM | 1 |
| McGrath, B | 1 |
| O'Connell, C | 1 |
| Sahm, LJ | 1 |
| Li, Q | 1 |
| Shen, X | 1 |
| Wang, S | 1 |
| Su, T | 1 |
| Yan, K | 1 |
| Zhang, Y | 2 |
| Qian, Y | 1 |
| Jiang, J | 1 |
| Zhang, P | 1 |
| Wang, Z | 3 |
| Perrotta, C | 1 |
| Chahla, J | 1 |
| Badariotti, G | 1 |
| Ramos, J | 1 |
| Mill, J | 1 |
| Olivares, AL | 1 |
| Arzamendi, D | 1 |
| Agudelo, V | 1 |
| Regueiro, A | 1 |
| Camara, O | 1 |
| Freixa, X | 1 |
| Verdoia, M | 1 |
| Khedi, E | 1 |
| Suryapranata, H | 2 |
| De Luca, G | 1 |
| O'Donoghue, ML | 1 |
| Murphy, SA | 1 |
| Sabatine, MS | 1 |
| Gonzalez Della Valle, A | 3 |
| Shanaghan, KA | 1 |
| Nguyen, J | 1 |
| Liu, J | 1 |
| Memtsoudis, S | 1 |
| Sharrock, NE | 2 |
| Salvati, EA | 5 |
| Cheng, D | 1 |
| Zhao, S | 1 |
| Hao, Y | 1 |
| Xanthopoulos, A | 1 |
| Tryposkiadis, K | 1 |
| Triposkiadis, F | 1 |
| Fukamachi, K | 1 |
| Soltesz, EG | 1 |
| Young, JB | 1 |
| Wolski, K | 1 |
| Blackstone, EH | 1 |
| Starling, RC | 2 |
| Oh, TK | 1 |
| Im, C | 1 |
| Song, IA | 1 |
| Smilowitz, NR | 2 |
| Berger, JS | 2 |
| Biagioni, RB | 1 |
| Lopes, RD | 4 |
| Agati, LB | 1 |
| Sacilotto, R | 1 |
| Wolosker, N | 1 |
| Sobreira, ML | 1 |
| de Freitas Soares, BL | 1 |
| Joviliano, EE | 1 |
| Bernardi, WH | 1 |
| Junior, VC | 1 |
| Caffaro, RA | 1 |
| Fioranelli, A | 1 |
| Van Bellen, B | 1 |
| Casella, IB | 1 |
| Fidelis, RJR | 1 |
| Flumignan, RLG | 1 |
| Comerota, AJ | 1 |
| Ramacciotti, E | 1 |
| Singh, V | 1 |
| Shahi, A | 1 |
| Saleh, U | 1 |
| Tarabichi, S | 1 |
| Oliashirazi, A | 1 |
| Santana, DC | 1 |
| Emara, AK | 1 |
| Orr, MN | 1 |
| Klika, AK | 2 |
| Higuera, CA | 2 |
| Krebs, VE | 1 |
| Molloy, RM | 1 |
| Piuzzi, NS | 2 |
| Tang, A | 2 |
| Zak, SG | 1 |
| Waren, D | 1 |
| Slover, JD | 1 |
| Bosco, JA | 1 |
| Schwarzkopf, R | 3 |
| Syed, M | 1 |
| Balla, S | 1 |
| Kheiri, B | 1 |
| Golwala, H | 1 |
| Zahr, F | 1 |
| Yerasi, C | 1 |
| Case, BC | 1 |
| Forrestal, BJ | 1 |
| Torguson, R | 1 |
| Weintraub, WS | 1 |
| Garcia-Garcia, HM | 1 |
| Waksman, R | 2 |
| Wintzer-Wehekind, J | 1 |
| Horlick, E | 1 |
| Ibrahim, R | 1 |
| Cheema, AN | 1 |
| Labinaz, M | 2 |
| Nadeem, N | 1 |
| Osten, M | 1 |
| Côté, M | 1 |
| Marsal, JR | 1 |
| Rivest, D | 1 |
| Marrero, A | 1 |
| Houde, C | 2 |
| Rodés-Cabau, J | 1 |
| Ashkenazi, I | 1 |
| Schermann, H | 1 |
| Gold, A | 1 |
| Gurel, R | 1 |
| Chechik, O | 1 |
| Warschawski, Y | 1 |
| Snir, N | 1 |
| Aleksova, N | 1 |
| Brahmbhatt, DH | 1 |
| Kiamanesh, O | 1 |
| Petropoulos, JA | 1 |
| Chang, Y | 1 |
| Chih, S | 1 |
| Ross, HJ | 1 |
| Zak, S | 1 |
| Lygrisse, K | 1 |
| Slover, J | 1 |
| Meftah, M | 1 |
| Lajam, C | 1 |
| Macaulay, W | 1 |
| Taha, A | 1 |
| Nielsen, SJ | 1 |
| Bergfeldt, L | 1 |
| Ahlsson, A | 1 |
| Friberg, L | 1 |
| Björck, S | 1 |
| Franzén, S | 1 |
| Jeppsson, A | 2 |
| Pellegrini, C | 1 |
| Xhepa, E | 1 |
| Ndrepepa, G | 1 |
| Alvarez-Covarrubias, H | 1 |
| Kufner, S | 1 |
| Lahmann, AL | 1 |
| Rheude, T | 1 |
| Rai, H | 1 |
| Mayr, NP | 1 |
| Schunkert, H | 2 |
| Kastrati, A | 3 |
| Joner, M | 1 |
| Cassese, S | 1 |
| Sakai, T | 1 |
| Aokage, K | 1 |
| Katsumata, S | 1 |
| Tane, K | 1 |
| Miyoshi, T | 1 |
| Tsuboi, M | 1 |
| Kanamori, F | 1 |
| Araki, Y | 1 |
| Yokoyama, K | 1 |
| Uda, K | 1 |
| Mamiya, T | 1 |
| Nishihori, M | 1 |
| Izumi, T | 1 |
| Okamoto, S | 1 |
| Natsume, A | 1 |
| Horev, A | 1 |
| Zlotnik, Y | 1 |
| Borodetsky, V | 1 |
| Biederko, R | 1 |
| Star, M | 1 |
| Zvenigorodsky, V | 1 |
| Shelef, I | 1 |
| Ifergane, G | 1 |
| Kirsch, JM | 1 |
| Gutman, M | 1 |
| Patel, M | 1 |
| Rondon, A | 1 |
| Ramsey, ML | 1 |
| Abboud, JA | 2 |
| Williams, GR | 1 |
| Namdari, S | 1 |
| McIntire, SC | 1 |
| Bernstein, EM | 1 |
| Tompane, TM | 1 |
| Briggs, AM | 1 |
| Ferris, WJ | 1 |
| Renninger, CH | 1 |
| McDonald, LS | 1 |
| Hurvitz, AP | 1 |
| Attard, C | 1 |
| Monagle, PT | 1 |
| d'Udekem, Y | 1 |
| Mackay, MT | 1 |
| Briody, J | 1 |
| Cordina, R | 1 |
| Hassan, EB | 1 |
| Simm, P | 1 |
| Rice, K | 1 |
| Ignjatovic, V | 1 |
| Hu, B | 1 |
| Jiang, L | 1 |
| Tang, H | 1 |
| Hu, M | 1 |
| Yu, J | 1 |
| Dai, Z | 1 |
| Borton, ZM | 1 |
| Bhangoo, NS | 1 |
| Quah, CS | 1 |
| Stephen, AB | 1 |
| Howard, PW | 2 |
| Grosso, MJ | 1 |
| Austin, MS | 2 |
| Ge, Z | 1 |
| Gao, XF | 1 |
| Kan, J | 1 |
| Kong, XQ | 1 |
| Zuo, GF | 1 |
| Ye, F | 1 |
| Tian, NL | 1 |
| Lin, S | 1 |
| Liu, ZZ | 1 |
| Shao, YB | 1 |
| He, YQ | 1 |
| Wen, SY | 1 |
| Xia, Y | 1 |
| Wang, ZZ | 1 |
| Xiao, PX | 1 |
| Li, F | 1 |
| Zeng, HS | 1 |
| Yang, S | 1 |
| Wang, Y | 1 |
| Tao, L | 1 |
| Gao, DS | 1 |
| Qu, H | 1 |
| Qian, XS | 1 |
| Han, YL | 1 |
| Chen, F | 1 |
| Zhang, JJ | 1 |
| Chen, SL | 1 |
| Surianarayanan, V | 1 |
| Hoather, TJ | 1 |
| Tingle, SJ | 1 |
| Thompson, ER | 1 |
| Hanley, J | 1 |
| Wilson, CH | 1 |
| Wang, Q | 2 |
| Yang, K | 1 |
| Omari, AM | 1 |
| Parcells, BW | 1 |
| Levine, HB | 1 |
| Seidenstein, A | 1 |
| Klein, GR | 1 |
| Hovik, O | 1 |
| Amlie, EJ | 1 |
| Jenssen, KK | 1 |
| Halbur, CR | 1 |
| Gulbrandsen, TR | 1 |
| West, CR | 1 |
| Brown, TS | 1 |
| Noiseux, NO | 1 |
| Ifuku, T | 1 |
| Nishiguchi, T | 1 |
| Johnson, SA | 1 |
| Jones, AE | 1 |
| Young, E | 1 |
| Jennings, C | 1 |
| Simon, K | 1 |
| Fleming, RP | 1 |
| Witt, DM | 1 |
| Benedetto, U | 1 |
| Altman, DG | 1 |
| Gerry, S | 1 |
| Gray, A | 1 |
| Lees, B | 1 |
| Flather, M | 1 |
| Taggart, DP | 1 |
| Korepta, LM | 1 |
| Watson, JJ | 1 |
| Mansour, MA | 1 |
| Chambers, CM | 1 |
| Cuff, RF | 1 |
| Slaikeu, JD | 1 |
| Wong, PY | 2 |
| Snyder, MA | 1 |
| Sympson, AN | 1 |
| Zan, P | 1 |
| Li, G | 1 |
| Hage, A | 1 |
| Jacques, F | 1 |
| Chetaille, P | 1 |
| Bourdages, M | 1 |
| Cloutier, K | 1 |
| Perron, J | 1 |
| Kim, S | 1 |
| Ahn, H | 1 |
| Shin, SA | 1 |
| Park, JH | 1 |
| Won, CW | 1 |
| Chu, JN | 1 |
| Maselli, J | 2 |
| Auerbach, AD | 3 |
| Fang, MC | 2 |
| Yhim, HY | 1 |
| Lee, J | 1 |
| Lee, JY | 1 |
| Lee, JO | 1 |
| Bang, SM | 1 |
| Bala, A | 1 |
| Huddleston, JI | 1 |
| Goodman, SB | 1 |
| Maloney, WJ | 1 |
| Amanatullah, DF | 1 |
| Hansson, EC | 1 |
| Ceylan, HH | 1 |
| Kucukdurmaz, F | 1 |
| Merli, G | 1 |
| Tuncay, I | 1 |
| Beverland, D | 1 |
| Zhao, Y | 3 |
| Zhang, Q | 1 |
| Zhang, D | 1 |
| Gordon, RJ | 1 |
| Lombard, FW | 1 |
| Emani, S | 1 |
| Zurakowski, D | 1 |
| Mulone, M | 1 |
| DiNardo, JA | 1 |
| Trenor, CC | 1 |
| Emani, SM | 1 |
| Zheng, J | 1 |
| Xiang, Y | 1 |
| Chen, X | 1 |
| Jin, Y | 1 |
| Jones, CW | 1 |
| Spasojevic, S | 1 |
| Goh, G | 1 |
| Joseph, Z | 1 |
| Wood, DJ | 1 |
| Yates, PJ | 1 |
| Garfinkel, JH | 1 |
| Gladnick, BP | 1 |
| Roland, N | 1 |
| Romness, DW | 1 |
| Pearcy, C | 1 |
| Almahmoud, K | 1 |
| Jackson, T | 1 |
| Hartline, C | 1 |
| Cahill, A | 1 |
| Spence, L | 1 |
| Kim, D | 1 |
| Olatubosun, O | 1 |
| Todd, SR | 1 |
| Campion, EM | 1 |
| Burlew, CC | 1 |
| Regner, J | 1 |
| Frazee, R | 1 |
| Michaels, D | 1 |
| Dissanaike, S | 1 |
| Stewart, C | 1 |
| Foley, N | 1 |
| Nelson, P | 1 |
| Agrawal, V | 1 |
| Truitt, MS | 1 |
| Peled, Y | 1 |
| Lavee, J | 1 |
| Raichlin, E | 1 |
| Katz, M | 1 |
| Arad, M | 1 |
| Kassif, Y | 1 |
| Peled, A | 1 |
| Asher, E | 1 |
| Elian, D | 1 |
| Har-Zahav, Y | 1 |
| Shlomo, N | 1 |
| Freimark, D | 1 |
| Goldenberg, I | 1 |
| Klempfner, R | 1 |
| Azboy, I | 1 |
| Barrack, R | 1 |
| Thomas, AM | 1 |
| Haddad, FS | 2 |
| Otto, BJ | 1 |
| Terry, RS | 1 |
| Lutfi, FG | 1 |
| Syed, JS | 1 |
| Hamann, HC | 1 |
| Gupta, M | 1 |
| Bird, VG | 1 |
| Llau, JV | 1 |
| Kamphuisen, P | 1 |
| Albaladejo, P | 3 |
| Graham, MM | 1 |
| Cook, DJ | 1 |
| Tandon, V | 1 |
| Alvarez-Garcia, J | 1 |
| Painter, TW | 2 |
| Le Manach, Y | 2 |
| Aphang-Lam, M | 1 |
| Cata, JP | 3 |
| Gao, P | 2 |
| Terblanche, NCS | 1 |
| Ramana, PV | 1 |
| Jamieson, KA | 1 |
| Bessissow, A | 1 |
| Mendoza, GR | 1 |
| Ramirez, S | 1 |
| Diemunsch, PA | 1 |
| Fluschnik, N | 1 |
| Becher, PM | 1 |
| Schnabel, R | 1 |
| Blankenberg, S | 1 |
| Westermann, D | 1 |
| Kryszkowski, B | 1 |
| Mendez, GM | 1 |
| Patel, YM | 1 |
| Ricketti, DA | 1 |
| Gaughan, JP | 1 |
| Lackman, RD | 1 |
| Kim, TWB | 1 |
| Sultan, SM | 1 |
| Jackson, DS | 1 |
| Erhard, HA | 1 |
| Greenspun, DT | 1 |
| Benacquista, T | 1 |
| Garfein, ES | 1 |
| Weichman, KE | 1 |
| Goel, R | 1 |
| Fleischman, AN | 1 |
| Tan, T | 1 |
| Sterbis, E | 1 |
| Huang, R | 3 |
| Higuera, C | 2 |
| Rothman, RH | 2 |
| Consolo, F | 1 |
| Pozzi, L | 1 |
| Sferrazza, G | 1 |
| Della Valle, P | 1 |
| D'Angelo, A | 3 |
| Slepian, MJ | 1 |
| Pappalardo, F | 1 |
| Ebrahimi, R | 1 |
| Gupta, S | 1 |
| Carr, BM | 1 |
| Bishawi, M | 1 |
| Bakaeen, FG | 1 |
| Almassi, GH | 1 |
| Collins, J | 1 |
| Grover, FL | 1 |
| Quin, JA | 2 |
| Wagner, TH | 1 |
| Shroyer, ALW | 1 |
| Hattler, B | 1 |
| Kopin, D | 1 |
| Jones, WS | 1 |
| Sherwood, MW | 1 |
| Wojdyla, DM | 1 |
| Wallentin, L | 1 |
| Lewis, BS | 1 |
| Verheugt, FWA | 1 |
| Vinereanu, D | 1 |
| Bahit, MC | 1 |
| Halvorsen, S | 1 |
| Parkhomenko, A | 1 |
| Granger, CB | 1 |
| Alexander, JH | 3 |
| Anderson, DR | 2 |
| Murnaghan, J | 1 |
| Kahn, SR | 2 |
| Gross, P | 1 |
| Forsythe, M | 1 |
| Pelet, S | 1 |
| Fisher, W | 1 |
| Belzile, E | 1 |
| Dolan, S | 1 |
| Crowther, M | 1 |
| Bohm, E | 1 |
| MacDonald, SJ | 1 |
| Gofton, W | 1 |
| Kim, P | 2 |
| Zukor, D | 1 |
| Pleasance, S | 1 |
| Andreou, P | 1 |
| Doucette, S | 1 |
| Theriault, C | 1 |
| Abianui, A | 1 |
| Carrier, M | 2 |
| Kovacs, MJ | 2 |
| Rodger, MA | 1 |
| Coyle, D | 1 |
| Wells, PS | 2 |
| Vendittoli, PA | 1 |
| Jermini-Gianinazzi, I | 1 |
| Bhogal, P | 1 |
| Ganslandt, O | 1 |
| Bäzner, H | 1 |
| Henkes, H | 1 |
| Aguilar Perez, M | 1 |
| Raheja, H | 1 |
| Garg, A | 1 |
| Goel, S | 1 |
| Banerjee, K | 1 |
| Hollander, G | 1 |
| Shani, J | 1 |
| Mick, S | 1 |
| White, J | 1 |
| Krishnaswamy, A | 1 |
| Kapadia, S | 1 |
| Wolff, G | 1 |
| Navarese, EP | 2 |
| Brockmeyer, M | 1 |
| Lin, Y | 1 |
| Karathanos, A | 1 |
| Kołodziejczak, M | 1 |
| Kubica, J | 1 |
| Polzin, A | 1 |
| Zeus, T | 1 |
| Westenfeld, R | 1 |
| Andreotti, F | 1 |
| Kelm, M | 1 |
| Schulze, V | 1 |
| Lippi, G | 1 |
| Cervellin, G | 1 |
| Faour, M | 1 |
| Brigati, DP | 1 |
| Barsoum, WK | 1 |
| Sheldon, SH | 1 |
| Cunnane, R | 1 |
| Lavu, M | 1 |
| Parikh, V | 1 |
| Atkins, D | 1 |
| Reddy, YM | 1 |
| Berenbom, LD | 1 |
| Emert, MP | 1 |
| Pimentel, R | 1 |
| Dendi, R | 1 |
| Lakkireddy, DR | 1 |
| Tsukiyama, Y | 2 |
| Kozuki, A | 1 |
| Shinke, T | 2 |
| Otake, H | 2 |
| Kijima, Y | 1 |
| Masano, T | 1 |
| Nagoshi, R | 1 |
| Shibata, H | 1 |
| Takeshige, R | 2 |
| Yanaka, KI | 1 |
| Shite, J | 2 |
| Hirata, KI | 2 |
| Wang, A | 1 |
| Wu, A | 1 |
| Wojdyla, D | 1 |
| Newby, LK | 3 |
| Newman, MF | 1 |
| Smith, PK | 2 |
| Beiswenger, AC | 1 |
| Jo, A | 1 |
| Harth, K | 1 |
| Kumins, NH | 1 |
| Shishehbor, MH | 1 |
| Kashyap, VS | 1 |
| Steurer, J | 2 |
| Puskas, JD | 1 |
| Gerdisch, M | 1 |
| Nichols, D | 1 |
| Fermin, L | 1 |
| Rhenman, B | 1 |
| Kapoor, D | 1 |
| Copeland, J | 1 |
| Quinn, R | 1 |
| Hughes, GC | 1 |
| Azar, H | 1 |
| McGrath, M | 1 |
| Wait, M | 1 |
| Kong, B | 1 |
| Martin, T | 1 |
| Douville, EC | 1 |
| Meyer, S | 1 |
| Ye, J | 2 |
| Jamieson, WRE | 1 |
| Landvater, L | 1 |
| Hagberg, R | 1 |
| Trotter, T | 1 |
| Armitage, J | 1 |
| Askew, J | 1 |
| Accola, K | 1 |
| Levy, P | 1 |
| Duncan, D | 1 |
| Yanagawa, B | 1 |
| Ely, J | 1 |
| Graeve, A | 1 |
| Uber, AM | 1 |
| Montez-Rath, ME | 1 |
| Kwiatkowski, DM | 1 |
| Krawczeski, CD | 1 |
| Sutherland, SM | 1 |
| Tittley, JG | 1 |
| Rapanos, T | 1 |
| Harlock, J | 1 |
| Szalay, D | 1 |
| Tiboni, ME | 1 |
| Vásquez, SM | 1 |
| Kabon, B | 1 |
| Mehra, BR | 1 |
| El Beheiry, H | 1 |
| Mata, E | 1 |
| Tena, B | 1 |
| Zainal Abidin, MK | 1 |
| Shah, VR | 1 |
| Chan, NC | 1 |
| Weitz, JI | 2 |
| Kitano, T | 1 |
| Matsubara, S | 1 |
| Uno, M | 1 |
| Yagita, Y | 1 |
| Xu, Q | 2 |
| Lv, Q | 1 |
| Kahlenberg, CA | 1 |
| Richardson, SS | 2 |
| Schairer, WW | 2 |
| Sculco, PK | 2 |
| Güzeltaş, A | 1 |
| Tanıdır, İC | 1 |
| Gökalp, S | 1 |
| Haydin, S | 1 |
| Bawa, H | 1 |
| Weick, JW | 1 |
| Dirschl, DR | 1 |
| Luu, HH | 1 |
| Smith, BB | 1 |
| Warner, MA | 1 |
| Warner, NS | 1 |
| Hanson, AC | 1 |
| Smith, MM | 1 |
| Rihal, CS | 1 |
| Gulati, R | 1 |
| Bell, MR | 1 |
| Nuttall, GA | 1 |
| Hasselgren, M | 1 |
| Runer, T | 1 |
| Janson, P | 1 |
| Ekström, M | 1 |
| Quintanilla-González, L | 1 |
| Torres-Villalobos, G | 1 |
| Hinojosa-Azaola, A | 1 |
| Greci, M | 1 |
| Russo, M | 1 |
| Pellegrino, A | 1 |
| Bassano, C | 1 |
| Nardi, P | 1 |
| Ruvolo, G | 1 |
| Wernly, B | 1 |
| Lichtenauer, M | 1 |
| Hoppe, UC | 1 |
| Lauten, A | 1 |
| Jung, C | 1 |
| Hackenberg, KAM | 1 |
| Hänggi, D | 1 |
| Etminan, N | 1 |
| Santillan, A | 1 |
| Knopman, J | 1 |
| Patsalides, A | 1 |
| Pierre Gobin, Y | 1 |
| Geraiely, B | 1 |
| Poorhosseini, H | 1 |
| Sadeghian, S | 1 |
| Sattarzadeh Badkoubeh, R | 1 |
| Mortazavi, SH | 1 |
| Berganza, FM | 1 |
| Gonzalez de Alba, C | 1 |
| Egbe, AC | 1 |
| Bartakian, S | 1 |
| Brownlee, J | 1 |
| Ng, C | 1 |
| Zavala, S | 1 |
| Davis, ES | 1 |
| Adams, W | 1 |
| Pinzur, MS | 1 |
| Bravata, DM | 1 |
| Coffing, JM | 1 |
| Kansagara, D | 1 |
| Myers, J | 1 |
| Murphy, L | 1 |
| Homoya, BJ | 1 |
| Perkins, AJ | 1 |
| Snow, K | 1 |
| Myers, LJ | 1 |
| Toba, T | 1 |
| Sugizaki, Y | 1 |
| Onishi, H | 1 |
| Nagasawa, A | 1 |
| Yanaka, K | 1 |
| Nagano, Y | 1 |
| Yamamoto, H | 1 |
| Kawamori, H | 1 |
| Matsuura, A | 1 |
| Ishihara, T | 1 |
| Matsumoto, D | 1 |
| Igarashi, N | 1 |
| Hayashi, T | 2 |
| Yasaka, Y | 1 |
| Kadotani, M | 1 |
| Fujii, T | 1 |
| Okada, M | 1 |
| Sakakibara, T | 1 |
| Woon, CYL | 1 |
| Shah, RR | 1 |
| Pardi, BM | 1 |
| Schwartz, BE | 1 |
| Goldstein, JM | 1 |
| Cipparrone, NE | 1 |
| Goldstein, WM | 1 |
| Alyea, E | 1 |
| Gaston, T | 1 |
| Austin, LS | 1 |
| Wowkanech, C | 1 |
| Cypel, B | 1 |
| Pontes, M | 1 |
| Williams, G | 1 |
| Bostrom, MP | 1 |
| Saini, A | 1 |
| Joshi, AD | 1 |
| Cowan, KM | 1 |
| Wayne Gatewood, C | 1 |
| Kumar, STK | 1 |
| Allen, J | 1 |
| Shah, SH | 1 |
| Nouer, SS | 1 |
| Jones, T | 1 |
| Knott-Craig, CJ | 1 |
| Boston, US | 1 |
| Vidale, S | 1 |
| Agostoni, E | 1 |
| Grampa, G | 1 |
| Consoli, A | 1 |
| Consoli, D | 1 |
| Wessels, F | 1 |
| Kriegmair, MC | 1 |
| Oehme, A | 1 |
| Rassweiler-Seyfried, MC | 1 |
| Erben, P | 1 |
| Oberneder, R | 1 |
| Kriegmair, M | 1 |
| Ritter, M | 1 |
| Michel, MS | 1 |
| Honeck, P | 1 |
| Bai, DS | 2 |
| Xia, BL | 2 |
| Zhang, C | 1 |
| Qian, JJ | 2 |
| Jin, SJ | 2 |
| Jiang, GQ | 2 |
| Rondon, AJ | 1 |
| Goswami, K | 1 |
| Huang, RC | 1 |
| Finn, MT | 1 |
| Redfors, B | 2 |
| Karmpaliotis, D | 1 |
| Kirtane, AJ | 3 |
| Green, P | 1 |
| McAndrew, T | 1 |
| Liu, M | 1 |
| Cloney, MB | 1 |
| Stuckey, TD | 1 |
| Brodie, BR | 1 |
| Rinaldi, MJ | 2 |
| Neumann, FJ | 3 |
| Metzger, DC | 1 |
| Henry, TD | 1 |
| Cox, DA | 1 |
| Duffy, PL | 1 |
| Mazzaferri, EL | 1 |
| Stone, GW | 5 |
| Mihara, M | 1 |
| Tamaki, Y | 1 |
| Nakura, N | 1 |
| Takayanagi, S | 1 |
| Saito, A | 1 |
| Ochiai, S | 1 |
| Hirakawa, K | 1 |
| Chen, AF | 3 |
| Siqueira, M | 1 |
| Hansen, EN | 1 |
| Sing, DC | 1 |
| Murillo, M | 1 |
| Vadhariya, A | 1 |
| Wilson, A | 1 |
| Putney, D | 1 |
| Muntz, J | 1 |
| Erkut, B | 1 |
| Ates, A | 1 |
| Szczeklik, W | 1 |
| Tatarunas, V | 1 |
| Kupstyte-Kristapone, N | 1 |
| Norvilaite, R | 1 |
| Tamakauskas, V | 1 |
| Skipskis, V | 1 |
| Audrone, V | 1 |
| Jurgaityte, J | 1 |
| Stuoka, M | 1 |
| Lesauskaite, V | 1 |
| Pina, LM | 1 |
| Dong, X | 1 |
| Zhang, L | 1 |
| Samtani, MN | 1 |
| Michelson, AD | 1 |
| Justino, H | 1 |
| Bonnet, D | 1 |
| Harris, KC | 1 |
| Jefferies, J | 1 |
| McCrindle, BW | 2 |
| Li, JS | 1 |
| Boening, A | 1 |
| von Scheidt, M | 1 |
| Lanig, C | 1 |
| Gusmini, F | 1 |
| de Waha, A | 1 |
| Kuna, C | 1 |
| Fach, A | 1 |
| Grothusen, C | 1 |
| Oberhoffer, M | 1 |
| Knosalla, C | 1 |
| Walther, T | 1 |
| Danner, BC | 1 |
| Misfeld, M | 1 |
| Zeymer, U | 1 |
| Wimmer-Greinecker, G | 1 |
| Siepe, M | 1 |
| Grubitzsch, H | 2 |
| Joost, A | 1 |
| Schaefer, A | 1 |
| Conradi, L | 1 |
| Cremer, J | 1 |
| Hamm, C | 1 |
| Lange, R | 1 |
| Radke, PW | 1 |
| Schulz, R | 1 |
| Laufer, G | 1 |
| Grieshaber, P | 1 |
| Pader, P | 1 |
| Attmann, T | 1 |
| Schmoeckel, M | 1 |
| Meyer, A | 1 |
| Ziegelhöffer, T | 1 |
| Hambrecht, R | 1 |
| Sandner, SE | 1 |
| Yoshimoto, Y | 1 |
| Tanaka, A | 2 |
| Hayashi, H | 1 |
| Shimoike, N | 1 |
| Kawamoto, H | 1 |
| Nakasuga, C | 1 |
| Yamamoto, T | 1 |
| Ishihara, S | 1 |
| Ito, K | 1 |
| Okada, S | 1 |
| Shimomura, M | 1 |
| Shimada, J | 1 |
| Yamaguchi, T | 1 |
| Inoue, M | 1 |
| Galvis, V | 1 |
| Tello, A | 1 |
| Carreño, NI | 1 |
| Sánchez, WA | 1 |
| Frederick, GA | 1 |
| Blanco, NA | 1 |
| Woo, PYM | 1 |
| Ng, BCF | 1 |
| Xiao, JX | 1 |
| Wong, D | 1 |
| Seto, A | 1 |
| Lam, S | 1 |
| Yim, C | 1 |
| Lo, HY | 1 |
| Po, YC | 1 |
| Wong, LYW | 1 |
| Lee, MWY | 1 |
| Yam, KY | 1 |
| Pu, JKS | 1 |
| Chan, KY | 1 |
| Poon, WS | 1 |
| Bogunovic, L | 1 |
| Haas, AK | 1 |
| Brophy, RH | 1 |
| Matava, MJ | 1 |
| Smith, MV | 1 |
| Wright, RW | 1 |
| Kerr, DL | 1 |
| Butler, S | 1 |
| Read, AC | 1 |
| Baumgartner, C | 1 |
| Wester, A | 1 |
| Attar, R | 1 |
| Mohammad, MA | 1 |
| Andell, P | 1 |
| Hofmann, R | 1 |
| Jensen, J | 1 |
| Szummer, K | 1 |
| Erlinge, D | 1 |
| Koul, S | 1 |
| Lynch, DR | 1 |
| Dantzler, D | 1 |
| Robbins, M | 1 |
| Chen, HC | 1 |
| Chen, YL | 1 |
| Guo, BF | 1 |
| Tsai, TH | 1 |
| Chang, JP | 1 |
| Pan, KL | 1 |
| Lin, YS | 1 |
| Chen, MC | 1 |
| Deo, SV | 1 |
| Dunlay, SM | 1 |
| Shah, IK | 1 |
| Altarabsheh, SE | 1 |
| Erwin, PJ | 1 |
| Boilson, BA | 1 |
| Park, SJ | 1 |
| Joyce, LD | 1 |
| Lau, WC | 1 |
| Froehlich, JB | 1 |
| Jewell, ES | 1 |
| Montgomery, DG | 1 |
| Eng, KM | 1 |
| Shields, TA | 1 |
| Henke, PK | 2 |
| Eagle, KA | 2 |
| Golan, S | 1 |
| Levkovitch-Verbin, H | 1 |
| Shemesh, G | 1 |
| Kurtz, S | 1 |
| Marullo, AG | 1 |
| Iacò, AL | 1 |
| Calafiore, AM | 1 |
| Eley, KA | 1 |
| Parker, RJ | 1 |
| Watt-Smith, SR | 1 |
| Duytschaever, M | 1 |
| Berte, B | 1 |
| Acena, M | 1 |
| De Meyer, G | 1 |
| Bun, SS | 1 |
| Van Heuverswyn, F | 1 |
| Vandekerckhove, Y | 1 |
| Tavernier, R | 1 |
| Jayaprasad, K | 1 |
| Mathew, J | 1 |
| Thankappan, K | 1 |
| Sharma, M | 1 |
| Duraisamy, S | 1 |
| Rajan, S | 1 |
| Paul, J | 1 |
| Iyer, S | 2 |
| Jussen, D | 1 |
| Horn, P | 1 |
| Vajkoczy, P | 1 |
| Petricevic, M | 5 |
| Biocina, B | 5 |
| Konosic, S | 2 |
| Burcar, I | 1 |
| Shao, IH | 1 |
| Hou, CP | 1 |
| Chen, SM | 1 |
| Chen, CL | 1 |
| Lin, YH | 1 |
| Chang, PL | 1 |
| Tsui, KH | 1 |
| Suri, RM | 1 |
| Thourani, VH | 1 |
| He, X | 1 |
| Brennan, JM | 1 |
| O'Brien, SM | 1 |
| Rankin, JS | 1 |
| Schaff, HV | 3 |
| Gammie, JS | 2 |
| Terrando, N | 1 |
| Gómez-Galán, M | 1 |
| Carlström, M | 1 |
| Gustavsson, D | 1 |
| Harding, RE | 1 |
| Lindskog, M | 1 |
| Eriksson, LI | 1 |
| Tanrıkulu, A | 1 |
| Ağırbaşlı, M | 1 |
| Scherner, M | 1 |
| Hekmat, K | 1 |
| Madershahian, N | 1 |
| Hellmich, M | 1 |
| Wahlers, T | 1 |
| Sun, J | 3 |
| Young, N | 2 |
| Yao, L | 1 |
| Silvestry, S | 3 |
| Sun, W | 2 |
| Zhao, N | 3 |
| Diehl, J | 3 |
| Lamberts, M | 1 |
| Gislason, GH | 1 |
| Olesen, JB | 1 |
| Kristensen, SL | 1 |
| Schjerning Olsen, AM | 1 |
| Mikkelsen, A | 1 |
| Christensen, CB | 1 |
| Lip, GY | 1 |
| Køber, L | 2 |
| Torp-Pedersen, C | 1 |
| Hansen, ML | 1 |
| López, J | 1 |
| Morales, C | 1 |
| Avanzas, P | 1 |
| Callejo, F | 1 |
| Hernández-Vaquero, D | 1 |
| Llosa, JC | 1 |
| Efthymiou, CA | 1 |
| Mills, RJ | 1 |
| O'Regan, DJ | 1 |
| Durães, AR | 1 |
| Durães, MA | 1 |
| Correia, LC | 1 |
| Aras, R | 1 |
| Mohammadi, R | 1 |
| Amini, K | 1 |
| Abdollahi-Pirbazari, M | 1 |
| Yousefi, A | 1 |
| Campo, G | 2 |
| Tebaldi, M | 3 |
| Vranckx, P | 2 |
| Biscaglia, S | 1 |
| Tumscitz, C | 1 |
| Ferrari, R | 1 |
| Benahmed, A | 1 |
| Kianda, M | 1 |
| Ghisdal, L | 1 |
| Broeders, N | 1 |
| Massart, A | 1 |
| Lemy, A | 1 |
| Mikhalski, D | 1 |
| Hoang, AD | 1 |
| Donckier, V | 1 |
| Sadis, C | 1 |
| Le Moine, A | 1 |
| Madhoun, P | 1 |
| Racapé, J | 1 |
| Wissing, M | 1 |
| Abramowicz, D | 1 |
| Calderaro, D | 1 |
| Pastana, AF | 1 |
| Flores da Rocha, TR | 1 |
| Yu, PC | 1 |
| Gualandro, DM | 1 |
| DeLuccia, N | 1 |
| D' Amico, EA | 1 |
| Caramelli, B | 1 |
| Miceli, A | 2 |
| Angelini, GD | 2 |
| Rubino, AS | 1 |
| Della Corte, A | 1 |
| Giordano, R | 1 |
| Menicanti, L | 1 |
| Garg, AX | 3 |
| Cuerden, M | 2 |
| Robinson, A | 3 |
| Parikh, C | 1 |
| Mizera, R | 3 |
| Jones, PM | 3 |
| Tiboni, M | 3 |
| Rodriguez, RG | 1 |
| Rojas Gomez, MF | 1 |
| Vanhelder, T | 3 |
| Chan, MT | 4 |
| Parlow, J | 2 |
| de Nadal Clanchet, M | 2 |
| Bidgoli, SJ | 2 |
| Pasin, L | 3 |
| Martinsen, K | 2 |
| Myles, P | 2 |
| Acedillo, R | 2 |
| Roshanov, P | 1 |
| Walsh, M | 3 |
| Dresser, G | 2 |
| Kumar, P | 2 |
| Painter, T | 5 |
| Biccard, B | 2 |
| Bergese, S | 2 |
| Chan, V | 3 |
| Mehra, B | 2 |
| Gasparovic, H | 2 |
| Kopjar, T | 2 |
| Djuric, Z | 1 |
| Svetina, L | 3 |
| Vaishnava, P | 1 |
| Alonso-Coello, P | 3 |
| Rodseth, RN | 1 |
| Botto, F | 1 |
| Lurati Buse, G | 1 |
| Cook, D | 2 |
| Pogue, J | 1 |
| Kearon, C | 4 |
| Baigent, C | 1 |
| Chow, C | 1 |
| Chrolavicius, S | 1 |
| Murray, AM | 1 |
| Keville, N | 1 |
| Gray, S | 1 |
| Geach, T | 1 |
| Oestreich, JH | 1 |
| Dobesh, PP | 1 |
| Nammas, W | 1 |
| Raatikainen, MJ | 1 |
| Korkeila, P | 1 |
| Lund, J | 1 |
| Ylitalo, A | 2 |
| Karjalainen, P | 2 |
| Virtanen, V | 1 |
| Koivisto, UM | 1 |
| Utriainen, S | 1 |
| Vasankari, T | 1 |
| Koistinen, J | 1 |
| Airaksinen, KE | 2 |
| Sfakianos, JP | 1 |
| Hakimi, AA | 1 |
| Kim, PH | 1 |
| Zabor, EC | 1 |
| Mano, R | 1 |
| Bernstein, M | 1 |
| Karellas, M | 1 |
| Russo, P | 1 |
| Treschan, TA | 1 |
| Kienbaum, P | 1 |
| Mitka, M | 1 |
| Gerstein, NS | 1 |
| Charlton, GA | 1 |
| Mårtensson, J | 1 |
| Bellomo, R | 1 |
| Parekh, P | 1 |
| Agrawal, N | 1 |
| Vasavada, A | 1 |
| Vinchurkar, M | 1 |
| Khan, J | 1 |
| Uhm, JS | 1 |
| Won, H | 1 |
| Joung, B | 1 |
| Nam, GB | 1 |
| Choi, KJ | 1 |
| Lee, MH | 1 |
| Kim, YH | 3 |
| Pak, HN | 1 |
| Basili, S | 1 |
| Tanzilli, G | 1 |
| Raparelli, V | 1 |
| Calvieri, C | 1 |
| Pignatelli, P | 1 |
| Carnevale, R | 1 |
| Dominici, M | 1 |
| Placanica, A | 1 |
| Arrivi, A | 1 |
| Farcomeni, A | 1 |
| Barillà, F | 1 |
| Mangieri, E | 1 |
| Violi, F | 1 |
| Escobar, C | 1 |
| Divisón, JA | 1 |
| Seguí Díaz, M | 1 |
| Kalil, DM | 1 |
| Silvestro, LS | 1 |
| Austin, PN | 1 |
| Winkle, RA | 1 |
| Mead, RH | 1 |
| Engel, G | 1 |
| Kong, MH | 1 |
| Patrawala, RA | 1 |
| Poujol-Robert, A | 1 |
| Boëlle, PY | 1 |
| Conti, F | 1 |
| Durand, F | 1 |
| Duvoux, C | 1 |
| Wendum, D | 1 |
| Paradis, V | 1 |
| Mackiewicz, V | 1 |
| Chazouillères, O | 1 |
| Corpechot, C | 1 |
| Poupon, R | 1 |
| Lader, E | 1 |
| Daels, FP | 1 |
| Gaizauskas, A | 1 |
| Rioja, J | 1 |
| Varshney, AK | 1 |
| Erkan, E | 1 |
| Ozgok, Y | 1 |
| Melekos, M | 1 |
| de la Rosette, JJ | 1 |
| Une, D | 1 |
| Al-Atassi, T | 2 |
| Kulik, A | 3 |
| Voisine, P | 1 |
| Le May, M | 1 |
| Ruel, M | 4 |
| Piątek, B | 1 |
| Piwnik, M | 1 |
| Podgórski, M | 1 |
| Strzelczyk, J | 1 |
| Torborg, A | 1 |
| Ryan, L | 1 |
| Kantor, G | 1 |
| Zamora-Berridi, G | 1 |
| Englesbe, MJ | 1 |
| Cai, S | 1 |
| Brooks, L | 1 |
| McKeown, E | 1 |
| Phillips, L | 1 |
| Lau, W | 1 |
| Campbell, DC | 1 |
| Barmparas, G | 1 |
| Jain, M | 1 |
| Mehrzadi, D | 1 |
| Melo, N | 1 |
| Chung, R | 1 |
| Bloom, M | 1 |
| Ley, EJ | 1 |
| Margulies, DR | 1 |
| Heinzl, S | 1 |
| Patel, PA | 1 |
| Fleisher, LA | 1 |
| Serak, J | 1 |
| Wang, MY | 1 |
| Pinnarelli, L | 1 |
| Mayer, F | 1 |
| Bauleo, L | 1 |
| Agabiti, N | 1 |
| Kirchmayer, U | 1 |
| Belleudi, V | 1 |
| Di Martino, M | 1 |
| Autore, C | 1 |
| Ricci, R | 1 |
| Violini, R | 1 |
| Fusco, D | 1 |
| Davoli, M | 1 |
| Perucci, CA | 1 |
| Deng, Y | 1 |
| Pisklak, PV | 1 |
| Lee, VV | 1 |
| Tolpin, DA | 1 |
| Collard, CD | 1 |
| Elayda, MA | 1 |
| Coselli, J | 1 |
| Pan, W | 1 |
| Schrör, K | 1 |
| Nitschmann, S | 1 |
| Parikh, CR | 1 |
| Font, A | 1 |
| Cegarra, V | 1 |
| Gomez, MF | 1 |
| Clanchet, Mde N | 1 |
| Roshanov, PS | 1 |
| Wijeysundera, DN | 3 |
| Leavitt, DA | 2 |
| Theckumparampil, N | 1 |
| Moreira, DM | 2 |
| Elsamra, SE | 1 |
| Morganstern, B | 1 |
| Hoenig, DM | 1 |
| Smith, AD | 1 |
| Okeke, Z | 1 |
| Gilard, M | 3 |
| Barragan, P | 1 |
| Noryani, AAL | 1 |
| Noor, HA | 1 |
| Majwal, T | 1 |
| Hovasse, T | 1 |
| Castellant, P | 1 |
| Schneeberger, M | 1 |
| Maillard, L | 1 |
| Bressolette, E | 1 |
| Wojcik, J | 1 |
| Delarche, N | 1 |
| Blanchard, D | 1 |
| Jouve, B | 1 |
| Ormezzano, O | 1 |
| Paganelli, F | 2 |
| Levy, G | 1 |
| Sainsous, J | 1 |
| Carrie, D | 1 |
| Furber, A | 1 |
| Berland, J | 1 |
| Darremont, O | 1 |
| Le Breton, H | 1 |
| Lyuycx-Bore, A | 1 |
| Gommeaux, A | 1 |
| Cassat, C | 1 |
| Kermarrec, A | 1 |
| Cazaux, P | 1 |
| Druelles, P | 1 |
| Dauphin, R | 1 |
| Armengaud, J | 1 |
| Dupouy, P | 1 |
| Champagnac, D | 1 |
| Ohlmann, P | 1 |
| Endresen, K | 1 |
| Benamer, H | 1 |
| Kiss, RG | 1 |
| Ungi, I | 2 |
| Boschat, J | 1 |
| Morice, MC | 4 |
| Tomkiewicz-Pajak, L | 1 |
| Wojcik, T | 1 |
| Chłopicki, S | 1 |
| Olszowska, M | 1 |
| Pajak, J | 1 |
| Podolec, J | 1 |
| Sitek, B | 1 |
| Musiałek, P | 1 |
| Rubis, P | 1 |
| Komar, M | 1 |
| Podolec, P | 1 |
| Wang, JT | 1 |
| Dong, MF | 1 |
| Song, GM | 1 |
| Ma, ZS | 1 |
| Ma, SJ | 1 |
| Wu, H | 1 |
| Wang, J | 1 |
| Sun, H | 1 |
| Lv, B | 1 |
| Wang, X | 2 |
| Hu, X | 1 |
| Ma, W | 1 |
| Zhang, J | 1 |
| Wada, N | 1 |
| Okazaki, S | 1 |
| Kobayashi, S | 1 |
| Hashizume, K | 1 |
| Hori, J | 1 |
| Azumi, M | 1 |
| Kita, M | 1 |
| Iwata, T | 1 |
| Matsumoto, S | 1 |
| Kakizaki, H | 1 |
| Brillat, E | 1 |
| Rouberol, F | 2 |
| Palombi, K | 2 |
| Quesada, JL | 1 |
| Bernheim, D | 1 |
| Aptel, F | 2 |
| Romanet, JP | 2 |
| Chiquet, C | 2 |
| Gallice, M | 1 |
| Brillat Zaratzian, E | 1 |
| Lawrie, GM | 1 |
| Garg, P | 1 |
| Galper, BZ | 1 |
| Yeh, RW | 4 |
| Mauri, L | 5 |
| Cegarra-Sanmartin, V | 1 |
| Paniagua-Iglesias, P | 1 |
| Plou, P | 1 |
| Mata Mena, E | 1 |
| Fernández-Riveira, C | 1 |
| García del Valle, S | 1 |
| Tena Blanco, B | 1 |
| Sabaté Tenas, S | 1 |
| Font Gual, A | 1 |
| Maestre Hittinger, ML | 1 |
| González Rodríguez, R | 1 |
| Patialiakas, A | 1 |
| Thury, A | 1 |
| McFadden, E | 1 |
| Colangelo, S | 1 |
| Tondi, S | 1 |
| Roffi, M | 1 |
| Menozzi, A | 1 |
| de Cesare, N | 1 |
| Garbo, R | 1 |
| Meliga, E | 2 |
| Testa, L | 2 |
| Gabriel, HM | 1 |
| Airoldi, F | 2 |
| Ferlini, M | 1 |
| Liistro, F | 1 |
| Dellavalle, A | 1 |
| Kereiakes, DJ | 4 |
| Steg, PG | 1 |
| Windecker, S | 2 |
| Gershlick, AH | 4 |
| Cutlip, DE | 1 |
| Tanguay, JF | 1 |
| Jacobs, A | 1 |
| Wiviott, SD | 1 |
| Massaro, JM | 1 |
| Iancu, AC | 1 |
| Zalawadiya, SK | 1 |
| Lindenfeld, J | 1 |
| DiSalvo, T | 1 |
| Maki, M | 1 |
| Tsubochi, H | 1 |
| Endo, T | 1 |
| Endo, S | 1 |
| Kiberd, MB | 1 |
| Hall, RI | 1 |
| Gandhi, S | 1 |
| Schwalm, JD | 1 |
| Velianou, JL | 1 |
| Natarajan, MK | 1 |
| Farkouh, ME | 2 |
| Ginsel, BL | 1 |
| Taher, A | 1 |
| Whitehouse, SL | 1 |
| Bell, JJ | 1 |
| Pulle, CR | 1 |
| Crawford, RW | 1 |
| Lee, YS | 1 |
| Jin, CD | 1 |
| Kim, MH | 2 |
| Guo, LZ | 1 |
| Cho, YR | 1 |
| Park, K | 1 |
| Park, JS | 1 |
| Park, TH | 1 |
| Kim, YD | 1 |
| Asopa, V | 1 |
| Cobain, W | 1 |
| Martin, D | 2 |
| Keene, G | 1 |
| Bauze, A | 1 |
| Yudi, MB | 1 |
| Eccleston, D | 1 |
| Andrianopoulos, N | 1 |
| Farouque, O | 1 |
| Duffy, SJ | 1 |
| Brennan, A | 1 |
| Reid, C | 1 |
| Clark, DJ | 1 |
| Ajani, AE | 1 |
| Capodanno, D | 1 |
| Musumeci, G | 1 |
| Lettieri, C | 1 |
| Limbruno, U | 1 |
| Senni, M | 2 |
| Guagliumi, G | 1 |
| Valsecchi, O | 1 |
| Cuellar, JM | 1 |
| Petrizzo, A | 1 |
| Vaswani, R | 1 |
| Goldstein, JA | 1 |
| Bendo, JA | 1 |
| Pierce, TP | 1 |
| Elmallah, RK | 1 |
| Jauregui, JJ | 1 |
| Cherian, JJ | 1 |
| Sahebally, SM | 1 |
| Healy, D | 1 |
| Walsh, SR | 1 |
| Viecelli, AK | 1 |
| Pascoe, E | 1 |
| Polkinghorne, KR | 1 |
| Hawley, C | 1 |
| Paul-Brent, PA | 1 |
| Badve, SV | 1 |
| Cass, A | 1 |
| Heritier, S | 1 |
| Kerr, PG | 1 |
| Mori, TA | 1 |
| Robertson, A | 1 |
| Seong, HL | 1 |
| Irish, AB | 1 |
| Madhavan, MV | 1 |
| Généreux, P | 2 |
| Xu, K | 1 |
| Ong, WL | 1 |
| Koh, TL | 1 |
| Fletcher, J | 1 |
| Gruen, R | 1 |
| Royce, P | 1 |
| Capranzano, P | 1 |
| Castiglioni, B | 1 |
| Siasos, G | 1 |
| Oikonomou, E | 1 |
| Zaromitidou, M | 1 |
| Kioufis, S | 1 |
| Kokkou, E | 1 |
| Mourouzis, K | 1 |
| Vlasis, K | 1 |
| Vavuranakis, M | 1 |
| Stone, PH | 1 |
| Papavassiliou, AG | 1 |
| Tousoulis, D | 1 |
| Pottegård, A | 1 |
| García Rodríguez, LA | 1 |
| Poulsen, FR | 1 |
| Hallas, J | 1 |
| Gaist, D | 1 |
| Brener, SJ | 1 |
| Maehara, A | 1 |
| Mintz, GS | 1 |
| de Bruyne, B | 1 |
| Serruys, PW | 1 |
| Milicic, D | 2 |
| van der Wall, SJ | 1 |
| Umans, VA | 1 |
| Schotten, J | 1 |
| Keijzers, M | 1 |
| Wolterbeek, R | 1 |
| Jansen, EK | 1 |
| Huisman, MV | 1 |
| Vonk, AB | 1 |
| Golukhova, EZ | 1 |
| Grigorian, MV | 1 |
| Ryabinina, MN | 1 |
| Bulaeva, NI | 1 |
| Fortmann, S | 1 |
| Serebruany, VL | 1 |
| Alsaied, T | 1 |
| Alsidawi, S | 1 |
| Allen, CC | 1 |
| Faircloth, J | 1 |
| Palumbo, JS | 1 |
| Veldtman, GR | 1 |
| Costa, F | 1 |
| Wong, P | 1 |
| Tesoro, E | 1 |
| Aletich, V | 1 |
| Alaraj, A | 2 |
| Rivera, CM | 1 |
| Copeland, LA | 1 |
| McNeal, CJ | 1 |
| Mortensen, EM | 1 |
| Pugh, MJ | 1 |
| MacCarthy, DJ | 1 |
| DeNino, WF | 1 |
| Floroff, C | 1 |
| Uber, WE | 1 |
| Ikonomidis, JS | 1 |
| van den Bergh, WM | 2 |
| Lansink-Hartgring, AO | 1 |
| van Duijn, AL | 1 |
| Engström, AE | 1 |
| Lahpor, JR | 1 |
| Slooter, AJ | 1 |
| Ganeshan, R | 1 |
| Malm, B | 1 |
| Concato, J | 1 |
| Keheila, M | 1 |
| Siev, M | 1 |
| Shah, PH | 1 |
| George, AK | 1 |
| Salami, SS | 1 |
| Schwartz, MJ | 1 |
| Richstone, L | 1 |
| Vira, MA | 1 |
| Kavoussi, LR | 1 |
| Kim, JY | 1 |
| Choi, YS | 1 |
| Kwon, A | 1 |
| Chung, WB | 1 |
| Park, CS | 1 |
| Kim, HY | 1 |
| Chang, K | 1 |
| Lee, MY | 1 |
| Chung, WS | 1 |
| Seung, KB | 1 |
| Yang, H | 1 |
| Li, Y | 1 |
| Jiang, Y | 1 |
| Hunter, JB | 1 |
| Carlson, ML | 1 |
| Sweeney, AD | 1 |
| Tombers, NM | 1 |
| Wanna, GB | 1 |
| Driscoll, CL | 1 |
| Haynes, DS | 1 |
| Na, YG | 1 |
| Fang, R | 1 |
| Cho, KJ | 1 |
| Kim, TK | 1 |
| Miao, SG | 1 |
| Zhang, XG | 1 |
| Lu, JH | 1 |
| Yang, Y | 1 |
| Lu, N | 2 |
| Valenti, A | 1 |
| Casutt, A | 1 |
| Koutsokera, A | 1 |
| Noetzli, J | 1 |
| Perentes, JY | 1 |
| Krueger, T | 1 |
| Pons, M | 1 |
| Nicod, LP | 1 |
| Lovis, A | 1 |
| Mospan, CM | 1 |
| Wąsowicz, M | 1 |
| Syed, S | 1 |
| Starzyk, Ł | 1 |
| Grewal, D | 1 |
| Ragoonanan, T | 1 |
| Harsha, P | 1 |
| Travis, G | 1 |
| Carroll, J | 1 |
| Karkouti, K | 1 |
| Beattie, WS | 1 |
| Nijenhuis, VJ | 1 |
| Bennaghmouch, N | 1 |
| Hassell, M | 1 |
| Baan, J | 1 |
| van Kuijk, JP | 2 |
| Agostoni, P | 2 |
| van 't Hof, A | 1 |
| Kievit, PC | 1 |
| Veenstra, L | 1 |
| van der Harst, P | 1 |
| van den Heuvel, AF | 1 |
| den Heijer, P | 1 |
| Kelder, JC | 3 |
| Deneer, VH | 1 |
| van der Kley, F | 1 |
| Onorati, F | 1 |
| Collet, JP | 3 |
| Maisano, F | 1 |
| Latib, A | 2 |
| Stella, PR | 1 |
| Ten Berg, JM | 3 |
| Mayor, S | 1 |
| Myles, PS | 4 |
| Smith, JA | 3 |
| Forbes, A | 2 |
| Silbert, B | 2 |
| Jayarajah, M | 2 |
| Cooper, DJ | 2 |
| Marasco, S | 2 |
| McNeil, J | 2 |
| Bussières, JS | 2 |
| Wallace, S | 2 |
| Klee, K | 1 |
| Gawaz, M | 1 |
| Meyer-Zürn, CS | 1 |
| Dad, T | 1 |
| Tighiouart, H | 1 |
| Joseph, A | 1 |
| Bostom, A | 1 |
| Carpenter, M | 1 |
| Hunsicker, L | 1 |
| Kusek, JW | 1 |
| Pfeffer, M | 1 |
| Levey, AS | 1 |
| Weiner, DE | 1 |
| Lim, GB | 1 |
| Verspohl, EJ | 1 |
| Kim, MS | 1 |
| Jo, KI | 1 |
| Yeon, JY | 1 |
| Kim, JS | 2 |
| Kim, KH | 1 |
| Jeon, P | 1 |
| Hong, SC | 1 |
| Chen, P | 1 |
| Zuo, SQ | 1 |
| Hastings, S | 1 |
| McIlroy, DR | 1 |
| Deirmengian, GK | 1 |
| Heller, S | 1 |
| Smith, EB | 1 |
| Maltenfort, M | 1 |
| Ong, W | 1 |
| Shen, T | 1 |
| Tan, WB | 1 |
| Lomanto, D | 1 |
| Hummel, T | 1 |
| Meves, SH | 1 |
| Rüdiger, K | 1 |
| Mügge, A | 1 |
| Mumme, A | 1 |
| Burkert, B | 1 |
| Mühlberger, D | 1 |
| Neubauer, H | 1 |
| Oltmann, SC | 1 |
| Alhefdhi, AY | 1 |
| Rajaei, MH | 1 |
| Schneider, DF | 1 |
| Sippel, RS | 1 |
| Chen, H | 1 |
| Bayley, E | 1 |
| Brown, S | 1 |
| Bhamber, NS | 1 |
| Zhang, F | 1 |
| Liu, L | 1 |
| Dadjou, Y | 1 |
| Safavi, S | 1 |
| Kojuri, J | 1 |
| Takahashi, K | 1 |
| Ito, H | 1 |
| Katsube, T | 1 |
| Tsuboi, A | 1 |
| Hashimoto, M | 1 |
| Ota, E | 1 |
| Mita, K | 1 |
| Asakawa, H | 1 |
| Fujino, K | 1 |
| Morrison, ML | 1 |
| Lockhart, CJ | 1 |
| Grant, B | 1 |
| Morici, N | 1 |
| Perna, E | 1 |
| Cipriani, M | 1 |
| Femia, EA | 1 |
| Oliva, F | 1 |
| Frigerio, M | 1 |
| Cattaneo, M | 1 |
| Alkhodair, A | 1 |
| Cairns, J | 1 |
| Li, WW | 1 |
| Wollersheim, LW | 1 |
| Morshuis, WJ | 1 |
| Westerman, ME | 1 |
| Sharma, V | 1 |
| Scales, J | 1 |
| Gearman, DJ | 1 |
| Ingimarsson, JP | 1 |
| Krambeck, AE | 1 |
| Engheta, A | 1 |
| Hadadi Abianeh, S | 1 |
| Atri, A | 1 |
| Sanatkarfar, M | 1 |
| Essandoh, MK | 1 |
| Dalia, AA | 1 |
| George, BS | 2 |
| Flores, AS | 1 |
| Otey, AJ | 1 |
| Broderick, TM | 1 |
| Rao, SV | 1 |
| Prates, PR | 1 |
| Williams, JB | 1 |
| Mehta, RH | 2 |
| Stevens, SR | 1 |
| Thomas, L | 1 |
| Kalil, RA | 1 |
| Shabani, S | 1 |
| Nguyen, HS | 1 |
| Doan, N | 1 |
| Baisden, JL | 1 |
| Chieffo, A | 2 |
| Palmerini, T | 1 |
| Feres, F | 1 |
| Abizaid, A | 1 |
| Costa, RA | 1 |
| Hong, MK | 1 |
| Kim, BK | 1 |
| Jang, Y | 1 |
| Kim, HS | 2 |
| Park, KW | 2 |
| Sawaya, F | 1 |
| Leon, MB | 2 |
| Bhatt, DL | 3 |
| Colombo, A | 6 |
| Eikelboom, JW | 2 |
| Douketis, J | 2 |
| Patel, A | 1 |
| Allard, R | 1 |
| Dennis, RJ | 1 |
| Bergese, SD | 1 |
| Duceppe, E | 1 |
| Miller, S | 1 |
| Diedericks, J | 1 |
| Peyronnet, B | 1 |
| Seisen, T | 1 |
| Khene, Z | 1 |
| Ruggiero, M | 1 |
| Vaessen, C | 1 |
| Mathieu, R | 1 |
| Roupret, M | 1 |
| Bensalah, K | 1 |
| Sedat, J | 1 |
| Chau, Y | 1 |
| Gaudart, J | 1 |
| Sachet, M | 1 |
| Beuil, S | 1 |
| Lonjon, M | 1 |
| Tamarappoo, BK | 1 |
| Klein, AL | 1 |
| Fichter, AM | 1 |
| Ritschl, LM | 1 |
| Robitzky, LK | 1 |
| Wagenpfeil, S | 1 |
| Mitchell, DA | 1 |
| Wolff, KD | 2 |
| Mücke, T | 1 |
| McGuinness, S | 1 |
| Byrne, K | 1 |
| Wang, E | 1 |
| Inaba, K | 1 |
| Cho, J | 1 |
| Byerly, S | 1 |
| Rowe, V | 1 |
| Benjamin, E | 1 |
| Lam, L | 2 |
| Demetriades, D | 1 |
| Czerwińska-Jelonkiewicz, K | 1 |
| Zembala, M | 1 |
| Dąbrowski, M | 1 |
| Witkowski, A | 1 |
| Ochała, A | 1 |
| Kochman, J | 1 |
| Kübler, P | 1 |
| Jagielak, D | 1 |
| Stępińska, J | 1 |
| Rafiq, S | 1 |
| Steinbrüchel, DA | 1 |
| Lilleør, NB | 1 |
| Møller, CH | 1 |
| Lund, JT | 1 |
| Thiis, JJ | 1 |
| Olsen, PS | 1 |
| Korsholm, K | 1 |
| Nielsen, KM | 1 |
| Jensen, JM | 1 |
| Jensen, HK | 1 |
| Andersen, G | 1 |
| Nielsen-Kudsk, JE | 1 |
| Piccolo, R | 1 |
| Ariotti, S | 1 |
| Gargiulo, G | 1 |
| Marino, M | 1 |
| Santucci, A | 1 |
| Franzone, A | 1 |
| Heg, D | 1 |
| Isbye, D | 1 |
| Halle, BM | 1 |
| Pedersen, S | 1 |
| Itenov, TS | 1 |
| Taskiran, M | 1 |
| Gögenur, I | 1 |
| van Diepen, S | 1 |
| Verma, S | 1 |
| Hamza, TH | 1 |
| Siami, FS | 1 |
| Goodman, SG | 1 |
| Goldhammer, JE | 1 |
| Herman, CR | 1 |
| Sun, JZ | 2 |
| Restrepo, C | 1 |
| Hozack, WJ | 1 |
| Lonner, JH | 3 |
| Saydam, F | 1 |
| Değirmenci, İ | 1 |
| Birdane, A | 1 |
| Özdemir, M | 1 |
| Ulus, T | 1 |
| Özbayer, C | 1 |
| Çolak, E | 1 |
| Ata, N | 1 |
| Güneş, HV | 1 |
| Moreno, R | 1 |
| Hudec, V | 1 |
| Bena, M | 1 |
| Artemiou, P | 1 |
| Gasparovic, I | 1 |
| Hulman, M | 1 |
| Kwak, HS | 1 |
| Cho, JH | 1 |
| Kim, JT | 1 |
| Yoo, JJ | 1 |
| Kim, HJ | 2 |
| Nakagawa, I | 2 |
| Park, HS | 1 |
| Wada, T | 1 |
| Yokoyama, S | 1 |
| Yamada, S | 1 |
| Motoyama, Y | 1 |
| Kichikawa, K | 1 |
| Nakase, H | 1 |
| Mackenzie, DG | 1 |
| Elders, A | 1 |
| Wild, S | 1 |
| Muir, R | 1 |
| Lundberg, GD | 1 |
| Boyd, HS | 1 |
| Callaghan, JJ | 1 |
| Warth, LC | 1 |
| Hoballah, JJ | 1 |
| Liu, SS | 1 |
| Wells, CW | 1 |
| Slaughter, MS | 2 |
| Sobieski, MA | 1 |
| Gallagher, C | 1 |
| Dia, M | 1 |
| Silver, MA | 1 |
| McKellar, SH | 1 |
| Thompson, JL | 1 |
| Garcia-Rinaldi, RF | 1 |
| Macdonald, RJ | 1 |
| Sundt, TM | 2 |
| Thachil, J | 1 |
| Gatt, A | 1 |
| Martlew, V | 1 |
| Algra, A | 5 |
| Rinkel, GJ | 1 |
| Brouquet, A | 1 |
| Benoist, S | 1 |
| Julie, C | 1 |
| Penna, C | 1 |
| Beauchet, A | 1 |
| Rougier, P | 1 |
| Nordlinger, B | 1 |
| Laalou, FZ | 1 |
| Kuntzmann, H | 1 |
| Mahoudeau, G | 1 |
| Kremer, S | 1 |
| Pain, L | 1 |
| Argüello Viudez, L | 1 |
| Rogacka, R | 1 |
| Michev, I | 1 |
| Cosgrave, J | 1 |
| Montorfano, M | 1 |
| Carlino, M | 1 |
| Sangiorgi, GM | 1 |
| Castelli, A | 1 |
| Godino, C | 1 |
| Magni, V | 1 |
| Aranzulla, TC | 1 |
| Romagnoli, E | 1 |
| Castellini, P | 1 |
| Lambru, G | 1 |
| Manzoni, GC | 1 |
| Torelli, P | 1 |
| Pecot, CV | 1 |
| Fuller, M | 1 |
| Muldowney, JA | 1 |
| Misra, S | 1 |
| Nicol, M | 1 |
| Sun, Y | 1 |
| Craig, N | 1 |
| Wardlaw, D | 1 |
| Ruthmann, O | 1 |
| Seitz, A | 1 |
| Richter, S | 1 |
| Marjanovic, G | 1 |
| Olschewski, M | 2 |
| Hopt, UT | 1 |
| Fischer, A | 1 |
| Schrag, HJ | 1 |
| Gao, C | 1 |
| Ren, C | 1 |
| Li, D | 1 |
| Li, L | 1 |
| Salomon, O | 2 |
| Dulitzky, M | 1 |
| Apter, S | 1 |
| Bozic, KJ | 1 |
| Vail, TP | 1 |
| Pekow, PS | 1 |
| Maselli, JH | 1 |
| Lindenauer, PK | 1 |
| Tetik, S | 1 |
| Ak, K | 1 |
| Isbir, S | 1 |
| Eksioglu-Demiralp, E | 1 |
| Arsan, S | 1 |
| Iqbal, O | 1 |
| Yardimci, T | 1 |
| Mathias, JM | 2 |
| Obalum, DC | 1 |
| Giwa, SO | 1 |
| Adekoya-Cole, TO | 1 |
| Ogo, CN | 1 |
| Enweluzo, GO | 1 |
| Bennett, P | 1 |
| Chatterjee, T | 1 |
| Akin, I | 1 |
| Rehders, TC | 1 |
| Chatterjee, A | 1 |
| Schüpfer, C | 1 |
| Nienaber, CA | 1 |
| Ince, H | 1 |
| Montalescot, G | 2 |
| Vermin, B | 1 |
| van Poorten, F | 1 |
| Stienstra, R | 1 |
| Kim, DH | 1 |
| Daskalakis, C | 1 |
| Silvestry, SC | 1 |
| Sheth, MP | 1 |
| Lee, AN | 1 |
| Adams, S | 1 |
| Hohmann, S | 1 |
| Medvedev, S | 1 |
| Whellan, DJ | 1 |
| Wait, SD | 1 |
| Abla, AA | 1 |
| Killory, BD | 1 |
| Starke, RM | 1 |
| Spetzler, RF | 1 |
| Nakaji, P | 1 |
| Kramer, E | 1 |
| Hadad, E | 1 |
| Westreich, M | 1 |
| Shalom, A | 2 |
| Oscarsson, A | 1 |
| Gupta, A | 1 |
| Fredrikson, M | 1 |
| Järhult, J | 1 |
| Nyström, M | 1 |
| Pettersson, E | 1 |
| Darvish, B | 1 |
| Krook, H | 1 |
| Swahn, E | 1 |
| Eintrei, C | 1 |
| Sanada, Y | 1 |
| Kawano, Y | 1 |
| Mizuta, K | 1 |
| Egami, S | 1 |
| Hayashida, M | 1 |
| Wakiya, T | 1 |
| Fujiwara, T | 1 |
| Sakuma, Y | 1 |
| Hydo, M | 1 |
| Nakata, M | 1 |
| Yasuda, Y | 1 |
| Kawarasaki, H | 1 |
| Doraiswamy, VA | 1 |
| García-Bracamonte, B | 1 |
| Vanaclocha, F | 1 |
| Sheth, NP | 1 |
| Lieberman, JR | 1 |
| Della Valle, CJ | 1 |
| Naka, Y | 1 |
| John, R | 1 |
| Boyle, A | 1 |
| Conte, JV | 1 |
| Russell, SD | 1 |
| Aaronson, KD | 1 |
| Sundareswaran, KS | 1 |
| Farrar, DJ | 1 |
| Pagani, FD | 1 |
| Sharpe, RY | 1 |
| Dennis, MJ | 1 |
| Nasim, A | 1 |
| McCarthy, MJ | 1 |
| Sayers, RD | 2 |
| London, NJ | 3 |
| Naylor, AR | 3 |
| Jacobs, AM | 1 |
| Möllmann, H | 1 |
| Nef, HM | 1 |
| Hamm, CW | 1 |
| Voute, MT | 1 |
| Flu, WJ | 1 |
| Schouten, O | 2 |
| Chonchol, M | 1 |
| Hoeks, SE | 1 |
| Boersma, EE | 1 |
| Verhagen, HJ | 1 |
| Bax, JJ | 2 |
| Poldermans, D | 2 |
| Schmidt, T | 1 |
| Tsakiris, DA | 1 |
| Grapow, M | 1 |
| Siegemund, M | 1 |
| Nagler, M | 1 |
| Haslauer, M | 1 |
| Wuillemin, WA | 1 |
| Etuwewe, B | 1 |
| Mangat, J | 1 |
| Ladusans, E | 1 |
| Suh, JW | 1 |
| Lee, SP | 1 |
| Lee, HY | 1 |
| Kang, HJ | 1 |
| Koo, BK | 1 |
| Cho, YS | 1 |
| Youn, TJ | 1 |
| Chae, IH | 1 |
| Choi, DJ | 1 |
| Rha, SW | 1 |
| Bae, JH | 1 |
| Kwon, TG | 1 |
| Bae, JW | 1 |
| Cho, MC | 1 |
| Rivera Gorrin, M | 1 |
| Jacob, M | 2 |
| Smedira, N | 3 |
| Blackstone, E | 2 |
| Williams, S | 2 |
| Cho, L | 2 |
| Vaduganathan, M | 1 |
| Suissa, S | 1 |
| Morofuji, Y | 1 |
| So, G | 1 |
| Hiu, T | 1 |
| Kawakubo, J | 1 |
| Hayashi, K | 1 |
| Kitagawa, N | 1 |
| Morikawa, M | 1 |
| Suyama, K | 1 |
| Nagata, I | 1 |
| Cook-Norris, RH | 1 |
| Michaels, JD | 1 |
| Weaver, AL | 1 |
| Phillips, PK | 1 |
| Brewer, JD | 1 |
| Roenigk, RK | 1 |
| Otley, CC | 3 |
| Widmer, BJ | 1 |
| Bassora, R | 1 |
| Warrender, WJ | 1 |
| Chinnakotla, S | 1 |
| Klintmalm, GB | 1 |
| Tomiyama, K | 1 |
| Klintmalm, E | 1 |
| Davis, GL | 1 |
| Trotter, JF | 1 |
| Saad, R | 1 |
| Landaverde, C | 1 |
| Levy, MF | 1 |
| Goldstein, RM | 1 |
| Stone, MJ | 1 |
| Barequet, IS | 1 |
| Sachs, D | 1 |
| Shenkman, B | 1 |
| Priel, A | 1 |
| Wasserzug, Y | 1 |
| Budnik, I | 1 |
| Moisseiev, J | 1 |
| Harjai, KJ | 1 |
| Shenoy, C | 1 |
| Orshaw, P | 1 |
| Usmani, S | 1 |
| Singh, M | 2 |
| Boura, J | 1 |
| Duggie, AJ | 1 |
| Dimech, J | 1 |
| Brown, JS | 1 |
| Mahmoud, TH | 1 |
| Nazerani, S | 1 |
| Motamedi, MH | 1 |
| Ebadi, MR | 1 |
| Nazerani, T | 1 |
| Bidarmaghz, B | 1 |
| Cardona, L | 1 |
| Ana, G | 1 |
| Luísa, B | 1 |
| Leal, A | 1 |
| António, F | 1 |
| Lídia, S | 1 |
| Cruz, FR | 1 |
| Cao, L | 2 |
| Mascarenhas, L | 1 |
| Patarroyo, M | 1 |
| Simbaqueba, C | 1 |
| Shrestha, K | 1 |
| Tang, WH | 1 |
| Taylor, DO | 1 |
| Mikkola, R | 1 |
| Wistbacka, JO | 1 |
| Gunn, J | 1 |
| Heikkinen, J | 1 |
| Lahtinen, J | 1 |
| Teittinen, K | 1 |
| Kuttila, K | 1 |
| Juvonen, T | 1 |
| Airaksinen, J | 1 |
| Biancari, F | 2 |
| Ji, HM | 1 |
| Lee, YK | 1 |
| Ha, YC | 1 |
| Kim, KC | 1 |
| Koo, KH | 1 |
| Guijarro de Armas, MA | 1 |
| Vega Piñero, B | 1 |
| Pavón de Paz, I | 1 |
| Alameda Hernando, C | 1 |
| Monereo Megías, S | 1 |
| Kamusella, P | 1 |
| Wissgott, C | 1 |
| Andresen, R | 1 |
| Akkus, NI | 1 |
| Rajpal, S | 1 |
| Agnani, S | 1 |
| Ramponi, F | 1 |
| Wilson, MK | 1 |
| Vedelago, J | 1 |
| Bayfield, MS | 1 |
| Malik, AI | 1 |
| Foster, RE | 1 |
| Correa, ZM | 1 |
| Petersen, MR | 1 |
| Miller, DM | 1 |
| Riemann, CD | 1 |
| Douketis, JD | 1 |
| Spyropoulos, AC | 1 |
| Spencer, FA | 1 |
| Mayr, M | 1 |
| Jaffer, AK | 1 |
| Eckman, MH | 1 |
| Dunn, AS | 1 |
| Kunz, R | 1 |
| Whitlock, RP | 1 |
| Sun, JC | 1 |
| Fremes, SE | 2 |
| Rubens, FD | 2 |
| Teoh, KH | 2 |
| Griffiths, JT | 1 |
| Matthews, L | 1 |
| Pearce, CJ | 1 |
| Calder, JD | 1 |
| Nowfar, S | 1 |
| Kopp, R | 1 |
| Palazzi-Churas, K | 1 |
| Derweesh, IH | 1 |
| Kane, CJ | 1 |
| Paikin, JS | 1 |
| Furlan, AJ | 1 |
| Reisman, M | 1 |
| Massaro, J | 1 |
| Adams, H | 1 |
| Albers, GW | 1 |
| Felberg, R | 1 |
| Herrmann, H | 1 |
| Kar, S | 1 |
| Landzberg, M | 1 |
| Raizner, A | 1 |
| Wechsler, L | 1 |
| Tzeng, SS | 1 |
| Liou, JT | 1 |
| Krittalak, K | 1 |
| Sawanyawisuth, K | 1 |
| Tiamkao, S | 1 |
| Kiviniemi, T | 1 |
| Pietilä, M | 1 |
| Niemelä, M | 1 |
| Vikman, S | 1 |
| Puurunen, M | 1 |
| Hamilton, SC | 1 |
| Whang, WW | 1 |
| Anderson, BJ | 1 |
| Bradbury, TL | 1 |
| Erens, GA | 1 |
| Roberson, JR | 1 |
| Ivancan, V | 1 |
| Arora, P | 1 |
| Kolli, H | 1 |
| Nainani, N | 1 |
| Nader, N | 1 |
| Lohr, J | 1 |
| Ghazali, N | 1 |
| Collyer, JC | 1 |
| Tighe, JV | 1 |
| Amin, AG | 1 |
| Ng, J | 1 |
| Hsu, W | 1 |
| Pradilla, G | 1 |
| Raza, S | 1 |
| Quinones-Hinojosa, A | 1 |
| Lim, M | 1 |
| Castillo Monsegur, J | 1 |
| Bisbe Vives, E | 1 |
| Santiveri Papiol, X | 1 |
| López Bosque, R | 1 |
| Ruiz, A | 1 |
| Kizilkilic, O | 1 |
| Kocer, N | 1 |
| Metaxas, GE | 1 |
| Babic, D | 1 |
| Homan, R | 1 |
| Islak, C | 1 |
| Uhry, S | 1 |
| Bessereau, J | 1 |
| Camoin-Jau, L | 1 |
| Bonello, L | 1 |
| Mrdovic, I | 1 |
| Savic, L | 1 |
| Krljanac, G | 1 |
| Asanin, M | 1 |
| Perunicic, J | 1 |
| Antonijevic, N | 1 |
| Lasica, R | 1 |
| Marinkovic, J | 1 |
| Kocev, N | 1 |
| Vasiljevic, Z | 1 |
| Harrasser, N | 1 |
| Harnoss, T | 1 |
| Brettner, F | 1 |
| Liska, F | 1 |
| Pauschinger, M | 1 |
| Vulcano, E | 1 |
| Gesell, M | 1 |
| Esposito, A | 1 |
| Ma, Y | 1 |
| Memtsoudis, SG | 1 |
| Duggan, SM | 1 |
| Aresu, G | 1 |
| de Siena, PM | 1 |
| Romeo, F | 1 |
| Glauber, M | 2 |
| Caputo, M | 1 |
| Than, KD | 1 |
| Rohatgi, P | 1 |
| Wilson, TJ | 1 |
| Gregory Thompson, B | 1 |
| Del Pozo, M | 1 |
| Martí, J | 1 |
| Guirado, L | 1 |
| Facundo, C | 1 |
| Canal, C | 1 |
| de la Torre, P | 1 |
| Ballarín, J | 1 |
| Díaz, JM | 1 |
| Van Hattum, ES | 1 |
| Tangelder, MJ | 4 |
| Lawson, JA | 3 |
| Moll, FL | 1 |
| Kan, P | 1 |
| Siddiqui, AH | 1 |
| Veznedaroglu, E | 1 |
| Liebman, KM | 1 |
| Binning, MJ | 1 |
| Dumont, TM | 1 |
| Ogilvy, CS | 1 |
| Gaughen, JR | 1 |
| Mocco, J | 1 |
| Velat, GJ | 1 |
| Ringer, AJ | 1 |
| Welch, BG | 1 |
| Horowitz, MB | 1 |
| Snyder, KV | 1 |
| Hopkins, LN | 1 |
| Levy, EI | 1 |
| Lam, K | 1 |
| Forgie, M | 1 |
| Boodhwani, M | 1 |
| Rubens, F | 1 |
| Hendry, P | 1 |
| Masters, R | 1 |
| Goldstein, W | 1 |
| Bedard, P | 1 |
| Mesana, T | 1 |
| Bausili, M | 1 |
| Abreu, S | 1 |
| Unzueta, MC | 1 |
| García Álvarez, M | 1 |
| Crespí, J | 1 |
| Moral, MV | 1 |
| Maekawa, H | 1 |
| Shiraishi, K | 1 |
| Lighthall, JG | 1 |
| Cain, R | 1 |
| Ghanem, TA | 1 |
| Wax, MK | 1 |
| Sadanandan, S | 1 |
| Singh, IM | 1 |
| Moffett, BS | 1 |
| Cabrera, A | 1 |
| Bötticher, G | 1 |
| Gäbel, G | 1 |
| Weiss, N | 1 |
| Saeger, HD | 1 |
| Bergert, H | 1 |
| Manocha, D | 1 |
| Mehta, N | 1 |
| Murthy, UK | 1 |
| Carlson, AP | 1 |
| Amin-Hanjani, S | 1 |
| Charbel, FT | 1 |
| Aletich, VA | 1 |
| Manlhiot, C | 1 |
| Cochrane, A | 1 |
| Roberts, R | 1 |
| Hughes, M | 1 |
| Szechtman, B | 1 |
| Weintraub, R | 1 |
| Andrew, M | 1 |
| Monagle, P | 1 |
| Riml, S | 1 |
| Wallner, H | 1 |
| Kompatscher, P | 1 |
| Mitchell, LA | 1 |
| Santarelli, JG | 1 |
| Singh, IP | 1 |
| Do, HM | 1 |
| Larson, CM | 1 |
| MacMillan, DP | 1 |
| Lachiewicz, PF | 4 |
| Shah, PB | 1 |
| Lilly, CM | 1 |
| Turpie, AG | 6 |
| Hiller, E | 1 |
| Scadding, GK | 1 |
| Mangano, DT | 1 |
| Topol, EJ | 3 |
| SoRelle, R | 1 |
| Reis, S | 1 |
| Hermoni, D | 1 |
| Livingstone, P | 1 |
| Borkan, J | 1 |
| Korkolis, DP | 1 |
| Passik, CS | 1 |
| Marshalko, SJ | 1 |
| Koullias, GJ | 1 |
| Cha, KS | 1 |
| Han, JY | 1 |
| Alam, M | 1 |
| Goldberg, LH | 2 |
| Meimoun, P | 1 |
| Mainardi, JL | 1 |
| Berrebi, A | 1 |
| Marino, JP | 1 |
| Waldmann, T | 1 |
| Carpentier, A | 1 |
| Kovich, O | 1 |
| Reitman, RD | 1 |
| Emerson, RH | 1 |
| Higgins, LL | 1 |
| Tarbox, TR | 1 |
| Narendran, N | 1 |
| Williamson, TH | 1 |
| Chesebro, JH | 6 |
| Pugo, FJ | 1 |
| Karzai, W | 1 |
| Priebe, HJ | 1 |
| Mueller, C | 1 |
| Roskamm, H | 2 |
| Hunziker, P | 1 |
| Marsch, S | 1 |
| Perruchoud, A | 1 |
| Buettner, HJ | 1 |
| Ng, HJ | 1 |
| Koh, LP | 1 |
| Lee, LH | 1 |
| Wong, L | 1 |
| Comunale, ME | 1 |
| Maslow, A | 1 |
| Robertson, LK | 1 |
| Haering, JM | 1 |
| Mashikian, JS | 1 |
| Lowenstein, E | 1 |
| Srinivasan, AK | 1 |
| Grayson, AD | 1 |
| Pullan, DM | 1 |
| Fabri, BM | 1 |
| Dihmis, WC | 1 |
| Tolleson, TR | 1 |
| Harrington, RA | 1 |
| Bhapkar, MV | 1 |
| Verheugt, FW | 3 |
| Berger, PB | 1 |
| Moliterno, DJ | 2 |
| White, HD | 1 |
| Ohman, EM | 1 |
| Van de Werf, F | 1 |
| Califf, RM | 1 |
| Ruygrok, PN | 1 |
| Sim, KH | 1 |
| Chan, C | 1 |
| Rachman, OJ | 1 |
| Adipranoto, JD | 1 |
| Trisnohadi, HB | 1 |
| Stewart, JT | 1 |
| Ahmad, N | 1 |
| Mak, KH | 1 |
| Yusak, M | 1 |
| Boestan, I | 1 |
| Santoso, T | 1 |
| Bruhn, HD | 1 |
| Mantilla, CB | 1 |
| Horlocker, TT | 1 |
| Schroeder, DR | 1 |
| Berry, DJ | 1 |
| Brown, DL | 1 |
| Lawson, J | 1 |
| van Urk, H | 1 |
| Eikelboom, BC | 3 |
| ABU-NASSAR, HJ | 1 |
| YOW, EM | 1 |
| ALEXANDER, JK | 1 |
| LEWIS, JM | 1 |
| SALEM, JE | 1 |
| TRICOT, R | 1 |
| NOGRETTE, P | 1 |
| VITSE, M | 1 |
| LIBERMTHEN, A | 1 |
| Peter, FW | 1 |
| Steinau, HU | 1 |
| Homann, HH | 1 |
| Barker, JH | 2 |
| Disa, JJ | 1 |
| Polvora, VP | 1 |
| Pusic, AL | 1 |
| Singh, B | 1 |
| Cordeiro, PG | 1 |
| Oates-Whitehead, RM | 2 |
| Mol, B | 2 |
| Moses, JW | 2 |
| Ludwig, J | 1 |
| Holmes, DR | 3 |
| Spanos, V | 1 |
| Louvard, Y | 1 |
| Desmedt, B | 1 |
| Di Mario, C | 2 |
| Potapov, EV | 2 |
| Ignatenko, S | 1 |
| Nasseri, BA | 1 |
| Loebe, M | 1 |
| Harke, C | 1 |
| Bettmann, M | 1 |
| Doller, A | 1 |
| Regitz-Zagrosek, V | 1 |
| Hetzer, R | 5 |
| Payne, DA | 2 |
| Jones, CI | 2 |
| Hayes, PD | 2 |
| Thompson, MM | 1 |
| Bell, PR | 2 |
| Goodall, AH | 2 |
| Ferguson, JJ | 1 |
| Farray, D | 1 |
| Carman, TL | 1 |
| Fernandez, BB | 1 |
| Torsney, E | 1 |
| Mayr, U | 1 |
| Zou, Y | 1 |
| Thompson, WD | 1 |
| Hu, Y | 1 |
| Luo, XJ | 1 |
| Yan, J | 1 |
| Wu, QY | 1 |
| Yang, KM | 1 |
| Xu, JP | 1 |
| Liu, YL | 1 |
| Masters, RG | 1 |
| Bédard, PJ | 1 |
| Pipe, AL | 1 |
| Goldstein, WG | 1 |
| Hendry, PJ | 1 |
| Mesana, TG | 1 |
| Grotz, W | 1 |
| Siebig, S | 1 |
| Strey, CW | 1 |
| Peter, K | 1 |
| Casselman, FP | 1 |
| Meco, M | 1 |
| Dom, H | 1 |
| Foubert, L | 1 |
| Van Praet, F | 1 |
| Vanermen, H | 1 |
| Gherli, T | 2 |
| Colli, A | 2 |
| Fragnito, C | 1 |
| Nicolini, F | 1 |
| Borrello, B | 1 |
| Saccani, S | 1 |
| D'Amico, R | 1 |
| Beghi, C | 1 |
| Warwick, D | 1 |
| Sedrakyan, A | 1 |
| Treasure, T | 2 |
| Elefteriades, JA | 1 |
| Rodger, M | 1 |
| Bates, SM | 1 |
| Desjardins, L | 1 |
| Solymoss, S | 1 |
| Klima, U | 1 |
| MacVaugh, H | 2 |
| Bagaev, E | 1 |
| Maringka, M | 1 |
| Kirschner, S | 1 |
| Beilner, J | 1 |
| Haverich, A | 1 |
| Ezekowitz, MD | 1 |
| Geerts, WH | 2 |
| Pineo, GF | 1 |
| Heit, JA | 2 |
| Bergqvist, D | 5 |
| Lassen, MR | 1 |
| Colwell, CW | 1 |
| Ray, JG | 1 |
| Salem, DN | 1 |
| Stein, PD | 1 |
| Al-Ahmad, A | 1 |
| Bussey, HI | 1 |
| Horstkotte, D | 1 |
| Miller, N | 1 |
| Pauker, SG | 1 |
| Humke, U | 1 |
| Takahashi, M | 1 |
| Siemer, S | 1 |
| Uder, M | 1 |
| Chu, MW | 1 |
| Wilson, SR | 1 |
| Novick, RJ | 2 |
| Stitt, LW | 1 |
| Quantz, MA | 1 |
| Kimyai-Asadi, A | 1 |
| Jih, MH | 1 |
| Rasmussen, HM | 1 |
| Chauhan, PA | 1 |
| Wille-Jørgensen, PA | 1 |
| Bavry, AA | 1 |
| Kumbhani, DJ | 1 |
| Helton, TJ | 1 |
| Akan, M | 1 |
| Cakir, B | 1 |
| Misirlioğlu, A | 1 |
| Yildirim, S | 1 |
| Taylan, G | 1 |
| Aköz, T | 1 |
| Chien, W | 1 |
| Varvares, MA | 1 |
| Hadlock, T | 1 |
| Cheney, M | 1 |
| Deschler, DG | 1 |
| Hölzle, F | 1 |
| Kesting, MR | 1 |
| Nolte, D | 1 |
| Loeffelbein, DJ | 1 |
| Swaid, S | 1 |
| Gosepath, J | 1 |
| Mann, WJ | 1 |
| Kwong, LM | 1 |
| Lotke, PA | 5 |
| Sarmiento, A | 2 |
| Goswami, A | 1 |
| Wilmshurst, PT | 1 |
| Nightingale, S | 1 |
| Walsh, KP | 1 |
| Morrison, WL | 1 |
| Bybee, KA | 1 |
| Powell, BD | 1 |
| Valeti, U | 1 |
| Rosales, AG | 1 |
| Kopecky, SL | 1 |
| Mullany, C | 1 |
| Wright, RS | 1 |
| Chaturvedi, S | 1 |
| Bruno, A | 1 |
| Feasby, T | 1 |
| Holloway, R | 1 |
| Benavente, O | 1 |
| Cohen, SN | 2 |
| Cote, R | 1 |
| Hess, D | 1 |
| Saver, J | 1 |
| Spence, JD | 1 |
| Stern, B | 1 |
| Wilterdink, J | 1 |
| Tantry, US | 1 |
| Bliden, KP | 1 |
| Gurbel, PA | 1 |
| Piomelli, S | 1 |
| Hitos, K | 1 |
| Fletcher, JP | 1 |
| Poston, RS | 2 |
| White, C | 2 |
| Gu, J | 2 |
| Brown, J | 1 |
| Gammie, J | 1 |
| Pierson, RN | 2 |
| Lee, A | 1 |
| Connerney, I | 1 |
| Avari, T | 1 |
| Christenson, R | 1 |
| Tandry, U | 1 |
| Griffith, BP | 2 |
| Brown, JM | 1 |
| Nie, L | 1 |
| García-Rinaldi, R | 1 |
| Berend, KR | 1 |
| Lombardi, AV | 1 |
| Cornelissen, J | 1 |
| Kirtland, S | 1 |
| Lim, E | 1 |
| Goddard, M | 1 |
| Bellm, S | 1 |
| Sheridan, K | 1 |
| Large, S | 1 |
| Vuylsteke, A | 1 |
| Haas, S | 1 |
| Dalainas, I | 1 |
| Nano, G | 1 |
| Schneider, CA | 1 |
| Klutmann, M | 1 |
| Tillmanns, C | 1 |
| Gulba, DC | 1 |
| Kikuta, K | 1 |
| Takagi, Y | 1 |
| Arakawa, Y | 1 |
| Miyamoto, S | 1 |
| Hashimoto, N | 1 |
| van de Pol, MA | 1 |
| van Houdenhoven, M | 1 |
| Hans, EW | 1 |
| Boersma, E | 1 |
| Feringa, HH | 1 |
| van Sambeek, MR | 1 |
| Merli, GJ | 1 |
| Spoor, MT | 1 |
| Geltz, A | 1 |
| Bolling, SF | 1 |
| Aoyagi, S | 1 |
| Arinaga, K | 1 |
| Fukunaga, S | 1 |
| Tayama, E | 1 |
| Kosuga, T | 1 |
| Akashi, H | 1 |
| Sharma, MS | 1 |
| Webber, SA | 1 |
| Morell, VO | 1 |
| Gandhi, SK | 1 |
| Wearden, PD | 1 |
| Buchanan, JR | 1 |
| Kormos, RL | 1 |
| Collins, P | 1 |
| Ford, I | 1 |
| Greaves, M | 1 |
| Macaulay, E | 1 |
| Brittenden, J | 1 |
| Khalifeh, MR | 1 |
| Redett, RJ | 1 |
| Gómez-Barrado, JJ | 1 |
| Vega, J | 1 |
| Turégano, S | 1 |
| Marcos, G | 1 |
| McAllister, RK | 1 |
| Dehmer, GJ | 1 |
| Meyer, TA | 1 |
| Patel, VP | 1 |
| Sehgal, B | 1 |
| Preston, C | 1 |
| DeWal, H | 1 |
| Di Cesare, PE | 1 |
| Wu, QH | 1 |
| Verhoye, JP | 1 |
| Leguerrier, A | 1 |
| Grines, CL | 1 |
| Bonow, RO | 1 |
| Casey, DE | 1 |
| Gardner, TJ | 1 |
| Lockhart, PB | 1 |
| O'Gara, P | 1 |
| Whitlow, P | 1 |
| Digne, F | 1 |
| Gérardin, B | 1 |
| Pillière, R | 1 |
| Estagnasié, P | 1 |
| Dib, JC | 1 |
| Terdjman, M | 1 |
| Grinda, JM | 1 |
| Dubois, C | 1 |
| Soileau, ES | 1 |
| Ziegelin, M | 1 |
| Hoschtitzky, A | 1 |
| Dunning, J | 1 |
| Hooper, T | 1 |
| Spiess, BD | 1 |
| van der Linden, J | 1 |
| Augoustides, JG | 1 |
| Hopkins, C | 1 |
| Browne, JP | 1 |
| Slack, R | 1 |
| Lund, V | 1 |
| Brown, P | 1 |
| Lotrionte, M | 1 |
| Biondi-Zoccai, GG | 1 |
| Abbate, A | 1 |
| Moretti, C | 1 |
| Cuisset, T | 1 |
| Alessi, MC | 1 |
| Di Sciascio, G | 1 |
| Sangiorgi, G | 1 |
| Laudito, A | 1 |
| Trevi, GP | 1 |
| Sheiban, I | 1 |
| Beksaç, B | 1 |
| Anderson, J | 1 |
| Sculco, TP | 2 |
| Salvato, EA | 1 |
| Nonaka, A | 1 |
| Suzuki, S | 1 |
| Nagamine, N | 1 |
| Furuya, A | 1 |
| Abe, F | 1 |
| Maguire, D | 1 |
| Pechlaner, C | 1 |
| Marschang, P | 1 |
| Holzmann, RD | 1 |
| Olbricht, SM | 2 |
| Thomas, VD | 1 |
| Schanbacher, CF | 1 |
| Parry, M | 1 |
| Wylde, V | 1 |
| Fernández-Meré, LA | 1 |
| Fernández Rogríguez, S | 1 |
| Alvarez-Blanco, M | 1 |
| Daniel, J | 1 |
| Pradhan, A | 1 |
| Pradhan, C | 1 |
| Ziaee, H | 1 |
| Moss, M | 1 |
| Freeman, J | 1 |
| McMinn, DJ | 1 |
| Awad, OG | 1 |
| Lee, JH | 1 |
| Fasano, MB | 1 |
| Graham, SM | 1 |
| Carli, A | 1 |
| Sowier, J | 2 |
| Zawilska, K | 1 |
| Wencel, D | 1 |
| Chojnacki, J | 1 |
| Jaroszewicz, S | 1 |
| Borow, M | 2 |
| Goldson, H | 1 |
| Lehmann, R | 1 |
| Severin, W | 1 |
| Voigt, T | 1 |
| Voigt, H | 1 |
| Westermann, K | 1 |
| Trentz, O | 1 |
| Pretschner, P | 1 |
| Mellmann, J | 1 |
| Kugelmeier, J | 1 |
| Egloff, L | 1 |
| Hocke, FM | 1 |
| Blind, R | 1 |
| Vinazzer, H | 4 |
| Zielinsky, A | 1 |
| Hirsh, J | 10 |
| Weinstein, GS | 1 |
| Mavroudis, C | 1 |
| Ebert, PA | 1 |
| Geyer, U | 1 |
| Russell, JC | 1 |
| Goldson, HJ | 1 |
| Bergentz, SE | 1 |
| Fredin, H | 1 |
| Sherry, S | 2 |
| Sautter, RD | 2 |
| Koch, EL | 1 |
| Myers, WO | 1 |
| Ray, JR | 1 |
| Mazza, JJ | 1 |
| Larson, DE | 1 |
| Chen, HM | 1 |
| Milbauer, JP | 1 |
| Treuhaft, PS | 1 |
| Plotka, ED | 1 |
| Marcus, AJ | 1 |
| Elveback, LR | 2 |
| Clements, IP | 2 |
| Smith, HC | 2 |
| Bardsley, WT | 2 |
| Pluth, JR | 3 |
| Wallace, RB | 2 |
| Puga, FJ | 3 |
| Skjelbred, P | 2 |
| Weber, M | 2 |
| von Schacky, C | 3 |
| Lorenz, R | 1 |
| Meister, W | 1 |
| Kotzur, J | 1 |
| Reichart, B | 1 |
| Theisen, K | 2 |
| Weber, PC | 1 |
| Rivey, MP | 1 |
| Alexander, MR | 1 |
| Taylor, JW | 1 |
| Ordinas, A | 1 |
| Viinikka, L | 1 |
| Goldman, M | 2 |
| Hall, C | 1 |
| Dykes, J | 1 |
| Hawker, RJ | 2 |
| McCollum, CN | 2 |
| Lucas, MA | 1 |
| Carrick, DG | 1 |
| Verstraete, M | 4 |
| Vermylen, J | 1 |
| Prioleau, WH | 1 |
| Voegele, LD | 1 |
| Hairston, P | 1 |
| Böhme, HR | 1 |
| Schottke, C | 1 |
| Thiel, J | 1 |
| Lück, U | 1 |
| Jahrmärker, H | 1 |
| Wang, ZG | 1 |
| Hagen, DO | 1 |
| Mikat, EM | 1 |
| Fuchs, JC | 1 |
| Weitzman, LB | 1 |
| Tinker, WP | 1 |
| Kronzon, I | 1 |
| Cohen, ML | 1 |
| Glassman, E | 1 |
| Spencer, FC | 1 |
| Kalkowski, H | 1 |
| Rinke, W | 1 |
| Dohse, D | 1 |
| Herzog, S | 1 |
| Slichter, SJ | 2 |
| Norcott, HC | 1 |
| Rafiqi, EI | 1 |
| Drolc, Z | 1 |
| Montgomery, RR | 1 |
| Hathaway, WE | 1 |
| Zekert, F | 7 |
| Hofbauer, F | 1 |
| Mühlbacher, F | 1 |
| Phillips, SJ | 1 |
| Kongtahworn, C | 1 |
| Zeff, RH | 1 |
| Beshany, SE | 1 |
| Donaldson, DR | 1 |
| Sreeharan, N | 1 |
| Crow, MJ | 1 |
| Rajah, SM | 1 |
| Hill, JD | 2 |
| LaFollette, L | 1 |
| Szarnicki, RJ | 1 |
| Avery, GJ | 1 |
| Wilson, RM | 1 |
| Gerbode, F | 2 |
| Kerth, WJ | 2 |
| Rodvien, R | 2 |
| De Vita, C | 1 |
| Kiwerski, J | 1 |
| McKenna, R | 3 |
| Galante, J | 1 |
| Bachmann, F | 2 |
| Wallace, DL | 1 |
| Kaushal, PS | 1 |
| Meredith, P | 1 |
| Covey, TH | 1 |
| Baue, AE | 1 |
| Willoughby, ML | 1 |
| Mayer, JE | 2 |
| Lindsay, WG | 1 |
| Castaneda, W | 1 |
| Nicoloff, DM | 1 |
| Harjola, PT | 1 |
| Meurala, H | 1 |
| Fields, WS | 1 |
| Frye, RL | 1 |
| Vlietstra, RE | 1 |
| Orszulak, TA | 2 |
| Piehler, JM | 1 |
| Danielson, GK | 2 |
| Harris, WH | 7 |
| Athanasoulis, CA | 3 |
| Waltman, AC | 4 |
| Salzman, EW | 9 |
| Nuñez, L | 2 |
| Aguado, MG | 1 |
| Celemín, D | 1 |
| Iglesias, A | 1 |
| Larrea, JL | 2 |
| Stulberg, BN | 1 |
| Dorr, LD | 1 |
| Ranawat, CS | 1 |
| Schneider, R | 1 |
| Guyer, RD | 1 |
| Booth, RE | 1 |
| Paris, GL | 1 |
| Waltuch, GF | 1 |
| Broomé, A | 1 |
| Davidsson, T | 1 |
| Eklöf, B | 1 |
| Hansson, L | 1 |
| Carson, S | 1 |
| Demling, R | 1 |
| Esquivel, C | 1 |
| Talken, L | 1 |
| Tillman, P | 1 |
| Kanto, J | 1 |
| Klossner, J | 1 |
| Mäntylä, R | 1 |
| Yrjänä, T | 1 |
| Weinstein, PR | 1 |
| Reinert, RL | 1 |
| Brittain, F | 1 |
| Scheibe, O | 1 |
| DeLee, JC | 1 |
| Rockwood, CA | 1 |
| Isbister, JP | 1 |
| Murkin, JM | 1 |
| Lux, J | 1 |
| Shannon, NA | 1 |
| Guiraudon, GM | 1 |
| Menkis, AH | 1 |
| McKenzie, FN | 1 |
| Labaye, A | 1 |
| Nores, JM | 1 |
| Bergal, S | 1 |
| Denormandie, P | 1 |
| Imperiale, TF | 1 |
| Speroff, T | 1 |
| Nozdrachev, IuI | 1 |
| Kibel, AS | 1 |
| Loughlin, KR | 1 |
| Yankah, AC | 1 |
| Alexi-Meskhishvili, V | 1 |
| Weng, Y | 1 |
| Berger, F | 1 |
| Lange, P | 1 |
| Van Belle, E | 1 |
| McFadden, EP | 1 |
| Lablanche, JM | 1 |
| Bauters, C | 1 |
| Hamon, M | 1 |
| Bertrand, ME | 1 |
| Monreal, M | 1 |
| Lafoz, E | 1 |
| Roca, J | 1 |
| Granero, X | 1 |
| Soler, J | 1 |
| Salazar, X | 1 |
| Olazabal, A | 1 |
| Spektor, S | 1 |
| Ashkenazi, E | 1 |
| Israel, Z | 1 |
| Wilson, DG | 1 |
| Wisheart, JD | 1 |
| Stuart, AG | 1 |
| Fiane, AE | 1 |
| Seem, E | 1 |
| Geiran, O | 1 |
| Lindberg, HL | 1 |
| Kongsgaard, E | 1 |
| Foerster, A | 1 |
| Aass, H | 1 |
| Madsen, S | 1 |
| Amlie, JP | 1 |
| Reininger, CB | 1 |
| Reininger, AJ | 1 |
| Steckmeier, B | 1 |
| Greinacher, A | 1 |
| Lasser, R | 1 |
| Schweiberer, L | 1 |
| Sturzenegger, M | 1 |
| Beer, JH | 1 |
| Rihs, F | 1 |
| Varty, K | 1 |
| Thompson, M | 1 |
| Hamelink, JK | 1 |
| Tang, DB | 1 |
| Barr, CF | 1 |
| Jackson, MR | 1 |
| Reid, TJ | 1 |
| Gomez, ER | 1 |
| Alving, BM | 1 |
| Heras, M | 1 |
| Penny, WJ | 1 |
| Grill, DE | 1 |
| Bailey, KR | 1 |
| Edmondson, RA | 1 |
| Cohen, AT | 1 |
| Das, SK | 2 |
| Wagner, MB | 1 |
| Kakkar, VV | 7 |
| Brack, MJ | 1 |
| Hubner, PJ | 1 |
| Blair, KL | 1 |
| Hatton, AC | 1 |
| White, WD | 1 |
| Smith, LR | 1 |
| Lowe, JE | 1 |
| Wolfe, WG | 1 |
| Young, WG | 1 |
| Oldham, HN | 1 |
| Douglas, JM | 1 |
| Glower, DD | 1 |
| Lawrence, C | 1 |
| Sakuntabhai, A | 1 |
| Tiling-Grosse, S | 1 |
| Kallis, P | 1 |
| Tooze, JA | 1 |
| Talbot, S | 1 |
| Cowans, D | 1 |
| Bevan, DH | 1 |
| Mulder, BJ | 1 |
| van der Doef, RM | 1 |
| van der Wall, EE | 2 |
| Tijssen, JG | 1 |
| Piek, JJ | 1 |
| van der Meer, J | 2 |
| Dunning, AJ | 1 |
| Hensler, MK | 1 |
| Madsen, PV | 1 |
| Rissel, U | 1 |
| Müller, T | 1 |
| Schulze-Waltrup, N | 1 |
| Krakau, I | 1 |
| Arens, R | 1 |
| Willgeroth, W | 1 |
| Heuer, H | 1 |
| Theilmann, L | 1 |
| Sauer, P | 1 |
| Roeren, T | 1 |
| Otto, G | 1 |
| Arnold, JC | 1 |
| Noeldge, G | 1 |
| Richter, G | 1 |
| Stiehl, A | 1 |
| Buckley, RC | 1 |
| Davidson, SF | 1 |
| Towne, JB | 1 |
| Hobson, RW | 1 |
| Albertal, J | 1 |
| Sutton, M | 1 |
| Pereyra, D | 1 |
| Segura, EV | 1 |
| Aramburu, DF | 1 |
| Lardani, H | 1 |
| Diaz, R | 1 |
| Hennerici, MG | 1 |
| Loeliger, EA | 1 |
| Malouf, JF | 1 |
| Alam, S | 1 |
| Gharzeddine, W | 1 |
| Stefadouros, MA | 1 |
| Flordal, PA | 1 |
| Sahlin, S | 1 |
| Lindblad, B | 2 |
| Persson, NH | 2 |
| Takolander, R | 1 |
| Bischof, G | 1 |
| Pratschner, T | 4 |
| Kail, M | 1 |
| Mittlböck, M | 1 |
| Turkof, E | 1 |
| Puig, S | 1 |
| Polterauer, P | 5 |
| Kretschmer, G | 5 |
| Hansen, F | 1 |
| Yamak, B | 1 |
| Karagöz, HY | 1 |
| Zorlutuna, Y | 1 |
| Eralp, A | 1 |
| Tasdemir, O | 1 |
| Bayazit, K | 1 |
| Sarin, S | 1 |
| Shami, SK | 1 |
| Cheatle, TR | 1 |
| Bearn, P | 1 |
| Scurr, JH | 1 |
| Coleridge Smith, PD | 1 |
| Løkken, P | 1 |
| Levinton, C | 1 |
| Naylor, CD | 1 |
| Chen, E | 1 |
| Christakis, GT | 3 |
| Goldman, BS | 1 |
| LeBlanc, JG | 1 |
| Sett, SS | 1 |
| Vince, DJ | 1 |
| Concannon, MJ | 1 |
| Meng, L | 1 |
| Welsh, CF | 1 |
| Puckett, CL | 1 |
| Kelsey, M | 1 |
| Goldsmith, SM | 1 |
| Leshin, B | 1 |
| Owen, J | 1 |
| Golan, A | 1 |
| Maymon, R | 1 |
| Winograd, I | 1 |
| Bukovsky, I | 1 |
| Palevsky, H | 1 |
| Keenan, AM | 1 |
| Meranze, S | 1 |
| Steinberg, ME | 1 |
| Ecker, ML | 1 |
| Kelley, MA | 1 |
| Schömig, A | 2 |
| Schühlen, H | 2 |
| Blasini, R | 1 |
| Hadamitzky, M | 2 |
| Walter, H | 2 |
| Zitzmann-Roth, EM | 1 |
| Richardt, G | 1 |
| Alt, E | 1 |
| Schmitt, C | 1 |
| Ulm, K | 2 |
| Gent, M | 4 |
| Ginsberg, JS | 1 |
| Powers, PJ | 2 |
| Levine, MN | 2 |
| Jay, RM | 2 |
| Leclerc, J | 1 |
| Neemeh, JA | 1 |
| Fewkes, JL | 1 |
| Frank, W | 1 |
| Stannard, JP | 1 |
| Harris, RM | 1 |
| Bucknell, AL | 1 |
| Cossi, A | 1 |
| Ward, J | 1 |
| Arrington, ED | 1 |
| Peters, FP | 1 |
| Doevendans, PA | 1 |
| Erdkamp, FL | 1 |
| Van Der Ent, FW | 1 |
| De Heer, F | 1 |
| Szefner, J | 1 |
| Gamba, A | 1 |
| Mamprin, F | 1 |
| Fiocchi, R | 1 |
| Somaschini, M | 1 |
| Ferrazzi, P | 1 |
| Westrich, GH | 1 |
| Labas, P | 1 |
| Vrtík, L | 1 |
| Svec, R | 1 |
| Sasváry, F | 1 |
| Stroobandt, G | 1 |
| Fransen, P | 1 |
| Thauvoy, C | 1 |
| Menard, E | 1 |
| Knowles, P | 1 |
| Poulton, B | 1 |
| Fatah, K | 1 |
| Beving, H | 1 |
| Albåge, A | 1 |
| Ivert, T | 1 |
| Blombäck, M | 1 |
| Goods, CM | 1 |
| al-Shaibi, KF | 1 |
| Liu, MW | 1 |
| Yadav, JS | 1 |
| Mathur, A | 1 |
| Jain, SP | 1 |
| Dean, LS | 1 |
| Iyer, SS | 1 |
| Parks, JM | 1 |
| Roubin, GS | 1 |
| Christenson, JT | 1 |
| Gras, PA | 1 |
| Grosclaude, A | 1 |
| Simonet, F | 1 |
| Schmuziger, M | 1 |
| Young, B | 1 |
| Moore, WS | 1 |
| Robertson, JT | 1 |
| Toole, JF | 1 |
| Ernst, CB | 1 |
| Broderick, JP | 1 |
| Dempsey, RJ | 1 |
| Hosking, JD | 1 |
| Klein, JA | 1 |
| Holleman, JB | 1 |
| Kelley, S | 1 |
| Meyer, BJ | 1 |
| Maugeri, N | 1 |
| Kempfer, AC | 1 |
| Evangelista, V | 1 |
| Cerletti, C | 1 |
| de Gaetano, G | 3 |
| Lazzari, MA | 2 |
| Albiero, R | 1 |
| Hall, P | 1 |
| Itoh, A | 1 |
| Blengino, S | 1 |
| Nakamura, S | 1 |
| Martini, G | 1 |
| Ferraro, M | 2 |
| Zubaid, M | 1 |
| Penn, IM | 1 |
| Buller, CE | 1 |
| Moscovich, MD | 1 |
| Ricci, DR | 1 |
| Chauhan, A | 1 |
| Ballotta, E | 1 |
| Abbruzzese, E | 1 |
| Thiene, G | 1 |
| Bottio, T | 1 |
| Dagiau, G | 1 |
| Angelini, A | 1 |
| Saladini, M | 1 |
| Herlitz, J | 1 |
| Albertsson, P | 1 |
| Brandrup-Wognsen, G | 1 |
| Emanuelsson, H | 1 |
| Haglid, M | 1 |
| Hartford, M | 1 |
| Hjalmarson, A | 1 |
| Karlson, BW | 1 |
| Karlsson, T | 1 |
| Sandén, W | 1 |
| Knelles, D | 2 |
| Barthel, T | 2 |
| Karrer, A | 1 |
| Kraus, U | 1 |
| Eulert, J | 2 |
| Kölbl, O | 1 |
| Hillis, GS | 1 |
| Jennings, KP | 1 |
| Adamec, M | 1 |
| Saudek, F | 1 |
| Prentice, CR | 2 |
| Théroux, P | 1 |
| Wolf, DC | 1 |
| Freni, MA | 1 |
| Boccagni, P | 1 |
| Mor, E | 1 |
| Chodoff, L | 1 |
| Birnbaum, A | 1 |
| Miller, CM | 1 |
| Schwartz, ME | 1 |
| Bodenheimer, HC | 1 |
| Reimers, B | 1 |
| Reinhardt, R | 1 |
| Moussa, I | 2 |
| Iturbe, T | 1 |
| Sánchez, C | 1 |
| Moreno, JA | 1 |
| Olave, T | 1 |
| Azaceta, G | 1 |
| Varo, MJ | 1 |
| Civeira, E | 1 |
| Peleato, J | 1 |
| Cornudella, R | 1 |
| Rutter, MK | 1 |
| Marshall, SM | 1 |
| McComb, JM | 1 |
| Choi, IY | 1 |
| Park, MR | 1 |
| Park, TS | 1 |
| Cho, JL | 1 |
| Hirschowitz, BI | 1 |
| Lanas, A | 1 |
| Oemrawsingh, PV | 2 |
| Tuinenburg, JC | 1 |
| Schalij, MJ | 2 |
| Jukema, JW | 1 |
| Reiber, JH | 1 |
| Bruschke, AV | 2 |
| McNeely, W | 1 |
| Goa, KL | 1 |
| Salat, A | 1 |
| Boehm, D | 1 |
| Pulaki, S | 1 |
| Murabito, M | 1 |
| Berlakovich, G | 1 |
| Mueller, MR | 1 |
| Udayachalerm, W | 1 |
| Sabbah, A | 1 |
| Drouet, M | 1 |
| el Founini, M | 1 |
| Muzii, L | 1 |
| Marana, R | 1 |
| Brunetti, L | 1 |
| Margutti, F | 1 |
| Vacca, M | 1 |
| Mancuso, S | 1 |
| Sarac, TP | 1 |
| Huber, TS | 1 |
| Back, MR | 1 |
| Ozaki, CK | 1 |
| Carlton, LM | 1 |
| Flynn, TC | 1 |
| Seeger, JM | 1 |
| Klootwijk, P | 1 |
| Meij, S | 1 |
| Melkert, R | 1 |
| Lenderink, T | 1 |
| Simoons, ML | 1 |
| Molloy, J | 1 |
| Martin, JF | 1 |
| Baskerville, PA | 1 |
| Fraser, SC | 1 |
| Markus, HS | 1 |
| Alvarez, JM | 1 |
| Harper, RW | 1 |
| Peverill, RE | 1 |
| Madan, M | 1 |
| Marquis, JF | 1 |
| de May, MR | 1 |
| Laramee, LA | 1 |
| Leddy, D | 1 |
| O'Brien, E | 1 |
| Williams, WL | 1 |
| Higginson, LA | 1 |
| Jelley, J | 1 |
| Reid, F | 1 |
| Johansen, H | 1 |
| Reffelmann, T | 1 |
| vom Dahl, J | 1 |
| Hendriks, F | 1 |
| Klues, HG | 1 |
| Hanrath, P | 1 |
| Maresta, A | 1 |
| Balducelli, M | 1 |
| Cantini, L | 1 |
| Casari, A | 1 |
| Chioin, R | 1 |
| Fontanelli, A | 1 |
| Monici Preti, PA | 1 |
| Repetto, S | 1 |
| Raffaghello, S | 1 |
| Morgan, MK | 1 |
| Sekhon, LH | 1 |
| Finfer, S | 1 |
| Grinnell, V | 1 |
| Hashimoto, K | 1 |
| Onoguchi, K | 1 |
| Sasaki, T | 1 |
| Hachiya, T | 1 |
| Takakura, H | 1 |
| Nagahori, R | 1 |
| Takeuchi, S | 1 |
| Elwood, PC | 1 |
| Hughes, C | 1 |
| O'Brien, JR | 5 |
| Oetgen, M | 1 |
| Roubin, G | 1 |
| Maida, R | 1 |
| Collins, M | 1 |
| Kreps, E | 1 |
| Nurmohamed, MT | 1 |
| Lems, WF | 1 |
| Dijkmans, BA | 1 |
| Holman, WL | 1 |
| Peterson, ED | 1 |
| Athanasuleas, CL | 1 |
| Allman, RM | 1 |
| Sansom, M | 1 |
| Kiefe, C | 1 |
| Sherrill, RG | 1 |
| Patel, ST | 1 |
| Haser, PB | 1 |
| Korn, P | 1 |
| Bush, HL | 1 |
| Deitch, JS | 1 |
| Kent, KC | 1 |
| Chew, EY | 1 |
| Benson, WE | 1 |
| Remaley, NA | 1 |
| Lindley, AA | 1 |
| Burton, TC | 1 |
| Csaky, K | 1 |
| Williams, GA | 1 |
| Ferris, FL | 1 |
| Jafary, FH | 1 |
| Kimmelstiel, CD | 1 |
| Rivard, M | 1 |
| Kostuk, W | 1 |
| Latter, D | 1 |
| Daly, P | 1 |
| Davies, R | 1 |
| Teo, K | 1 |
| Gudas, V | 1 |
| Sullivan, J | 1 |
| White, M | 1 |
| Müller, C | 1 |
| Büttner, HJ | 1 |
| Petersen, J | 1 |
| Miller, JL | 1 |
| Ardekian, L | 1 |
| Gaspar, R | 1 |
| Peled, M | 1 |
| Brener, B | 1 |
| Laufer, D | 1 |
| Sors, H | 1 |
| Meyer, G | 1 |
| Van Langenhove, G | 1 |
| Vermeersch, P | 1 |
| Serrano, P | 1 |
| Kutryk, MJ | 1 |
| Stockman, D | 1 |
| Convens, C | 1 |
| Van den Branden, F | 1 |
| Vanagt, E | 1 |
| Albertal, M | 1 |
| Van den Heuvel, P | 1 |
| Adolfsson, J | 1 |
| Taha, R | 1 |
| White, SA | 1 |
| Horsburgh, T | 1 |
| Nicholson, ML | 1 |
| Kobza, II | 1 |
| Irving, RJ | 1 |
| Oram, SH | 1 |
| Boyd, J | 1 |
| Rutledge, P | 1 |
| McRae, F | 1 |
| Bloomfield, P | 1 |
| Madi, A | 1 |
| Plavec, M | 1 |
| Nawaz, H | 1 |
| Katz, DL | 1 |
| Suttorp, MJ | 1 |
| Mast, EG | 1 |
| Bal, E | 1 |
| Ernst, SM | 1 |
| Plokker, HW | 2 |
| Henley, E | 1 |
| Calver, AL | 1 |
| Blows, LJ | 1 |
| Harmer, S | 1 |
| Dawkins, KD | 1 |
| Gray, HH | 1 |
| Morgan, JH | 1 |
| Simpson, IA | 1 |
| Poliantsev, AA | 1 |
| Spasov, AA | 1 |
| Mozgovoĭ, PV | 1 |
| Karpenko, AV | 1 |
| Shcherbakov, VN | 1 |
| Kuznetsov, VI | 1 |
| Khomutnikova, AI | 1 |
| Kirichenko, OM | 1 |
| Robertson, AJ | 1 |
| Nargund, V | 1 |
| Gray, DW | 1 |
| Morris, PJ | 1 |
| Silber, S | 1 |
| Krischke, I | 1 |
| Prohaska, M | 1 |
| Kreikemeier, J | 1 |
| Tobias, JD | 1 |
| Dacey, LJ | 1 |
| Munoz, JJ | 1 |
| Johnson, ER | 1 |
| Leavitt, BJ | 1 |
| Maloney, CT | 1 |
| Morton, JR | 1 |
| Olmstead, EM | 1 |
| Birkmeyer, JD | 1 |
| O'Connor, GT | 1 |
| Chew, DP | 1 |
| Hirsch, AT | 1 |
| Ringleb, PA | 1 |
| Hacke, W | 1 |
| Gaziano, JM | 1 |
| Skerrett, PJ | 1 |
| Buring, JE | 1 |
| Bassand, JP | 1 |
| Brookenthal, KR | 1 |
| Freedman, KB | 1 |
| Fitzgerald, RH | 1 |
| Chen, TC | 1 |
| Ng, KF | 1 |
| Jeng, LB | 1 |
| Yeh, TS | 1 |
| Chen, CM | 1 |
| Hutten, BA | 1 |
| Anand, SS | 1 |
| Tanabe, Y | 1 |
| Ito, E | 1 |
| Suzuki, K | 1 |
| Griffo, R | 1 |
| Walenga, JM | 1 |
| Hoppensteadt, D | 1 |
| Pifarré, R | 1 |
| Fox, NL | 1 |
| Forman, S | 1 |
| Hunninghake, DB | 1 |
| Campeau, L | 1 |
| Herd, JA | 1 |
| Hoogwerf, BJ | 1 |
| Hickey, A | 1 |
| Probstfield, JL | 1 |
| Terrin, ML | 1 |
| Mehta, BC | 1 |
| Wollert, HG | 1 |
| Eckel, L | 1 |
| Oostenbrink, JB | 1 |
| Busschbach, JJ | 1 |
| van Hout, BA | 1 |
| Buskens, E | 1 |
| Grace, DL | 1 |
| Tcheng, JE | 1 |
| Lincoff, AM | 1 |
| Kleiman, NS | 1 |
| Sane, DC | 1 |
| Cines, DB | 1 |
| Jordan, RE | 1 |
| Mascelli, MA | 1 |
| Langrall, MA | 1 |
| Damaraju, L | 1 |
| Schantz, A | 1 |
| Effron, MB | 1 |
| Braden, GA | 1 |
| Mesko, JW | 1 |
| Brand, RA | 1 |
| Gradisar, I | 1 |
| Heekin, R | 1 |
| Leighton, R | 1 |
| Thornberry, R | 1 |
| Haulon, S | 1 |
| Susen, S | 1 |
| Koussa, M | 1 |
| Jude, B | 1 |
| Samama, MM | 1 |
| Yende, S | 1 |
| D'Ancona, G | 1 |
| Donias, HW | 1 |
| Karamanoukian, RL | 1 |
| Bergsland, J | 1 |
| Karamanoukian, HL | 1 |
| Bartorelli, AL | 1 |
| Trabattoni, D | 1 |
| Montorsi, P | 1 |
| Fabbiocchi, F | 1 |
| Galli, S | 1 |
| Ravagnani, P | 1 |
| Grancini, L | 1 |
| Cozzi, S | 1 |
| Loaldi, A | 1 |
| Johnson, WC | 1 |
| Williford, WO | 1 |
| Ehlers, R | 1 |
| Felbinger, TW | 1 |
| Eltzschig, HK | 1 |
| Jablonski, P | 1 |
| Howden, BO | 1 |
| Hui, CK | 1 |
| Lai, KC | 1 |
| Yuen, MF | 1 |
| Wong, WM | 1 |
| Lam, SK | 1 |
| Lai, CL | 1 |
| Sarasin, FP | 1 |
| Bounameaux, H | 1 |
| Walker, N | 1 |
| Rodgers, A | 1 |
| Gray, H | 1 |
| Leali, A | 1 |
| Fetto, J | 1 |
| Moroz, A | 1 |
| Kiberd, BA | 1 |
| Serradimigni, A | 1 |
| Loo, J | 1 |
| Björk, VO | 1 |
| Henze, A | 1 |
| Faergeman, O | 2 |
| Gormsen, J | 1 |
| Meinertz, H | 1 |
| Fletcher, AP | 1 |
| Alkjaersig, NK | 1 |
| Tulevski, V | 2 |
| Hartung, B | 2 |
| Schreiber, U | 2 |
| Rödiger, H | 1 |
| Riffelmacher, F | 1 |
| Wiggins, CE | 1 |
| Rich, WJ | 1 |
| Torosian, M | 2 |
| Michelson, EL | 2 |
| Morganroth, J | 2 |
| McGaul, T | 1 |
| Mac Vaugh, H | 1 |
| Rubin, RN | 1 |
| Hume, M | 3 |
| Bierbaum, B | 1 |
| Kuriakose, TX | 1 |
| Surprenant, J | 1 |
| Fisher, M | 1 |
| Loew, D | 7 |
| Brücke, P | 1 |
| Simma, W | 1 |
| Dienstl, E | 1 |
| Boehme, K | 3 |
| DeSanctis, RW | 3 |
| Weiss, HJ | 2 |
| Núñez González, L | 1 |
| Roldán Pascual, T | 1 |
| Gil Aguado, M | 2 |
| Morales Pérez, R | 1 |
| Collantes Puertas, P | 1 |
| Sánchez Martínez, F | 1 |
| Hernández Díaz, A | 1 |
| Sáez Martin, L | 1 |
| Donaldson, WR | 1 |
| Suprenant, J | 1 |
| Reyers, I | 1 |
| Di Minno, G | 1 |
| Donati, MB | 2 |
| Aosaki, M | 1 |
| Kitamura, N | 1 |
| Sasahara, AA | 1 |
| Sharma, GV | 1 |
| Parisi, AF | 1 |
| Uhl, JF | 1 |
| Huguier, M | 1 |
| Dettori, AG | 1 |
| Pini, M | 2 |
| Quintavalla, R | 1 |
| Rose, SD | 1 |
| Gantmacher, ML | 1 |
| Schöndorf, TH | 6 |
| Hey, D | 4 |
| Schricker, KT | 1 |
| Raithel, D | 2 |
| Juchelka, L | 1 |
| Bell, W | 1 |
| Long, DM | 1 |
| Swedberg, J | 1 |
| Larsson, S | 1 |
| Roberts, D | 1 |
| Südow, G | 1 |
| Guimont, A | 1 |
| Fradet, JF | 1 |
| Sigwart, U | 1 |
| Gleichmann, U | 1 |
| Trieb, G | 1 |
| Oelert, H | 1 |
| Connolly, K | 1 |
| Ward, OC | 1 |
| Ansbro, J | 1 |
| Adappa, MG | 1 |
| Kamm, B | 1 |
| Obermeyer, P | 1 |
| Clarke, AK | 1 |
| Rahmer, H | 2 |
| Gurewich, V | 1 |
| Nunn, T | 1 |
| Kuriakose, TT | 1 |
| Moggio, RA | 1 |
| Hammond, GL | 2 |
| Stansel, HC | 1 |
| Glenn, WW | 1 |
| Adolf, J | 1 |
| Buttermann, G | 2 |
| Weidenbach, A | 2 |
| Gmeineder, F | 1 |
| Stamatakis, JD | 1 |
| Lawrence, D | 1 |
| Bentley, PG | 1 |
| Nairn, D | 1 |
| Ward, V | 1 |
| Boxer, MA | 1 |
| Braun, J | 1 |
| Ellman, L | 1 |
| Räber, G | 1 |
| Canzler, E | 1 |
| Lutze, G | 1 |
| Bauermeister, U | 1 |
| Kunze, M | 1 |
| Wyss, M | 1 |
| Diez, C | 1 |
| Balavoine, JF | 1 |
| Bouvier, CA | 1 |
| Pokrovskii, AV | 1 |
| Aleksandrova, NP | 1 |
| Kovalenko, VI | 1 |
| Lasch, HG | 2 |
| Renney, JT | 2 |
| O'Sullivan, EF | 2 |
| Burke, PF | 1 |
| Breddin, K | 2 |
| Scharrer, I | 1 |
| Kohn, P | 2 |
| Vormittag, E | 2 |
| Green, AE | 1 |
| Schulz, G | 1 |
| Brady, LP | 1 |
| Feinstein, PA | 1 |
| Habermann, ET | 1 |
| Ehresmann, U | 1 |
| Alemany, J | 1 |
| Artik, N | 2 |
| Feri, P | 1 |
| Michelazzi, L | 1 |
| Polatti, F | 1 |
| Pagnin, A | 1 |
| Strandness, DE | 1 |
| Ward, K | 1 |
| Krugmire, R | 1 |
| Friedman, EW | 1 |
| Frank, HA | 1 |
| Ponn, R | 1 |
| Weber, U | 1 |
| Rosenbaum, TJ | 1 |
| Theisinger, W | 1 |
| Hartung, R | 1 |
| Welzel, D | 1 |
| Pabst, HW | 1 |
| Pfenninger, M | 1 |
| Gruber, UF | 1 |
| Flemming, F | 1 |
| Thomas, E | 1 |
| Widera, R | 1 |
| Heitland, W | 1 |
| Lachiewicz, P | 1 |
| Jennings, JJ | 2 |
| Kaushal, SP | 1 |
| Galante, JO | 1 |
| Klement, AA | 1 |
| Khanina, TM | 1 |
| Kotovshchikova, MA | 1 |
| Osipov, SN | 1 |
| Lavrinovitsch, TS | 1 |
| Petuchova, LI | 1 |
| Slutskii, LI | 1 |
| Encke, A | 2 |
| Stock, C | 1 |
| Dumke, HO | 1 |
| Schuh, W | 1 |
| Liedloff, H | 1 |
| Schramm, G | 1 |
| Kelly, G | 1 |
| Eiseman, B | 2 |
| Evans, CC | 1 |
| Levine, B | 1 |
| Bahn, S | 1 |
| Garattini, S | 1 |
| Altman, R | 1 |
| Boullon, F | 1 |
| Rouvier, J | 1 |
| Raca, R | 1 |
| de la Fuente, L | 1 |
| Favaloro, R | 1 |
| Rittenhouse, M | 1 |
| McFee, AS | 1 |
| Aust, JB | 1 |
| Baulande, M | 1 |
| Baulande, G | 1 |
| Tournay, R | 1 |
| Joffe, SN | 1 |
| Soreff, J | 1 |
| Johnsson, H | 1 |
| Diener, L | 1 |
| Göransson, L | 1 |
| Genton, E | 3 |
| Harker, LA | 3 |
| McBride, JA | 1 |
| Kraus, V | 1 |
| Hilz, C | 1 |
| Clagett, GP | 5 |
| Schneider, P | 1 |
| Rosoff, CB | 2 |
| Kelly, GL | 1 |
| Buckingham, JM | 1 |
| Remine, WH | 1 |
| Hellinger, J | 3 |
| Seidel, M | 1 |
| Vecsey, D | 1 |
| Dechavanne, M | 1 |
| Ville, D | 1 |
| Viala, JJ | 1 |
| Kher, A | 1 |
| Faivre, J | 1 |
| Pousset, MB | 1 |
| Dejour, H | 1 |
| Matsuda, M | 1 |
| Wakabayshi, K | 1 |
| Yamanaka, M | 1 |
| Uekane, K | 1 |
| Uetake, M | 1 |
| Dragojevic, D | 1 |
| Dittrich, A | 2 |
| Bolze, H | 2 |
| Ardelt, W | 2 |
| Cosgrove, DM | 1 |
| Heric, B | 1 |
| Lytle, BW | 1 |
| Taylor, PC | 1 |
| Novoa, R | 1 |
| Golding, LA | 1 |
| Stewart, RW | 1 |
| McCarthy, PM | 1 |
| Loop, FD | 1 |
| Paiement, GD | 1 |
| Schutzer, SF | 1 |
| Wessinger, SJ | 1 |
| Johnson, PC | 1 |
| Darius, H | 1 |
| Meyer, J | 1 |
| Leyvraz, PF | 1 |
| Holden, MP | 1 |
| Anderson, FA | 1 |
| Wheeler, HB | 1 |
| Gratz, I | 1 |
| Koehler, J | 1 |
| Olsen, D | 1 |
| Afshar, M | 1 |
| DeCastro, N | 1 |
| Spagna, PM | 1 |
| Ablaza, SG | 1 |
| Larijani, GE | 1 |
| Mohr, DN | 1 |
| Silverstein, MD | 1 |
| Ilstrup, DM | 1 |
| Morrey, BF | 1 |
| Wahlström, O | 1 |
| Maller, R | 1 |
| Djerf, K | 1 |
| Ivarsson, I | 1 |
| Haas, SB | 2 |
| Tribus, CB | 1 |
| Insall, JN | 2 |
| Becker, MW | 1 |
| Windsor, RE | 2 |
| Leivonen, M | 1 |
| Sipponen, P | 1 |
| Kivilaakso, E | 1 |
| Hach-Wunderle, V | 1 |
| Agnew, TM | 1 |
| French, JK | 1 |
| Neutze, JM | 1 |
| Whitlock, RM | 1 |
| Brandt, PW | 1 |
| Kerr, AR | 1 |
| Webber, BJ | 1 |
| Rutherford, JD | 1 |
| Ratnatunga, CP | 1 |
| Edmondson, SF | 1 |
| Rees, GM | 1 |
| Kovacs, IB | 1 |
| Kjaersgaard-Andersen, P | 1 |
| Ritter, MA | 1 |
| Mohr, VD | 1 |
| Lenz, J | 1 |
| Waters, D | 1 |
| O'Meara, PM | 1 |
| Kaufman, EE | 1 |
| Vara Thorbeck, R | 1 |
| Rosell Pradas, J | 1 |
| Mekinassi, KL | 1 |
| Prados Olleta, N | 1 |
| Guerrero Fernandez-Marcote, JA | 1 |
| Broeng, L | 1 |
| Jørgensen, PS | 1 |
| Tørholm, C | 1 |
| Genyk, SN | 1 |
| Orishchak, DT | 1 |
| Bakhoviddinova, GSh | 1 |
| Leblhuber, F | 1 |
| Költringer, P | 1 |
| Reisecker, F | 1 |
| Salemark, L | 1 |
| Wieslander, JB | 1 |
| Dougan, P | 1 |
| Arnljots, B | 1 |
| Gruss, JD | 1 |
| Hiemer, W | 1 |
| Kroiss, A | 1 |
| Geissler, C | 1 |
| Shirvani, R | 1 |
| Wildsmith, JA | 1 |
| McClure, JH | 1 |
| McCollum, C | 2 |
| Kenchington, G | 2 |
| Alexander, C | 2 |
| Franks, PJ | 2 |
| Greenhalgh, RM | 1 |
| Greenhalgh, R | 1 |
| Gavaghan, TP | 1 |
| Gebski, V | 1 |
| Baron, DW | 1 |
| Diener, HC | 1 |
| Loherstorfer, E | 1 |
| Seboldt, H | 1 |
| Dichgans, J | 1 |
| Prager, M | 3 |
| Wenzl, E | 1 |
| Ehringer, H | 2 |
| Rossmann, E | 2 |
| Gruber, E | 1 |
| Schemper, M | 2 |
| Piza, F | 1 |
| Függer, R | 1 |
| Sautner, T | 1 |
| Campbell, FW | 1 |
| Tyson, GS | 1 |
| Gravlee, GP | 1 |
| Horrow, JC | 1 |
| Tuman, KJ | 1 |
| McCardel, BR | 1 |
| Jones, K | 1 |
| Orthner, E | 1 |
| Hertz, H | 1 |
| Kwasny, O | 1 |
| Maier, R | 1 |
| Höfer, R | 1 |
| Bergmann, H | 1 |
| Havlick, E | 1 |
| Wohlzogen, FX | 1 |
| McFadden, EA | 1 |
| Kany, RJ | 1 |
| Fink, JN | 1 |
| Toohill, RJ | 1 |
| Ekeström, SA | 1 |
| Gunnes, S | 1 |
| Brodin, UB | 1 |
| Landercasper, J | 1 |
| Merz, BJ | 1 |
| Cogbill, TH | 1 |
| Strutt, PJ | 1 |
| Cochrane, RH | 1 |
| Olson, RA | 1 |
| Hutter, RD | 1 |
| Watson, CJ | 1 |
| Deane, AM | 1 |
| Doyle, PT | 1 |
| Bullock, KN | 1 |
| Scuderi, GR | 1 |
| Ghelman, B | 1 |
| Edwards, WH | 2 |
| Mulherin, JL | 1 |
| Jenkins, JM | 1 |
| Hull, RD | 2 |
| Raskob, GE | 2 |
| Vara-Thorbeck, R | 1 |
| Rosell-Pradas, J | 1 |
| Gavriliuk, AI | 1 |
| Knahr, K | 1 |
| Salzer, M | 1 |
| Eyb, R | 1 |
| Frank, P | 1 |
| Blauensteiner, W | 1 |
| Reisch, JS | 1 |
| Nand, S | 1 |
| Robinson, JA | 1 |
| Mazzaferro, V | 1 |
| Esquivel, CO | 1 |
| Makowka, L | 1 |
| Belle, S | 1 |
| Kahn, D | 1 |
| Koneru, B | 1 |
| Scantlebury, VP | 1 |
| Stieber, AC | 1 |
| Todo, S | 1 |
| Tzakis, AG | 1 |
| Pfisterer, M | 1 |
| Burkart, F | 1 |
| Jockers, G | 1 |
| Meyer, B | 1 |
| Regenass, S | 1 |
| Burckhardt, D | 1 |
| Schmitt, HE | 1 |
| Müller-Brand, J | 1 |
| Skarvan, K | 1 |
| Stulz, P | 1 |
| Spadini, E | 1 |
| Carluccio, L | 1 |
| Giovanardi, C | 1 |
| Magnani, E | 1 |
| Ugolotti, U | 1 |
| Uggeri, E | 1 |
| Meuwissen, OJ | 1 |
| Zichner, R | 1 |
| Weihrauch, TR | 1 |
| Julian, DH | 1 |
| Levine, M | 1 |
| Sarris, GE | 1 |
| Mitchell, RS | 1 |
| Billingham, ME | 1 |
| Glasson, JR | 1 |
| Cahill, PD | 1 |
| Miller, DC | 1 |
| Nielsen, HK | 1 |
| Husted, SE | 1 |
| Krusell, LR | 1 |
| Fasting, H | 1 |
| Bianchi, A | 1 |
| Salvans, F | 1 |
| Doncel, F | 1 |
| Sirvent, JM | 1 |
| Leon, A | 1 |
| Ayuso, A | 1 |
| Tsujinaka, T | 1 |
| Itoh, T | 1 |
| Uemura, Y | 1 |
| Sakon, M | 1 |
| Kambayashi, J | 1 |
| Mori, T | 1 |
| Zanasi, R | 1 |
| Fioretta, G | 1 |
| Ciocia, G | 1 |
| Bergonzi, M | 1 |
| Naguib, M | 1 |
| Farag, H | 1 |
| Magbagbeola, JA | 1 |
| Greenspan, B | 1 |
| Pillari, G | 1 |
| Schulman, ML | 1 |
| Badhey, M | 1 |
| Kudo, T | 1 |
| Shimizu, T | 1 |
| Kawachi, K | 1 |
| Konagai, N | 1 |
| Hino, H | 1 |
| Furukawa, K | 1 |
| Cerillo, A | 1 |
| Donzelli, R | 1 |
| Donati, PA | 1 |
| Vizioli, L | 1 |
| Cantatore, G | 1 |
| Maio, N | 1 |
| Villano, M | 1 |
| Perla, N | 1 |
| Muras, I | 1 |
| Ferraris, VA | 1 |
| Ferraris, SP | 1 |
| Lough, FC | 1 |
| Berry, WR | 1 |
| Kristensen, S | 1 |
| Tveteraas, K | 1 |
| Hein, P | 1 |
| Poulsen, HB | 1 |
| Outzen, KE | 1 |
| Hertzer, NR | 1 |
| Valbonesi, M | 1 |
| Valente, U | 1 |
| Pellicci, R | 1 |
| Piri, C | 1 |
| Ferrari, M | 1 |
| Frisoni, R | 1 |
| Zia, S | 1 |
| Quaratino, S | 1 |
| Fella, M | 1 |
| Müller, R | 1 |
| Musikić, P | 1 |
| Josefsson, G | 1 |
| Dahlqvist, A | 1 |
| Bodfors, B | 1 |
| Weisel, RD | 1 |
| Mee, AV | 1 |
| Ivanov, J | 1 |
| Madonik, MM | 1 |
| Levitt, DS | 1 |
| Reilly, PA | 1 |
| Rosenfeld, JM | 1 |
| Pinna, AD | 1 |
| Argiolu, F | 1 |
| Marongiu, L | 1 |
| Pinna, DC | 1 |
| Hopp, H | 1 |
| Hopp, A | 1 |
| Knispel, J | 1 |
| Stern, D | 1 |
| Vasey, H | 1 |
| da Rocha Neto, JM | 1 |
| da Rocha Filho, JM | 1 |
| da Rocha, AM | 1 |
| Thaulow, E | 1 |
| Frøysaker, T | 1 |
| Dale, J | 2 |
| Vatne, K | 1 |
| Sheng, FC | 1 |
| Busuttil, RW | 1 |
| Maekawa, T | 1 |
| Thibert, MR | 1 |
| Carroll, SE | 1 |
| Rosenthal, D | 1 |
| Lamis, PA | 1 |
| Stanton, PE | 1 |
| Clark, MD | 1 |
| Ellison, RG | 1 |
| Werblin, TP | 1 |
| Peiffer, RL | 1 |
| Clayton, ML | 1 |
| Thompson, TR | 1 |
| Mazuch, J | 1 |
| Mihalovics, T | 1 |
| Filo, M | 1 |
| Woods, A | 1 |
| Vargas, J | 1 |
| Berri, G | 1 |
| Kreutzer, G | 1 |
| Meschengieser, S | 1 |
| Pinto, AG | 1 |
| Connor, FO | 1 |
| Nitter-Hauge, S | 1 |
| Hartz, RS | 1 |
| LoCicero, J | 1 |
| Kucich, V | 1 |
| DeBoer, A | 1 |
| O'Mara, S | 1 |
| Meyers, SN | 1 |
| Michaelis, LL | 1 |
| Nordestgaard, AG | 1 |
| Buckels, JA | 1 |
| Wilson, SE | 1 |
| Steidler, NE | 1 |
| Mok, CK | 1 |
| Boey, J | 1 |
| Wang, R | 1 |
| Chan, TK | 1 |
| Cheung, KL | 1 |
| Lee, PK | 1 |
| Chow, J | 1 |
| Ng, RP | 1 |
| Tse, TF | 1 |
| Satiani, B | 1 |
| Findlay, JM | 1 |
| Lougheed, WM | 1 |
| Gentili, F | 1 |
| Walker, PM | 1 |
| Glynn, MF | 1 |
| Houle, S | 1 |
| Páramo, JA | 1 |
| Alfaro, MJ | 1 |
| Rocha, E | 1 |
| Ribeiro, PA | 1 |
| Al Zaibag, M | 1 |
| Idris, M | 1 |
| Al Kasab, S | 1 |
| Davies, G | 1 |
| Mashat, E | 1 |
| Wareham, E | 1 |
| Al Fagih, M | 1 |
| Uppington, J | 1 |
| Pulaski, JP | 1 |
| David, TE | 1 |
| Ho, WI | 1 |
| Wagner, R | 2 |
| Adams, CB | 1 |
| Heady, JA | 1 |
| Mayrhofer, EF | 1 |
| Kidd, EA | 1 |
| Wade, AB | 1 |
| Poigenfürst, J | 1 |
| Thien, M | 1 |
| Aglietti, P | 1 |
| Mendes, DG | 1 |
| Wilson, PD | 1 |
| Lazansky, MG | 1 |
| Silverstein, MJ | 1 |
| DeKernion, J | 1 |
| Morton, DL | 1 |
| Athanasoulis, C | 1 |
| Baum, S | 1 |
| Brier, DF | 1 |
| Schneider, PB | 1 |
| Keskitalo, E | 1 |
| Persson, G | 1 |
| Wangensteen, SL | 1 |
| Golden, T | 1 |
| Jona, JZ | 1 |
| Kwaan, HC | 1 |
| Bjelan, M | 1 |
| Raffensperger, JG | 1 |
| Lataste, J | 1 |
| Le Picard, P | 1 |
| Lyon, LJ | 1 |
| Nevins, MA | 1 |
| Neef, H | 1 |
| Preusser, KP | 1 |
| Edwards, IR | 1 |
| Walker, AE | 1 |
| O'Brien, BM | 1 |
| MacLeod, AM | 1 |
| Miller, GD | 1 |
| Newing, RK | 1 |
| Hayhurst, JW | 1 |
| Morrison, WA | 1 |
| Welch, CE | 1 |
| Hedberg, S | 1 |
| Kozinn, PJ | 1 |
| Lynfield, J | 1 |
| Seelig, MS | 1 |
| Andrassy, K | 1 |
| Malluche, H | 1 |
| Bornefeld, H | 1 |
| Comberg, M | 1 |
| Ritz, E | 1 |
| Jesdinsky, H | 1 |
| Möhring, K | 1 |
| Duckert, F | 1 |
| Gallus, AS | 1 |
| Büttinghaus, K | 1 |
| Tenhaeff, D | 1 |
| Harrison, JF | 1 |
| Parker, RW | 1 |
| De Silva, KL | 1 |
| Zeitler, E | 1 |
| Reichold, J | 1 |
| Schoop, W | 1 |
| Butterfield, WJ | 1 |
| Spängler, P | 1 |
| Staffen, A | 1 |
| Schürer-Waldheim, H | 1 |
| Wood, EH | 1 |
| McGrouther, DA | 1 |
| Sinclair, J | 1 |
| McNicol, GP | 1 |
| Heinrich, D | 1 |
| Burkhardt, H | 1 |
| Skillman, JJ | 1 |
| Tulevski, VG | 1 |
| Etherington, M | 1 |
| Madgwick, T | 1 |
| Alkjaersig, N | 1 |
| Fletcher, A | 1 |
| Wellmer, HK | 1 |
| Baer, U | 1 |
| Merguet, H | 1 |
| Rumpf, P | 1 |
| Petersen, H | 1 |
| Bromig, G | 1 |
| Persch, WF | 1 |
| Marx, FJ | 1 |
| von Bary, SM | 1 |
| Hill, RC | 1 |
| Turner, P | 1 |
| Parkhouse, J | 1 |
| Heppenstall, C | 1 |
| Smith, E | 1 |
| Wright, V | 1 |
| Ivey, KJ | 1 |
| Nelson, R | 1 |
| Elcock, HW | 1 |
| Fredrickson, JM | 1 |
| Quick, AJ | 1 |
| Stafford, ES | 1 |
| Zuidema, GD | 1 |
| Cameron, JL | 1 |
| Rubinstein, A | 1 |
| Beck, EA | 1 |
| Lerber, W | 1 |
| Torriani, R | 1 |
| Hugh, TB | 1 |
| Donnellan, M | 1 |
| Fagan, PA | 1 |
| Shagrin, JW | 1 |
| Frame, B | 1 |
| Duncan, H | 1 |
| Worsoe-Petersen, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Comparative Effectiveness of Pulmonary Embolism Prevention After Hip and Knee Replacement: Balancing Safety and Effectiveness[NCT02810704] | Phase 4 | 20,000 participants (Anticipated) | Interventional | 2016-12-31 | Recruiting | ||
| The Effect of Aspirin on Patency of Metal Stent in Malignant Distal Bile Duct Obstruction[NCT03279809] | 52 participants (Actual) | Interventional | 2017-10-12 | Terminated (stopped due to One grade 4 adverse event (AE) and common (47.2%) grade 3 AEs) | |||
| Low Molecular Weight hEparin vs. Aspirin Post-partum[NCT05058924] | 50 participants (Anticipated) | Interventional | 2021-08-29 | Recruiting | |||
| Platelet Sub-study of the TWILIGHT Trial[NCT04001374] | 40 participants (Actual) | Observational | 2015-06-28 | Completed | |||
| Platelet Function Evaluation in Patients With Acute Coronary Syndromes on Potent P2Y12 Inhibitor Monotherapy Versus Dual Antiplatelet Therapy With Aspirin and a Potent P2Y12 Inhibitor[NCT05767723] | Phase 4 | 48 participants (Anticipated) | Interventional | 2023-02-06 | Recruiting | ||
| Ticagrelor With Aspirin or Alone in High-Risk Patients After Coronary Intervention[NCT02270242] | Phase 4 | 9,006 participants (Actual) | Interventional | 2015-07-31 | Completed | ||
| Efficacy and Safety of Apixaban in Reducing Restenosis and Limb Loss in Subjects With Symptomatic Peripheral Artery Disease (PAD) Undergoing Infrapopliteal Endovascular Peripheral Revascularization Procedures in Patients With Critical Limb[NCT04229264] | Phase 3 | 200 participants (Anticipated) | Interventional | 2020-01-09 | Recruiting | ||
| Pneumatic Compression Versus Anti-thromboembolic Exercises: Effects on Edema of the Lower Limbs and the Outcomes of Patients Undergoing Total Hip Arthroplasty: Randomized Controlled Clinical Trial[NCT05312060] | 48 participants (Anticipated) | Interventional | 2022-04-11 | Enrolling by invitation | |||
| Clopidogrel On Top of Aspirin For the Prevention of New Onset Migraine Headache Occurrence Following Transcatheter Closure of Atrial Septal Defects: A Prospective Randomized Trial (the CANOA Study)[NCT00799045] | Phase 4 | 220 participants (Actual) | Interventional | 2008-10-31 | Completed | ||
| Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG[NCT04045665] | Phase 3 | 3,200 participants (Anticipated) | Interventional | 2019-12-13 | Recruiting | ||
| Comparison of 1-month Versus 12-month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents Guided by Either Intravascular Ultrasound or Angiography in Patients With Acute Coronary Syndrome: The Prospective, Multicenter, Randomized, Placebo-[NCT03971500] | 3,710 participants (Actual) | Interventional | 2019-08-20 | Active, not recruiting | |||
| A Large, International, Placebo-controlled, Factorial Trial to Assess the Impact of Clonidine and Acetyl-salicylic Acid (ASA) in Patients Undergoing Noncardiac Surgery Who Are at Risk of a Perioperative Cardiovascular Event[NCT01082874] | Phase 3 | 10,010 participants (Actual) | Interventional | 2010-07-31 | Completed | ||
| Analysis of the Platelet Activity State in Patients Implanted With Ventricular Assist Device (VAD)[NCT03255928] | 60 participants (Anticipated) | Observational [Patient Registry] | 2017-06-29 | Recruiting | |||
| A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation[NCT00412984] | Phase 3 | 20,976 participants (Actual) | Interventional | 2006-12-31 | Completed | ||
| Clinical Investigation of a Novel Approach for the Prevention of Deep Venous Thrombosis After Total Knee Replacement[NCT04979026] | 90 participants (Actual) | Interventional | 2019-10-17 | Completed | |||
| Extended Venous Thromboembolism Prophylaxis Comparing Rivaroxaban to Aspirin Following Total Hip and Knee Arthroplasty[NCT01720108] | Phase 3 | 3,426 participants (Actual) | Interventional | 2013-02-24 | Completed | ||
| Aspirin for Prevention of Venous Thromboembolism Among Ovarian Cancer Patients Receiving Neoadjuvant Chemotherapy[NCT04352439] | Phase 4 | 19 participants (Actual) | Interventional | 2020-08-08 | Completed | ||
| A Prospective, Randomized, Active (Warfarin) Controlled, Parallel-arm Clinical Trial to Determine if Participants With an On-X Aortic Valve Can be Maintained Safely and Effectively on Apixaban[NCT04142658] | Phase 3 | 863 participants (Actual) | Interventional | 2020-05-01 | Terminated (stopped due to Safety) | ||
| Prospective Randomized On-X Anticoagulation Clinical Trial (PROACT)[NCT00291525] | 1,200 participants (Anticipated) | Interventional | 2006-06-06 | Active, not recruiting | |||
| A Clinical Multicenter, Prospective, Observational Cohort Study to Validate a Prediction Mobile APP for Perioperative Hypothermia[NCT05333120] | 3,000 participants (Anticipated) | Observational [Patient Registry] | 2021-05-25 | Recruiting | |||
| Influence of Different Inspired Oxygen Fractions on Perioperative Myocardial Biomarkers, Myocardial Strain and Outcome in Patients Undergoing General Anaesthesia for Elective Non-cardiac Surgery: A Prospective Randomized Open-label Single Centre Pilot Stu[NCT04808401] | 110 participants (Anticipated) | Interventional | 2021-05-07 | Recruiting | |||
| Closed Incision Negative Pressure Therapy Compared to Conventional Dressing Following Autologous Abdominal Tissue Breast Reconstruction: A Randomized Control Trial[NCT05907941] | 114 participants (Anticipated) | Interventional | 2023-07-31 | Not yet recruiting | |||
| A Randomized, Parallel Group, Double-Blind Study of Ticagrelor Compared With Aspirin for Prevention of Vascular Events in Patients Undergoing Coronary Artery Bypass Graft Operation TiCAB- Ticagrelor in CABG[NCT01755520] | Phase 3 | 1,893 participants (Actual) | Interventional | 2013-04-24 | Terminated (stopped due to DSMB Interim Analyses) | ||
| Bivalirudin vs Heparin in NSTEMI and STEMI in Patients on Modern Antiplatelet Therapy in SWEDEHEART A Multicenter, Prospective, Randomized Controlled Clinical Trial Based on the SWEDEHEART Platform[NCT02311231] | Phase 4 | 6,012 participants (Actual) | Interventional | 2014-06-30 | Completed | ||
| Evaluating the Role of Pre-existing Resolvins in the Resolution of ICU Delirium[NCT04575753] | 100 participants (Anticipated) | Observational | 2023-10-07 | Not yet recruiting | |||
| PROlonging Dual Antiplatelet Treatment In Patients With Coronary Artery Disease After Graded Stent-induced Intimal Hyperplasia studY[NCT00611286] | Phase 4 | 1,700 participants (Anticipated) | Interventional | 2006-12-31 | Completed | ||
| Dual Antiplatelet Therapy in Patients With Aspirin Resistance Following Coronary Artery Bypass Grafting[NCT01159639] | Phase 4 | 200 participants (Actual) | Interventional | 2010-06-30 | Completed | ||
| MET: REevaluation for Perioperative cArdIac Risk (MET-REPAIR): a Prospective, Multi-centre Cohort Observational Study- Presepsin (sCD14-ST) for Perioperative Risk Prediction Nested Cohort Study[NCT03489486] | 1,695 participants (Anticipated) | Observational | 2018-06-15 | Recruiting | |||
| MET: REevaluation for Perioperative cArdIac Risk (MET-REPAIR) Observational Multicentre Study[NCT03016936] | 15,000 participants (Actual) | Observational | 2017-08-01 | Completed | |||
| Effect of Spinal Versus General Anesthesia on Cardiac and Renal Biomarker Levels in Hip and Knee Arthroplasty Surgery[NCT03940651] | Phase 4 | 1 participants (Actual) | Interventional | 2019-09-04 | Terminated (stopped due to Funding ended) | ||
| Effect of Vitamin C Infusion on Coronary Reperfusion Indexes[NCT01090895] | Phase 4 | 80 participants (Anticipated) | Interventional | 2010-03-31 | Recruiting | ||
| Preprocedural Asprin Reload for Native Coronary Disease Treated by Angioplasty: Reperfusion Indexes Evaluation and Improvement of Clinical Outcome -PANTAREI Study[NCT01374698] | Phase 4 | 100 participants (Actual) | Interventional | 2011-01-31 | Completed | ||
| Comparison of Two Induction Regimens Using Topical Lidocaine or Muscle Relaxant; Impact on Postoperative Sore Throat and Haemodynamics[NCT03031808] | Phase 4 | 100 participants (Anticipated) | Interventional | 2017-10-31 | Recruiting | ||
| Impact of Preoperative FFR on Arterial Bypass Graft Functionality: Towards a New CABG Paradigm[NCT02527044] | 120 participants (Anticipated) | Interventional | 2015-11-30 | Active, not recruiting | |||
| Clopidogrel After Surgery for Coronary Artery Disease (CASCADE Trial): Does Clopidogrel Prevent Saphenous Vein Graft Disease After Coronary Bypass?[NCT00228423] | Phase 2 | 113 participants (Actual) | Interventional | 2006-05-31 | Completed | ||
| Is There A LIfe for DES After Discontinuation of Clopidogrel:The ITALIC PLUS Trial[NCT01476020] | 1,240 participants (Anticipated) | Observational | 2011-11-30 | Not yet recruiting | |||
| Zotarolimus-eluting Endeavor Sprint Stent in Uncertain DES Candidates (ZEUS) Study[NCT01385319] | Phase 3 | 1,606 participants (Actual) | Interventional | 2011-06-30 | Active, not recruiting | ||
| A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal S[NCT00977938] | Phase 4 | 25,682 participants (Actual) | Interventional | 2009-10-31 | Completed | ||
| Comparison of Prasugrel and Ticagrelor Antiplatelet Effects in Korean Patients Presenting With ST-segment Elevation Myocardial Infarction[NCT02075125] | Phase 3 | 39 participants (Actual) | Interventional | 2014-01-31 | Terminated (stopped due to Enrolling participants has halted prematurely and will not resume) | ||
| Management of Antiplatelet Regimen During Surgical Procedures (MARS Registry)[NCT03981835] | 1,492 participants (Anticipated) | Observational [Patient Registry] | 2019-08-01 | Recruiting | |||
| Association Between Perioperative Bleeding and Aspirin Use in Spine Surgery: A Randomized, Controlled Trial[NCT02807441] | Phase 3 | 0 participants (Actual) | Interventional | 2016-07-31 | Withdrawn | ||
| The Association Between Platelet Inhibition and Perioperative Major Adverse Cardiac Events In Post-Percutaneous Coronary Intervention (PCI) Patients Undergoing Non-Cardiac Surgery[NCT01707459] | 201 participants (Actual) | Observational | 2010-03-31 | Completed | |||
| Antiplatelet Therapy for Patients Undergoing Transcatheter Aortic Valve Implantation[NCT02247128] | Phase 4 | 1,016 participants (Actual) | Interventional | 2014-01-31 | Completed | ||
| PercutaNEOus Coronary Intervention Followed by Monotherapy INstead of Dual Antiplatelet Therapy in the SETting of Acute Coronary Syndromes: The NEO-MINDSET Trial A Drug Reduction Study for Patients With Acute Coronary Syndrome in the Unified Health System[NCT04360720] | Phase 3 | 3,400 participants (Anticipated) | Interventional | 2020-10-15 | Recruiting | ||
| The Effect of Remote Ischemic Preconditioning on Myocardial Injury After Noncardiac Surgery in Patients at a High Risk of Cardiac Events[NCT05733208] | 766 participants (Anticipated) | Interventional | 2023-05-06 | Recruiting | |||
| Effect of Protocol-based Management on Perioperative Outcomes in Patients With Chronic Antithrombotic Therapy: a Pragmatic Interventional Study[NCT04852406] | 526 participants (Anticipated) | Interventional | 2021-04-21 | Recruiting | |||
| Effects of Artificial Intelligence Assisted Follow-up Strategy Based on a New Remote Contactless Sleep Monitoring System on Secondary Prevention in Patients Received Coronary Artery Bypass Grafting Surgery[NCT04636996] | 200 participants (Anticipated) | Interventional | 2021-01-01 | Not yet recruiting | |||
| The Effect of Local Tranexamic Acid on Post-operative Edema and Ecchymosis in Eyelid Surgery[NCT04951128] | Phase 4 | 50 participants (Anticipated) | Interventional | 2021-08-01 | Not yet recruiting | ||
| Tranexamic Acid for the Prevention of Obstetrical Hemorrhage After Cesarean Delivery: A Randomized Controlled Trial[NCT03364491] | Phase 3 | 11,000 participants (Actual) | Interventional | 2018-03-15 | Completed | ||
| Tranexamic Acid to Prevent OpeRation in Chronic Subdural Hematoma. A Double-blind, Placebo-controlled, Multicentre, Randomized Controlled Clinical Trial[NCT03582293] | Phase 3 | 140 participants (Anticipated) | Interventional | 2018-06-19 | Recruiting | ||
| DEPOSITION: Pilot Study Decreasing Postoperative Blood Loss by Topical vs. Intravenous Tranexamic Acid in Open Cardiac Surgery[NCT03376061] | Phase 4 | 97 participants (Actual) | Interventional | 2017-12-21 | Completed | ||
| Decreasing Postoperative Blood Loss by Topical vs. Intravenous Tranexamic Acid in Open Cardiac Surgery (DEPOSITION) Study[NCT03954314] | Phase 3 | 3,242 participants (Actual) | Interventional | 2019-09-17 | Terminated (stopped due to Upon the Data Safety Monitoring Board review of the interim analysis (75% of participants have finished their follow-up) on November 17, 2023, they made a recommendation to stop recruitment into the trial.) | ||
| Future Revascularization Evaluation in Patients With Diabetes Mellitus: Optimal Management of Multivessel Disease (FREEDOM)[NCT00086450] | Phase 3 | 1,900 participants (Actual) | Interventional | 2004-04-30 | Active, not recruiting | ||
| A Different Approach to Preventing Thrombosis (ADAPT): A Randomized Controlled Trial Comparing Low Molecular Weight Heparin to Acetylsalicylic Acid in Orthopedic Trauma Patients[NCT02774265] | Phase 3 | 329 participants (Actual) | Interventional | 2016-01-31 | Completed | ||
| A Prospective, Nonrandomized, Study Comparing the Use of Aspirin and Intraoperative Blood Loss and Postoperative Complications Following Open Inguinal Hernia Repair.[NCT02084615] | 300 participants (Anticipated) | Interventional | 2014-08-31 | Enrolling by invitation | |||
| Maintenance of an Antiaggregation by Acetylsalicylic Acid, Less or Equal to 250mg While a Extracorporeal Lithotripsy (ECL) Session on a Kidney Stone is Perfomed: Comparative Unicentric Prospective Study[NCT03437057] | 300 participants (Anticipated) | Interventional | 2018-01-08 | Recruiting | |||
| Effect of Tailored Use of Tirofiban in Patients With Non-ST-elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention[NCT03114995] | Phase 4 | 140 participants (Actual) | Interventional | 2012-02-01 | Completed | ||
| Influence of CILostazol-based Triple Anti-platelet Therapy ON Ischemic Complication After Drug-eluting stenT Implantation[NCT00776828] | Phase 4 | 960 participants (Actual) | Interventional | 2006-11-30 | Completed | ||
| Maintenance Of aNtiplatElet Therapy in Patients With Coronary Stenting Undergoing Surgery[NCT03445273] | 1,800 participants (Anticipated) | Observational [Patient Registry] | 2018-11-21 | Not yet recruiting | |||
| Must Aspirin be Discontinued Prior to TURBT: a Prospective, Randomized, Non-inferiority Trial Comparing Peri-operative Aspirin Continuation Versus Discontinuation.[NCT02350543] | Phase 4 | 50 participants (Actual) | Interventional | 2015-02-28 | Terminated (stopped due to Insufficient recruitment.) | ||
| A Prospective, Multicenter, Randomized Controlled Trial to Evaluate the Safety and Efficacy of the STARFlex® Septal Closure System Versus Best Medical Therapy in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism [NCT00201461] | Phase 2/Phase 3 | 900 participants (Anticipated) | Interventional | 2003-06-30 | Active, not recruiting | ||
| China Research for Severe Spontaneous Intracerebral Hemorrhage（CRISIH）[NCT05975398] | 450 participants (Anticipated) | Observational [Patient Registry] | 2022-07-01 | Recruiting | |||
| Effect and Safety of Surgical Intervention for Severe Spontaneous Intracerebral Hemorrhage Patients on Long-term Oral Antiplatelet Treatment[NCT05766865] | 450 participants (Actual) | Observational | 2019-07-10 | Completed | |||
| Pipeline Flex With SHield Technology Embolization - An International MulticEnter ObservationaL Post Market StuDy of Treated Intra Cranial Aneurysms (SHIELD)[NCT02719522] | 205 participants (Actual) | Observational | 2016-03-31 | Completed | |||
| An International Multi Centre Randomized Clinical Trial Of Anticoagulation In Children Following Fontan Procedures[NCT00182104] | Phase 4 | 111 participants | Interventional | 1998-08-31 | Completed | ||
| Effect of Low Molecular Weight Heparin vs Unfractionated Heparin on Bleeding After Cardiac Surgery[NCT00420667] | 43 participants (Actual) | Interventional | 2004-11-30 | Completed | |||
| Phase 4 Study of Postoperative Prostaglandin E1 in Head and Neck Microsurgery[NCT00733434] | Phase 4 | 242 participants (Anticipated) | Interventional | 2008-07-31 | Recruiting | ||
| SEA-SIDE: Sirolimus Versus Everolimus-eluting Stent Randomized Assessment in Bifurcated Lesions and Clinical SIgnificance of Residual siDE-branch Stenosis[NCT00697372] | Phase 4 | 150 participants (Actual) | Interventional | 2007-09-30 | Completed | ||
| Prospective Randomized Study of the Paclitaxel-Coated Balloon Catheter in Bifurcated Coronary Lesions / BABILON Study (Paclitaxel-Coated Balloon in Bifurcated Lesions)[NCT01278186] | Phase 4 | 190 participants (Anticipated) | Interventional | 2010-06-30 | Active, not recruiting | ||
| Prospective, Randomized, Single-Center Evaluation of the Cypher™ Sirolimus Eluting Coronary Stent System in the Treatment of Bifurcated Coronary Lesions[NCT00288535] | Phase 4 | 200 participants (Anticipated) | Interventional | 2005-03-31 | Recruiting | ||
| Study of Lipid Core Plaque Shift at Sites of Native Coronary Artery Bifurcation[NCT00905671] | Phase 4 | 20 participants (Actual) | Interventional | 2009-06-30 | Completed | ||
| Z-SEA-SIDE: Sirolimus Versus Everolimus Versus Zotarolimus-eluting Stent Assessment in Bifurcated Lesions and Clinical SIgnificance of Residual siDE-branch Stenosis[NCT01200693] | Phase 4 | 80 participants (Actual) | Interventional | 2008-11-30 | Completed | ||
| Approaches to Chronic Occlusions With Sirolimus Stents-Cypher (ACROSS-Cypher) Total Occlusion Study of Coronary Arteries 4 Trial[NCT00378612] | Phase 3 | 200 participants (Actual) | Interventional | 2005-06-30 | Completed | ||
| "Transcranial Doppler Assessment of Cerebral Embolization During Early Anti-thrombotic Therapy After Bioprosthetic Aortic Valve Replacement: Comparison of High-dose Aspirin Versus Warfarin Plus Low-dose Aspirin"[NCT00465218] | 56 participants (Actual) | Observational | 2007-03-31 | Completed | |||
| Observatory of Anticoagulation After Bioprosthetic Aortic Valve Replacement[NCT01293188] | 434 participants (Actual) | Observational | 2011-01-31 | Completed | |||
| Multicenter Ambispective Study of Clinical Outcomes of the CoreValve™Evolut R™ 34mm System: All Comers Post-market Registry[NCT03621709] | 100 participants (Anticipated) | Observational | 2017-08-01 | Active, not recruiting | |||
| A Double Blind Randomized Control Trial of Post-Operative Low Molecular Weight Heparin Bridging Therapy Versus Placebo Bridging Therapy for Patients Who Are at High Risk for Arterial Thromboembolism (PERIOP 2)[NCT00432796] | Phase 3 | 1,473 participants (Actual) | Interventional | 2006-12-31 | Active, not recruiting | ||
| Clinically-Important Venous Thromboembolism Following Lower Extremity Fractures: Epidemiology & Prevention[NCT00187408] | Phase 4 | 700 participants | Interventional | 2002-08-31 | Completed | ||
| Effect of Anticoagulation in Reducing the Incidence of Splenic/Portal Vein Thrombosis Post-Laparoscopic Splenectomy Protocol Number: 5698[NCT00769873] | Phase 2 | 35 participants (Actual) | Interventional | 2006-10-31 | Terminated (stopped due to Recruitment was slower than anticipated. Insufficient funding to expand to multi-centered trial.) | ||
| Multiple Algorithms System Of All Scores in Embolism - MOSE[NCT02911012] | 15,208 participants (Anticipated) | Observational | 2016-10-31 | Recruiting | |||
| Toronto Thromboprophylaxis Patient Safety Initiative (TOPPS): A Cluster Randomized Trial[NCT01869075] | 1,895 participants (Actual) | Interventional | 2006-07-31 | Completed | |||
| Multi-Screen Electronic Alert for Venous Thromboembolism Prevention[NCT00550082] | 880 participants (Actual) | Observational | 2007-07-31 | Completed | |||
| The Protective Effect of Transcutaneous Electrical Acupoint Stimulation (TEAS) on Aged Patients Undergoing Lower Extremity Arthroplasty: A Single-Center, Double-Blinded, Randomised Controlled Trial[NCT02979028] | 300 participants (Anticipated) | Interventional | 2017-05-01 | Not yet recruiting | |||
| Norwegian Intensive Care Unit Dalteparin Effect Study[NCT01721928] | 70 participants (Actual) | Observational | 2012-12-03 | Completed | |||
| The Use of Fondaparinux in Preventing Thromboembolism in High Risk Trauma Patients[NCT00531843] | Phase 2/Phase 3 | 105 participants (Actual) | Interventional | 2007-12-31 | Completed | ||
| The Blood Saving Effect and Wound-related Complications of Tranexamic Acid in Mininally Invasive Total Knee Arthroplasty With Rivaroxaban as Thromboprophylaxis[NCT02458729] | Phase 4 | 294 participants (Actual) | Interventional | 2012-08-31 | Completed | ||
| Effect of Thymoquinone and Olive Oil on Wound Healing After Endoscopic Sinus Surgery in Patients With Nasal Polyposis[NCT06070311] | 50 participants (Anticipated) | Interventional | 2023-10-31 | Not yet recruiting | |||
| Role of Short Term Systemic Corticosteroid Therapy in the Management of Chronic Rhinosinusitis Without Nasal Polyps[NCT01676415] | Phase 4 | 9 participants (Actual) | Interventional | 2012-08-31 | Terminated (stopped due to participants are no longer receiving intervention due to clinical logistics) | ||
| Gel-Sinuplasty for Chronic Rhinosinusitis With and Without Nasal Polyposis[NCT03472144] | Phase 3 | 60 participants (Anticipated) | Interventional | 2017-07-07 | Recruiting | ||
| High Volume Saline Irrigation in the Post-operative Management of Chronic Rhinosinusitis: A Multicenter Randomized Single-Blind Controlled Trial[NCT02636959] | Early Phase 1 | 20 participants (Anticipated) | Interventional | 2015-12-31 | Recruiting | ||
| Role of Epithelial Barrier Integrity in Biologic Treatment Response of Severe Asthmatics With/Out Chronic Rhinosinusitis With Nasal Polyps (CRSwNP). Can Shedding of Epithelial Barrier Proteins be Used as Biomarker in Severe Asthma With/Out CRSwNP Manageme[NCT05365841] | 85 participants (Anticipated) | Observational | 2022-05-15 | Not yet recruiting | |||
| Ideal Frequency of Postoperative High Volume Saline Irrigations Following Endoscopic Sinus Surgery[NCT01680705] | 75 participants (Actual) | Interventional | 2012-07-31 | Completed | |||
| Influence of Tourniquet Use and Surgery Duration on the Incidence of Deep Vein Thrombosis in Total Knee Arthroplasty[NCT01559532] | 78 participants (Actual) | Observational | 2008-02-29 | Completed | |||
| In-vivo Thrombus Imaging With 18F-GP1, a Novel Platelet PET Radiotracer[NCT03943966] | 73 participants (Actual) | Interventional | 2019-11-11 | Completed | |||
| Dabigatran Versus Warfarin After Mitral and Aortic Bioprosthesis Replacement for the Management of Atrial Fibrillation Postoperatively: Pilot Study[NCT01868243] | Phase 2/Phase 3 | 27 participants (Actual) | Interventional | 2013-08-31 | Terminated (stopped due to because a significant decrease of viable candidates for the study.) | ||
| Non-randomized, Open-label, Historical Control, Single Group Assignment Trial of a Reduced Dose of Unfractionated Heparin in Patients Undergoing Percutaneous Coronary Interventions[NCT00735280] | Phase 4 | 2,505 participants (Actual) | Interventional | 2008-08-31 | Completed | ||
| Intracoronary Stenting and Antithrombotic Regimen: Testing of a Six-week Versus a Six-month Clopidogrel Treatment Regimen in Patients With Concomitant Aspirin and Oral Anticoagulant Therapy Following Drug-eluting Stenting[NCT00776633] | Phase 4 | 614 participants (Actual) | Interventional | 2008-09-30 | Active, not recruiting | ||
| The Use of Tranexamic Acid to Reduce Blood Loss in Acetabular Surgery[NCT02684851] | Phase 3 | 87 participants (Actual) | Interventional | 2012-10-31 | Completed | ||
| Early and Long-Term Outcome of Elective Stenting of the Infarct-Related Artery in Patients With Viability in the Infarct-Area Early After Acute Myocardial Infarction. The VIAMI-Trial.[NCT00149591] | 300 participants | Interventional | 2001-04-30 | Active, not recruiting | |||
| A Multicenter, Randomized Trial Evaluating 30-day and 6-month Clinical Outcomes With Three Different Treatment Strategies (Coronary Angioplasty + Abciximab, Intracoronary Stent + Abciximab, and Intracoronary Stent + Placebo) in Patients Undergoing Percuta[NCT00271401] | Phase 3 | 2,399 participants (Actual) | Interventional | 1996-07-31 | Completed | ||
| MRI Evaluation of Nidus Occlusion After Gamma Knife Radiosurgery of Cerebral Arteriovenous Malformations - A Prospective Preliminary Study[NCT03995823] | 50 participants (Anticipated) | Observational | 2019-07-01 | Recruiting | |||
| A Randomized Clinical Trial of Intravitreal dexamethasOne Versus Bevacizumab in Aboriginal and Torres Strait Islander patientS With Diabetic Macular Oedema (The OASIS Study)[NCT04619303] | Phase 4 | 59 participants (Actual) | Interventional | 2017-02-07 | Completed | ||
| Effects on Bleeding in Knee Arthroplasty After Ischemic Preconditioning With Sevoflurane[NCT03379103] | 30 participants (Actual) | Interventional | 2018-02-02 | Completed | |||
| E-CRANIO Trial Study on Elective CRAniotomies: Postoperative Neurointensive Care, Imaging and Outcome[NCT01987648] | 1,969 participants (Actual) | Observational | 2011-11-01 | Completed | |||
| Efficacy in Controlling Bleeding Post-coronary Bypass Surgery Using Combination of Local Application of Tranexamic Acid and Intravenous Tranexamic Compared to Intravenous Tranexamic Acid Alone. A Randomized Controlled Trial[NCT01600599] | 40 participants (Actual) | Interventional | 2011-01-31 | Completed | |||
| A Double-blind, Randomized, Placebo Controlled Pilot Trial to Evaluate the Safety and Efficacy of Vorapaxar in Maturation of Arteriovenous Fistulae for Hemodialysis Access[NCT02475837] | Phase 2 | 17 participants (Actual) | Interventional | 2015-08-26 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Number of participants with first occurrence of clinically relevant bleeding episode, defined as Bleeding Academic Research Consortium (BARC) Types 2, 3 or 5 bleeding. BARC bleeding types range from 0 (no bleeding) to 5 (fatal bleeding). (NCT02270242)
Timeframe: 12 months after randomization
| Intervention | Participants (Count of Participants) |
|---|---|
| Placebo + Ticagrelor | 141 |
| Aspirin + Ticagrelor | 250 |
Number of participants with first occurrence of confirmed all-cause death, non-fatal myocardial infarction or stroke. (NCT02270242)
Timeframe: 12 months after randomization
| Intervention | Participants (Count of Participants) |
|---|---|
| Placebo + Ticagrelor | 135 |
| Aspirin + Ticagrelor | 137 |
(NCT01082874)
Timeframe: 30 days
| Intervention | participants (Number) |
|---|---|
| Active Clonidine and Active ASA | 173 |
| Active Clonidine and Placebo ASA | 194 |
| Placebo Clonidine and Active ASA | 178 |
| Placebo Clonidine and Placebo ASA | 161 |
All bleeding events include major bleeding, CRNM bleeding (see Outcome Measure 12 Description for definitions), plus events of minor bleeding and fatal bleeding. Minor bleeding: All acute clinically overt bleeding events not meeting the criteria for either major bleeding or clinically relevant non-major bleeding will be classified as minor bleeding. Fatal bleeding is defined as a bleeding event that the Clinical Events Committee determines is the primary cause of death or contributes directly to death. (NCT00412984)
Timeframe: "Treatment Period started with first dose of blinded study drug and ended 2 days after the last dose of blinded study drug. Mean duration of exposure to double-blind study drug was 1.7 years in each treatment group."
| Intervention | participants (Number) |
|---|---|
| Apixaban | 2356 |
| Warfarin | 3060 |
ISTH Bleeding Criteria: Major bleeding=a bleeding event that was: clinically overt bleeding accompanied by a decrease in hemoglobin (Hgb) of 2 g/dL or more, and/or a transfusion of 2 or more units of packed red blood cells; bleeding that occurred in at least 1 of the following critical sites: intracranial, intraspinal, intraocular (within the corpus of the eye; a conjunctival bleed is not an intraocular bleed), pericardial, intra-articular, intramuscular with compartment syndrome, and retroperitoneal; bleeding that was fatal. (NCT00412984)
Timeframe: "Treatment Period started with first dose of blinded study drug and ended 2 days after the last dose of blinded study drug. Mean duration of exposure to double-blind study drug was 1.7 years in each treatment group."
| Intervention | participants (Number) |
|---|---|
| Apixaban | 327 |
| Warfarin | 462 |
Death was defined as all-cause mortality. All unobserved deaths were assumed to be cardiovascular in nature unless a non-cardiovascular cause could be clearly provided. Cardiovascular=deaths due to ischemic and hemorrhagic stroke, SE, myocardial infarction (MI), sudden death, heart failure, other cardiovascular, and unobserved deaths. Non-cardiovascular=all deaths due to a clearly documented non-cardiovascular cause (further classified into the categories: bleeding, study drug toxicity other than bleeding, malignancy, infection, trauma, and pulmonary causes of death). (NCT00412984)
Timeframe: "Intended Treatment Period started on the day of randomization and ended at the efficacy cut-off date (date on which it was expected that the target number of primary efficacy events [448] would have occurred; set to 30-Jan-2011, prior to unblinding)."
| Intervention | participants (Number) |
|---|---|
| Apixaban | 603 |
| Warfarin | 669 |
Major bleeding=bleeding that is clinically overt and that either resulted in a decrease in hemoglobin of 2 g/dL or more over a 24-hour period, led to a transfusion of 2 or more units of packed red blood cells, occurred in a critical site, or led to death. CRNM bleeding=bleeding that is clinically overt, that satisfies none of the additional criteria required for the event to be adjudicated as a major bleeding event, that led to either hospital admission for bleeding, physician-guided medical or surgical treatment for bleeding, or a change in antithrombotic therapy. (NCT00412984)
Timeframe: "Treatment Period started with first dose of blinded study drug and ended 2 days after the last dose of blinded study drug. Mean duration of exposure to double-blind study drug was 1.7 years in each treatment group."
| Intervention | participants (Number) |
|---|---|
| Apixaban | 613 |
| Warfarin | 877 |
Net-Clinical Benefit = Composite of stroke, systemic embolism and ISTH major bleeding. (NCT00412984)
Timeframe: "Treatment Period started with first dose of blinded study drug and ended 2 days after the last dose of blinded study drug. Mean duration of exposure to double-blind study drug was 1.7 years in each treatment group."
| Intervention | participants (Number) |
|---|---|
| Apixaban | 459 |
| Warfarin | 608 |
For descriptions of Stroke and SE, see Outcome Measure 1. For description of Major bleeding, see Outcome Measure 3. (NCT00412984)
Timeframe: "Intended Treatment Period started on the day of randomization and ended at the efficacy cut-off date (date on which it was expected that the target number of primary efficacy events [448] would have occurred; set to 30-Jan-2011, prior to unblinding)."
| Intervention | participants (Number) |
|---|---|
| Apixaban | 229 |
| Warfarin | 285 |
All unobserved deaths were assumed to be cardiovascular in nature unless a non-cardiovascular cause could be clearly provided. Cardiovascular=deaths due to ischemic and hemorrhagic stroke, SE, MI, sudden death, heart failure, other cardiovascular, and unobserved deaths. Non-cardiovascular=all deaths due to a clearly documented non-cardiovascular cause (further classified into the categories: bleeding, study drug toxicity other than bleeding, malignancy, infection, trauma, and pulmonary causes of death). (NCT00412984)
Timeframe: "Intended Treatment Period started on the day of randomization and ended at the efficacy cut-off date (date on which it was expected that the target number of primary efficacy events [448] would have occurred; set to 30-Jan-2011, prior to unblinding)."
| Intervention | Number of events per 100 patient years (Number) |
|---|---|
| Apixaban | 3.52 |
| Warfarin | 3.94 |
Rate=number of adjudicated major (ISTH) bleed events per 100 patient years. ISTH Bleeding Criteria: Major bleeding=a bleeding event that was: clinically overt bleeding accompanied by a decrease in hemoglobin (Hgb) of 2 g/dL or more and/or a transfusion of 2 or more units of packed red blood cells; bleeding that occurred in at least 1 of the following sites: intracranial, intraspinal, intraocular (within the corpus of the eye; a conjunctival bleed is not an intraocular bleed), pericardial, intra-articular, intramuscular with compartment syndrome, and retroperitoneal; bleeding that was fatal. (NCT00412984)
Timeframe: "Treatment Period started with first dose of blinded study drug and ended 2 days after the last dose of blinded study drug. Mean duration of exposure to double-blind study drug was 1.7 years in each treatment group."
| Intervention | Number of events per 100 patient years (Number) |
|---|---|
| Apixaban | 2.13 |
| Warfarin | 3.09 |
Rate=Number of adjudicated stroke or SE events per 100 patient years. Diagnosis of stroke=the nontraumatic focal neurological deficit lasting at least 24 hours, and includes ischemic stroke, hemorrhagic stroke, ischemic stroke with hemorrhagic conversion, stroke of uncertain type, and retinal ischemic event (embolism, infarction). Diagnosis of SE=clinical history consistent with an acute loss of blood flow to a peripheral artery (or arteries), supported by evidence of embolism from surgical specimens, autopsy, angiography, vascular imaging, or other objective testing. (NCT00412984)
Timeframe: "Intended Treatment Period started on the day of randomization and ended at the efficacy cut-off date (date on which it was expected that the target number of primary efficacy events [448] would have occurred; set to 30-Jan-2011, prior to unblinding)."
| Intervention | Number of events per 100 patient years (Number) |
|---|---|
| Apixaban | 1.27 |
| Warfarin | 1.60 |
"Rate=number of all bleeding events per 100 patient years. All bleeding events include major bleeding, CRNM bleeding (see Outcome Measure 12 Description for definitions), plus events of minor bleeding and fatal bleeding. Minor bleeding: All acute clinically overt bleeding events not meeting the criteria for either major bleeding or clinically relevant non-major bleeding will be classified as minor bleeding. Fatal bleeding is defined as a bleeding event that the Clinical Events Committee determines is the primary cause of death or contributes directly to death." (NCT00412984)
Timeframe: "Treatment Period started with first dose of blinded study drug and ended 2 days after the last dose of blinded study drug. Mean duration of exposure to double-blind study drug was 1.7 years in each treatment group."
| Intervention | number of events per 100 patient years (Number) |
|---|---|
| Apixaban | 18.08 |
| Warfarin | 25.82 |
(NCT00412984)
Timeframe: "Intended Treatment Period started on the day of randomization and ended at the efficacy cut-off date (date on which it was expected that the target number of primary efficacy events [448] would have occurred; set to 30-Jan-2011, prior to unblinding)."
| Intervention | Number of events per 100 patient years (Number) |
|---|---|
| Apixaban | 3.21 |
| Warfarin | 4.06 |
Rate=number of major or CRNM bleed events per 100 patient years. Major=clinically overt and either 1) resulted in a decrease in hemoglobin of 2 g/dL or more, or 2) led to a transfusion of 2 or more units of packed red blood cells, or 3) occurred in a critical site, or 4) led to death. CRNM bleeding=clinically overt, but satisfied no additional criteria required to be adjudicated as a major bleeding event, and led to either 1) hospital admission for bleeding or 2) physician guided medical or surgical treatment for bleeding or 3) a change in antithrombotic therapy. (NCT00412984)
Timeframe: "Treatment Period started with first dose of blinded study drug and ended 2 days after the last dose of blinded study drug. Mean duration of exposure to double-blind study drug was 1.7 years in each treatment group."
| Intervention | number of events / 100 patient years (Number) |
|---|---|
| Apixaban | 4.07 |
| Warfarin | 6.01 |
Rate=number of events of net-clinical benefit per 100 patient years. Net-Clinical Benefit = Composite of stroke, systemic embolism and ISTH major bleeding (NCT00412984)
Timeframe: "Treatment Period started with first dose of blinded study drug and ended 2 days after the last dose of blinded study drug. Mean duration of exposure to double-blind study drug was 1.7 years in each treatment group."
| Intervention | Number of events per 100 patient years (Number) |
|---|---|
| Apixaban | 3.01 |
| Warfarin | 4.09 |
AE: all SAEs or AEs with onset from first dose through 2 days (AEs) or 30 days (SAEs) after the last dose of blinded study drug (BSD). SAE: all SAEs with onset from first dose through 30 days after the last dose of BSD. Bleeding AE: all serious or non-serious bleeding-related AEs with onset from first dose through 2 days after the last dose of BSD. Discontinuations due to AE: all SAEs or AEs with onset from first dose of BSD and with action taken=drug discontinued. Deaths: all deaths occurring from first dose through 30 days after the last dose of BSD. (NCT00412984)
Timeframe: "Treatment Period started with first dose of blinded study drug and ended 2 days after the last dose of blinded study drug. Mean duration of exposure to double-blind study drug was 1.7 years in each treatment group."
| Intervention | participants (Number) | ||||
|---|---|---|---|---|---|
| AE | SAE | Bleeding AE | Discontinuations due to AE | Deaths | |
| Apixaban | 7406 | 3182 | 2288 | 688 | 429 |
| Warfarin | 7521 | 3302 | 2961 | 758 | 468 |
All suspected efficacy events were adjudicated by the Central Events Committee (CEC). Diagnosis of stroke=the nontraumatic focal neurological deficit lasting at least 24 hours, and includes ischemic stroke, hemorrhagic stroke, ischemic stroke with hemorrhagic conversion, stroke of uncertain type, and retinal ischemic event (embolism, infarction). Diagnosis of SE=clinical history consistent with an acute loss of blood flow to a peripheral artery (or arteries), supported by evidence of embolism from surgical specimens, autopsy, angiography, vascular imaging, or other objective testing. (NCT00412984)
Timeframe: "Time to first event in Intended Treatment Period: started on day of randomization, ended at efficacy cut-off date (date target number of primary efficacy events [448] was expected to have occurred; set to 30-Jan-2011, prior to unblinding)."
| Intervention | participants (Number) | ||
|---|---|---|---|
| Ischemic or Unspecified Stroke | Hemorrhagic Stroke | Systemic Embolism | |
| Apixaban | 159 | 38 | 15 |
| Warfarin | 173 | 76 | 16 |
Rate=number of adjudicated GUSTO bleeding events per 100 patient years. GUSTO Bleeding Criteria: GUSTO severe (or life-threatening) bleeding: either intracranial hemorrhage or bleeding that causes hemodynamic compromise and requires intervention. GUSTO moderate bleeding: bleeding that requires blood transfusion but does not result in hemodynamic compromise. (NCT00412984)
Timeframe: "Treatment Period started with first dose of blinded study drug and ended 2 days after the last dose of blinded study drug. Mean duration of exposure to double-blind study drug was 1.7 years in each treatment group."
| Intervention | Number of events per 100 patient years (Number) | |
|---|---|---|
| Severe (n=80, 172)) | Severe or Moderate (n=199, 328) | |
| Apixaban | 0.52 | 1.29 |
| Warfarin | 1.13 | 2.18 |
Rate=number of adjudicated TIMI bleeding events per 100 patient years. TIMI Bleeding Criteria: Major bleeding=Intracranial bleeding and/or clinically overt bleeding associated with ≥5 gm/dL fall in Hgb or 15% fall in hematocrit (Hct) from baseline, accounting for transfusions. Minor bleeding=Clinically overt bleeding associated with ≥3 gm/dL fall in Hgb or a ≥10% fall in Hct from baseline, accounting for transfusions. (NCT00412984)
Timeframe: "Treatment Period started with first dose of blinded study drug and ended 2 days after the last dose of blinded study drug. Mean duration of exposure to double-blind study drug was 1.7 years in each treatment group."
| Intervention | Number of events per 100 patient years (Number) | |
|---|---|---|
| Major (n=148, 256) | Major or Minor (n=239, 370) | |
| Apixaban | 0.96 | 1.55 |
| Warfarin | 1.69 | 2.46 |
Diagnosis for an acute or evolving MI=elevation of creatine kinase-MB isoenzyme (CK-MB) or Troponin T or I ≥ 2 × the upper limit of normal (ULN), or if no CK-MB or troponin values are available, a total CK ≥ 2×ULN, or new, significant (≥0.04 s) Q waves in ≥2 contiguous leads. For descriptions of Stroke and SE, see Outcome Measure 1. (NCT00412984)
Timeframe: "Intended Treatment Period started on the day of randomization and ended at the efficacy cut-off date (date on which it was expected that the target number of primary efficacy events [448] would have occurred; set to 30-Jan-2011, prior to unblinding)."
| Intervention | Number of events per 100 patient years (Number) | |||
|---|---|---|---|---|
| Ischemic or Unspecified Stroke (n=162, 175) | Hemorrhagic Stroke (n=40, 78) | Systemic Embolism (n=15, 17) | Myocardial Infarction (n=90, 102) | |
| Apixaban | 0.97 | 0.24 | 0.09 | 0.53 |
| Warfarin | 1.05 | 0.47 | 0.10 | 0.61 |
Diagnosis for an acute or evolving MI=elevation of CK-MB or Troponin T or I ≥ 2 × the ULN, or if no CK-MB or troponin values are available, a total CK ≥ 2×ULN, or new, significant (≥0.04 s) Q waves in ≥2 contiguous leads. For descriptions of Stroke and SE, see Outcome Measure 1. For description of ACD, see Outcome Measure 5. (NCT00412984)
Timeframe: "Intended Treatment Period started on the day of randomization and ended at the efficacy cut-off date (date on which it was expected that the target number of primary efficacy events [448] would have occurred; set to 30-Jan-2011, prior to unblinding)."
| Intervention | Number of events per 100 patient years (Number) | |||||||
|---|---|---|---|---|---|---|---|---|
| Stroke / SE / Major Bleeding (n=521, 666) | Stroke / SE / All-Cause Death (ACD) (n=752, 837) | Stroke / SE / Major Bleeding / ACD (n=1009, 1168) | Stroke / SE / MI / ACD (n=810, 906) | Ischemic or Unspecified Stroke / ACD (n=725, 796) | Hemorrhagic Stroke / ACD (n=622, 703) | SE / ACD (n=613, 679) | MI / ACD (n=663, 740) | |
| Apixaban | 3.17 | 4.49 | 6.13 | 4.85 | 4.32 | 3.68 | 3.63 | 3.93 |
| Warfarin | 4.11 | 5.04 | 7.20 | 5.49 | 4.78 | 4.20 | 4.05 | 4.43 |
(NCT04352439)
Timeframe: Up to six months
| Intervention | Participants (Count of Participants) |
|---|---|
| Aspirin | 4 |
Adverse events will only include those that are determined to be related to the study drug. (NCT04352439)
Timeframe: Up to six months
| Intervention | Participants (Count of Participants) |
|---|---|
| Aspirin | 0 |
(NCT00228423)
Timeframe: 1 year
| Intervention | Participants (Count of Participants) |
|---|---|
| 75mg Clopidogrel | 4 |
| Placebo | 5 |
(NCT00228423)
Timeframe: 1 year
| Intervention | Participants (Count of Participants) |
|---|---|
| 75mg Clopidogrel | 1 |
| Placebo | 0 |
Postoperative angiogram 12 months post-CABG (NCT00228423)
Timeframe: One year following surgery
| Intervention | percentage (Number) |
|---|---|
| 75mg Clopidogrel | 94.3 |
| Placebo | 93.2 |
IVUS imaging 12 months post-CABG, and the average intimal area in the proximal 40 mm of one vein graft per patient will be assessed (NCT00228423)
Timeframe: One year following surgery
| Intervention | mm (Mean) |
|---|---|
| 75mg Clopidogrel | 4.1 |
| Placebo | 4.5 |
Secondary powered endpoint (NCT00977938)
Timeframe: 33 months (0-33 months post-index procedure)
| Intervention | percentage of patients (Number) |
|---|---|
| Propensity-matched DES | 1.70 |
| Propensity-matched BMS | 2.61 |
ST was assessed according to the Academic Research Consortium (ARC) definitions. (NCT00977938)
Timeframe: 18 months (12-30 months post-index procedure)
| Intervention | percentage of patients (KM estimate) (Number) |
|---|---|
| BMS 30-month DAPT | 0.50 |
| BMS 12-month DAPT | 1.11 |
ST was assessed according to the Academic Research Consortium (ARC) definitions. (NCT00977938)
Timeframe: 21 months (12-33 months post-index procedure)
| Intervention | percentage of patients (KM estimate) (Number) |
|---|---|
| BMS 30-month DAPT | 0.50 |
| BMS 12-month DAPT | 1.11 |
ST was assessed according to the Academic Research Consortium (ARC) definitions. (NCT00977938)
Timeframe: 21 months (12-33 months post-index procedure)
| Intervention | percentage of patients (KM estimate) (Number) |
|---|---|
| DES 30-month DAPT | 0.69 |
| DES 12-month DAPT | 1.45 |
The coprimary efficacy endpoints were the cumulative incidence of MACCE and the cumulative incidence of definite or probable ST within randomized DES ITT patients between 12 and 30 months post procedure. ST was assessed according to the Academic Research Consortium (ARC) definitions. (NCT00977938)
Timeframe: 18 months (12-30 months post-index procedure)
| Intervention | percentage of patients (KM estimate) (Number) |
|---|---|
| DES 30-month DAPT | 0.40 |
| DES 12-month DAPT | 1.35 |
Bleeding was assessed according to the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Arteries (GUSTO) criteria. (NCT00977938)
Timeframe: 18 months (12-30 months post-index procedure)
| Intervention | percentage of patients (Number) |
|---|---|
| BMS 30-month DAPT | 2.03 |
| BMS 12-month DAPT | 0.90 |
Bleeding was assessed according to the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Arteries (GUSTO) criteria. (NCT00977938)
Timeframe: 21 months (12-33 months post-index procedure)
| Intervention | percentage of patients (Number) |
|---|---|
| BMS 30-month DAPT | 2.09 |
| BMS 12-month DAPT | 1.05 |
Bleeding was assessed according to the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Arteries (GUSTO) criteria. (NCT00977938)
Timeframe: 21 months (12-33 months post-index procedure)
| Intervention | percentage of patients (Number) |
|---|---|
| DES 30-month DAPT | 2.74 |
| DES 12-month DAPT | 1.88 |
The primary safety endpoint was moderate or severe bleeding within randomized DES ITT patients between 12 and 30 months post procedure. Bleeding was assessed according to the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Arteries (GUSTO) criteria. (NCT00977938)
Timeframe: 18 months (12-30 months post-index procedure)
| Intervention | percentage of patients (Number) |
|---|---|
| DES 30-month DAPT | 2.53 |
| DES 12-month DAPT | 1.57 |
Secondary powered endpoint (NCT00977938)
Timeframe: 33 months (0-33 months post-index procedure)
| Intervention | percentage of patients (Number) |
|---|---|
| Propensity-matched DES | 11.37 |
| Propensity-matched BMS | 13.24 |
(NCT00977938)
Timeframe: 18 months (12-30 months post-index procedure)
| Intervention | percentage of patients (KM estimate) (Number) |
|---|---|
| BMS 30-month DAPT | 4.04 |
| BMS 12-month DAPT | 4.69 |
(NCT00977938)
Timeframe: 21 months (12-33 months post-index procedure)
| Intervention | percentage of patients (KM estimate) (Number) |
|---|---|
| BMS 30-month DAPT | 4.68 |
| BMS 12-month DAPT | 5.48 |
(NCT00977938)
Timeframe: 21 months (12-33 months post-index procedure)
| Intervention | percentage of patients (KM estimate) (Number) |
|---|---|
| DES 30-month DAPT | 5.62 |
| DES 12-month DAPT | 6.49 |
The coprimary efficacy endpoints were the cumulative incidence of MACCE and the cumulative incidence of ARC definite or probable stent thrombosis within randomized DES ITT patients between 12 and 30 months post procedure. (NCT00977938)
Timeframe: 18 months (12-30 months post-index procedure)
| Intervention | percentage of patients (KM estimate) (Number) |
|---|---|
| DES 30-month DAPT | 4.34 |
| DES 12-month DAPT | 5.92 |
Any adverse reaction related to study drug until 30 days after percutaneous coronary intervention. (NCT02075125)
Timeframe: 30 days
| Intervention | participants (Number) |
|---|---|
| Prasugrel | 0 |
| Ticagrelor | 0 |
Any event related to bleeding including access site bleeding and peri-procedural bleeding based on Bleeding Academic Research Consortium (BARC) criteria. (NCT02075125)
Timeframe: 30 days
| Intervention | participants (Number) |
|---|---|
| Prasugrel | 0 |
| Ticagrelor | 0 |
Any major adverse cardiac and cerebrovascular event including (death, myocardial infarction, or revascularization and stroke) until day 30. (NCT02075125)
Timeframe: 30 days
| Intervention | participants (Number) |
|---|---|
| Prasugrel | 0 |
| Ticagrelor | 0 |
Platelet reactivity was measured using VerifyNow (volumetrics accuretic, San Diego, California, USA). Platelet reactivity values were presented as P2Y12 reaction units (PRU). (NCT02075125)
Timeframe: Baseline
| Intervention | PRU units (Median) |
|---|---|
| Prasugrel | 259 |
| Ticagrelor | 261 |
Platelet reactivity was measured using vasodilator-stimulated phosphoprotein (VASP) phosphorylation P2Y12 assay. Platelet reactivity values were presented as platelet reactivity index (PRI). (NCT02075125)
Timeframe: Baseline
| Intervention | percentage (Median) |
|---|---|
| Prasugrel | 51.2 |
| Ticagrelor | 47.5 |
Platelet reactivity were measured by VerifyNow (volumetrics accuretic，San Diego, California, USA), and vasodilator-stimulated phosphoprotein (VASP) phosphorylation P2Y12 assay (BioCytex, Marseille, France) with FACSCalibur flow cytometer (BD Biosciences, San Jose, California, USA) using. Measurement time gap +/- 12 hours were allowed. High platelet reactivity (HPR) is defined as the result of P2Y12 reaction units (PRU) >235 and platelet reactivity index (PRI) >50%. (NCT02075125)
Timeframe: 48 hours after loading dose of study drug
| Intervention | participants (Number) | |
|---|---|---|
| PRU>235 | VASP-PRI>50% | |
| Prasugrel | 0 | 0 |
| Ticagrelor | 0 | 0 |
Platelet reactivity were measured using VerifyNow (volumetrics accuretic, San Diego, California, USA), and vasodilator-stimulated phosphoprotein (VASP) phosphorylation P2Y12 assay (BioCytex, Marseille, France) with FACSCalibur flow cytometer (BD Biosciences, San Jose, California, USA) using. Measurement time gap +/- 12 hours were allowed. Low platelet reactivity (LPR) is defined as the result of P2Y12 reaction units (PRU) <85 and platelet reactivity index (PRI)<16%. The PRU value for LPR, 18 patients were in prasugrel groups and 19 patients in ticagrelor groups, regarding the PRI value for LPR, 16 patients were in each groups. (NCT02075125)
Timeframe: 48 hours after loading dose of study drug
| Intervention | participants (Number) | |
|---|---|---|
| PRU<85 | VASP-PRI<16% | |
| Prasugrel | 18 | 16 |
| Ticagrelor | 19 | 16 |
[Key secondary outcome] Change in hemoglobin from the most recent measured before delivery to lowest measured in the 48 hours after delivery (NCT03364491)
Timeframe: from 4 weeks before delivery to 48 hours postpartum
| Intervention | grams per deciliter (Mean) |
|---|---|
| Tranexamic Acid | -1.8 |
| Placebo | -1.9 |
Mother's length of stay from delivery to discharge (NCT03364491)
Timeframe: Until hospital discharge, an average of 3 days
| Intervention | days (Median) |
|---|---|
| Tranexamic Acid | 3 |
| Placebo | 3 |
(NCT03364491)
Timeframe: within 6 weeks postpartum
| Intervention | Participants (Count of Participants) |
|---|---|
| Tranexamic Acid | 35 |
| Placebo | 32 |
This is the number of mothers who were treated with any amount of open-label TXA (not blinded study drug) or another antifibrinolytic (eg., Amicar) (NCT03364491)
Timeframe: within 7 days postpartum
| Intervention | Participants (Count of Participants) |
|---|---|
| Tranexamic Acid | 108 |
| Placebo | 109 |
This is the number of mothers who required any of the following types of surgical procedures to control bleeding: laparotomy, evacuation of hematoma, hysterectomy, uterine packing, intrauterine balloon tamponade, interventional radiology (NCT03364491)
Timeframe: within 7 days postpartum
| Intervention | Participants (Count of Participants) |
|---|---|
| Tranexamic Acid | 233 |
| Placebo | 231 |
[Key secondary outcome] This is the number of mothers who received treatments and interventions to control bleeding such as: uterotonics such as prostaglandins or methergine, but excluding oxytocin; open label TXA or other antifibrinolytics; transfusion of 1 or more units of fresh frozen plasma, cryoprecipitate, or platelets or administration of any factor concentrates; laparotomy, evacuation of hematoma, hysterectomy, uterine packing, intrauterine balloon tamponade, interventional radiology (NCT03364491)
Timeframe: within 7 days postpartum
| Intervention | Participants (Count of Participants) |
|---|---|
| Tranexamic Acid | 892 |
| Placebo | 986 |
Participants were categorized according to the amount of packed red blood cells or whole blood transfused, either as 0 to 3 units, or 4 or more units (NCT03364491)
Timeframe: within 7 days postpartum
| Intervention | Participants (Count of Participants) |
|---|---|
| Tranexamic Acid | 20 |
| Placebo | 19 |
This is the number of mothers who received during the first 7 days after delivery a transfusion of 1 or more units of fresh frozen plasma, cryoprecipitate, or platelets, or received any factor concentrates (NCT03364491)
Timeframe: within 7 days postpartum
| Intervention | Participants (Count of Participants) |
|---|---|
| Tranexamic Acid | 29 |
| Placebo | 31 |
This is the number of mothers who were treated with uterotonics such as prostaglandins or methergine, but excluding oxytocin, from delivery through 48 hours after delivery. (NCT03364491)
Timeframe: within 48 hours postpartum
| Intervention | Participants (Count of Participants) |
|---|---|
| Tranexamic Acid | 649 |
| Placebo | 732 |
[Key secondary outcome] This is the number of mothers who experienced a thromboembolic event, ischemic stroke, or myocardial infarction during the 6 weeks after delivery. (NCT03364491)
Timeframe: within 6 weeks postpartum
| Intervention | Participants (Count of Participants) |
|---|---|
| Tranexamic Acid | 12 |
| Placebo | 13 |
[Major secondary outcome] The surgeon or anesthesiologist estimated the blood loss during the delivery in milliliters, which was recorded in the anesthesia record and/or operative report (NCT03364491)
Timeframe: From skin incision to transfer from operating room, average of 1 hour
| Intervention | Participants (Count of Participants) |
|---|---|
| Tranexamic Acid | 339 |
| Placebo | 368 |
Participants were monitored from delivery until hospital discharge or 7 days after delivery (postpartum), whichever is sooner. This is the number of mothers who died for any reason, or had a blood transfusion of 1 or more units (of packed red blood cells, including whole blood or cell saver). (NCT03364491)
Timeframe: by hospital discharge or by 7 days postpartum, whichever is sooner
| Intervention | Participants (Count of Participants) |
|---|---|
| Tranexamic Acid | 201 |
| Placebo | 233 |
[Key Secondary Outcome] This is the number of mothers who experienced any of the following infectious complications in the 6 weeks after delivery: endometritis, surgical site infection, pelvic abscess (NCT03364491)
Timeframe: within 6 weeks postpartum
| Intervention | Participants (Count of Participants) |
|---|---|
| Tranexamic Acid | 162 |
| Placebo | 125 |
This is the number of mothers who experienced seizure activity, confirmed by central review, whose onset is after enrollment (NCT03364491)
Timeframe: within 6 weeks postpartum
| Intervention | Participants (Count of Participants) |
|---|---|
| Tranexamic Acid | 2 |
| Placebo | 0 |
Plasma TxA concentrations measured from blood samples taken upon arrival in the ICU (NCT03376061)
Timeframe: on arrival in ICU within 3 hours
| Intervention | microgram per milliliter per kilogram (Mean) |
|---|---|
| Topical TxA (Intervention) | 0.58 |
| Intravenous TxA (Control) | 1.10 |
Number of hours participants spent in the intensive care unit (ICU) (NCT03376061)
Timeframe: Number of hours spent in ICU from arrival to exit (collected at the Post-Operative Visit).
| Intervention | hours (Median) |
|---|---|
| Topical TxA (Intervention) | 23 |
| Intravenous TxA (Control) | 26 |
Cumulative volume (mL) of fluid collected from mediastinal drainage tubes 24 hours after the surgical procedure (NCT03376061)
Timeframe: Fluid collected in the first 24 hours after the surgical procedure
| Intervention | mL (Median) |
|---|---|
| Topical TxA (Intervention) | 500 |
| Intravenous TxA (Control) | 540 |
The occurrence of death due to any cause (NCT03376061)
Timeframe: Patients will be followed post-operatively until hospital discharge
| Intervention | Participants (Count of Participants) |
|---|---|
| Topical TxA (Intervention) | 1 |
| Intravenous TxA (Control) | 1 |
Patients requiring a red blood cell transfusion (NCT03376061)
Timeframe: Intra-operative and post-operative RBC transfusions
| Intervention | Participants (Count of Participants) |
|---|---|
| Topical TxA (Intervention) | 19 |
| Intravenous TxA (Control) | 23 |
Occurrence of re-operation for the purpose of bleeding or cardiac tamponade (NCT03376061)
Timeframe: Patients will be followed post-operatively until hospital discharge
| Intervention | Participants (Count of Participants) |
|---|---|
| Topical TxA (Intervention) | 0 |
| Intravenous TxA (Control) | 1 |
Patients experiencing a post-operative seizure (NCT03376061)
Timeframe: Patients will be followed post-operatively until hospital discharge
| Intervention | Participants (Count of Participants) |
|---|---|
| Topical TxA (Intervention) | 0 |
| Intravenous TxA (Control) | 1 |
median 3.8 years of follow-up (NCT00086450)
Timeframe: Measured at Year 5
| Intervention | percentage of participants (Number) |
|---|---|
| Percutaneous Coronary Intervention | 26.6 |
| Coronary Artery Bypass Graft | 18.7 |
(NCT00086450)
Timeframe: Measured at Year 5
| Intervention | percentage of participants (Number) |
|---|---|
| Percutaneous Coronary Intervention | 16.3 |
| Coronary Artery Bypass Graft | 10.9 |
(NCT00086450)
Timeframe: Measured at Year 1
| Intervention | percentage of participants (Number) |
|---|---|
| Percutaneous Coronary Intervention | 16.8 |
| Coronary Artery Bypass Graft | 11.8 |
Major adverse cardiovascular and cerebrovascular events (NCT00086450)
Timeframe: Measured at Day 30
| Intervention | percentage of participants (Number) |
|---|---|
| Percutaneous Coronary Intervention | 4.8 |
| Coronary Artery Bypass Graft | 5.2 |
DVT and how the diagnosis was made will be recorded. The number of events in participants in each arm will be compared to evaluate efficacy. (NCT02774265)
Timeframe: 90 days
| Intervention | Participants (Count of Participants) |
|---|---|
| VTE Prophylaxis With Enoxaparin 30mg BID | 5 |
| VTE Prophylaxis With Aspirin 81mg BID | 9 |
Bases on imaging obtained for symptoms. (NCT02774265)
Timeframe: 90 days
| Intervention | Participants (Count of Participants) |
|---|---|
| VTE Prophylaxis With Enoxaparin 30mg BID | 6 |
| VTE Prophylaxis With Aspirin 81mg BID | 2 |
Includes a greater than 2g/dL drop in hemoglobin, blood transfusion, hematoma evacuation, re-operation for a deep surgical site infection or minor procedure for bleeding and GI bleed (NCT02774265)
Timeframe: 90 days
| Intervention | Participants (Count of Participants) |
|---|---|
| VTE Prophylaxis With Enoxaparin 30mg BID | 52 |
| VTE Prophylaxis With Aspirin 81mg BID | 53 |
An area under the curve of serial levels of Troponin I and creatine kinase-MB isoenzyme during 36 hours (NCT03114995)
Timeframe: 0,6,12,18,24,30,36 hours
| Intervention | Hours*ng/ml (Median) | |
|---|---|---|
| Troponin I | creatine kinase-MB isoenzyme | |
| Control C1 (High Platelet Reactivity - no Tirofiban) | 38.0 | 92.7 |
| Control C2 (Low Platelet Reactivity - no Tirofiban) | 121.4 | 185.6 |
| Group A (High Platelet Reactivity - Tirofiban) | 197.2 | 252.5 |
"Percentage of participants with periprocedural myonecrosis under the criteria described below.~When the cardiac biomarkers before the procedure were within the 99th percentile upper reference limit (URL), more than a 5-fold elevation in the URL within 12 hours after percutaneous coronary intervention (PCI) was defined as periprocedural myonecrosis. If the cardiac biomarker level was already above the 99th percentile URL before the procedure and the trend was stationary or decreasing, a ≥20% increase compared to the previous level was considered periprocedural myonecrosis. If the trend was still increasing, the levels at the post-6 hour and 12-hour were compared to determine periprocedural myonecrosis." (NCT03114995)
Timeframe: 0,6,12,18,24,30,36 hours
| Intervention | Participants (Count of Participants) | |
|---|---|---|
| Troponin I | creatine kinase-MB isoenzyme | |
| Control C1 (High Platelet Reactivity - no Tirofiban) | 15 | 10 |
| Control C2 (Low Platelet Reactivity - no Tirofiban) | 26 | 25 |
| Group A (High Platelet Reactivity - Tirofiban) | 16 | 11 |
Percentage (%) of Participants who have achieved complete aneurysm occlusion (defined as Raymond-Roy grade 1) without significant parent artery stenosis (≤ 50%) or retreatment of the target aneurysm post-procedure (1-year) (NCT02719522)
Timeframe: 1 year
| Intervention | percentage of patients (Number) |
|---|---|
| Intention to Treat (ITT) | 71.67 |
"Percentage (%) of Participants who have had a successful deployment of the device at the target site.~A device is considered properly deployed when it covers the entire length of the aneurysm neck." (NCT02719522)
Timeframe: 1 year
| Intervention | Participants (Count of Participants) |
|---|---|
| Intention to Treat (ITT) | 200 |
Percentage (%) of Participants who experienced a delayed intracerebral hemorrhage > 30 days post-procedure (NCT02719522)
Timeframe: 1 year
| Intervention | Participants (Count of Participants) |
|---|---|
| Intention to Treat (ITT) | 0 |
Percentage (%) of Participants who experienced a major stroke in the territory supplied by the treated artery or neurological death post-procedure (1-year) (NCT02719522)
Timeframe: 1 year
| Intervention | percentage of patients with event (Number) |
|---|---|
| Intention to Treat (ITT) | 3.23 |
Percentage (%) of Participants who experienced a major stroke in the territory supplied by the treated artery or neurological death at 30 days post-procedure due to procedural complications (NCT02719522)
Timeframe: 30 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Intention to Treat (ITT) | 6 |
"Rates of appropriate VTE prophylaxis were determined as the number of patients who received VTE prophylaxis as a proportion of the number of patient at risk.~Rates reported are for the active phases (phase 1 and phase 2) and compare intervention to control.~Appropriate VTE prophylaxis was defined as:~in Hip Fracture Surgery - evidence-based VTE prophylaxis ordered within 24 of admission, restarted within 24 hours after surgery and continued for at least 10 days post-discharge in Major General Surgery - evidence-based VTE prophylaxis ordered within 24 hours post-surgery and continued for the duration of hospital stay in Acute Medical Illness - evidence-based VTE prophylaxis ordered within 24 hours of admission and continued for the duration of hospital stay.~Evidence-based VTE prophylaxis was determined to be according to the American College of Chest Physicians (ACCP) guidelines. The 9th version was the most current version at the time of the study." (NCT01869075)
Timeframe: End of study (end of phase 2) - measured over duration of hospital stay.
| Intervention | percentage of patients (Number) |
|---|---|
| AMI - Knowledge Translation Toolkit | 64 |
| AMI - Usual Care | 62 |
| MGS - Knowledge Translation Toolkit | 67 |
| MGS - Usual Care | 54 |
| HFS - Knowledge Translation Toolkit | 85 |
| HFS - Usual Care | 76 |
Coagulopathic bleeding due to fondaparinux was suspected in patients requiring packed red cell transfusions after initiation of fondaparinux therapy only if the change in hematocrit prompting transfusion was not clinically commensurate with the degree of injuries that the patient had sustained (primarily orthopaedic) and/or the hematocrit did not respond appropriately post-transfusion. (NCT00531843)
Timeframe: 3 weeks post injury
| Intervention | participants (Number) |
|---|---|
| Fondaparinux Sodium | 0 |
Serum samples were collected 30 minutes before (trough) and 2 hours after (peak) the third dose of fondaparinux. Normative data plots comparing study participants with healthy volunteers were supplied by the company outsourced to analyze samples. (NCT00531843)
Timeframe: Day 3
| Intervention | Participants (Number) | |
|---|---|---|
| Trough values outside normative range | Peak values outside normative range | |
| Fondaparinux Sodium | 0 | 0 |
Color-flow duplex venous ultrasonography examinations of upper and lower extremities were performed within 48 hours of injury, and then weekly until discharge or 3 weeks. DVT was defined as any clot occurring in the subclavian, iliac, femoral, or popliteal location. Patients were examined daily for clinical signs and symptoms of venous thromboembolism (VTE) and PE. Small, nonocclusive clots discovered in other locations were observed for progression on sequential ultrasonography examinations. (NCT00531843)
Timeframe: within 3 weeks post injury
| Intervention | participants (Number) | ||
|---|---|---|---|
| DVT | DVT after fondaparinux | PE | |
| Fondaparinux Sodium | 2 | 1 | 0 |
| No Fondaparinux | 2 | NA | 0 |
The medication side-effect and compliance inventory is a questionnaire to evaluate the frequency and severity of common side effects associated with the medications used in this study. (NCT01676415)
Timeframe: 4-6 weeks and 3 months after initiation of treatment
| Intervention | Participants (Count of Participants) |
|---|---|
| Prednisone | 0 |
| Topical Mometasone | 0 |
Change from baseline in individual symptom severity. The taskforce symptom inventory is a visual analog scale of the severity of the 4 major symptoms making up the clinical diagnostic criteria of CRS. (NCT01676415)
Timeframe: 4-6 weeks and 3 months after initiation of treatment
| Intervention | Participants (Count of Participants) |
|---|---|
| Prednisone | 0 |
| Topical Mometasone | 0 |
"The Sino-nasal Outcome Test-22 is a validated questionnaire that measures 22 nasal and quality of life symptoms (nasal obstruction and loss of smell and taste) ranked from 0 (not a problem) to 5 (problem as bad as it can be).~Min score= 0, Max score= 110 (worst possible problem on all symptoms)~Change from baseline of the SNOT-22 score. The SNOT-22 questionnaire is a 22-item disease-specific health related quality of life instrument validated for use in chronic rhinosinusitis." (NCT01676415)
Timeframe: 4-6 weeks and 3 months after initiation of treatment
| Intervention | units on a scale (Mean) | |
|---|---|---|
| 4-6 WEEKS | 3 MONTHS | |
| Prednisone | 45.75 | 49 |
| Topical Mometasone | 34.4 | 34.4 |
The primary endpoint was the detection of intracardiac thrombus in TEE at the end of follow-up (90 days). (NCT01868243)
Timeframe: 90 days
| Intervention | participants (Number) |
|---|---|
| Dabigatran | 0 |
| Warfarin | 1 |
Spontaneous Echo Contrast showed in Transesophageal echocardiography (NCT01868243)
Timeframe: 90 days
| Intervention | participants (Number) |
|---|---|
| Dabigatran | 2 |
| Warfarin | 1 |
Number of participant received allogenic blood transfusions. (NCT02684851)
Timeframe: post-operative
| Intervention | Participants (Count of Participants) |
|---|---|
| Tranexamic | 21 |
| Placebo | 13 |
To measure average estimate perioperative blood loss (NCT02684851)
Timeframe: perioperative
| Intervention | mL (Mean) |
|---|---|
| Tranexamic | 727.6 |
| Placebo | 560.1 |
Do patients undergoing acetabular ORIF who receive tranexamic acid have a higher risk for thromboembolic events than patients who receive placebo? (NCT02684851)
Timeframe: 30 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Tranexamic | 1 |
| Placebo | 0 |
Average units packed red blood cells transfused among participants (NCT02684851)
Timeframe: perioperative
| Intervention | Units of packed red blood cells (Mean) |
|---|---|
| Tranexamic | 2.65 |
| Placebo | 2.36 |
Bleeding events according to GUSTO (criteria for bleeding: Severe, Moderate or Mild) and BARC (bleeding criteria Type 0-5, with 0 being no bleeding and 5 referring to probable or definite fatal bleeding) Criteria (NCT02475837)
Timeframe: up to 238 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Vorapaxar Intervention | 0 |
| Placebo Intervention | 1 |
Participants able to use their AV fistula for dialysis within 180 days of surgery were considered to have met the outcome. (NCT02475837)
Timeframe: up to 238 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Vorapaxar Intervention | 2 |
| Placebo Intervention | 4 |
Criteria for outcome: AV fistula patency at 150-180 days, with at least 50% increase in vein diameter by ultrasound compared with preoperative vein diameter measurement. (NCT02475837)
Timeframe: 150-238 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Vorapaxar Intervention | 1 |
| Placebo Intervention | 5 |
Time to AV fistula functional maturation (defined as successful cannulation of the AV fistula for six hemodialysis sessions within three weeks). (NCT02475837)
Timeframe: up to 238 days
| Intervention | Days to functional maturation (Median) |
|---|---|
| Vorapaxar Intervention | 169 |
| Placebo Intervention | 145 |
178 reviews available for aspirin and Complication, Postoperative
| Article | Year |
|---|---|
Comparison between use of direct oral anticoagulants and aspirin for risk of thromboembolism complications in patients undergoing total knee and hip arthroplasty: a systematic review and meta-analysis.
Topics: Aged; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Factor Xa Inhibitors | 2021 |
A Meta-Analysis of Randomized and Observational Studies: Aspirin Protects from Cardiac Surgery-Associated Acute Kidney Injury.
Topics: Acute Kidney Injury; Aspirin; Cause of Death; Coma; Coronary Artery Bypass; Heart Arrest; Heart Bloc | 2019 |
Postoperative Venous Thromboembolism Prophylaxis: Changes in the Daily Clinical Practice, Modified Guidelines.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Humans; Po | 2020 |
Venous thromboembolism in plastic surgery: the current state of evidence in risk assessment and chemoprophylactic options.
Topics: Administration, Oral; Anticoagulants; Aspirin; Chemoprevention; Heparin, Low-Molecular-Weight; Human | 2019 |
Preventing Metachronous Gastric Cancer after the Endoscopic Resection of Gastric Epithelial Neoplasia: Roles of
Topics: Aspirin; Endoscopic Mucosal Resection; Female; Gastric Mucosa; Gastritis, Atrophic; Helicobacter Inf | 2020 |
Clinical Effectiveness and Safety of Aspirin for Venous Thromboembolism Prophylaxis After Total Hip and Knee Replacement: A Systematic Review and Meta-analysis of Randomized Clinical Trials.
Topics: Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Fibrinolytic Agents; Human | 2020 |
Dual Versus Triple Therapy for Atrial Fibrillation After Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis.
Topics: Acute Coronary Syndrome; Aspirin; Atrial Fibrillation; Drug Therapy, Combination; Fibrinolytic Agent | 2020 |
Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy.
Topics: Adult; Anticoagulants; Arthroscopy; Aspirin; Factor Xa Inhibitors; Hemorrhage; Heparin, Low-Molecula | 2020 |
Very short dual antiplatelet therapy after PCI and new DES: a meta-analysis of 5 randomized trials.
Topics: Aspirin; Clopidogrel; Drug Therapy, Combination; Drug-Eluting Stents; Hemorrhage; Humans; Percutaneo | 2021 |
The Safety and Efficacy of Aspirin Discontinuation on a Background of a P2Y
Topics: Acute Coronary Syndrome; Aspirin; Clopidogrel; Dual Anti-Platelet Therapy; Hemorrhage; Humans; Percu | 2020 |
Perioperative Cardiovascular Risk Assessment and Management for Noncardiac Surgery: A Review.
Topics: Adrenergic beta-Antagonists; Age Factors; Aged; Angiotensin-Converting Enzyme Inhibitors; Anticoagul | 2020 |
An Update on Venous Thromboembolism Rates and Prophylaxis in Hip and Knee Arthroplasty in 2020.
Topics: Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Fibrinolytic Agents; Hemor | 2020 |
Meta-Analysis of Aspirin Monotherapy Versus Dual Antiplatelet Therapy After Transcatheter Aortic Valve Implantation.
Topics: Aspirin; Dual Anti-Platelet Therapy; Fibrinolytic Agents; Humans; Postoperative Complications; Trans | 2020 |
Optimizing Monotherapy Selection, Aspirin Versus P2Y12 Inhibitors, Following Percutaneous Coronary Intervention.
Topics: Algorithms; Aspirin; Dual Anti-Platelet Therapy; Fibrinolytic Agents; Hemorrhage; Humans; Percutaneo | 2020 |
The effect of antiplatelet therapy on survival and cardiac allograft vasculopathy following heart transplantation: A systematic review and meta-analysis.
Topics: Allografts; Aspirin; Female; Heart Transplantation; Humans; Male; Middle Aged; Platelet Aggregation | 2021 |
Antithrombotic therapy with or without clopidogrel after transcatheter aortic valve replacement. A meta-analysis of randomized controlled trials.
Topics: Aspirin; Clopidogrel; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Platelet Aggregation I | 2022 |
Rivaroxaban versus aspirin in prevention of venous thromboembolism following total joint arthroplasty or hip fracture surgery: a meta-analysis.
Topics: Aged; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Female; Fracture Fix | 2021 |
Aspirin monotherapy is a suitable standard thromboprophylactic agent following total hip arthroplasty.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Aspirin; Heparin, Low-Molecular-Weight; Humans; Post | 2022 |
Interventions for preventing thrombosis in solid organ transplant recipients.
Topics: Anticoagulants; Aspirin; Bias; Dipyridamole; Hemorrhage; Heparin; Heparin, Low-Molecular-Weight; Hum | 2021 |
Dual therapy with an oral non-vitamin K antagonist and a P2Y12 inhibitor vs triple therapy with aspirin, a P2Y12 inhibitor and a vitamin K antagonist for the treatment of diabetes mellitus patients with co-existing atrial fibrillation following percutaneo
Topics: 4-Hydroxycoumarins; Aged; Aspirin; Atrial Fibrillation; Diabetes Mellitus; Diabetic Cardiomyopathies | 2021 |
Antiplatelet Therapy, Platelet Function Testing, and Bleeding Complications in Cardiac Surgery Patients.
Topics: Aspirin; Blood Platelets; Cardiac Surgical Procedures; Hemorrhage; Humans; Platelet Aggregation Inhi | 2017 |
Venous Thromboembolism Following Hip and Knee Arthroplasty: The Role of Aspirin.
Topics: Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Drug Administration Schedu | 2017 |
Perioperative Venous Thromboembolism: A Review.
Topics: Anticoagulants; Aspirin; Fibrinolytic Agents; Hemorrhage; Humans; Hydroxymethylglutaryl-CoA Reductas | 2017 |
Effectiveness and Tolerability of Anticoagulants for Thromboprophylaxis after Major Joint Surgery: a Network Meta-Analysis.
Topics: Anticoagulants; Aspirin; Databases, Factual; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Join | 2017 |
Aspirin and the prevention of venous thromboembolism following total joint arthroplasty: commonly asked questions.
Topics: Anticoagulants; Arthroplasty, Replacement; Aspirin; Drug Administration Schedule; Humans; Postoperat | 2017 |
The use of preoperative aspirin in cardiac surgery: A systematic review and meta-analysis.
Topics: Aspirin; Cardiac Surgical Procedures; Erythrocyte Transfusion; Humans; Models, Statistical; Odds Rat | 2017 |
Comparison of single versus dual antiplatelet therapy after TAVR: A systematic review and meta-analysis.
Topics: Aged; Aged, 80 and over; Aspirin; Clopidogrel; Drug Therapy, Combination; Female; Hemorrhage; Humans | 2018 |
Perioperative aspirin therapy in non-cardiac surgery: A systematic review and meta-analysis of randomized controlled trials.
Topics: Aspirin; Cardiovascular Diseases; Hemorrhage; Humans; Mortality; Perioperative Care; Platelet Aggreg | 2018 |
A systematic review of the efficacy of aspirin monotherapy versus other antiplatelet therapy regimens in peripheral arterial disease.
Topics: Aspirin; Endovascular Procedures; Fibrinolytic Agents; Humans; Peripheral Arterial Disease; Platelet | 2018 |
Triple therapy: worth the risk?
Topics: Anticoagulants; Aspirin; Clopidogrel; Drug Synergism; Drug Therapy, Combination; Factor Xa Inhibitor | 2018 |
Unruptured Intracranial Aneurysms.
Topics: Aneurysm, Ruptured; Antihypertensive Agents; Aspirin; Cyclooxygenase Inhibitors; Disease Management; | 2018 |
Delayed intracranial aneurysm formation after cardiac myxoma resection: Report of two cases and review of the literature.
Topics: Aged; Anticoagulants; Aspirin; Cerebral Angiography; Female; Heart Neoplasms; Humans; Intracranial A | 2019 |
Medical and endovascular treatments of symptomatic intracranial stenosis. A Bayesian network meta-analysis.
Topics: Anticoagulants; Aspirin; Bayes Theorem; Cerebrovascular Disorders; Constriction, Pathologic; Endovas | 2019 |
Massive Hyphaema Following Laser Iridotomy in a Patient on Dual Antiplatelet Therapy (Aspirin plus Ticagrelor): Case report and literature review.
Topics: Aspirin; Colombia; Glaucoma, Angle-Closure; Humans; Hyphema; Iridectomy; Laser Therapy; Male; Middle | 2019 |
Does the form of venous thromboembolism prophylaxis following primary total knee arthroplasty alter the rate of early reoperation or revision surgery?
Topics: Arthroplasty, Replacement, Knee; Aspirin; Australia; Case-Control Studies; Clinical Decision-Making; | 2019 |
Considerations in antithrombotic therapy among patients undergoing transcatheter aortic valve implantation.
Topics: Aortic Valve Stenosis; Aspirin; Cardiac Catheterization; Clopidogrel; Fibrinolytic Agents; Heart Val | 2013 |
Dual anti-platelet therapy after coronary artery bypass grafting: is there any benefit? A systematic review and meta-analysis.
Topics: Angina Pectoris; Aspirin; Clopidogrel; Coronary Artery Bypass; Drug Therapy, Combination; Graft Occl | 2013 |
Triple therapy (aspirin, clopidogrel and oral anticoagulant) after percutaneous coronary intervention: another call for personalized medicine.
Topics: Administration, Oral; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combi | 2013 |
Early postoperative thrombosis of an aortic bioprosthetic valve: should anticoagulation be patient specific?
Topics: Administration, Oral; Aged; Anticoagulants; Aortic Valve; Aortic Valve Stenosis; Aspirin; Bioprosthe | 2013 |
Antithrombotic strategy in the three first months following bioprosthetic heart valve implantation.
Topics: Aspirin; Bioprosthesis; Fibrinolytic Agents; Heart Valve Prosthesis; Heart Valve Prosthesis Implanta | 2013 |
Prevention of renal dysfunction in postoperative elderly patients.
Topics: Acute Kidney Injury; Aged; Aging; Aspirin; Humans; Kidney; Postoperative Care; Postoperative Complic | 2014 |
Myocardial injury after noncardiac surgery.
Topics: Aspirin; Cause of Death; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Monitoring, Intraop | 2014 |
Novel preoperative pharmacologic methods of preventing postoperative sore throat due to tracheal intubation.
Topics: Anesthesia, General; Anesthetics, Local; Anti-Inflammatory Agents; Aspirin; Azulenes; Benzydamine; C | 2014 |
Aspirin, clopidogrel, and the surgeon.
Topics: Aspirin; Cardiovascular Diseases; Cerebrovascular Disorders; Clopidogrel; Humans; Platelet Aggregati | 2014 |
[Managing antithrombotic therapy in vitreoretinal surgery].
Topics: Anesthesia, Local; Anticoagulants; Aspirin; Blood Coagulation; Eye Diseases; Fibrinolytic Agents; He | 2015 |
Aspirin in the perioperative period: a review of the recent literature.
Topics: Aspirin; Drug Interactions; Humans; Intraoperative Complications; Perioperative Care; Perioperative | 2015 |
Comparison of Dual-antiplatelet Therapy to Mono-antiplatelet Therapy After Transcatheter Aortic Valve Implantation: Systematic Review and Meta-analysis.
Topics: Aged; Aged, 80 and over; Aortic Valve Stenosis; Aspirin; Clopidogrel; Drug Therapy, Combination; Fem | 2015 |
What's New in Venous Thromboembolic Prophylaxis Following Total Knee and Total Hip Arthroplasty? An Update.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Heparin; H | 2015 |
Aspirin in the primary prophylaxis of venous thromboembolism in surgical patients.
Topics: Aspirin; Fibrinolytic Agents; Global Health; Humans; Incidence; Postoperative Complications; Primary | 2015 |
Strategies for thromboprophylaxis in Fontan circulation: a meta-analysis.
Topics: Anticoagulants; Aspirin; Chemoprevention; Comparative Effectiveness Research; Fontan Procedure; Huma | 2015 |
Perioperative Management to Reduce Cardiovascular Events.
Topics: Adrenergic beta-Antagonists; Aged; Anesthesia; Anticoagulants; Arthroplasty, Replacement, Knee; Aspi | 2016 |
Aspirin and coronary artery surgery: an updated meta-analysis.
Topics: Aspirin; Coronary Vessels; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Postopera | 2016 |
Case Report and Review of Literature of Delayed Acute Subdural Hematoma.
Topics: Accidental Falls; Aged; Aspirin; Cerebral Hemorrhage; Decompressive Craniectomy; Female; Glasgow Com | 2016 |
Secondary prevention after coronary artery bypass graft surgery: a primer.
Topics: Aspirin; Coronary Artery Bypass; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Myocardial | 2016 |
What is the impact of preoperative aspirin administration on patients undergoing coronary artery bypass grafting?
Topics: Aged; Aspirin; Blood Transfusion; Coronary Artery Bypass; Coronary Artery Disease; Humans; Myocardia | 2017 |
Post-pericardiotomy Syndrome.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; C-Reactive Protein; Colchicine; Echocardiography; | 2016 |
[Practical management of troponin screening after non-cardiac surgery].
Topics: Aspirin; Fibrinolytic Agents; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Myocardial Inf | 2017 |
Perioperative Aspirin in Cardiac and Noncardiac Surgery.
Topics: Aspirin; Coronary Artery Bypass; Coronary Artery Disease; Humans; Perioperative Care; Postoperative | 2017 |
Antithrombotic Therapy After Transcatheter Aortic Valve Implantation.
Topics: Anticoagulants; Aspirin; Fibrinolytic Agents; Heart Valve Diseases; Humans; Postoperative Complicati | 2017 |
Management of surgical patients receiving anticoagulation and antiplatelet agents.
Topics: Anticoagulants; Aspirin; Emergency Treatment; Heparin; Humans; Intraoperative Care; Platelet Aggrega | 2008 |
Antiplatelet therapy and coronary artery bypass graft surgery: perioperative safety and efficacy.
Topics: Aspirin; Clopidogrel; Coronary Artery Bypass; Drug Administration Schedule; Drug Therapy, Combinatio | 2009 |
Deep vein thrombosis: risk factors and prevention in surgical patients.
Topics: Anticoagulants; Aspirin; Awareness; Clinical Competence; Cyclooxygenase Inhibitors; Dextrans; Dihydr | 2009 |
[Perioperative antiplatelet therapy of patients with coronary stents].
Topics: Administration, Oral; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Cohort S | 2009 |
DVT prophylaxis in total joint reconstruction.
Topics: Anticoagulants; Arthroplasty, Replacement; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement | 2010 |
Perioperative management of the patient with rheumatoid arthritis.
Topics: Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Aspirin; Cervical Vertebrae; | 2010 |
Multimodal prophylaxis for venous thromboembolic disease after total hip and knee arthroplasty: current perspectives.
Topics: Anesthesia, Epidural; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Fact | 2010 |
Preventable risk factors for acute kidney injury in patients undergoing cardiac surgery.
Topics: Acute Kidney Injury; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Asp | 2012 |
Latest evidence in personalized antiplatelet therapy in patients with acute coronary syndromes undergoing percutaneous coronary intervention.
Topics: Acute Coronary Syndrome; Aryl Hydrocarbon Hydroxylases; Aryldialkylphosphatase; Aspirin; Clopidogrel | 2012 |
[Antiplatelet therapy after coronary stenting and its importance in total joint arthroplasty].
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replac | 2012 |
Clopidogrel: the data, the experience, and the controversies.
Topics: Acute Coronary Syndrome; Aspirin; Clopidogrel; Drug Therapy, Combination; Evidence-Based Medicine; H | 2012 |
[Antithrombotic therapy after peripheral vascular treatment: what is evidence-based?].
Topics: Aortic Diseases; Aspirin; Blood Vessel Prosthesis Implantation; Clopidogrel; Dose-Response Relations | 2012 |
Interventional therapy for coronary artery disease.
Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Aspirin; Atherectomy, Coronary; B | 2002 |
State of the art--a journey through the world of antithrombotic therapy.
Topics: Ambulatory Care; Arterial Occlusive Diseases; Aspirin; Clopidogrel; Coronary Disease; Fibrinolytic A | 2002 |
Comparison of medical and surgical treatment of nasal polyposis.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Aspirin; Desensit | 2002 |
Case report of paroxysmal atrial fibrillation and anticoagulation.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Attitude of Health Personnel; Attitude to Health; Comm | 2002 |
Anticoagulant and aspirin prophylaxis for preventing thromboembolism after major gynaecological surgery.
Topics: Anticoagulants; Aspirin; Female; Gynecologic Surgical Procedures; Heparin; Humans; Postoperative Com | 2003 |
Duration of venous thromboembolism prophylaxis after surgery.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Drug Admin | 2003 |
The treatment and prevention of deep vein thrombosis in the preoperative management of patients who have neurologic diseases.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Brain Diseases; Chondroitin Sulfat | 2004 |
New concepts in orthopaedic thromboprophylaxis.
Topics: Anticoagulants; Aspirin; Humans; Musculoskeletal Diseases; Postoperative Complications; Thrombin; Th | 2004 |
Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: a systematic review and meta-analysis of randomized clinical trials.
Topics: Aprotinin; Aspirin; Blood Transfusion; Coronary Artery Bypass; Hemostatics; Humans; Platelet Aggrega | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therap | 2004 |
Antithrombotic therapy in valvular heart disease--native and prosthetic: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Aspirin; Bioprosthesis; Evidence-Based Medicine; Fibrinolytic Agents; Heart Valve Diseases; Heart Va | 2004 |
Perioperative primary stroke: is aspirin cessation to blame?
Topics: Aged; Aspirin; Carcinoma, Basal Cell; Diagnosis, Differential; Drug Administration Schedule; Humans; | 2004 |
What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention?: a meta-analysis.
Topics: Aged; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Aspirin; Blood Vessel Prost | 2005 |
Effects of aspirin and low-dose heparin in head and neck reconstruction using microvascular free flaps.
Topics: Adolescent; Adult; Aged; Anticoagulants; Aspirin; Child; Child, Preschool; Cohort Studies; Female; F | 2005 |
Current concepts in therapy of chronic rhinosinusitis and nasal polyposis.
Topics: Anti-Bacterial Agents; Antifungal Agents; Aspirin; Chronic Disease; Endoscopy; Eosinophilia; Histami | 2005 |
Carotid endarterectomy--an evidence-based review: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
Topics: Aspirin; Carotid Stenosis; Causality; Clinical Trials as Topic; Dose-Response Relationship, Drug; En | 2005 |
Multimodal venous thromboembolic disease prevention for patients undergoing primary or revision total joint arthroplasty: the role of aspirin.
Topics: Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Dose-Response Relationship | 2006 |
Prevention of thrombosis with warfarin, aspirin, and mechanical methods.
Topics: Anticoagulants; Aspirin; Bandages; Combined Modality Therapy; Heparin, Low-Molecular-Weight; Intermi | 2005 |
The management of patients on anticoagulants prior to cutaneous surgery: case report of a thromboembolic complication, review of the literature, and evidence-based recommendations.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Atrial Fibrillation; Brain Damage, | 2006 |
[Application of anticoagulating medicine after surgery of cavity of pelvis and abdomen].
Topics: Abdomen; Anticoagulants; Aspirin; Heparin; Humans; Pelvis; Postoperative Complications; Venous Throm | 2006 |
Anticoagulation or antiplatelet therapy of bioprosthetic heart valves recipients: an unresolved issue.
Topics: Anticoagulants; Aortic Valve; Aspirin; Bioprosthesis; Heart Valve Prosthesis; Humans; Platelet Aggre | 2007 |
[Very late intrastent thrombosis--at 27 months!].
Topics: Aspirin; Clopidogrel; Coronary Thrombosis; Fatal Outcome; Flurbiprofen; Follow-Up Studies; Hernia, I | 2007 |
WITHDRAWN: Anticoagulant and aspirin prophylaxis for preventing thromboembolism after major gynaecological surgery.
Topics: Anticoagulants; Aspirin; Female; Gynecologic Surgical Procedures; Heparin; Humans; Postoperative Com | 2007 |
Does clopidogrel rather than aspirin plus a proton-pump inhibitor reduce the frequency of gastrointestinal complications after cardiac surgery?
Topics: Aspirin; Cardiac Surgical Procedures; Clopidogrel; Drug Therapy, Combination; Evidence-Based Medicin | 2007 |
Con: continuation of aspirin/clopidogrel for cardiac surgery.
Topics: Aspirin; Cardiac Surgical Procedures; Clopidogrel; Drug Therapy, Combination; Heart Diseases; Humans | 2007 |
Pro: continuation of aspirin/clopidogrel for cardiac surgery.
Topics: Aspirin; Cardiac Surgical Procedures; Clopidogrel; Heart Diseases; Humans; Platelet Aggregation Inhi | 2007 |
Meta-analysis appraising high clopidogrel loading in patients undergoing percutaneous coronary intervention.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Stenosis; Drug Administration Schedul | 2007 |
Aspirin prophylaxis for thromboembolic disease after total joint arthroplasty.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthroplasty, Replacement; Aspirin; Humans; Postoperative C | 2007 |
How to prevent perioperative myocardial injury: the conundrum continues.
Topics: Adrenergic Agents; Angioplasty, Balloon, Coronary; Aspirin; Coronary Artery Bypass; Heart Diseases; | 2007 |
[Method for preventing postoperative thrombophlebitis].
Topics: Aerosols; Anticoagulants; Aspirin; Dextrans; Dipyridamole; Heparin; Humans; Injections, Subcutaneous | 1984 |
[Pulmonary embolism in surgical patients (author's transl)].
Topics: Age Factors; Aged; Anticoagulants; Aspirin; Bed Rest; Dextrans; Female; Heart Failure; Humans; Intes | 1980 |
Prophylaxis of postoperative deep vein thrombosis and pulmonary embolism.
Topics: Adult; Age Factors; Anticoagulants; Aspirin; Clothing; Dextrans; Early Ambulation; Heparin; Hip Join | 1983 |
Effect of prostaglandin-mediated platelet-suppressant drugs on acute cardiovascular catastrophes.
Topics: Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Artery Bypas | 1982 |
Dipyridamole: a critical evaluation.
Topics: Angina Pectoris; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Coro | 1984 |
[Current clinical results of antiplatelet medication].
Topics: Animals; Anticoagulants; Aspirin; Blood Platelets; Brain Ischemia; Coronary Disease; Dipyridamole; D | 1984 |
An antagonist of prostaglandin synthesis in cardiovascular diseases.
Topics: Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Brain Diseases; Cardiovascular Diseases; Con | 1984 |
Identification & management of defects in platelet hemostasis in massively transfused patients.
Topics: Animals; Aspirin; Bleeding Time; Blood Preservation; Blood Transfusion; Cardiopulmonary Bypass; Cell | 1982 |
[Critical evaluation of the usefulness of drugs inhibiting platelet function in the prevention of postoperative deep venous thrombosis and in ischemic cardiopathy].
Topics: Anticoagulants; Aspirin; Clofibrate; Coronary Disease; Dipyridamole; Fibrinolytic Agents; Flurbiprof | 1980 |
Low-dose heparin: an aid to therapy.
Topics: Aspirin; Clinical Trials as Topic; Dihydroergotamine; Double-Blind Method; Electric Stimulation; Hem | 1980 |
[Congenital and acquired thrombocyte function disorders].
Topics: Aspirin; Blood Platelet Disorders; Dipyridamole; Fibrin Fibrinogen Degradation Products; Heart Defec | 1980 |
Potential and problems with the clinical use of heparin.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Synergism; Fibrinolytic Agents; Hepa | 1980 |
[Medical or chirurgical treatment in transient cerebral ischemia? (author's transl)].
Topics: Aged; Anticoagulants; Aspirin; Carotid Arteries; Cerebrovascular Disorders; Endarterectomy; Female; | 1981 |
[Prophylaxis of deep vein thrombosis in orthopedic surgery. Discussion and review of the literature].
Topics: 4-Hydroxycoumarins; Anticoagulants; Aspirin; Dextrans; Heparin; Hip Prosthesis; Humans; Indenes; Kne | 1994 |
A meta-analysis of methods to prevent venous thromboembolism following total hip replacement.
Topics: Aspirin; Bandages; Dextrans; Heparin; Heparin, Low-Molecular-Weight; Hip Prosthesis; Humans; Postope | 1994 |
Pathogenesis and prophylaxis of postoperative thromboembolic disease in urological pelvic surgery.
Topics: Aspirin; Bandages; Dextrans; Heparin; Humans; Pelvis; Postoperative Complications; Thromboembolism; | 1995 |
[Acetylsalicylic acid treatment after peripheral vascular surgery].
Topics: Anticoagulants; Aspirin; Cardiovascular Diseases; Humans; Ischemia; Leg; Postoperative Complications | 1994 |
[Carotid endarterectomy--results of current studies and their consequences].
Topics: Aspirin; Carotid Stenosis; Cerebral Infarction; Clinical Trials as Topic; Endarterectomy, Carotid; H | 1993 |
When do vascular surgeons prescribe antiplatelet therapy? Current attitudes.
Topics: Angioplasty, Balloon; Arteriosclerosis; Aspirin; Dipyridamole; Graft Occlusion, Vascular; Humans; Is | 1993 |
Optimal antithrombotic therapy following aortocoronary bypass: a meta-analysis.
Topics: Anticoagulants; Aspirin; Coronary Artery Bypass; Dipyridamole; Drug Therapy, Combination; Graft Occl | 1993 |
Management of patients taking anticoagulants and platelet inhibitors prior to dermatologic surgery.
Topics: Anticoagulants; Aspirin; Blood Loss, Surgical; Clinical Protocols; Humans; Patient Care Planning; Po | 1993 |
Advances in antithrombotic therapy: novel agents.
Topics: Angina, Unstable; Angioplasty, Balloon, Coronary; Antithrombins; Aspirin; Clinical Trials as Topic; | 1995 |
[Current approach in antithrombotic treatment during coronary interventions: specific thrombocyte aggregation inhibitors and direct thrombin antagonists in high-risk patients].
Topics: Adolescent; Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Antithrombins; Aspirin; Drug Thera | 1996 |
Treating the non-electrical risks of atrial fibrillation.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Clinical Trials as Topic; Heart Valve Diseases; | 1997 |
Dipyridamole: an unfulfilled promise?
Topics: Aspirin; Coronary Artery Bypass; Dipyridamole; Fibrinolytic Agents; Heart Valve Prosthesis Implantat | 1997 |
Antiplatelet therapy: do the new platelet inhibitors add significantly to the clinical benefits of aspirin?
Topics: Angioplasty, Balloon, Coronary; Aspirin; Clinical Trials as Topic; Coronary Disease; Drug Therapy, C | 1997 |
Triflusal.
Topics: Adult; Angina Pectoris; Animals; Aspirin; Carotid Stenosis; Humans; In Vitro Techniques; Middle Aged | 1998 |
[Inhibition of thrombocyte aggregation after heart valve replacement].
Topics: Aspirin; Drug Therapy, Combination; Fibrinolytic Agents; Heart Valve Prosthesis Implantation; Humans | 1998 |
Platelets, aspirin, and cardiovascular disease.
Topics: Aspirin; Blood Platelets; Cardiovascular Diseases; Fibrinolytic Agents; Humans; Platelet Adhesivenes | 1998 |
Risk of post-discharge venous thromboembolism in patients with rheumatoid arthritis undergoing knee or hip arthroplasty. Is prolonged thromboprophylaxis warranted or dangerous?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Arthroplasty, Replacement; Arthropla | 1999 |
Systematic review of randomized controlled trials of aspirin and oral anticoagulants in the prevention of graft occlusion and ischemic events after infrainguinal bypass surgery.
Topics: Administration, Oral; Amputation, Surgical; Anticoagulants; Aspirin; Graft Occlusion, Vascular; Huma | 1999 |
Antiplatelet therapy in interventional cardiology: I. Newer oral antiplatelet agents.
Topics: Administration, Oral; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Artery Bypass; | 2000 |
Aspirin in the treatment and prevention of cardiovascular disease.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Aspirin; Cardiovascular Diseases; Case-Control Studie | 2000 |
Low-molecular-weight heparin and other antithrombotic agents in the setting of a fast-track revascularization in unstable coronary artery disease.
Topics: Abciximab; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; | 2000 |
A meta-analysis of thromboembolic prophylaxis in total knee arthroplasty.
Topics: Aged; Arthroplasty, Replacement, Knee; Aspirin; Female; Heparin, Low-Molecular-Weight; Humans; Male; | 2001 |
A meta-analysis of thromboembolic prophylaxis in total knee arthroplasty.
Topics: Aged; Arthroplasty, Replacement, Knee; Aspirin; Female; Heparin, Low-Molecular-Weight; Humans; Male; | 2001 |
A meta-analysis of thromboembolic prophylaxis in total knee arthroplasty.
Topics: Aged; Arthroplasty, Replacement, Knee; Aspirin; Female; Heparin, Low-Molecular-Weight; Humans; Male; | 2001 |
A meta-analysis of thromboembolic prophylaxis in total knee arthroplasty.
Topics: Aged; Arthroplasty, Replacement, Knee; Aspirin; Female; Heparin, Low-Molecular-Weight; Humans; Male; | 2001 |
A meta-analysis of thromboembolic prophylaxis in total knee arthroplasty.
Topics: Aged; Arthroplasty, Replacement, Knee; Aspirin; Female; Heparin, Low-Molecular-Weight; Humans; Male; | 2001 |
A meta-analysis of thromboembolic prophylaxis in total knee arthroplasty.
Topics: Aged; Arthroplasty, Replacement, Knee; Aspirin; Female; Heparin, Low-Molecular-Weight; Humans; Male; | 2001 |
A meta-analysis of thromboembolic prophylaxis in total knee arthroplasty.
Topics: Aged; Arthroplasty, Replacement, Knee; Aspirin; Female; Heparin, Low-Molecular-Weight; Humans; Male; | 2001 |
A meta-analysis of thromboembolic prophylaxis in total knee arthroplasty.
Topics: Aged; Arthroplasty, Replacement, Knee; Aspirin; Female; Heparin, Low-Molecular-Weight; Humans; Male; | 2001 |
A meta-analysis of thromboembolic prophylaxis in total knee arthroplasty.
Topics: Aged; Arthroplasty, Replacement, Knee; Aspirin; Female; Heparin, Low-Molecular-Weight; Humans; Male; | 2001 |
Abnormal coagulation in the postoperative period contributing to excessive bleeding.
Topics: Adult; Anticoagulants; Aspirin; Blood Coagulation; Blood Coagulation Disorders; Blood Transfusion; D | 2001 |
[Peripheral arterial revascularization: which antithrombotic agents?].
Topics: 4-Hydroxycoumarins; Anticoagulants; Arteries; Aspirin; Drug Therapy, Combination; Fibrinolytic Agent | 2001 |
[Advances and perspectives in the prevention of venous thromboembolic disease].
Topics: Anesthesia, Conduction; Anticoagulants; Aspirin; Heparin, Low-Molecular-Weight; Humans; Myocardial I | 2001 |
[Aspirin, a risk factor for bleeding at dental procedures].
Topics: Antifibrinolytic Agents; Aspirin; Blood Loss, Surgical; Humans; Intraoperative Complications; Oral H | 1995 |
Cardiovascular risk reduction in renal transplantation. Strategies for success.
Topics: Arteriosclerosis; Aspirin; Cardiovascular Agents; Cardiovascular Diseases; Comorbidity; Cost-Benefit | 2002 |
[Prevention of postoperative thrombosis].
Topics: Adult; Aspirin; Collagen; Coumarins; Dextrans; Epinephrine; Heparin; Humans; Platelet Aggregation; P | 1977 |
[Possibilities of drug-induced prevention of thrombosis with special reference to pre-, per- and postoperative time of treatment].
Topics: Aspirin; Coumarins; Dextrans; Heparin; Humans; Phlebography; Postoperative Complications; Thromboemb | 1977 |
[Thrombosis prevention and platelet functions following heart valve replacement].
Topics: Adult; Anticoagulants; Aspirin; Blood Flow Velocity; Blood Platelets; Dipyridamole; Female; Heart Va | 1978 |
New developments in the detection and prevention of venous thromboembolism.
Topics: Aspirin; Clothing; Dextrans; Electric Stimulation Therapy; Fibrinolytic Agents; Heparin; Hip Joint; | 1979 |
[Prevention of thrombosis and embolism in digestive surgery].
Topics: Anticoagulants; Aspirin; Coumarins; Dextrans; Digestive System Surgical Procedures; Dipyridamole; He | 1979 |
Platelet inhibitors in the treatment of thrombosis.
Topics: Adult; Aged; Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Clinical Trials as Topic; Clof | 1978 |
[Treatment with antiplatelet drugs. Current status of knowledge].
Topics: Aspirin; Blood Platelet Disorders; Cerebrovascular Disorders; Clofibrate; Coronary Disease; Dextrans | 1979 |
[Prophylactic value of platelet anti-aggregants in coronary disease].
Topics: Anticoagulants; Arteriosclerosis; Aspirin; Clofibrate; Coronary Disease; Dipyridamole; Embolism; Hea | 1979 |
Antiplatelet agents: a review.
Topics: Angina Pectoris; Aspirin; Blood Platelets; Cardiovascular Diseases; Cerebrovascular Disorders; Clofi | 1979 |
Deep vein thrombosis. Detection and prevention.
Topics: Administration, Oral; Anticoagulants; Aspirin; Dextrans; Dipyridamole; Female; Fibrinogen; Heparin; | 1975 |
Low dose heparin in the prevention of venous thromboembolism. Rationale and results.
Topics: Acenocoumarol; Adult; Aspirin; Clinical Trials as Topic; Dextrans; Dipyridamole; Heparin; Hip; Human | 1975 |
The prevention of postoperative deep vein thrombosis.
Topics: Adult; Aspirin; Atmospheric Pressure; Clinical Trials as Topic; Dextrans; Electric Stimulation; Ethy | 1975 |
Thrombosis and antithrombotic therapy in microvascular surgery.
Topics: Aspirin; Dextrans; Fibrinolytic Agents; Heparin; Humans; Microsurgery; Postoperative Complications; | 1992 |
[Acetylsalicylic acid in unstable angina, after coronary revascularization and in prevention of cardiac thromboembolism].
Topics: Angina, Unstable; Aspirin; Coronary Artery Bypass; Graft Occlusion, Vascular; Heart Valve Prosthesis | 1992 |
[Preventive measures in thromboembolic accidents in surgery].
Topics: Anticoagulants; Aspirin; Bandages; Dextrans; Early Ambulation; Electric Stimulation Therapy; Heparin | 1992 |
Prevention of venous thromboembolism.
Topics: Anticoagulants; Aspirin; Bandages; Cerebrovascular Disorders; Gravity Suits; Humans; Myocardial Infa | 1992 |
Prophylaxis for venous thromboembolism in total hip arthroplasty: a review.
Topics: Aspirin; Bandages; Dextrans; Dihydroergotamine; Drug Combinations; Heparin; Heparin, Low-Molecular-W | 1990 |
[Pulmonary thromboembolism].
Topics: Aspirin; Dextrans; Drug Evaluation; Fibrinolytic Agents; Heparin; Humans; Postoperative Complication | 1991 |
[Prevention of postoperative venous thrombosis and pulmonary embolism. Consensus conference 8 March 1991 by Assistance Publique-Hopitaux de Paris].
Topics: Anesthesia; Aspirin; Bandages; Dextrans; Female; France; Heparin, Low-Molecular-Weight; Humans; Male | 1991 |
Prevention of venous thromboembolism in general surgical patients. Results of meta-analysis.
Topics: Adult; Aspirin; Clinical Trials as Topic; Clothing; Dextrans; Dihydroergotamine; Drug Combinations; | 1988 |
Antithrombotic therapy in peripheral vascular disease.
Topics: Anticoagulants; Arterial Occlusive Diseases; Aspirin; Blood Vessel Prosthesis; Humans; Platelet Aggr | 1989 |
[Optimal dosage of acetylsalicylic acid. I: Use in primary and secondary prevention of myocardial infarct and following aortocoronary bypass operation].
Topics: Aspirin; Coronary Artery Bypass; Dose-Response Relationship, Drug; Humans; Myocardial Infarction; Po | 1989 |
[Acetylsalicylic acid in the treatment of arterial thromboembolytic diseases. 2. Clinical documentation].
Topics: Aspirin; Cardiac Surgical Procedures; Diabetic Angiopathies; Female; Glomerulonephritis, Membranopro | 1989 |
Hemorheology in surgery--a review.
Topics: Adult; Age Factors; Aged; Anesthesia, General; Animals; Aspirin; Blood; Blood Coagulation; Blood Phy | 1987 |
Clinical trials evaluating platelet-modifying drugs in patients with atherosclerotic cardiovascular disease and thrombosis.
Topics: Anticoagulants; Aspirin; Blood Platelets; Blood Vessel Prosthesis; Cardiovascular Diseases; Clinical | 1986 |
Role of platelets and platelet inhibitors in aortocoronary artery vein-graft disease.
Topics: Animals; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Artery Bypass; Dipyridamole; D | 1986 |
Effectiveness of anticoagulants.
Topics: Administration, Oral; Adult; Aged; Angina Pectoris; Angina, Unstable; Anticoagulants; Aspirin; Blood | 1986 |
Carotid surgery in stroke prevention.
Topics: Aged; Arteriosclerosis; Aspirin; Blindness; Carotid Arteries; Carotid Artery Diseases; Cerebrovascul | 1986 |
[Antiplatelet therapy of thrombosis].
Topics: Animals; Aspirin; Cerebrovascular Disorders; Coronary Disease; Humans; Postoperative Complications; | 1986 |
[Hemorheologic applications in vascular surgery].
Topics: Aortic Aneurysm; Aspirin; Humans; Pentoxifylline; Postoperative Complications; Rheology; Vascular Su | 1986 |
Prevention of thromboembolism after hip fracture.
Topics: Aged; Anticoagulants; Aspirin; Bandages; Coumarins; Dextrans; Exercise Therapy; Femoral Neck Fractur | 1973 |
[Urgency and technic of thromboembolism prevention in surgery].
Topics: Anticoagulants; Aspirin; Blood Circulation; Blood Platelets; Heparin; Humans; Postoperative Complica | 1973 |
Deep venous thrombosis. II. Management.
Topics: Anticoagulants; Aspirin; Dextrans; Heparin; Humans; Postoperative Complications; Pulmonary Embolism; | 1973 |
Thromboembolism. Diagnosis and treatment.
Topics: Adult; Aspirin; Dipyridamole; Femoral Vein; Fibrinogen; Heparin; Humans; Iliac Vein; Iodine Radioiso | 1974 |
Gastrointestinal hemorrhage. I. General considerations of diagnosis and the rapy.
Topics: Anus Diseases; Aspirin; Biliary Tract Diseases; Blood Coagulation Disorders; Burns; Child; Child, Pr | 1973 |
[New possibilities for the prophylaxis of postoperative acute deep thrombophlebitis].
Topics: Administration, Oral; Anticoagulants; Ascorbic Acid; Aspirin; Dextrans; Ethylestrenol; Fibrinogen; H | 1974 |
The diagnosis and prevention of post operative venous thrombosis.
Topics: Administration, Oral; Anticoagulants; Aspirin; Blood Platelets; Depression, Chemical; Dextrans; Fibr | 1973 |
Acute haemorrhagic gastritis: modern concepts based on pathogenesis.
Topics: Acute Disease; Aspirin; Blood Transfusion; Cell Membrane Permeability; Endoscopy; Gastrectomy; Gastr | 1971 |
256 trials available for aspirin and Complication, Postoperative
| Article | Year |
|---|---|
Effect of Aspirin vs Enoxaparin on Symptomatic Venous Thromboembolism in Patients Undergoing Hip or Knee Arthroplasty: The CRISTAL Randomized Trial.
Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Aust | 2022 |
Is Enoxaparin Associated With a Higher Risk of Persistent Wound Drainage Than Aspirin? A Secondary Analysis of Data From the CRISTAL Randomized Trial.
Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Aspirin; Australia; Drainage; Enoxaparin; Huma | 2023 |
Continuation of low-dose acetylsalicylic acid during perioperative period of laparoscopic inguinal hernia repair is safe: results of a prospective clinical trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aspirin; Cardiovascular Diseases; Dose-Response Relation | 2019 |
CRISTAL: protocol for a cluster randomised, crossover, non-inferiority trial of aspirin compared to low molecular weight heparin for venous thromboembolism prophylaxis in hip or knee arthroplasty, a registry nested study.
Topics: Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Australia; Cross-Over Stud | 2019 |
Aspirin for metal stent in malignant distal common bile duct obstruction (AIMS): study protocol for a multicenter randomized controlled trial.
Topics: Aspirin; Cholangiopancreatography, Endoscopic Retrograde; Cholestasis; Common Bile Duct; Double-Blin | 2020 |
One-year Results of a Factorial Randomized Trial of Aspirin versus Placebo and Clonidine versus Placebo in Patients Having Noncardiac Surgery.
Topics: Aged; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clonidine; Female; Follow-Up Stu | 2020 |
Ticagrelor With or Without Aspirin After PCI: The TWILIGHT Platelet Substudy.
Topics: Aged; Aspirin; Blood; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle A | 2020 |
Ticagrelor With or Without Aspirin After PCI: The TWILIGHT Platelet Substudy.
Topics: Aged; Aspirin; Blood; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle A | 2020 |
Ticagrelor With or Without Aspirin After PCI: The TWILIGHT Platelet Substudy.
Topics: Aged; Aspirin; Blood; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle A | 2020 |
Ticagrelor With or Without Aspirin After PCI: The TWILIGHT Platelet Substudy.
Topics: Aged; Aspirin; Blood; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle A | 2020 |
Ticagrelor With or Without Aspirin in High-Risk Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention.
Topics: Aspirin; Diabetes Mellitus; Double-Blind Method; Drug Therapy, Combination; Hemorrhage; Humans; Perc | 2020 |
Ticagrelor With or Without Aspirin After Complex PCI.
Topics: Aged; Aspirin; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Hemorrhage | 2020 |
Rationale and design for the study Apixaban versus ClopidoGRel on a background of aspirin in patient undergoing InfraPoPliteal angioplasty for critical limb ischemia: AGRIPPA trial.
Topics: Angioplasty; Aspirin; Clopidogrel; Critical Illness; Factor Xa Inhibitors; Humans; Ischemia; Leg; Mu | 2020 |
Effect of Clopidogrel and Aspirin vs Aspirin Alone on Migraine Headaches After Transcatheter Atrial Septal Defect Closure: One-Year Results of the CANOA Randomized Clinical Trial.
Topics: Adult; Aspirin; Cardiac Catheterization; Clopidogrel; Dual Anti-Platelet Therapy; Duration of Therap | 2021 |
New-Onset Atrial Fibrillation After Coronary Artery Bypass Grafting and Long-Term Outcome: A Population-Based Nationwide Study From the SWEDEHEART Registry.
Topics: Aged; Aspirin; Atrial Fibrillation; Coronary Artery Bypass; Coronary Artery Disease; Factor Xa Inhib | 2021 |
Comparison of one-month versus twelve-month dual antiplatelet therapy after implantation of drug-eluting stents guided by either intravascular ultrasound or angiography in patients with acute coronary syndrome: rationale and design of prospective, multice
Topics: Acute Coronary Syndrome; Adult; Aspirin; Coronary Angiography; Drug-Eluting Stents; Dual Anti-Platel | 2021 |
Impact of dual antiplatelet therapy after coronary artery bypass surgery on 1-year outcomes in the Arterial Revascularization Trial.
Topics: Aspirin; Clopidogrel; Coronary Artery Bypass; Coronary Artery Disease; Dose-Response Relationship, D | 2017 |
Aspirin in Patients With Previous Percutaneous Coronary Intervention Undergoing Noncardiac Surgery.
Topics: Aged; Antihypertensive Agents; Aspirin; Biomarkers; Clonidine; Drug Administration Schedule; Drug Th | 2018 |
Comparison of Outcomes and Costs Associated With Aspirin ± Clopidogrel After Coronary Artery Bypass Grafting.
Topics: Aged; Aspirin; Clopidogrel; Comorbidity; Coronary Artery Bypass; Coronary Disease; Costs and Cost An | 2018 |
Percutaneous coronary intervention and antiplatelet therapy in patients with atrial fibrillation receiving apixaban or warfarin: Insights from the ARISTOTLE trial.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Coronary Artery Disease; Drug Monitoring; Female | 2018 |
Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthroplasty.
Topics: Aged; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Double-Blind Method; | 2018 |
Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthroplasty.
Topics: Aged; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Double-Blind Method; | 2018 |
Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthroplasty.
Topics: Aged; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Double-Blind Method; | 2018 |
Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthroplasty.
Topics: Aged; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Double-Blind Method; | 2018 |
Topics: Aspirin; Coronary Thrombosis; Dose-Response Relationship, Drug; Humans; Myocardial Infarction; Percu | 2018 |
Dual antiplatelet therapy for perioperative myocardial infarction following CABG surgery.
Topics: Acute Coronary Syndrome; Aged; Aspirin; Clopidogrel; Coronary Artery Bypass; Dose-Response Relations | 2018 |
Topics: Aged; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Double-Blind Method; | 2018 |
Anticoagulation and Antiplatelet Strategies After On-X Mechanical Aortic Valve Replacement.
Topics: Adult; Aged; Anticoagulants; Aortic Valve; Aspirin; Clopidogrel; Female; Heart Valve Prosthesis Impl | 2018 |
Anticoagulation and Antiplatelet Strategies After On-X Mechanical Aortic Valve Replacement.
Topics: Adult; Aged; Anticoagulants; Aortic Valve; Aspirin; Clopidogrel; Female; Heart Valve Prosthesis Impl | 2018 |
Anticoagulation and Antiplatelet Strategies After On-X Mechanical Aortic Valve Replacement.
Topics: Adult; Aged; Anticoagulants; Aortic Valve; Aspirin; Clopidogrel; Female; Heart Valve Prosthesis Impl | 2018 |
Anticoagulation and Antiplatelet Strategies After On-X Mechanical Aortic Valve Replacement.
Topics: Adult; Aged; Anticoagulants; Aortic Valve; Aspirin; Clopidogrel; Female; Heart Valve Prosthesis Impl | 2018 |
Effect of aspirin in vascular surgery in patients from a randomized clinical trial (POISE-2).
Topics: Aged; Aspirin; Constriction, Pathologic; Female; Humans; Male; Myocardial Infarction; Perioperative | 2018 |
Warfarin versus aspirin prevents portal vein thrombosis after laparoscopic splenectomy and azygoportal disconnection: A randomized clinical trial.
Topics: Aged; Aged, 80 and over; Aspirin; Female; Humans; Incidence; Laparoscopy; Liver Cirrhosis; Male; Mid | 2019 |
Adverse events in patients with high platelet reactivity following successful chronic total occlusion PCI: The Assessment of Dual AntiPlatelet Therapy with Drug-Eluting Stents (ADAPT-DES) study.
Topics: Aged; Aspirin; Blood Platelets; Coronary Occlusion; Drug-Eluting Stents; Female; Fibrinolytic Agents | 2019 |
Rivaroxaban, a direct Factor Xa inhibitor, versus acetylsalicylic acid as thromboprophylaxis in children post-Fontan procedure: Rationale and design of a prospective, randomized trial (the UNIVERSE study).
Topics: Aspirin; Child; Child, Preschool; Factor Xa Inhibitors; Female; Fibrinolytic Agents; Fontan Procedur | 2019 |
Randomized trial of ticagrelor vs. aspirin in patients after coronary artery bypass grafting: the TiCAB trial.
Topics: Aged; Aspirin; Coronary Artery Bypass; Double-Blind Method; Early Termination of Clinical Trials; Fe | 2019 |
Impact of adding aspirin to beta-blocker and statin in high-risk patients undergoing major vascular surgery.
Topics: Adrenergic beta-Antagonists; Aged; Aspirin; Dose-Response Relationship, Drug; Drug Therapy, Combinat | 2013 |
Anterior chamber bleeding after laser peripheral iridotomy.
Topics: Adult; Aged; Aged, 80 and over; Anterior Chamber; Anticoagulants; Aspirin; Clopidogrel; Eye Color; F | 2013 |
Short- versus long-term duration of dual antiplatelet therapy in patients treated for in-stent restenosis: a PRODIGY trial substudy (Prolonging Dual Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia).
Topics: Aged; Aged, 80 and over; Aspirin; Clopidogrel; Coronary Restenosis; Female; Humans; Italy; Male; Mid | 2014 |
Aspirin and clonidine in non-cardiac surgery: acute kidney injury substudy protocol of the Perioperative Ischaemic Evaluation (POISE) 2 randomised controlled trial.
Topics: Acute Kidney Injury; Adrenergic alpha-2 Receptor Agonists; Anti-Inflammatory Agents, Non-Steroidal; | 2014 |
Impact of dual antiplatelet therapy on outcomes among aspirin-resistant patients following coronary artery bypass grafting.
Topics: Aged; Aspirin; Clopidogrel; Coronary Artery Bypass; Coronary Artery Disease; Croatia; Dose-Response | 2014 |
Aspirin in patients undergoing noncardiac surgery.
Topics: Aged; Aspirin; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Peri | 2014 |
Aspirin in patients undergoing noncardiac surgery.
Topics: Aged; Aspirin; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Peri | 2014 |
Aspirin in patients undergoing noncardiac surgery.
Topics: Aged; Aspirin; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Peri | 2014 |
Aspirin in patients undergoing noncardiac surgery.
Topics: Aged; Aspirin; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Peri | 2014 |
Aspirin in patients undergoing noncardiac surgery.
Topics: Aged; Aspirin; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Peri | 2014 |
Aspirin in patients undergoing noncardiac surgery.
Topics: Aged; Aspirin; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Peri | 2014 |
Aspirin in patients undergoing noncardiac surgery.
Topics: Aged; Aspirin; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Peri | 2014 |
Aspirin in patients undergoing noncardiac surgery.
Topics: Aged; Aspirin; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Peri | 2014 |
Aspirin in patients undergoing noncardiac surgery.
Topics: Aged; Aspirin; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Peri | 2014 |
Rationale and design of the PeriOperative ISchemic Evaluation-2 (POISE-2) trial: an international 2 × 2 factorial randomized controlled trial of acetyl-salicylic acid vs. placebo and clonidine vs. placebo in patients undergoing noncardiac surgery.
Topics: Aged; Aspirin; Clonidine; Double-Blind Method; Female; Humans; Intraoperative Complications; Male; M | 2014 |
Aspirin reload before elective percutaneous coronary intervention: impact on serum thromboxane b2 and myocardial reperfusion indexes.
Topics: Aged; Aspirin; Female; Humans; Male; Microvessels; Middle Aged; Myocardial Reperfusion Injury; Percu | 2014 |
Aspirin reload before elective percutaneous coronary intervention: impact on serum thromboxane b2 and myocardial reperfusion indexes.
Topics: Aged; Aspirin; Female; Humans; Male; Microvessels; Middle Aged; Myocardial Reperfusion Injury; Percu | 2014 |
Aspirin reload before elective percutaneous coronary intervention: impact on serum thromboxane b2 and myocardial reperfusion indexes.
Topics: Aged; Aspirin; Female; Humans; Male; Microvessels; Middle Aged; Myocardial Reperfusion Injury; Percu | 2014 |
Aspirin reload before elective percutaneous coronary intervention: impact on serum thromboxane b2 and myocardial reperfusion indexes.
Topics: Aged; Aspirin; Female; Humans; Male; Microvessels; Middle Aged; Myocardial Reperfusion Injury; Percu | 2014 |
Perioperative aspirin and clonidine and risk of acute kidney injury: a randomized clinical trial.
Topics: Acute Kidney Injury; Administration, Cutaneous; Administration, Oral; Adrenergic alpha-2 Receptor Ag | 2014 |
6- versus 24-month dual antiplatelet therapy after implantation of drug-eluting stents in patients nonresistant to aspirin: the randomized, multicenter ITALIC trial.
Topics: Aged; Aspirin; Clopidogrel; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Drug-Elu | 2015 |
Combined low-dose aspirin and warfarin anticoagulant therapy of postoperative atrial fibrillation following mechanical heart valve replacement.
Topics: Adult; Anticoagulants; Aspirin; Atrial Fibrillation; Female; Fibrinolytic Agents; Heart Valve Prosth | 2014 |
[Perioperative acetylsalicylic acid and clonidine in noncardiac surgery patients (POISE-2 trial)].
Topics: Adrenergic alpha-2 Receptor Agonists; Aged; Aged, 80 and over; Aspirin; Cardiovascular Diseases; Clo | 2015 |
Zotarolimus-eluting versus bare-metal stents in uncertain drug-eluting stent candidates.
Topics: Aged; Aged, 80 and over; Aspirin; Biocompatible Materials; Clopidogrel; Coronary Angiography; Corona | 2015 |
Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI in Patients With and Without Acute Myocardial Infarction.
Topics: Aspirin; Double-Blind Method; Female; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous | 2015 |
Comparison of Prasugrel and Ticagrelor Antiplatelet Effects in Korean Patients Presenting With ST-Segment Elevation Myocardial Infarction.
Topics: Adenosine; Adult; Aged; Asian People; Aspirin; Cardiac Catheterization; Double-Blind Method; Female; | 2015 |
The Omega-3 fatty acids (Fish Oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study: the updated final trial protocol and rationale of post-initiation trial modifications.
Topics: Arteriovenous Shunt, Surgical; Aspirin; Central Venous Catheters; Docosahexaenoic Acids; Double-Blin | 2015 |
Is routine post-procedural anticoagulation warranted after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction? Insights from the HORIZONS-AMI trial.
Topics: Aged; Antithrombins; Aspirin; Clopidogrel; Dose-Response Relationship, Drug; Drug Therapy, Combinati | 2017 |
Effect of Prior Aspirin Treatment on Patients With Acute Coronary Syndromes: Insights From the PROSPECT Study.
Topics: Acute Coronary Syndrome; Aged; Aspirin; Coronary Angiography; Dose-Response Relationship, Drug; Fema | 2015 |
Postoperative Atrial Fibrillation Is Associated With High On-Aspirin Platelet Reactivity.
Topics: Aged; Aspirin; Atrial Fibrillation; Blood Platelets; Coronary Artery Bypass; Coronary Artery Disease | 2015 |
Effectiveness of platelet inhibition on major adverse cardiac events in non-cardiac surgery after percutaneous coronary intervention: a prospective cohort study.
Topics: Aged; Aspirin; Cardiomyopathy, Dilated; Clopidogrel; Cohort Studies; Female; Heart Diseases; Humans; | 2016 |
Rationale and design of POPular-TAVI: antiPlatelet therapy fOr Patients undergoing Transcatheter Aortic Valve Implantation.
Topics: Administration, Oral; Aortic Valve Stenosis; Aspirin; Clopidogrel; Dose-Response Relationship, Drug; | 2016 |
Stopping vs. Continuing Aspirin before Coronary Artery Surgery.
Topics: Aged; Aspirin; Blood Transfusion; Coronary Artery Bypass; Double-Blind Method; Female; Humans; Lengt | 2016 |
Aspirin Use and Incident Cardiovascular Disease, Kidney Failure, and Death in Stable Kidney Transplant Recipients: A Post Hoc Analysis of the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiovascular Diseases; Cohort Studi | 2016 |
Anticoagulation Therapy with Warfarin Versus Low-Dose Aspirin Prevents Portal Vein Thrombosis After Laparoscopic Splenectomy and Azygoportal Disconnection.
Topics: Adolescent; Adult; Aged; Anticoagulants; Aspirin; Azygos Vein; Female; Heparin, Low-Molecular-Weight | 2016 |
[Prevalence of acetylsalicylic acid (ASA) - low response in vascular surgery].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Arterial Occlusive Diseases; Aspirin; Carotid Stenosi | 2016 |
Risks and Benefits of Dual Antiplatelet Therapy Beyond 12 Months After Coronary Stenting: A Prospective Randomized Cohort Study.
Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Angiography; | 2016 |
Aspirin use and bleeding volume in skin cancer patients undergoing surgery: a randomized controlled trial.
Topics: Aged; Anticoagulants; Aspirin; Double-Blind Method; Female; Hemorrhage; Humans; Intraoperative Compl | 2016 |
Perioperative Aspirin for Prevention of Venous Thromboembolism: The PeriOperative ISchemia Evaluation-2 Trial and a Pooled Analysis of the Randomized Trials.
Topics: Aged; Aspirin; Female; Fibrinolytic Agents; Humans; Male; Odds Ratio; Perioperative Care; Postoperat | 2016 |
Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Aspirin; Blood Transfusion; Coronary Artery Bypass | 2017 |
Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Aspirin; Blood Transfusion; Coronary Artery Bypass | 2017 |
Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Aspirin; Blood Transfusion; Coronary Artery Bypass | 2017 |
Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Aspirin; Blood Transfusion; Coronary Artery Bypass | 2017 |
Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Aspirin; Blood Transfusion; Coronary Artery Bypass | 2017 |
Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Aspirin; Blood Transfusion; Coronary Artery Bypass | 2017 |
Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Aspirin; Blood Transfusion; Coronary Artery Bypass | 2017 |
Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Aspirin; Blood Transfusion; Coronary Artery Bypass | 2017 |
Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Aspirin; Blood Transfusion; Coronary Artery Bypass | 2017 |
Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Aspirin; Blood Transfusion; Coronary Artery Bypass | 2017 |
Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Aspirin; Blood Transfusion; Coronary Artery Bypass | 2017 |
Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Aspirin; Blood Transfusion; Coronary Artery Bypass | 2017 |
Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Aspirin; Blood Transfusion; Coronary Artery Bypass | 2017 |
Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Aspirin; Blood Transfusion; Coronary Artery Bypass | 2017 |
Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Aspirin; Blood Transfusion; Coronary Artery Bypass | 2017 |
Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Aspirin; Blood Transfusion; Coronary Artery Bypass | 2017 |
Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Aspirin; Blood Transfusion; Coronary Artery Bypass | 2017 |
Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Aspirin; Blood Transfusion; Coronary Artery Bypass | 2017 |
Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Aspirin; Blood Transfusion; Coronary Artery Bypass | 2017 |
Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Aspirin; Blood Transfusion; Coronary Artery Bypass | 2017 |
Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Aspirin; Blood Transfusion; Coronary Artery Bypass | 2017 |
Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Aspirin; Blood Transfusion; Coronary Artery Bypass | 2017 |
Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Aspirin; Blood Transfusion; Coronary Artery Bypass | 2017 |
Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Aspirin; Blood Transfusion; Coronary Artery Bypass | 2017 |
Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Aspirin; Blood Transfusion; Coronary Artery Bypass | 2017 |
Antithrombotic therapy after bioprosthetic aortic valve implantation: Warfarin versus aspirin, a randomized controlled trial.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aortic Valve; Aspirin; Bioprosthesis; Heart Valve Prosthesi | 2017 |
Ischaemic and bleeding outcomes in elderly patients undergoing a prolonged versus shortened duration of dual antiplatelet therapy after percutaneous coronary intervention: insights from the PRODIGY randomised trial.
Topics: Age Factors; Aged; Aged, 80 and over; Aging; Aspirin; Clopidogrel; Drug Therapy, Combination; Female | 2017 |
Efficacy of cilostazol-based dual antiplatelet treatment in patients undergoing carotid artery stenting.
Topics: Aged; Aged, 80 and over; Aspirin; Carotid Stenosis; Cilostazol; Clopidogrel; Drug Therapy, Combinati | 2017 |
Magnesium and aspirin treatment in patients with subarachnoid haemorrhage. Comparison of effects after endovascular and neurosurgical aneurysm occlusion.
Topics: Aspirin; Brain Ischemia; Embolization, Therapeutic; Female; Humans; Intracranial Aneurysm; Magnesium | 2009 |
Clopidogrel and aspirin versus clopidogrel alone on graft patency after coronary artery bypass grafting.
Topics: Aged; Aspirin; Clopidogrel; Coronary Angiography; Coronary Artery Bypass; Coronary Stenosis; Dose-Re | 2009 |
Clopidogrel provides significantly greater inhibition of platelet activity than aspirin when combined with atorvastatin after coronary artery bypass grafting: a prospective randomized study.
Topics: Adenosine Diphosphate; Aged; Aspirin; Atorvastatin; Clopidogrel; Comorbidity; Coronary Artery Bypass | 2010 |
To continue or discontinue aspirin in the perioperative period: a randomized, controlled clinical trial.
Topics: Aged; Aged, 80 and over; Aspirin; Blood Loss, Surgical; Cardiovascular Diseases; Double-Blind Method | 2010 |
To continue or discontinue aspirin in the perioperative period: a randomized, controlled clinical trial.
Topics: Aged; Aged, 80 and over; Aspirin; Blood Loss, Surgical; Cardiovascular Diseases; Double-Blind Method | 2010 |
To continue or discontinue aspirin in the perioperative period: a randomized, controlled clinical trial.
Topics: Aged; Aged, 80 and over; Aspirin; Blood Loss, Surgical; Cardiovascular Diseases; Double-Blind Method | 2010 |
To continue or discontinue aspirin in the perioperative period: a randomized, controlled clinical trial.
Topics: Aged; Aged, 80 and over; Aspirin; Blood Loss, Surgical; Cardiovascular Diseases; Double-Blind Method | 2010 |
The efficacy and safety of clopidogrel in vascular surgery patients with immediate postoperative asymptomatic troponin T release for the prevention of late cardiac events: Rationale and design of the Dutch Echocardiographic Cardiac Risk Evaluation Applyin
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clopidogrel; Echocardiography, Stress; Humans; Myo | 2010 |
Multicenter randomized trial evaluating the efficacy of cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease: results of the CILON-T (influence of CILostazol-based triple antiplatelet therapy ON is
Topics: Aged; Aspirin; Brain Ischemia; Cilostazol; Clopidogrel; Coronary Disease; Drug Therapy, Combination; | 2011 |
Multicenter randomized trial evaluating the efficacy of cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease: results of the CILON-T (influence of CILostazol-based triple antiplatelet therapy ON is
Topics: Aged; Aspirin; Brain Ischemia; Cilostazol; Clopidogrel; Coronary Disease; Drug Therapy, Combination; | 2011 |
Multicenter randomized trial evaluating the efficacy of cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease: results of the CILON-T (influence of CILostazol-based triple antiplatelet therapy ON is
Topics: Aged; Aspirin; Brain Ischemia; Cilostazol; Clopidogrel; Coronary Disease; Drug Therapy, Combination; | 2011 |
Multicenter randomized trial evaluating the efficacy of cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease: results of the CILON-T (influence of CILostazol-based triple antiplatelet therapy ON is
Topics: Aged; Aspirin; Brain Ischemia; Cilostazol; Clopidogrel; Coronary Disease; Drug Therapy, Combination; | 2011 |
Closure or medical therapy for cryptogenic stroke with patent foramen ovale.
Topics: Adolescent; Adult; Anticoagulants; Aspirin; Clopidogrel; Combined Modality Therapy; Drug Therapy, Co | 2012 |
Impact of high post-loading platelet aggregation on 30-day clinical outcomes after primary percutaneous coronary intervention. The antiplatelet regimen tailoring after primary PCI (ART-PCI) trial.
Topics: Aged; Aspirin; Clopidogrel; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; P | 2013 |
Angioplasty and stent treatment of transplant renal artery stenosis.
Topics: Adult; Aged; Angioplasty; Anticoagulants; Aspirin; Clopidogrel; Female; Follow-Up Studies; Humans; H | 2012 |
Cerebral microembolization after bioprosthetic aortic valve replacement: comparison of warfarin plus aspirin versus aspirin only.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aortic Valve Stenosis; Aspirin; Bioprosthesis; Collagen; Co | 2012 |
Factors associated with thrombotic complications after the Fontan procedure: a secondary analysis of a multicenter, randomized trial of primary thromboprophylaxis for 2 years after the Fontan procedure.
Topics: Anticoagulants; Aspirin; Child; Child, Preschool; Female; Fontan Procedure; Humans; Male; Postoperat | 2013 |
Aspirin and mortality from coronary bypass surgery.
Topics: Aged; Antifibrinolytic Agents; Aspirin; Coronary Artery Bypass; Coronary Disease; Female; Humans; Is | 2002 |
Effect of antioxidant probucol for preventing stent restenosis.
Topics: Aged; Antioxidants; Aspirin; Blood Vessel Prosthesis Implantation; Coronary Angiography; Coronary Ar | 2002 |
A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary artery stents.
Topics: Aged; Aspirin; Blood Vessel Prosthesis Implantation; Clopidogrel; Coronary Artery Disease; Drug Ther | 2003 |
Effect of site of venous protamine administration, previously alleged risk factors, and preoperative use of aspirin on acute protamine-induced pulmonary vasoconstriction.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Aspirin; Cardiopulmonary Bypass; Constriction, Pathol | 2003 |
Frequency of stent thrombosis after acute coronary syndromes (from the SYMPHONY and 2nd SYMPHONY trials).
Topics: Acute Disease; Aspirin; Causality; Coronary Disease; Coronary Thrombosis; Female; Humans; Incidence; | 2003 |
Coronary intervention with a heparin-coated stent and aspirin only.
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Asia; Aspirin; Blood Vessel Prosthesis Implantation; Co | 2003 |
Risk factors for clinically relevant pulmonary embolism and deep venous thrombosis in patients undergoing primary hip or knee arthroplasty.
Topics: Aged; Anesthesia; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; A | 2003 |
Dextran-related complications in head and neck microsurgery: do the benefits outweigh the risks? A prospective randomized analysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Child; Dextrans; Female; Head a | 2003 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; | 2004 |
Beneficial effects of clopidogrel combined with aspirin in reducing cerebral emboli in patients undergoing carotid endarterectomy.
Topics: Aged; Aged, 80 and over; Aspirin; Clopidogrel; Disease Progression; Drug Therapy, Combination; Endar | 2004 |
Comparing warfarin with aspirin after biological aortic valve replacement: a prospective study.
Topics: Aged; Anticoagulants; Aspirin; Bioprosthesis; Brain Ischemia; Disease-Free Survival; Female; Heart V | 2004 |
Comparing warfarin with aspirin after biological aortic valve replacement: a prospective study.
Topics: Aged; Anticoagulants; Aspirin; Bioprosthesis; Brain Ischemia; Disease-Free Survival; Female; Heart V | 2004 |
Comparing warfarin with aspirin after biological aortic valve replacement: a prospective study.
Topics: Aged; Anticoagulants; Aspirin; Bioprosthesis; Brain Ischemia; Disease-Free Survival; Female; Heart V | 2004 |
Comparing warfarin with aspirin after biological aortic valve replacement: a prospective study.
Topics: Aged; Anticoagulants; Aspirin; Bioprosthesis; Brain Ischemia; Disease-Free Survival; Female; Heart V | 2004 |
Comparing warfarin with aspirin after biological aortic valve replacement: a prospective study.
Topics: Aged; Anticoagulants; Aspirin; Bioprosthesis; Brain Ischemia; Disease-Free Survival; Female; Heart V | 2004 |
Comparing warfarin with aspirin after biological aortic valve replacement: a prospective study.
Topics: Aged; Anticoagulants; Aspirin; Bioprosthesis; Brain Ischemia; Disease-Free Survival; Female; Heart V | 2004 |
Comparing warfarin with aspirin after biological aortic valve replacement: a prospective study.
Topics: Aged; Anticoagulants; Aspirin; Bioprosthesis; Brain Ischemia; Disease-Free Survival; Female; Heart V | 2004 |
Comparing warfarin with aspirin after biological aortic valve replacement: a prospective study.
Topics: Aged; Anticoagulants; Aspirin; Bioprosthesis; Brain Ischemia; Disease-Free Survival; Female; Heart V | 2004 |
Comparing warfarin with aspirin after biological aortic valve replacement: a prospective study.
Topics: Aged; Anticoagulants; Aspirin; Bioprosthesis; Brain Ischemia; Disease-Free Survival; Female; Heart V | 2004 |
Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin.
Topics: Anticoagulants; Arterial Occlusive Diseases; Aspirin; Atrial Fibrillation; Blood Loss, Surgical; Coh | 2004 |
Magnetic Vascular Port in minimally invasive direct coronary artery bypass grafting.
Topics: Aged; Aspirin; Clopidogrel; Comorbidity; Coronary Angiography; Drug Therapy, Combination; Equipment | 2004 |
What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention?: a meta-analysis.
Topics: Aged; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Aspirin; Blood Vessel Prost | 2005 |
Aprotinin shows both hemostatic and antithrombotic effects during off-pump coronary artery bypass grafting.
Topics: Aprotinin; Aspirin; Biomarkers; Blood Coagulation Tests; Blood Loss, Surgical; Coronary Artery Bypas | 2006 |
Biological efficacy of low against medium dose aspirin regimen after coronary surgery: analysis of platelet function.
Topics: Adenosine Diphosphate; Administration, Oral; Adult; Aged; Aspirin; Blood Platelets; Collagen; Corona | 2006 |
Mechanical calf compression and aspirin prophylaxis for total knee arthroplasty.
Topics: Adult; Aged; Aged, 80 and over; Arthroplasty, Replacement, Knee; Aspirin; Combined Modality Therapy; | 2007 |
Therapeutic benefit of low-dose clopidogrel in patients undergoing carotid surgery is linked to variability in the platelet adenosine diphosphate response and patients' weight.
Topics: Adenosine Diphosphate; Aspirin; Blood Platelets; Body Weight; Clopidogrel; Endarterectomy, Carotid; | 2007 |
Dabigatran versus enoxaparin after total hip replacement.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthroplasty, Replacement, Hip; Aspirin; Hematoma, Subdural | 2007 |
Thromboembolism after hip surgery.
Topics: Aspirin; Clinical Trials as Topic; Dextrans; Dihydroergotamine; Dipyridamole; Drug Therapy, Combinat | 1981 |
[Thromboembolism prophylaxis in general surgery. Comparative study of complications from acetylsalicylic acid, heparin as well as the combination of acetylsalicylic acid with heparin and dextran].
Topics: Adult; Aged; Aspirin; Dextrans; Drug Therapy, Combination; Heparin; Humans; Middle Aged; Postoperati | 1981 |
Effect of prostaglandin-mediated platelet-suppressant drugs on acute cardiovascular catastrophes.
Topics: Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Artery Bypas | 1982 |
Platelets and platelet-inhibitor drugs in aortocoronary vein bypass operations.
Topics: Anticoagulants; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Artery Bypass; Coronary | 1983 |
Aspirin-sulfinpyrazone in prophylaxis of deep venous thrombosis in total hip replacement.
Topics: Adult; Aged; Aspirin; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Fema | 1983 |
Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations.
Topics: Adult; Aged; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Artery Bypass; Dipyridamol | 1984 |
The effects of acetylsalicylic acid on swelling, pain and other events after surgery.
Topics: Adolescent; Adult; Aspirin; Body Temperature; Clinical Trials as Topic; Double-Blind Method; Edema; | 1984 |
[Low-dose acetylsalicylic acid (100 mg/day) following aortocoronary bypass operation].
Topics: Aspirin; Clinical Trials as Topic; Coronary Angiography; Coronary Artery Bypass; Coronary Circulatio | 1984 |
Dipyridamole: a critical evaluation.
Topics: Angina Pectoris; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Coro | 1984 |
Variation in the use of angiography and carotid endarterectomy by neurologists in the UK-TIA aspirin trial.
Topics: Aged; Angiography; Aspirin; Carotid Arteries; Cerebrovascular Disorders; Clinical Trials as Topic; E | 1983 |
Does 111indium-platelet deposition predict patency in prosthetic arterial grafts?
Topics: Aspirin; Blood Platelets; Blood Vessel Prosthesis; Dipyridamole; Double-Blind Method; Drug Combinati | 1983 |
Prevention of post-operative thrombosis in peripheral arteriopathies. Pentoxifylline vs. conventional antiaggregants: a six-month randomized follow-up study.
Topics: Aged; Aspirin; Dipyridamole; Drug Tolerance; Female; Follow-Up Studies; Humans; Male; Middle Aged; P | 1984 |
[Anti-edematous pharmacotherapy in ambulatory oral surgery].
Topics: Adolescent; Adult; Ascorbic Acid; Aspirin; Edema; Humans; Mouth; Phenylbutazone; Postoperative Compl | 1984 |
Platelet inhibitory drugs: an in vivo method of evaluation in patients.
Topics: Aorta, Abdominal; Aspirin; Blood Vessel Prosthesis; Clinical Trials as Topic; Dipyridamole; Double-B | 1982 |
Prevention of venous thromboembolism after total knee replacement by high-dose aspirin or intermittent calf and thigh compression.
Topics: Adult; Age Factors; Aged; Aspirin; Blood Coagulation Tests; Clinical Trials as Topic; Drug Administr | 1980 |
Low-dose heparin: an aid to therapy.
Topics: Aspirin; Clinical Trials as Topic; Dihydroergotamine; Double-Blind Method; Electric Stimulation; Hem | 1980 |
Influence of aspirin and dipyridamole on patency of coronary artery bypass grafts.
Topics: Aspirin; Clinical Trials as Topic; Coronary Artery Bypass; Dipyridamole; Drug Therapy, Combination; | 1981 |
[The antithrombotic effect of dipyridamole and acetylsalicylic acid. A prospective clinical examination].
Topics: Aspirin; Clinical Trials as Topic; Dipyridamole; Drug Therapy, Combination; Humans; Postoperative Co | 1981 |
A platelet-inhibitor-drug trial in coronary-artery bypass operations: benefit of perioperative dipyridamole and aspirin therapy on early postoperative vein-graft patency.
Topics: Adult; Aged; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Artery Bypass; Dipyridamol | 1982 |
High and low-dose aspirin prophylaxis against venous thromboembolic disease in total hip replacement.
Topics: Adult; Aspirin; Bleeding Time; Double-Blind Method; Female; Hip Prosthesis; Humans; Male; Postoperat | 1982 |
Aprotinin significantly decreases bleeding and transfusion requirements in patients receiving aspirin and undergoing cardiac operations.
Topics: Aged; Aprotinin; Aspirin; Blood Loss, Surgical; Blood Transfusion; Blood Volume; Cardiac Surgical Pr | 1994 |
Two-pronged antiplatelet therapy with aspirin and ticlopidine without systemic anticoagulation: an alternative therapeutic strategy after bailout stent implantation.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Coronary Disease; Drug Therapy, Combination; Female; | 1995 |
Platelet count, antiplatelet therapy and pulmonary embolism--a prospective study in patients with hip surgery.
Topics: Aged; Aged, 80 and over; Aspirin; Double-Blind Method; Drug Therapy, Combination; Female; Hemorrhage | 1995 |
Low-molecular weight heparin versus aspirin and dipyridamole after femoropopliteal bypass grafting.
Topics: Adult; Aged; Aspirin; Dipyridamole; Drug Therapy, Combination; Female; Femoral Artery; Graft Occlusi | 1994 |
Comparison of anticoagulation regimens after Carpentier-Edwards aortic or mitral valve replacement.
Topics: Aortic Valve; Aspirin; Atrial Fibrillation; Bioprosthesis; Female; Follow-Up Studies; Heart Valve Pr | 1994 |
Pre-operative aspirin decreases platelet aggregation and increases post-operative blood loss--a prospective, randomised, placebo controlled, double-blind clinical trial in 100 patients with chronic stable angina.
Topics: Aspirin; Blood Coagulation Tests; Blood Loss, Surgical; Blood Transfusion; Coronary Artery Bypass; C | 1994 |
Effect of various antithrombotic regimens (aspirin, aspirin plus dipyridamole, anticoagulants) on the functional status of patients and grafts one year after coronary artery bypass grafting.
Topics: Acenocoumarol; Adult; Aged; Anticoagulants; Aspirin; Coronary Artery Bypass; Coronary Circulation; C | 1994 |
Acetylsalicylic acid in the prevention of early stenosis and occlusion of transjugular intrahepatic portal-systemic stent shunts: a controlled study.
Topics: Aged; Aspirin; Constriction, Pathologic; Female; Follow-Up Studies; Humans; Liver; Liver Transplanta | 1994 |
4. Current status of operative treatment for asymptomatic carotid stenosis.
Topics: Aspirin; Carotid Stenosis; Cerebrovascular Disorders; Combined Modality Therapy; Endarterectomy, Car | 1994 |
Use of desmopressin to prevent bleeding complications in patients treated with aspirin.
Topics: Adult; Aged; Aspirin; Bleeding Time; Cholecystectomy; Deamino Arginine Vasopressin; Female; Hemorrha | 1993 |
Does low-dose acetylsalicylic acid prevent stroke after carotid surgery? A double-blind, placebo-controlled randomized trial.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Cerebrovascular Disorders; Dose-Response Relationship, Drug | 1993 |
Can recurrent stenosis after carotid endarterectomy be prevented by low-dose acetylsalicylic acid? A double-blind, randomised and placebo-controlled study.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Carotid Artery, Internal; Carotid Stenosis; Dose-Response R | 1993 |
Thromboembolism after THR: prophylaxis and treatment.
Topics: Adult; Aged; Anesthesia, Epidural; Anesthesia, General; Aspirin; Bandages; Blood Loss, Surgical; Fem | 1995 |
Aspirin and warfarin for thromboembolic disease after total joint arthroplasty.
Topics: Aged; Anticoagulants; Aspirin; Female; Humans; Joint Prosthesis; Male; Platelet Aggregation Inhibito | 1996 |
A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents.
Topics: Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Coronary Disease; Drug Therapy, Combi | 1996 |
A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents.
Topics: Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Coronary Disease; Drug Therapy, Combi | 1996 |
A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents.
Topics: Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Coronary Disease; Drug Therapy, Combi | 1996 |
A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents.
Topics: Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Coronary Disease; Drug Therapy, Combi | 1996 |
Low-molecular-weight heparinoid orgaran is more effective than aspirin in the prevention of venous thromboembolism after surgery for hip fracture.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Chondroitin Sulfates; | 1996 |
Complications of cutaneous surgery in patients who are taking warfarin, aspirin, or nonsteroidal anti-inflammatory drugs.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dermat | 1996 |
Prophylaxis of deep venous thrombosis after total hip arthroplasty by using intermittent compression of the plantar venous plexus.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Combined Modality Therapy; Foot; Heparin; H | 1996 |
Prophylaxis against deep venous thrombosis after total knee arthroplasty. Pneumatic plantar compression and aspirin compared with aspirin alone.
Topics: Arthritis, Rheumatoid; Aspirin; Bandages; Combined Modality Therapy; Female; Foot; Humans; Joint Pro | 1996 |
Acetylsalicylic acid may protect the patient by increasing fibrin gel porosity. Is withdrawing of treatment harmful to the patient?
Topics: Adult; Aged; Analysis of Variance; Angina Pectoris; Aspirin; Coronary Artery Bypass; Coronary Diseas | 1996 |
Reactive thrombocytosis following coronary artery bypass surgery: a possible link to a lipid dysfunction.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Coronary Artery Bypass; Female; Humans; Male; Middle Aged; | 1996 |
An analysis of perioperative surgical mortality and morbidity in the asymptomatic carotid atherosclerosis study. ACAS Investigators. Asymptomatic Carotid Atherosclerosis Study.
Topics: Anesthesia; Arteriosclerosis; Aspirin; Carotid Stenosis; Cerebral Infarction; Combined Modality Ther | 1996 |
Results of a consecutive series of patients receiving only antiplatelet therapy after optimized stent implantation. Comparison of aspirin alone versus combined ticlopidine and aspirin therapy.
Topics: Angioplasty, Balloon; Aspirin; Coronary Angiography; Coronary Disease; Drug Therapy, Combination; Eq | 1997 |
Major benefit from antiplatelet therapy for patients at high risk for adverse cardiac events after coronary Palmaz-Schatz stent placement: analysis of a prospective risk stratification protocol in the Intracoronary Stenting and Antithrombotic Regimen (ISA
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Cardiovascular Diseases; Combined Modality | 1997 |
The elongation of the internal carotid artery: early and long-term results of patients having surgery compared with unoperated controls.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Carotid Artery Diseases; Carotid Artery, Internal; Cerebrov | 1997 |
Prevention of heterotopic ossification after total hip replacement. A prospective, randomised study using acetylsalicylic acid, indomethacin and fractional or single-dose irradiation.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Female; Hip Prosthesis; Humans; Indomethacin | 1997 |
[Heterotopic ossifications].
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthrography; Arthroplasty, Replacement, Hip; Aspirin | 1997 |
PAMI (Primary Angioplasty in Myocardial Infarction) Stent Pilot Trial.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Drug Therapy, Combination; Follow-Up Studies; Humans; Myoca | 1998 |
Prophylaxis for deep vein thrombosis with aspirin or low molecular weight dextran in Korean patients undergoing total hip replacement. A randomized controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Hip; Aspirin; Dextrans; F | 1998 |
Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade.
Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Aspirin; Coronary Disease; Corona | 1998 |
Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade.
Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Aspirin; Coronary Disease; Corona | 1998 |
Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade.
Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Aspirin; Coronary Disease; Corona | 1998 |
Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade.
Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Aspirin; Coronary Disease; Corona | 1998 |
Warfarin improves the outcome of infrainguinal vein bypass grafting at high risk for failure.
Topics: Aged; Anticoagulants; Arteries; Aspirin; Female; Hematoma; Heparin; Humans; Inguinal Canal; Leg; Mal | 1998 |
Reduction of recurrent ischemia with abciximab during continuous ECG-ischemia monitoring in patients with unstable angina refractory to standard treatment (CAPTURE).
Topics: Abciximab; Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Aspirin; | 1998 |
S-nitrosoglutathione reduces the rate of embolization in humans.
Topics: Aged; Anticoagulants; Aspirin; Carotid Stenosis; Endarterectomy, Carotid; Female; Glutathione; Hepar | 1998 |
The trapidil restenosis trial (STARC study): background, methods and clinical characteristics of the patient population.
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Aspirin; Clinical Protocols; Cohort Studies; Coronary D | 1994 |
Strategy for balancing anticoagulation and hemostasis in aortocoronary bypass surgery: blood conservation and graft patency.
Topics: Adult; Anticoagulants; Aprotinin; Aspirin; Coronary Artery Bypass; Drug Administration Schedule; Hem | 1999 |
Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin in preventing stent thrombosis after coronary stent implantation.
Topics: Aged; Aspirin; Clopidogrel; Coronary Angiography; Coronary Disease; Coronary Thrombosis; Diarrhea; D | 1999 |
Is carotid endarterectomy cost-effective in symptomatic patients with moderate (50% to 69%) stenosis?
Topics: Aged; Aspirin; Carotid Stenosis; Cohort Studies; Cost-Benefit Analysis; Decision Support Techniques; | 1999 |
Results after lens extraction in patients with diabetic retinopathy: early treatment diabetic retinopathy study report number 25.
Topics: Aspirin; Cataract; Cataract Extraction; Diabetic Retinopathy; Disease Progression; Female; Humans; L | 1999 |
A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary-artery stents.
Topics: Aged; Aspirin; Clopidogrel; Coronary Thrombosis; Coronary Vessels; Drug Therapy, Combination; Female | 2000 |
Does low-dose aspirin therapy complicate oral surgical procedures?
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Loss, Surgical; Female; Humans; | 2000 |
Place of aspirin in prophylaxis of venous thromboembolism.
Topics: Arthroplasty, Replacement, Hip; Aspirin; Dose-Response Relationship, Drug; Hip Fractures; Humans; Pl | 2000 |
Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial.
Topics: Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Aspirin; Cause of Death; Dose-Response Rela | 2000 |
Antithrombotic effects of aspirin after renal transplantation.
Topics: Aspirin; Cadaver; Graft Rejection; Humans; Kidney Transplantation; Platelet Aggregation Inhibitors; | 2000 |
[The drug prevention of postoperative thromboses in patients with critical lower limb ischemia].
Topics: Anticoagulants; Aspirin; Critical Illness; Humans; Ischemia; Leg; Nadroparin; Platelet Aggregation I | 1999 |
Effect of coumarins started before coronary angioplasty on acute complications and long-term follow-up: a randomized trial.
Topics: Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Coronary Disease; Coumarins; Female; | 2000 |
Effect of preoperative aspirin use on mortality in coronary artery bypass grafting patients.
Topics: Aged; Aspirin; Case-Control Studies; Cause of Death; Coronary Artery Bypass; Female; Humans; Male; M | 2000 |
Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery.
Topics: Aspirin; Cardiac Surgical Procedures; Clopidogrel; Double-Blind Method; Female; Hospitalization; Hum | 2001 |
Oral anticoagulant therapy during and after coronary angioplasty the intensity and duration of anticoagulation are essential to reduce thrombotic complications.
Topics: Administration, Oral; Aneurysm, False; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Cere | 2001 |
The hemostatic effects of warfarin titration in post CABG patients in comparison to placebo treatment.
Topics: Adult; Aged; Anticoagulants; Aspirin; Coronary Artery Bypass; Coronary Disease; Dose-Response Relati | 2001 |
Cost-effectiveness of oral anticoagulants versus aspirin in patients after infrainguinal bypass grafting surgery.
Topics: Aged; Anticoagulants; Aspirin; Cost-Benefit Analysis; Female; Fibrinolytic Agents; Humans; Leg; Male | 2001 |
Abciximab readministration: results of the ReoPro Readministration Registry.
Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies; Antibodies, Monoclonal; Aspirin; Coronary Dis | 2001 |
Aspirin alone antiplatelet regimen after intracoronary placement of the Carbostent: the ANTARES study.
Topics: Adult; Aged; Arterial Occlusive Diseases; Aspirin; Blood Vessel Prosthesis Implantation; Carbon; Coa | 2002 |
Benefits, morbidity, and mortality associated with long-term administration of oral anticoagulant therapy to patients with peripheral arterial bypass procedures: a prospective randomized study.
Topics: Administration, Oral; Aged; Anticoagulants; Aspirin; Blood Vessel Prosthesis; Boston; Combined Modal | 2002 |
Does withholding aspirin for one week reduce the risk of post-sphincterotomy bleeding?
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Comorbidity; Female; Humans; Incidence; Male | 2002 |
Out of hospital antithrombotic prophylaxis after total hip replacement: low-molecular-weight heparin, warfarin, aspirin or nothing? A cost-effectiveness analysis.
Topics: Ambulatory Care; Anticoagulants; Arthroplasty, Replacement, Hip; Aspirin; Cost-Benefit Analysis; Dal | 2002 |
Prevention of thromboembolic disease after non-cemented hip arthroplasty. A multimodal approach.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthroplasty, Replacement, Hip; Aspirin; Combi | 2002 |
[Possibilities and limits of controlled clinical therapy studies for the demonstration of the effectiveness of antithrombotic therapy].
Topics: Adult; Anticoagulants; Aspirin; Clinical Trials as Topic; Dextrans; Dipyridamole; Dose-Response Rela | 1975 |
[Study of the platelet aggregation inhibitor MICRISTIN as to its efficacy in the prevention of thromboembolism in the postoperative phase following surgical interventions].
Topics: Adolescent; Adult; Aged; Aspirin; Clinical Trials as Topic; Humans; Middle Aged; Platelet Aggregatio | 1979 |
Prevention of postoperative thrombosis by aspirin.
Topics: Aspirin; Clinical Trials as Topic; Drug Evaluation; Hip Joint; Humans; Hydroxychloroquine; Joint Pro | 1977 |
Acetylsalicylic acid, low dose heparin, and a combination of both substances in the prevention of postoperative thromboembolism. A double blind study.
Topics: Aspirin; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Drug Thera | 1977 |
Aspirin prophylaxis of venous thromboembolism after total hip replacement.
Topics: Adult; Aspirin; Clinical Trials as Topic; Female; Fibrinogen; Hip Joint; Humans; Joint Prosthesis; M | 1977 |
Aspirin for prophylaxis of venous thromboembolism.
Topics: Aspirin; Clinical Trials as Topic; Female; Humans; Male; Postoperative Complications; Thromboembolis | 1978 |
Drug therapy: antiplatelet therapy (second of two parts).
Topics: Aged; Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical T | 1978 |
[Use of aspirin in patients with replaced mitral valve by a bioprosthesis].
Topics: Adolescent; Adult; Aged; Aspirin; Clinical Trials as Topic; Drug Evaluation; Female; Fibrinolytic Ag | 1978 |
Sex, aspirin, and venous thrombosis.
Topics: Aspirin; Clinical Trials as Topic; Double-Blind Method; Female; Hip; Humans; Joint Prosthesis; Leg; | 1978 |
Platelet inhibitors in the treatment of thrombosis.
Topics: Adult; Aged; Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Clinical Trials as Topic; Clof | 1978 |
Prophylaxis of thromboembolic disease.
Topics: Abdomen; Aspirin; Clinical Trials as Topic; Dextrans; Double-Blind Method; Early Ambulation; Hemorrh | 1979 |
[Prevention of postoperative thromboembolism with micristin in general surgical patients (author's transl)].
Topics: Aspirin; Crystallization; Dosage Forms; Drug Administration Schedule; Drug Evaluation; Humans; Posto | 1979 |
[Optimation of postoperative prophylaxis of thrombosis in gynaecology (author's transl)].
Topics: Adult; Aspirin; Dihydroergotamine; Drug Therapy, Combination; Female; Genital Diseases, Female; Hepa | 1978 |
[Heparin in the prevention of thromboembolism after elective hip-joint operations (author's transl)].
Topics: Aspirin; Female; Germany, West; Heparin; Hip Joint; Humans; Male; Middle Aged; Postoperative Complic | 1978 |
Prevention of postoperative deep vein thrombosis with dipyridamole and aspirin.
Topics: Adult; Aged; Aspirin; Clinical Trials as Topic; Dipyridamole; Female; Humans; Male; Middle Aged; Pla | 1976 |
Mechanism of action and clinical use of acetylsalicylic acid as a prophylactic agent against thrombosis.
Topics: Aspirin; Cardiac Surgical Procedures; Clinical Trials as Topic; Humans; Leg; Placebos; Platelet Aggr | 1975 |
[A randomized study on the prevention of postoperative thrombosis with acetylsalicylic acid].
Topics: Aspirin; Clinical Trials as Topic; Humans; Placebos; Postoperative Complications; Pulmonary Embolism | 1976 |
[THE German multicenter double blind study on the prevention of thrombosis with ASA].
Topics: Adult; Aspirin; Clinical Trials as Topic; Drug Evaluation; Female; Germany, West; Humans; Male; Midd | 1976 |
A clinical trial of pentazocine and aspirin following minor oral surgery.
Topics: Adult; Aspirin; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Male; Mouth; Pain; Pentaz | 1976 |
[Use of acetylsalicylic acid in the prevention of re-occlusion following revascularization interventions. Results of a double-blind long term study].
Topics: Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Double-Blind Method; Female; Follow-Up Studi | 1977 |
[Planning, realization, and biometric evaluation of a long term study with acetylsalicylic acid].
Topics: Aged; Arterial Occlusive Diseases; Aspirin; Biometry; Female; Follow-Up Studies; Humans; Male; Middl | 1977 |
[Low-dose heparin and acetyl-salicylic acid after elective operations on the hip joint (author's transl)].
Topics: Aged; Aspirin; Female; Heparin; Hip Joint; Humans; Joint Prosthesis; Male; Middle Aged; Postoperativ | 1977 |
[Quantitative assessment of drug-induced prophylaxis of postoperative thromboembolism. Comparison of frequencies of deep vein thrombosis and pulmonary embolism using acetylsalicylic-acid, dextran, dihydroergotamine, low-dose heparin and the fixed combinat
Topics: Adult; Aged; Aspirin; Dextrans; Dihydroergotamine; Drug Therapy, Combination; Female; Heparin; Human | 1977 |
[Double-blind study for the prevention of postoperative thrombosis].
Topics: Abdomen; Aspirin; Dipyridamole; Humans; Platelet Aggregation; Postoperative Complications; Thrombosi | 1976 |
[Thrombosis, embolism and aggregation inhibitors in surgery].
Topics: Aged; Anticoagulants; Aspirin; Dipyridamole; Female; Humans; Male; Platelet Aggregation; Postoperati | 1976 |
Low dose heparin in the prevention of venous thromboembolism. Rationale and results.
Topics: Acenocoumarol; Adult; Aspirin; Clinical Trials as Topic; Dextrans; Dipyridamole; Heparin; Hip; Human | 1975 |
The prevention of postoperative deep vein thrombosis.
Topics: Adult; Aspirin; Atmospheric Pressure; Clinical Trials as Topic; Dextrans; Electric Stimulation; Ethy | 1975 |
Acetylsalicylic acid in a trial to diminish thromboembolic complications after elective hip surgery.
Topics: Adult; Aged; Aspirin; Clinical Trials as Topic; Female; Hip; Humans; Male; Middle Aged; Osteoarthrit | 1975 |
The current status of platelet suppressive drugs in the treatment of thrombosis.
Topics: Aged; Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Cardiac Catheterization; Cell Surviva | 1975 |
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (third of three parts).
Topics: Anticoagulants; Aspirin; Clinical Trials as Topic; Clofibrate; Dipyridamole; Drug Evaluation; Fibrin | 1975 |
Proceedings: Failure of aspirin and dipyridamole to influence the incidence of leg scan detected venous thrombosis after elective hip surgery.
Topics: Aspirin; Clinical Trials as Topic; Dipyridamole; Hip; Humans; Leg; Postoperative Complications; Thro | 1975 |
The influence of aspirin on postoperative platelet kinetics and venous thrombosis.
Topics: Adult; Aged; Aspirin; Blood Cell Count; Blood Platelets; Cell Survival; Chromium Radioisotopes; Fema | 1975 |
Controlled trial of platelet anti-aggregating agents and subcutaneous heparin in prevention of postoperative deep vein thrombosis in high risk patients.
Topics: Aged; Aspirin; Blood Platelets; Dipyridamole; Female; Heparin; Humans; Injections, Subcutaneous; Mal | 1975 |
Aprotinin therapy for reoperative myocardial revascularization: a placebo-controlled study.
Topics: Aged; Aprotinin; Aspartate Aminotransferases; Aspirin; Blood Loss, Surgical; Blood Transfusion; Ches | 1992 |
Influence of prophylaxis on proximal venous thrombus formation after total hip arthroplasty.
Topics: Adult; Aspirin; Combined Modality Therapy; Dextrans; Female; Gravity Suits; Hemorrhage; Hip Prosthes | 1992 |
The effect of desmopressin acetate on postoperative hemorrhage in patients receiving aspirin therapy before coronary artery bypass operations.
Topics: Aged; Aspirin; Blood Coagulation Factors; Cardiopulmonary Bypass; Coronary Artery Bypass; Deamino Ar | 1992 |
Results of a randomized controlled trial of carotid endarterectomy for asymptomatic carotid stenosis. Mayo Asymptomatic Carotid Endarterectomy Study Group.
Topics: Aged; Aspirin; Carotid Stenosis; Cerebrovascular Disorders; Endarterectomy, Carotid; Female; Follow- | 1992 |
The role of dipyridamole in addition to low dose aspirin in the prevention of occlusion of coronary artery bypass grafts.
Topics: Aged; Aspirin; Cardiac Catheterization; Cineangiography; Coronary Artery Bypass; Dipyridamole; Drug | 1992 |
Aspirin halves pulmonary embolism.
Topics: Aspirin; Humans; Postoperative Complications; Pulmonary Embolism | 1991 |
[Prevention of thromboembolic disease and post-transfusional complications using normovolemic hemodilution in arthroplasty surgery of the hip].
Topics: Aged; Aspirin; Blood Transfusion, Autologous; Dextrans; Hemodilution; Heparin; Hip Prosthesis; Human | 1990 |
[Experiences with adjuvant prostaglandin therapy in vascular surgery interventions].
Topics: Alprostadil; Arteriovenous Shunt, Surgical; Aspirin; Graft Occlusion, Vascular; Heparin; Humans; Isc | 1991 |
An evaluation of clinical aspects of post-operative autotransfusion, either alone or in conjunction with pre-operative aspirin, in cardiac surgery.
Topics: Aspirin; Blood Transfusion, Autologous; Coronary Artery Bypass; Hemorrhage; Hemostasis, Surgical; Hu | 1991 |
PTFE or HUV for femoro-popliteal bypass: a multi-centre trial.
Topics: Arterial Occlusive Diseases; Aspirin; Bioprosthesis; Blood Vessel Prosthesis; Combined Modality Ther | 1991 |
Antiplatelet drugs in femoropopliteal vein bypasses: a multicenter trial.
Topics: Aspirin; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Femoral Artery; Follow-Up Stu | 1991 |
Immediate postoperative aspirin improves vein graft patency early and late after coronary artery bypass graft surgery. A placebo-controlled, randomized study.
Topics: Angiography; Aspirin; Blood Transfusion; Coronary Artery Bypass; Graft Occlusion, Vascular; Hemorrha | 1991 |
[Acetylsalicylic acid after iliac-femoro-popliteal interventions?].
Topics: Arterial Occlusive Diseases; Aspirin; Combined Modality Therapy; Femoral Artery; Humans; Iliac Arter | 1991 |
[Synthetic vascular reconstructions in the pelvis: function and survival].
Topics: Aortic Diseases; Arterial Occlusive Diseases; Aspirin; Blood Vessel Prosthesis; Combined Modality Th | 1990 |
[Prevention of thromboembolism in para-articular femoral fractures of the hip--results of a prospective randomized study of heparin-DHE and ASS-DHE].
Topics: Aged; Aged, 80 and over; Aspirin; Bone Screws; Cause of Death; Dihydroergotamine; Drug Combinations; | 1990 |
Effect of dipyridamole (Persantin) on blood flow and patency of aortocoronary vein bypass grafts.
Topics: Aspirin; Blood Flow Velocity; Coronary Artery Bypass; Dipyridamole; Female; Humans; Male; Middle Age | 1990 |
Pneumatic sequential-compression boots compared with aspirin prophylaxis of deep-vein thrombosis after total knee arthroplasty.
Topics: Aged; Aspirin; Bandages; Female; Humans; Knee Joint; Knee Prosthesis; Male; Postoperative Complicati | 1990 |
[Prevention of deep venous thrombosis in hip surgery].
Topics: Aged; Aspirin; Dextrans; Dose-Response Relationship, Drug; Early Ambulation; Hemodilution; Heparin; | 1986 |
Prevention of venous thromboembolism in general surgical patients. Results of meta-analysis.
Topics: Adult; Aspirin; Clinical Trials as Topic; Clothing; Dextrans; Dihydroergotamine; Drug Combinations; | 1988 |
Trial of low-dose aspirin plus dipyridamole versus anticoagulants for prevention of aortocoronary vein graft occlusion.
Topics: 4-Hydroxycoumarins; Adult; Aged; Aspirin; Clinical Trials as Topic; Coronary Artery Bypass; Coronary | 1989 |
Prophylaxis of deep-vein thrombosis after total hip replacement. Dextran and external pneumatic compression compared with 1.2 or 0.3 gram of aspirin daily.
Topics: Aspirin; Clinical Trials as Topic; Dextrans; Female; Hip Prosthesis; Humans; Male; Methods; Postoper | 1985 |
Dextran/aspirin versus heparin/dihydroergotamine in preventing thrombosis after hip fractures.
Topics: Aged; Aspirin; Clinical Trials as Topic; Dextrans; Dihydroergotamine; Double-Blind Method; Drug Ther | 1985 |
A randomized trial of less intense postoperative warfarin or aspirin therapy in the prevention of venous thromboembolism after surgery for fractured hip.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Clinical Trials as Topic; Female; Follow-Up Studies; Hemorr | 1989 |
Prevention of deep venous thrombosis in orthopedic surgery: effects of defibrotide.
Topics: Aged; Aspirin; Female; Fibrinolytic Agents; Heparin; Hip Joint; Humans; Male; Orthopedics; Polydeoxy | 1988 |
Effect of pre-treatment with lysine acetyl salicylate on suxamethonium-induced myalgia.
Topics: Adult; Analgesics; Aspirin; Double-Blind Method; Fasciculation; Female; Humans; Lysine; Muscular Dis | 1987 |
Preoperative aspirin ingestion increases operative blood loss after coronary artery bypass grafting.
Topics: Aged; Aspirin; Blood Transfusion; Coronary Artery Bypass; Female; Hemorrhage; Humans; Male; Middle A | 1988 |
Relief of pain and trismus in patients treated with naproxen or acetylsalicylic acid after tonsillectomy.
Topics: Adolescent; Adult; Aspirin; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Mid | 1988 |
Carotid endarterectomy--a crisis in confidence.
Topics: Aspirin; Carotid Arteries; Cerebrovascular Disorders; Clinical Trials as Topic; Endarterectomy; Huma | 1988 |
Hemorheology in surgery--a review.
Topics: Adult; Age Factors; Aged; Anesthesia, General; Animals; Aspirin; Blood; Blood Coagulation; Blood Phy | 1987 |
Prevention of thromboembolism in total hip replacement. Aspirin versus dihydroergotamine-heparin.
Topics: Aspirin; Clinical Trials as Topic; Dihydroergotamine; Drug Combinations; Drug Therapy, Combination; | 1987 |
Dipyridamole preserved platelets and reduced blood loss after cardiopulmonary bypass.
Topics: Administration, Oral; Aspirin; Blood Platelets; Blood Transfusion; Cardiopulmonary Bypass; Dipyridam | 1988 |
[A combination of dihydroergotamine and acetylsalicylic acid--prevention of postoperative thromboembolic complications. Clinical study in orthopedics].
Topics: Acenocoumarol; Adult; Aged; Aspirin; Dihydroergotamine; Drug Evaluation; Drug Therapy, Combination; | 1987 |
Failure of combined acetylsalicylic acid and dipyridamole to prevent occlusion of aortocoronary venous bypass graft.
Topics: Aspirin; Coronary Angiography; Coronary Artery Bypass; Dipyridamole; Drug Combinations; Graft Occlus | 1987 |
Clinical trials evaluating platelet-modifying drugs in patients with atherosclerotic cardiovascular disease and thrombosis.
Topics: Anticoagulants; Aspirin; Blood Platelets; Blood Vessel Prosthesis; Cardiovascular Diseases; Clinical | 1986 |
Role of platelets and platelet inhibitors in aortocoronary artery vein-graft disease.
Topics: Animals; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Artery Bypass; Dipyridamole; D | 1986 |
Effectiveness of anticoagulants.
Topics: Administration, Oral; Adult; Aged; Angina Pectoris; Angina, Unstable; Anticoagulants; Aspirin; Blood | 1986 |
Warfarin versus dipyridamole-aspirin and pentoxifylline-aspirin for the prevention of prosthetic heart valve thromboembolism: a prospective randomized clinical trial.
Topics: Adult; Aspirin; Clinical Trials as Topic; Dipyridamole; Drug Combinations; Female; Heart Valve Prost | 1985 |
A prospective randomized trial of aspirin in femoral popliteal and tibial bypass grafts.
Topics: Adult; Aged; Aneurysm; Aspirin; Blood Vessel Prosthesis; Clinical Trials as Topic; Female; Femur; Gr | 1985 |
Effect of perioperative platelet inhibition on postcarotid endarterectomy mural thrombus formation. Results of a prospective randomized controlled trial using aspirin and dipyridamole in humans.
Topics: Aged; Aspirin; Blood Platelets; Carotid Arteries; Carotid Artery Diseases; Cerebrovascular Disorders | 1985 |
Effect of aspirin on postoperative venous thrombosis. Report of the Steering Committee of a trial sponsored by the Medical Research Council.
Topics: Adult; Age Factors; Aspirin; Blood Group Antigens; Blood Platelets; Clinical Trials as Topic; Female | 1972 |
Aspirin and postoperative venous thrombosis.
Topics: Aspirin; Clinical Trials as Topic; Humans; Postoperative Complications; Thrombophlebitis | 1972 |
Penicillin control of swelling and pain after periodontal osseous surgery.
Topics: Administration, Oral; Adult; Alveoloplasty; Aspirin; Female; Humans; Inflammation; Male; Middle Aged | 1974 |
[Prevention of thromboembolism using acetylsalicylic acid in the surgery of hip-joint proximal fractures].
Topics: Adult; Aged; Aspirin; Clinical Trials as Topic; Female; Femoral Fractures; Femoral Neck Fractures; H | 1974 |
[Thromboembolic complications following total hip prosthesis. Study of 478 cases of relative efficacy of 3 preventive methods].
Topics: Anticoagulants; Aspirin; Clinical Trials as Topic; Dextrans; Drug Evaluation; Drug Therapy, Combinat | 1974 |
Effect of aspirin on postoperative platelet kinetics and venous thrombosis.
Topics: Aged; Aspirin; Blood Cell Count; Blood Platelets; Cell Movement; Chromium Radioisotopes; Humans; Iod | 1974 |
Prevention of p.o. clotting of av. cimino fistulae with acetylsalicyl acid. Results of a prospective double blind study.
Topics: Arteriovenous Shunt, Surgical; Aspirin; Blood Coagulation; Clinical Trials as Topic; Female; Humans; | 1974 |
Review of present status of prophylaxis of venous thromboembolism.
Topics: Adult; Aspirin; Clinical Trials as Topic; Dextrans; Dipyridamole; Fibrinolysis; Heparin; Humans; Phy | 1974 |
[Clinical aspects of postoperative embolism prevention using acetylsalicylic acid].
Topics: Adult; Aspirin; Embolism; Female; Hemorrhage; Humans; Middle Aged; Postoperative Complications | 1973 |
[Effect of acteylsalicylic acid on early results following percutaneous recanalisation of arterial occlusions (Dotter's method)].
Topics: Arterial Occlusive Diseases; Aspirin; Endarterectomy; Evaluation Studies as Topic; Femoral Artery; F | 1973 |
Trial of aspirin and RA 233 in prevention of post-operative deep vein thrombosis.
Topics: Aspirin; Dipyridamole; Femoral Neck Fractures; Fibrinogen; Humans; Iodine Radioisotopes; Placebos; P | 1973 |
Platelet function studies before and after operation and the effect of postoperative thrombosis.
Topics: Adenosine Diphosphate; Adult; Aged; Aspirin; Blood Cell Count; Blood Platelets; Chromatography; Coll | 1974 |
[A model for studying the antithrombotic effect of acetylsalicylic acid in the prevention of postoperative thrombo-embolism (author's transl)].
Topics: Age Factors; Anticoagulants; Aspirin; Blood Coagulation Disorders; Body Weight; Female; Humans; Male | 1974 |
[Prevention of postoperative thrombo-embolism with acetylsalicyclic acid (author's transl)].
Topics: Age Factors; Angina Pectoris; Aspirin; Body Weight; Diabetes Complications; Female; Follow-Up Studie | 1974 |
Post-operative pain in the assessment of analgesics in man.
Topics: Analgesics; Aspirin; Clinical Trials as Topic; Humans; Meperidine; Pain; Postoperative Complications | 1969 |
An attempt to evaluate a rapidly acting oral analgesic.
Topics: Adult; Analgesia; Aspirin; Buffers; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Pla | 1969 |
Prevention of postoperative venous thrombosis.
Topics: Aspirin; Clinical Trials as Topic; Heparin; Hip; Humans; Postoperative Complications; Thromboembolis | 1971 |
Fiorinal with codeine as a postoperative analgesic in dental surgery.
Topics: Adolescent; Adult; Anesthesia, Dental; Aspirin; Barbiturates; Caffeine; Child; Clinical Trials as To | 1971 |
Reduction in venous thromboembolism by agents affecting platelet function.
Topics: Adult; Aged; Arthroplasty; Aspirin; Blood Platelets; Chromium Alloys; Dextrans; Dipyridamole; Female | 1971 |
685 other studies available for aspirin and Complication, Postoperative
| Article | Year |
|---|---|
In-hospital Bleeding Outcomes of Oral Anticoagulant and Dual Antiplatelet Therapy During Percutaneous Coronary Intervention: An Analysis From the Japanese Nationwide Registry.
Topics: Aged; Aspirin; Clopidogrel; Coronary Artery Disease; Coronary Restenosis; Dual Anti-Platelet Therapy | 2021 |
Continuing acetylsalicylic acid during Robotic-Assisted Radical Cystectomy with intracorporeal urinary diversion does not increase hemorrhagic complications: results from a large multicentric cohort.
Topics: Aspirin; Cystectomy; Female; Humans; Male; Platelet Aggregation Inhibitors; Postoperative Complicati | 2022 |
Patients Who Do Not Receive Aspirin Because of Allergy Have an Increased Risk of Venous Thromboembolism Following Total Joint Arthroplasty.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Arthroplasty, Replacement; Asp | 2022 |
Revascularisation for Symptomatic Peripheral Artery Disease: External Applicability of the VOYAGER PAD Trial.
Topics: Aged; Aspirin; Clinical Trials, Phase III as Topic; Denmark; Dose-Response Relationship, Drug; Drug | 2022 |
Impact of aspirin discontinuation on thrombotic complications in laparoscopic colorectal cancer surgery.
Topics: Aspirin; Colorectal Neoplasms; Humans; Laparoscopy; Platelet Aggregation Inhibitors; Postoperative C | 2022 |
Aspirin, heparin and ischemia time in microvascular free flap surgery - their influence and an optimal anticoagulation protocol.
Topics: Anticoagulants; Aspirin; Free Tissue Flaps; Heparin; Humans; Ischemia; Postoperative Complications | 2022 |
Patient-specific prescription of aspirin after total joint replacement: a case control study with propensity score matching.
Topics: Anticoagulants; Arthroplasty, Replacement; Arthroplasty, Replacement, Hip; Aspirin; Case-Control Stu | 2022 |
Aspirin May Be a Suitable Prophylaxis for Patients with a History of Venous Thromboembolism Undergoing Total Joint Arthroplasty.
Topics: Anticoagulants; Arthroplasty; Arthroplasty, Replacement, Hip; Aspirin; Humans; Postoperative Complic | 2022 |
Postoperative Acute Kidney Injury With Dual NSAID Use After Outpatient Primary Total Joint Arthroplasty.
Topics: Acute Kidney Injury; Anti-Inflammatory Agents, Non-Steroidal; Arthroplasty, Replacement, Hip; Aspiri | 2022 |
Cost-Effective Modeling of Thromboembolic Chemoprophylaxis for Total Ankle Arthroplasty.
Topics: Ankle; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Che | 2022 |
Mortality and incidence of cardiovascular events in patients treated with aspirin and statins at one year after myocardial injury in noncardiac surgery: a prospective observational study.
Topics: Aspirin; Cohort Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Myocardi | 2023 |
Aspirin vs Enoxaparin and Symptomatic Venous Thromboembolism in Hip or Knee Arthroplasty-Reply.
Topics: Anticoagulants; Arthroplasty, Replacement; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement | 2023 |
Aspirin vs Enoxaparin and Symptomatic Venous Thromboembolism in Hip or Knee Arthroplasty.
Topics: Anticoagulants; Arthroplasty, Replacement; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement | 2023 |
Aspirin vs Enoxaparin and Symptomatic Venous Thromboembolism in Hip or Knee Arthroplasty.
Topics: Anticoagulants; Arthroplasty, Replacement; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement | 2023 |
Aspirin vs Enoxaparin and Symptomatic Venous Thromboembolism in Hip or Knee Arthroplasty.
Topics: Anticoagulants; Arthroplasty, Replacement; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement | 2023 |
Trends of Venous Thromboembolism After Total Hip Arthroplasty in the United States: Analysis From 2011 to 2019.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Aspirin; Fibrinolytic Agents; Humans; Postoperative | 2023 |
Enoxaparin Is Better Than Aspirin for the Prevention of Venous Thromboembolism After Total Hip or Knee Arthroplasty.
Topics: Anticoagulants; Arthroplasty, Replacement, Knee; Aspirin; Enoxaparin; Humans; Postoperative Complica | 2023 |
Comparison of 90-Day Adverse Events Associated With Aspirin and Potent Anticoagulation Use for Venous Thromboembolism Prophylaxis: A Cohort Study of 72,288 Total Knee and 35,142 Total Hip Arthroplasty Patients.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Aspirin; Cohort Studies; Factor Xa Inhibitors; Hepar | 2023 |
Acetylsalicylic Acid Is Not Associated With Improved Clinical Outcomes After Microsurgical Breast Reconstruction.
Topics: Aspirin; Breast Neoplasms; Female; Humans; Mammaplasty; Mastectomy; Middle Aged; Necrosis; Postopera | 2023 |
The impact of adopting low-molecular-weight heparin in place of aspirin as routine thromboprophylaxis for patients with hip fracture.
Topics: Anticoagulants; Aspirin; Heparin, Low-Molecular-Weight; Hip Fractures; Humans; Postoperative Complic | 2023 |
Combination of enoxaparin and low-dose aspirin for thromboprophylaxis in selective patients after primary total joint arthroplasty in a Taiwanese population.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Aspirin; Enoxaparin; Humans; Postoperative Complicat | 2023 |
Perioperative continuation or ultra-early resumption of antithrombotics in elective neurosurgical cranial procedures.
Topics: Aspirin; Elective Surgical Procedures; Fibrinolytic Agents; Hemorrhage; Humans; Neurosurgical Proced | 2023 |
The impact of long-term aspirin use on the patients undergoing shoulder arthroplasty.
Topics: Adult; Aged; Arthroplasty, Replacement, Shoulder; Aspirin; Comorbidity; Female; Humans; Medicare; Po | 2023 |
Effect of Acetylsalicylic Acid Dose and Time Discontinued Preoperatively on Outcomes After Total Knee and Hip Arthroplasty.
Topics: Aged; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Emergency Service, H | 2019 |
Anticoagulation in Revision Total Joint Arthroplasty: A Retrospective Review of 1917 Cases.
Topics: Adult; Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspiri | 2019 |
Very Short Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Patients With High Bleeding Risk: Insight From the STOPDAPT-2 Trial.
Topics: Aged; Aspirin; Chromium Alloys; Clopidogrel; Coronary Restenosis; Drug Administration Schedule; Drug | 2019 |
Perioperative Management of Foot and Ankle Surgical Patients.
Topics: Ankle; Anticoagulants; Aspirin; Continuous Positive Airway Pressure; Exercise Therapy; Foot; Humans; | 2019 |
Highlighting the Roles of Anemia and Aspirin in Predicting Ninety-Day Readmission Following Aseptic Revision Total Joint Arthroplasty.
Topics: Anemia; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Humans; Patient Re | 2020 |
Timing Strategy of Preoperative Aspirin and Its Impact on Early Outcomes in Patients Undergoing Coronary Artery Bypass Grafting: A Propensity Score Matching Analysis.
Topics: Aged; Aspirin; Coronary Artery Bypass; Coronary Artery Disease; Female; Hospital Mortality; Humans; | 2020 |
Association between preoperative aspirin and acute kidney injury following coronary artery bypass grafting.
Topics: Acute Kidney Injury; Aged; Aspirin; Coronary Artery Bypass; Female; Humans; Male; Middle Aged; Plate | 2020 |
Comparison of the Efficacy and Safety of Aspirin and Rivaroxaban Following Enoxaparin Treatment for Prevention of Venous Thromboembolism after Hip Fracture Surgery.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Drug Ther | 2019 |
Validation of the Spartan RXCYP2C19 Genotyping Assay Utilizing Blood Samples.
Topics: Aspirin; Clopidogrel; Cytochrome P-450 CYP2C19; DNA; Dual Anti-Platelet Therapy; Genotyping Techniqu | 2020 |
Comparative external validation of the PRECISE-DAPT and PARIS risk scores in 4424 acute coronary syndrome patients treated with prasugrel or ticagrelor.
Topics: Acute Coronary Syndrome; Aged; Aspirin; Drug Therapy, Combination; Female; Humans; Male; Middle Aged | 2020 |
The surgeon's role in optimizing medical therapy and maintaining compliance with secondary prevention guidelines in patients undergoing coronary artery bypass grafting.
Topics: Aspirin; Coronary Artery Bypass; Humans; Hypolipidemic Agents; Patient Compliance; Physician's Role; | 2020 |
Selection Bias, Orthopaedic Style: Knowing What We Don't Know About Aspirin.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Humans; Po | 2020 |
85-Year-Old Man With Chest Pain.
Topics: Aged, 80 and over; Anti-Inflammatory Agents; Aspirin; Chest Pain; Colchicine; Diagnosis, Differentia | 2020 |
Risk of perioperative bleeding complications in rhegmatogenous retinal detachment surgery: a retrospective single-center study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Child; Child, Preschool; Clopid | 2020 |
Prophylaxis for Pediatric Venous Thromboembolism: Current Status and Changes Across Pediatric Orthopaedic Society of North America From 2011.
Topics: Aspirin; Enoxaparin; Guideline Adherence; Humans; North America; Orthopedic Procedures; Pediatrics; | 2020 |
Myocardial injury in non-cardiac surgery: complexities and challenges.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Heart Injuries; Humans; Myocardium; Perioperative | 2020 |
Hospital Variability Drives Inconsistency in Antiplatelet Use After Coronary Bypass.
Topics: Aged; Aspirin; Comorbidity; Coronary Artery Bypass; Coronary Artery Bypass, Off-Pump; Drug Therapy, | 2020 |
Incidence of venous thromboembolism after total hip, total knee and hip fracture surgery at Waitemata District Health Board following a peer-reviewed audit.
Topics: Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, | 2020 |
Impact of preoperative aspirin continuation on bleeding complications during or after liver resection: Propensity score-matched analysis.
Topics: Aspirin; Hepatectomy; Humans; Laparoscopy; Liver; Platelet Aggregation Inhibitors; Postoperative Com | 2020 |
Aspirin compared to enoxaparin or rivaroxaban for thromboprophylaxis following hip and knee replacement.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Hip; Arthropl | 2020 |
Combined aspirin and clopidogrel therapy in phacoemulsification cataract surgery: a risk factor for ocular hemorrhage?
Topics: Aspirin; Cataract; Clopidogrel; Humans; Lens Implantation, Intraocular; Phacoemulsification; Postope | 2020 |
Impact of Flow Dynamics on Device-Related Thrombosis After Left Atrial Appendage Occlusion.
Topics: Aged; Antithrombins; Aspirin; Atrial Appendage; Atrial Fibrillation; Cardiac Catheterization; Comput | 2020 |
Multimodal prophylaxis in patients with a history of venous thromboembolism undergoing primary elective hip arthroplasty.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Conduction; Anticoagulants; Arthroplasty, Replacement, H | 2020 |
Net platelet clot strength of thromboelastography platelet mapping assay for the identification of high on-treatment platelet reactivity in post-PCI patients.
Topics: Aged; Angina, Unstable; Aspirin; Blood Platelets; Female; Humans; Male; Middle Aged; Myocardial Infa | 2020 |
Postimplant Phosphodiesterase Type 5 Inhibitors Use Is Associated With Lower Rates of Thrombotic Events After Left Ventricular Assist Device Implantation.
Topics: Adult; Aged; Aspirin; Cohort Studies; Female; Heart-Assist Devices; Humans; Male; Middle Aged; Phosp | 2020 |
Antiplatelet Therapy in Patients Without a Coronary Stent and Mortality After Noncardiac Surgery.
Topics: Adult; Aged; Aspirin; Clopidogrel; Elective Surgical Procedures; Female; Hospital Mortality; Humans; | 2020 |
Persistent Wound Drainage among Total Joint Arthroplasty Patients Receiving Aspirin vs Coumadin.
Topics: Arthroplasty, Replacement, Hip; Aspirin; Drainage; Humans; Postoperative Complications; Retrospectiv | 2020 |
Low-Dose Aspirin is Safe and Effective for Venous Thromboembolism Prevention in Patients Undergoing Revision Total Knee Arthroplasty: A Retrospective Cohort Study.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Humans; Po | 2022 |
Is continuation of anti-platelet treatment safe for elective total hip arthroplasty patients?
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Aspirin; Blood Los | 2020 |
Discontinued Use of Outpatient Portable Intermittent Pneumatic Compression Devices May Be Safe for Venous Thromboembolism Prophylaxis in Primary Total Knee Arthroplasty Using Low-Dose Aspirin.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Humans; In | 2022 |
Continuation of aspirin perioperatively for lung resection: a propensity matched analysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aspirin; Child; Female; Hemorrhage; Humans; Lung; Male; | 2021 |
Effects of aspirin and heparin treatment on perioperative outcomes in patients with Moyamoya disease.
Topics: Adult; Anticoagulants; Aspirin; Cerebral Revascularization; Heparin; Humans; Male; Middle Aged; Midd | 2021 |
Adjunctive treatment with low dose intra-arterial eptifibatide and intravenous aspirin during carotid stenting: A case series.
Topics: Aged; Aspirin; Carotid Stenosis; Clopidogrel; Endovascular Procedures; Eptifibatide; Female; Humans; | 2021 |
Low-dose aspirin and the rate of symptomatic venous thromboembolic complications following primary shoulder arthroplasty.
Topics: Arthroplasty, Replacement, Shoulder; Aspirin; Humans; Incidence; Postoperative Complications; Pulmon | 2021 |
Aspirin for Deep-Venous Thrombosis Prophylaxis After Anterior Cruciate Ligament Reconstruction.
Topics: Anterior Cruciate Ligament Reconstruction; Aspirin; Humans; Postoperative Complications; Retrospecti | 2021 |
Long-term outcomes of warfarin versus aspirin after Fontan surgery.
Topics: Anticoagulants; Aspirin; Australia; Bone Density; Chemoprevention; Child; Cohort Studies; Female; Fo | 2021 |
Aspirin Is Safe for Venous Thromboembolism Prophylaxis for Patients With a History of Gastrointestinal Issues.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Aspirin; Humans; Postoperative Complications; Retros | 2021 |
2021 John N. Insall Award: Aspirin is effective in preventing propagation of infrapopliteal deep venous thrombosis following total knee arthroplasty.
Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Knee; Aspirin; Awards and Prizes; Female; Humans; M | 2021 |
No Increased Risk of Venous Thromboembolism in High-Risk Patients Continuing Their Dose of 75 mg Aspirin Compared to Healthier Patients Given Low-Molecular-Weight Heparin.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Heparin, L | 2021 |
Weight-Based Aspirin Dosing May Further Reduce the Incidence of Venous Thromboembolism Following Primary Total Joint Arthroplasty.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Humans; In | 2021 |
Spontaneous Spinal Epidural Hematoma in an Adult Patient with Complex Congenital Heart Disease.
Topics: Adult; Anticoagulants; Aortic Valve Stenosis; Aspirin; Heart Defects, Congenital; Heart Septal Defec | 2021 |
A risk-stratified approach to venous thromboembolism prophylaxis with aspirin or warfarin following total hip and knee arthroplasty: A cohort study.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Cohort Stu | 2021 |
Outcomes of a single-center experience with classification and treatment of endothermal heat-induced thrombosis after endovenous ablation.
Topics: Anticoagulants; Aspirin; Catheter Ablation; Disease Progression; Endovascular Procedures; Female; Ho | 2017 |
Response to Letter to the Editor on "Efficacy in Deep Vein Thrombosis Prevention With Extended Mechanical Compression Device Therapy and Prophylactic Aspirin Following Total Knee Arthroplasty: A Randomized Control Trial".
Topics: Anticoagulants; Arthroplasty, Replacement, Knee; Aspirin; Bandages; Humans; Postoperative Complicati | 2017 |
Letter to the Editor on "Efficacy in Deep Vein Thrombosis Prevention With Extended Mechanical Compression Device Therapy and Prophylactic Aspirin Following Total Knee Arthroplasty: A Randomized Control Trial".
Topics: Anticoagulants; Arthroplasty, Replacement, Knee; Aspirin; Bandages; Humans; Postoperative Complicati | 2017 |
Thrombolysis of prosthetic mitral valve thrombosis in an infant.
Topics: Aspirin; Coronary Vessels; Female; Fibrinolytic Agents; Heart Septal Defects, Ventricular; Heart Val | 2017 |
Trends of thromboprophylaxis and complications after major lower limb orthopaedic surgeries in Korea: National Health Insurance Claim Data.
Topics: Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, | 2017 |
The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Hip; Arthropl | 2017 |
Pharmacological thromboprophylaxis and its impact on venous thromboembolism following total knee and hip arthroplasty in Korea: A nationwide population-based study.
Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Eryt | 2017 |
Venous Thromboembolism Prophylaxis After TKA: Aspirin, Warfarin, Enoxaparin, or Factor Xa Inhibitors?
Topics: Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Knee; Aspirin; Cohort Studies; D | 2017 |
Effect of Aspirin in Postoperative Management of Adult Ischemic Moyamoya Disease.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Disease Management; Female; Humans; Male; M | 2017 |
Platelet testing to guide aspirin dose adjustment in pediatric patients after cardiac surgery.
Topics: Aspirin; Body Weight; Cardiac Surgical Procedures; Chemoprevention; Child, Preschool; Dose-Response | 2017 |
Wound Discharge After Pharmacological Thromboprophylaxis in Lower Limb Arthroplasty.
Topics: Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, | 2018 |
Increased Incidence of Bleeding and Wound Complications With Factor-Xa Inhibitors After Total Joint Arthroplasty.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement; Aspirin; Chemoprevention; | 2018 |
Risky business? Investigating outcomes of patients undergoing urgent laparoscopic appendectomy on antithrombotic therapy.
Topics: Adult; Appendectomy; Appendicitis; Aspirin; Blood Loss, Surgical; Blood Transfusion; Clopidogrel; Fe | 2017 |
Early aspirin initiation following heart transplantation is associated with reduced risk of allograft vasculopathy during long-term follow-up.
Topics: Adult; Allografts; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Female; Follow-Up Studies; Graf | 2017 |
The Effect of Continued Low Dose Aspirin Therapy in Patients Undergoing Percutaneous Nephrolithotomy.
Topics: Administration, Oral; Aged; Aspirin; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Hu | 2018 |
European guidelines on perioperative venous thromboembolism prophylaxis: Chronic treatments with antiplatelet agents.
Topics: Anesthesiology; Anticoagulants; Aspirin; Blood Coagulation; Clopidogrel; European Union; Hemorrhage; | 2018 |
The use of preoperative aspirin in cardiac surgery: The ruling on the field stands.
Topics: Acute Kidney Injury; Aspirin; Coronary Artery Bypass; Erythrocyte Transfusion; Hemorrhage; Humans; M | 2017 |
Anticoagulation strategies in patients with atrial fibrillation after PCI or with ACS : The end of triple therapy?
Topics: Acute Coronary Syndrome; Administration, Oral; Anticoagulants; Aspirin; Atrial Fibrillation; Clopido | 2018 |
Aspirin for Prophylaxis Against Venous Thromboembolism After Orthopaedic Oncologic Surgery.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Bone Neoplasms; Female; Humans; | 2017 |
Risk Factors for Postoperative Venous Thromboembolic Complications after Microsurgical Breast Reconstruction.
Topics: Adult; Aged; Aspirin; Body Mass Index; Comorbidity; Female; Humans; Mammaplasty; Microsurgery; Middl | 2018 |
Venous thromboembolic prophylaxis after simultaneous bilateral total knee arthroplasty: aspirin
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Knee; Aspirin; Dose-Respo | 2018 |
Which Antiplatelet Therapy in Patients With Left Ventricular Assist Device and Aspirin Allergy?
Topics: Aspirin; Clopidogrel; Drug Hypersensitivity; Drug Therapy, Combination; Heart Failure; Heart-Assist | 2018 |
Treatment of Unruptured, Saccular, Anterior Choroidal Artery Aneurysms with Flow Diversion : A Single Centre Experience.
Topics: Adult; Aged; Aspirin; Cerebral Arteries; Clopidogrel; Endovascular Procedures; Female; Humans; Intra | 2019 |
Aspirin for thromboprophylaxis in major orthopedic surgery: old drug, new tricks?
Topics: Anticoagulants; Arthroplasty, Replacement, Knee; Aspirin; Contraindications, Drug; Drug Evaluation; | 2018 |
Low-Dose Aspirin Is Safe and Effective for Venous Thromboembolism Prophylaxis Following Total Knee Arthroplasty.
Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Knee; Aspirin; Electronic Health Records; Female; H | 2018 |
Perioperative hematoma with subcutaneous ICD implantation: Impact of anticoagulation and antiplatelet therapies.
Topics: Anticoagulants; Aspirin; Clopidogrel; Defibrillators, Implantable; Female; Hematoma; Humans; Male; M | 2018 |
Potent effect of prasugrel on acute phase resolution of intra-stent athero-thrombotic burden after percutaneous intervention to acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Aspirin; Blood Platelets; Clopidogrel; Drug Therapy, Combination; Fem | 2018 |
Nephrotoxin exposure and acute kidney injury in critically ill children undergoing congenital cardiac surgery.
Topics: Acute Kidney Injury; Adolescent; Aspirin; Cardiac Surgical Procedures; Child; Child, Preschool; Crit | 2018 |
Antiplatelet therapy in the management of atherothrombosis: recent clinical advances.
Topics: Aspirin; Atherosclerosis; Atrial Fibrillation; Humans; Percutaneous Coronary Intervention; Platelet | 2018 |
Vessel wall enhancement by gadolinium-enhanced MRI in a patient with delayed stenosis after mechanical thrombectomy.
Topics: Angiography, Digital Subtraction; Aspirin; Coronary Stenosis; Female; Gadolinium; Humans; Image Proc | 2018 |
Clopidogrel-associated genetic variants on inhibition of platelet activity and clinical outcome for acute coronary syndrome patients.
Topics: Acute Coronary Syndrome; Aged; Aryldialkylphosphatase; Aspirin; Biotransformation; Clopidogrel; Cyto | 2019 |
Type of Anticoagulant Used After Total Knee Arthroplasty Affects the Rate of Knee Manipulation for Postoperative Stiffness.
Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Knee; Aspirin; Female; Heparin, Low-Molecular-Weigh | 2018 |
Hybrid transcatheter pulmonary valve implantation: The first case series from Turkey.
Topics: Adolescent; Adult; Aspirin; Blood Transfusion; Cardiopulmonary Bypass; Fibrinolytic Agents; Heart Va | 2018 |
Trends in Deep Vein Thrombosis Prophylaxis and Deep Vein Thrombosis Rates After Total Hip and Knee Arthroplasty.
Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Clin | 2018 |
Cardiac Risk of Noncardiac Surgery After Percutaneous Coronary Intervention With Second-Generation Drug-Eluting Stents.
Topics: Adult; Aged; Aspirin; Drug-Eluting Stents; Electronic Health Records; Female; Humans; Incidence; Mal | 2019 |
Antithrombotic treatment and risk of complications after head and neck full thickness skin graft surgery.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aspirin; Cohort Studies; Female; Fibrinolytic Agents; He | 2018 |
Risk factors for development of early infectious and noninfectious complications in systemic lupus erythematosus patients undergoing major surgery.
Topics: Adolescent; Adult; Aged; Anemia; Aspirin; Child; Elective Surgical Procedures; Female; Humans; Logis | 2018 |
Coronary embolism following Bentall procedure and hemiarch resection for acute Type A aortic dissection.
Topics: Acute Disease; Anticoagulants; Aortic Aneurysm; Aortic Dissection; Aspirin; Blood Vessel Prosthesis | 2018 |
Are Prior Aspirin Users With ST-Elevation Myocardial Infarction at Increased Risk of Adverse Events and Worse Angiographic Features?
Topics: Aspirin; Coronary Angiography; Disease Progression; Female; Follow-Up Studies; Humans; Iran; Male; M | 2018 |
Prevalence of aspirin resistance by thromboelastography plus platelet mapping in children with CHD: a single-centre experience.
Topics: Adolescent; Adult; Aspirin; Cardiac Surgical Procedures; Child; Child, Preschool; Drug Resistance; F | 2019 |
Evaluation of a Simplified Risk Stratification Twice-Daily Aspirin Protocol for Venous Thromboembolism Prophylaxis After Total Joint Replacement.
Topics: Anticoagulants; Arthroplasty, Replacement; Aspirin; Humans; Postoperative Complications; Retrospecti | 2020 |
Association Between Antithrombotic Medication Use After Bioprosthetic Aortic Valve Replacement and Outcomes in the Veterans Health Administration System.
Topics: Aged; Aortic Valve; Aspirin; Bioprosthesis; Female; Fibrinolytic Agents; Heart Valve Prosthesis; Hea | 2019 |
Impact of dual antiplatelet therapy with adjusted-dose prasugrel on mid-term vascular response in patients undergoing elective percutaneous coronary intervention with everolimus-eluting stents.
Topics: Aged; Aged, 80 and over; Aspirin; Coronary Artery Disease; Cytochrome P-450 CYP2C19; Drug-Eluting St | 2019 |
Aspirin Alone Is Not Enough to Prevent Deep Venous Thrombosis After Total Joint Arthroplasty.
Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Chem | 2019 |
The Effectiveness of Aspirin for Venous Thromboembolism Prophylaxis for Patients Undergoing Arthroscopic Rotator Cuff Repair.
Topics: Adult; Aged; Aged, 80 and over; Arthroscopy; Aspirin; Case-Control Studies; Female; Humans; Male; Mi | 2019 |
Comparison of pharmacologic prophylaxis in prevention of venous thromboembolism following total knee arthroplasty.
Topics: Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Knee; Aspirin; Chemoprevention; | 2019 |
High acetylsalicylic acid dosing in infants after modified Blalock-Taussig shunt.
Topics: Administration, Oral; Aspirin; Blalock-Taussig Procedure; Computed Tomography Angiography; Dose-Resp | 2019 |
Topics: Arthroplasty, Replacement, Knee; Aspirin; Humans; Postoperative Complications; Rivaroxaban; Thromboe | 2019 |
Radical cystectomy under continuous antiplatelet therapy with acetylsalicylic acid.
Topics: Aged; Aspirin; Blood Loss, Surgical; Blood Transfusion; Cardiovascular Diseases; Case-Control Studie | 2019 |
The Use of Aspirin for Prophylaxis Against Venous Thromboembolism Decreases Mortality Following Primary Total Joint Arthroplasty.
Topics: Aged; Arthroplasty, Replacement; Aspirin; Body Mass Index; Female; Fibrinolytic Agents; Humans; Male | 2019 |
Clinical efficacy of risk-stratified prophylaxis with low-dose aspirin for the management of symptomatic venous thromboembolism after total hip arthroplasty.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthroplasty, Replacement, Hip; Aspirin; Female; Huma | 2020 |
Potent Anticoagulation Does Not Reduce Venous Thromboembolism in High-Risk Patients.
Topics: Aged; Anticoagulants; Arthroplasty, Replacement; Aspirin; Female; Heparin, Low-Molecular-Weight; Hum | 2019 |
Direct oral anticoagulants versus aspirin for venous thromboembolism prophylaxis after orthopedic surgery.
Topics: Administration, Oral; Aged; Anticoagulants; Aspirin; Blood Transfusion; Female; Hemorrhage; Humans; | 2019 |
The Effect of Aspirin as an Irreversible COX1 Inhibitor in Preventing Non-Valvular Atrial Fibrillation After Coronary Bypass Surgery.
Topics: Aged; Aspirin; Atrial Fibrillation; Coronary Artery Bypass; Cyclooxygenase 1; Cyclooxygenase Inhibit | 2019 |
Myocardial injury after non-cardiac surgery: diagnosis and management.
Topics: Aspirin; Cardiovascular Diseases; Hemorrhage; Humans; Myocardial Ischemia; Postoperative Complicatio | 2020 |
Myocardial injury after non-cardiac surgery: diagnosis and management.
Topics: Aspirin; Cardiovascular Diseases; Hemorrhage; Humans; Myocardial Ischemia; Postoperative Complicatio | 2020 |
Myocardial injury after non-cardiac surgery: diagnosis and management.
Topics: Aspirin; Cardiovascular Diseases; Hemorrhage; Humans; Myocardial Ischemia; Postoperative Complicatio | 2020 |
Myocardial injury after non-cardiac surgery: diagnosis and management.
Topics: Aspirin; Cardiovascular Diseases; Hemorrhage; Humans; Myocardial Ischemia; Postoperative Complicatio | 2020 |
Myocardial injury after non-cardiac surgery: diagnosis and management.
Topics: Aspirin; Cardiovascular Diseases; Hemorrhage; Humans; Myocardial Ischemia; Postoperative Complicatio | 2020 |
Myocardial injury after non-cardiac surgery: diagnosis and management.
Topics: Aspirin; Cardiovascular Diseases; Hemorrhage; Humans; Myocardial Ischemia; Postoperative Complicatio | 2020 |
Myocardial injury after non-cardiac surgery: diagnosis and management.
Topics: Aspirin; Cardiovascular Diseases; Hemorrhage; Humans; Myocardial Ischemia; Postoperative Complicatio | 2020 |
Myocardial injury after non-cardiac surgery: diagnosis and management.
Topics: Aspirin; Cardiovascular Diseases; Hemorrhage; Humans; Myocardial Ischemia; Postoperative Complicatio | 2020 |
Myocardial injury after non-cardiac surgery: diagnosis and management.
Topics: Aspirin; Cardiovascular Diseases; Hemorrhage; Humans; Myocardial Ischemia; Postoperative Complicatio | 2020 |
The impact of
Topics: Aged; Alleles; Aspirin; Clopidogrel; Cytochrome P450 Family 4; Female; Genotype; Hemorrhage; Humans; | 2019 |
Optimal use of antiplatelet agents, especially aspirin, in the perioperative management of colorectal cancer patients undergoing laparoscopic colorectal resection.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Blood Loss, Surgical; Colorectal Neoplasms; Female; Follow- | 2019 |
Suppressive Effects of Aspirin for Postthoracotomy Pleural Adhesion in Rats.
Topics: Actins; Animals; Anti-Inflammatory Agents; Aspirin; Cautery; Gene Expression Regulation; Humans; Lun | 2019 |
The importance of aspirin, catheterization accuracy, and catheter design in external ventricular drainage-related hemorrhage: a multicenter study of 1002 procedures.
Topics: Adult; Aged; Aspirin; Catheterization; Catheters; Drainage; Female; Humans; Intracranial Hemorrhages | 2019 |
The Perioperative Continuation of Aspirin in Patients Undergoing Arthroscopic Surgery of the Knee.
Topics: Aged; Arthroscopy; Aspirin; Cohort Studies; Female; Hematoma; Humans; Knee Joint; Male; Middle Aged; | 2019 |
Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replac | 2019 |
Impact of Baseline Anemia in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: A Prespecified Analysis From the VALIDATE-SWEDEHEART Trial.
Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Anemia; Aspirin; Case-Control Studies; Dual Anti-P | 2019 |
Thrombocytopenia, dual antiplatelet therapy, and heparin bridging strategy increase pocket hematoma complications in patients undergoing cardiac rhythm device implantation.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; China; Clopidogrel; Cross-Sectional Studies; Defib | 2013 |
[The difficult choice of antithrombotic therapy after bioprosthetic aortic valve implantation: aspirin, warfarin, or both?].
Topics: Anticoagulants; Aortic Valve; Aspirin; Bioprosthesis; Fibrinolytic Agents; Heart Valve Prosthesis Im | 2013 |
Low molecular weight heparin in patients undergoing free tissue transfer following head and neck ablative surgery: review of efficacy and associated complications.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Dalteparin; Dose-Response Relationship, Dru | 2013 |
Catheter ablation of atrial fibrillation in patients at low thrombo-embolic risk: efficacy and safety of a simplified periprocedural anticoagulation strategy.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Catheter Ablation; Echocardiography, Transesophageal; | 2013 |
Safety and efficacy of low molecular weight dextran (dextran 40) in head and neck free flap reconstruction.
Topics: Adult; Aged; Aspirin; Dextrans; Female; Fibrinolytic Agents; Free Tissue Flaps; Graft Survival; Head | 2013 |
Aspirin resistance in patients with hemodynamic cerebral ischemia undergoing extracranial-intracranial bypass surgery.
Topics: Adolescent; Adult; Angiography, Digital Subtraction; Aspirin; Blood Coagulation Disorders; Brain Isc | 2013 |
Preoperative aspirin use and outcomes in cardiac surgery patients: a role of platelet function assessment.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiovascular Surgical Procedures; Female; Heart | 2013 |
The safety and efficacy of aspirin intake in photoselective vaporization laser treatment of benign prostate hyperplasia.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Humans; Laser Coagulation; M | 2013 |
Variation in warfarin thromboprophylaxis after mitral valve repair: does equipoise exist and is a randomized trial warranted?
Topics: Aged; Anticoagulants; Aspirin; Cohort Studies; Confidence Intervals; Databases, Factual; Female; Fol | 2013 |
Aspirin-triggered resolvin D1 prevents surgery-induced cognitive decline.
Topics: Animals; Aspirin; Brain; Cognition; Docosahexaenoic Acids; Electrophysiology; Immunohistochemistry; | 2013 |
Preoperative aspirin use in cardiac surgery.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiovascular Surgical Procedures; Female; Heart | 2013 |
Reply to letters: "Preoperative aspirin use and outcomes in cardiac surgery patients: a role of platelet function assessment" and "Preoperative aspirin use in cardiac surgery".
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiovascular Surgical Procedures; Female; Heart | 2013 |
Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clopido | 2013 |
Long-term effect of dual antiplatelet treatment after off-pump coronary artery bypass grafting.
Topics: Acute Coronary Syndrome; Aged; Aspirin; Cardiovascular Diseases; Clopidogrel; Cohort Studies; Corona | 2013 |
Acetyl salicylic acid locally enhances functional recovery after sciatic nerve transection in rat.
Topics: Administration, Topical; Animals; Aspirin; Axotomy; Drug Evaluation, Preclinical; Guided Tissue Rege | 2013 |
Ticlopidine and clopidogrel, sometimes combined with aspirin, only minimally increase the surgical risk in renal transplantation: a case-control study.
Topics: Aspirin; Blood Loss, Surgical; Case-Control Studies; Clopidogrel; Dose-Response Relationship, Drug; | 2014 |
Aspirin responsiveness safely lowers perioperative cardiovascular risk.
Topics: Aged; Aspirin; Brazil; Cardiovascular Diseases; Dose-Response Relationship, Drug; Female; Follow-Up | 2013 |
Reply to Rubino et al.
Topics: Aspirin; Coronary Artery Bypass; Female; Humans; Male; Myocardial Infarction; Platelet Aggregation I | 2014 |
Impact of preoperative antiplatelet therapy on in-hospital outcomes after coronary artery bypass grafting.
Topics: Aspirin; Coronary Artery Bypass; Female; Humans; Male; Myocardial Infarction; Platelet Aggregation I | 2014 |
The yin and yang of perioperative medicine.
Topics: Adrenergic alpha-2 Receptor Agonists; Aspirin; Clonidine; Female; Humans; Hypotension; Male; Myocard | 2014 |
A cautionary tale on the use of antiplatelet treatment following TURP.
Topics: Aged; Aspirin; Clopidogrel; Coronary Thrombosis; Drug-Eluting Stents; Hematuria; Humans; Male; Myoca | 2014 |
Surgery: Low-dose aspirin and clonidine--no benefit during surgery.
Topics: Adrenergic alpha-2 Receptor Agonists; Aspirin; Clonidine; Female; Humans; Hypotension; Male; Myocard | 2014 |
Cangrelor for treatment during percutaneous coronary intervention.
Topics: Acute Coronary Syndrome; Adenosine Monophosphate; Aspirin; Clinical Trials as Topic; Coronary Thromb | 2014 |
Predictors of pocket hematoma in patients on antithrombotic therapy undergoing cardiac rhythm device implantation: insights from the FinPAC trial.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Female; Finland; Hematoma; Humans; Incidence; Male | 2014 |
Outcomes in patients undergoing nephrectomy for renal cancer on chronic anticoagulation therapy.
Topics: Age Factors; Aged; Anticoagulants; Aspirin; Blood Transfusion; Female; Fibrinolytic Agents; Humans; | 2014 |
[Comments on: perioperative administration of clonidine or aspirin].
Topics: Adrenergic alpha-2 Receptor Agonists; Aspirin; Clonidine; Female; Humans; Hypotension; Male; Myocard | 2014 |
Myocardial infarction risks remain for patients undergoing noncardiac elective surgery.
Topics: Antihypertensive Agents; Aspirin; Clonidine; Elective Surgical Procedures; Humans; Myocardial Infarc | 2014 |
Questions linger over POISE-2 and perioperative aspirin management.
Topics: Aspirin; Female; Humans; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Postoperative | 2014 |
An atypical presentation of an extremely late stent thrombosis after more than 7 years (2634 days) of DES implantation in a patient without obvious risk factors on regular dual antiplatelet therapy.
Topics: Aspirin; Clopidogrel; Coronary Angiography; Coronary Thrombosis; Drug Therapy, Combination; Drug-Elu | 2014 |
Safety and efficacy of switching anticoagulation to aspirin three months after successful radiofrequency catheter ablation of atrial fibrillation.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Catheter Ablation; Female; Hemorrhage; Humans; K | 2014 |
[Aspirin does not prevent myocardial infarcts in and after non-cardiac operations].
Topics: Aged; Aspirin; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Postoperative Complic | 2014 |
[Utility of aspirin in patients undergoing noncardiac surgery. Commentary].
Topics: Aspirin; Female; Humans; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Postoperative | 2014 |
Peri-procedural interrupted oral anticoagulation for atrial fibrillation ablation: comparison of aspirin, warfarin, dabigatran, and rivaroxaban.
Topics: Administration, Oral; Aged; Algorithms; Anticoagulants; Aspirin; Atrial Fibrillation; Benzimidazoles | 2014 |
Aspirin may reduce liver fibrosis progression: Evidence from a multicenter retrospective study of recurrent hepatitis C after liver transplantation.
Topics: Aspirin; Disease Progression; Female; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Liver Transplan | 2014 |
ACP Journal Club. In noncardiac surgery, perioperative aspirin did not reduce death or MI at 30 d but increased major bleeding.
Topics: Aspirin; Female; Humans; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Postoperative | 2014 |
Age-related prevalence of diabetes mellitus, cardiovascular disease and anticoagulation therapy use in a urolithiasis population and their effect on outcomes: the Clinical Research Office of the Endourological Society Ureteroscopy Global Study.
Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Cardiovascula | 2015 |
Impact of clopidogrel plus aspirin versus aspirin alone on the progression of native coronary artery disease after bypass surgery: analysis from the Clopidogrel After Surgery for Coronary Artery DiseasE (CASCADE) randomized trial.
Topics: Aged; Aspirin; Clopidogrel; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; C | 2014 |
Impact of clopidogrel plus aspirin versus aspirin alone on the progression of native coronary artery disease after bypass surgery: analysis from the Clopidogrel After Surgery for Coronary Artery DiseasE (CASCADE) randomized trial.
Topics: Aged; Aspirin; Clopidogrel; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; C | 2014 |
Impact of clopidogrel plus aspirin versus aspirin alone on the progression of native coronary artery disease after bypass surgery: analysis from the Clopidogrel After Surgery for Coronary Artery DiseasE (CASCADE) randomized trial.
Topics: Aged; Aspirin; Clopidogrel; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; C | 2014 |
Impact of clopidogrel plus aspirin versus aspirin alone on the progression of native coronary artery disease after bypass surgery: analysis from the Clopidogrel After Surgery for Coronary Artery DiseasE (CASCADE) randomized trial.
Topics: Aged; Aspirin; Clopidogrel; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; C | 2014 |
Anticoagulants as a risk factor in patients operated on for abdominal hernia.
Topics: Adult; Aged; Anticoagulants; Aspirin; Blood Coagulation Disorders; Drainage; Female; Hemorrhage; Hep | 2014 |
The pharmacoeconomics of routine postoperative troponin surveillance to prevent and treat myocardial infarction after non-cardiac surgery.
Topics: Aspirin; Cost-Benefit Analysis; Economics, Pharmaceutical; Hospital Costs; Humans; Hydroxymethylglut | 2014 |
A case-cohort study of postoperative myocardial infarction: impact of anemia and cardioprotective medications.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Anemia; Aspirin; Cardiotonic Agents; Ca | 2014 |
Discussion.
Topics: Adrenergic beta-Antagonists; Anemia; Aspirin; Cardiotonic Agents; Female; Humans; Male; Myocardial I | 2014 |
Aspirin increases the risk of venous thromboembolism in surgical patients.
Topics: Adult; Aged; Aspirin; Female; Humans; Intensive Care Units; Logistic Models; Male; Middle Aged; Plat | 2014 |
[Can perioperative aspirin prevent heart attacks?].
Topics: Aspirin; Heart Diseases; Humans; Intraoperative Complications; Perioperative Care; Platelet Aggregat | 2014 |
Weighing the risks of perioperative aspirin.
Topics: Aspirin; Female; Humans; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Postoperative | 2014 |
Adherence to antiplatelet therapy after percutaneous coronary intervention: a population study in a region of Italy.
Topics: Adult; Aged; Aspirin; Cardiovascular Diseases; Clopidogrel; Female; Humans; Italy; Longitudinal Stud | 2015 |
Association Between Preoperative Aspirin-dosing Strategy and Mortality After Coronary Artery Bypass Graft Surgery.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Coronary Artery Bypass; Drug Administration Schedule; Femal | 2015 |
[Perioperative aspirin treatment in patients undergoing surgery: Perioperative Ischemic Evaluation 2 (POISE-2)].
Topics: Aspirin; Female; Humans; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Postoperative | 2014 |
Percutaneous nephrolithotomy during uninterrupted aspirin therapy in high-cardiovascular risk patients: preliminary report.
Topics: Aged; Aspirin; Blood Transfusion; Body Mass Index; Cardiovascular Diseases; Female; Humans; Kidney C | 2014 |
Aspirin resistance in adult patients after Fontan surgery.
Topics: Adult; Aspirin; CD40 Antigens; Drug Resistance; Endothelium, Vascular; Female; Fontan Procedure; Hea | 2015 |
Preoperative continuation of aspirin therapy may improve perioperative saphenous venous graft patency after off-pump coronary artery bypass grafting.
Topics: Aspirin; Cohort Studies; Coronary Artery Bypass, Off-Pump; Female; Graft Occlusion, Vascular; Humans | 2015 |
[Perioperative complications of transurethral resection of bladder tumor in patients receiving antithrombotic therapy].
Topics: Aged; Aged, 80 and over; Angina Pectoris; Aspirin; Cystectomy; Female; Fibrinolytic Agents; Hemorrha | 2014 |
A case-control study to assess aspirin as a risk factor of bleeding in rhegmatogenous retinal detachment surgery.
Topics: Aged; Aspirin; Case-Control Studies; Choroid Hemorrhage; Cryotherapy; Female; Humans; Intraoperative | 2015 |
Invited commentary.
Topics: Aspirin; Coronary Artery Bypass, Off-Pump; Female; Graft Occlusion, Vascular; Humans; Male; Platelet | 2015 |
Balancing the risks of bleeding and stent thrombosis: a decision analytic model to compare durations of dual antiplatelet therapy after drug-eluting stents.
Topics: Acute Coronary Syndrome; Aspirin; Clopidogrel; Decision Support Techniques; Drug-Eluting Stents; Fem | 2015 |
Rapid diagnosis of cardiac tamponade using pulsatility index variability in a patient with a HeartWare ventricular assist device.
Topics: Anticoagulants; Aspirin; Cardiac Tamponade; Diastole; Heart Failure; Heart-Assist Devices; Humans; H | 2015 |
[Management of patients with ischemic heart disease in lung cancer resection].
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Female; Heparin; H | 2015 |
Effects of anticoagulants on outcome of femoral neck fracture surgery.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Clopidogrel; Female; Femoral Neck Fractures; Human | 2015 |
Staged venous thromboemolic events prophylaxis with low-molecular-weight heparin followed by aspirin is safe and effective after arthroplasty.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Hip | 2015 |
Double antiplatelet therapy duration: standardize or personalize?
Topics: Aspirin; Female; Humans; Male; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet A | 2015 |
Pre-treatment with dual antiplatelet therapy in patients with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention.
Topics: Acute Coronary Syndrome; Aged; Aspirin; Australia; Clopidogrel; Female; Hemorrhage; Humans; Logistic | 2015 |
Impact of bridging with perioperative low-molecular-weight heparin on cardiac and bleeding outcomes of stented patients undergoing non-cardiac surgery.
Topics: Acute Coronary Syndrome; Aged; Aspirin; Comorbidity; Coronary Disease; Coronary Restenosis; Drug Sub | 2015 |
Does aspirin administration increase perioperative morbidity in patients with cardiac stents undergoing spinal surgery?
Topics: Aged; Aspirin; Cardiac Surgical Procedures; Cohort Studies; Endovascular Procedures; Female; Humans; | 2015 |
Perioperative Management of Antiplatelets and Anticoagulants Among Patients Undergoing Elective Transurethral Resection of the Prostate--A Single Institution Experience.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Aspirin, Dipyridamole Drug Combination; Clopidogre | 2015 |
[The ISAR-SAFE study].
Topics: Aspirin; Cardiovascular Diseases; Clopidogrel; Coronary Disease; Coronary Restenosis; Drug Administr | 2015 |
Clopidogrel response variability is associated with endothelial dysfunction in coronary artery disease patients receiving dual antiplatelet therapy.
Topics: Activation, Metabolic; Aged; Aspirin; Brachial Artery; Clopidogrel; Coronary Disease; Cytochrome P-4 | 2015 |
Antithrombotic drugs and subarachnoid haemorrhage risk. A nationwide case-control study in Denmark.
Topics: Aged; Aspirin; Case-Control Studies; Clopidogrel; Denmark; Drug Therapy, Combination; Female; Fibrin | 2015 |
Antithrombotic strategy after bioprosthetic aortic valve replacement in patients in sinus rhythm: evaluation of guideline implementation.
Topics: Acenocoumarol; Aged; Aged, 80 and over; Aortic Valve; Aspirin; Bioprosthesis; Electrocardiography; F | 2016 |
Independent Predictors of Major Adverse Events following Coronary Stenting over 28 Months of Follow-Up.
Topics: Acute Coronary Syndrome; Adult; Aged; Aspirin; Case-Control Studies; Clopidogrel; Coronary Angiograp | 2015 |
Impact of Clinical Presentation on Dual Antiplatelet Therapy Duration: Let's Re-Evaluate Our Priorities.
Topics: Aspirin; Female; Humans; Male; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet A | 2015 |
Reply: Impact of Clinical Presentation on Dual Antiplatelet Therapy Duration: Let's Re-Evaluate Our Priorities.
Topics: Aspirin; Female; Humans; Male; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet A | 2015 |
Accumetrics-based clopidogrel dosing in endovascular neurosurgery.
Topics: Aged; Aspirin; Cerebral Hemorrhage; Clopidogrel; Drug Therapy, Combination; Endovascular Procedures; | 2015 |
Use of Health Care System-Supplied Aspirin by Veterans With Postoperative Heart Attack or Unstable Angina.
Topics: Aged; Angina, Unstable; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiology; Evidence-Based | 2015 |
Aspirin resistance: A role in left ventricular assist device thrombosis?
Topics: Aspirin; Drug Resistance; Female; Heart-Assist Devices; Humans; Middle Aged; Postoperative Complicat | 2015 |
Thromboembolic stroke in patients with a HeartMate-II left ventricular assist device - the role of anticoagulation.
Topics: Adult; Anticoagulants; Aspirin; Female; Heart Failure; Heart-Assist Devices; Heparin; Humans; Intern | 2015 |
Analysis of Dual Antiplatelet Therapy.
Topics: Aspirin; Female; Humans; Male; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet A | 2015 |
Reply: Analysis of Dual Antiplatelet Therapy.
Topics: Aspirin; Female; Humans; Male; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet A | 2015 |
Outcomes of Laparoscopic Partial Nephrectomy in Patients Continuing Aspirin Therapy.
Topics: Aspirin; Blood Loss, Surgical; Feasibility Studies; Humans; Laparoscopy; Length of Stay; Nephrectomy | 2016 |
It Is Not Mandatory to Use Triple Rather Than Dual Anti-Platelet Therapy After a Percutaneous Coronary Intervention With a Second-Generation Drug-Eluting Stent.
Topics: Adult; Aged; Aspirin; Cilostazol; Clopidogrel; Drug Therapy, Combination; Drug-Eluting Stents; Evero | 2015 |
Insufficient platelet inhibition and thromboembolic complications in patients with intracranial aneurysms after stent placement.
Topics: Adult; Aged; Aspirin; Clopidogrel; Drug Resistance; Female; Humans; Intracranial Aneurysm; Male; Mid | 2016 |
Cochlear Implantation in the Setting of Perioperative Anticoagulation and Antiplatelet Therapy.
Topics: Aged; Anticoagulants; Aspirin; Blood Loss, Surgical; Clopidogrel; Cochlear Implantation; Female; Hem | 2016 |
Clinical Performance of the 1st American Academy of Orthopaedic Surgeons Clinical Guideline on Prevention of Symptomatic Pulmonary Embolism after Total Knee Arthroplasty in Korean Patients.
Topics: Aged; Arthroplasty, Replacement, Knee; Aspirin; Cohort Studies; Enoxaparin; Female; Fibrinolytic Age | 2015 |
[Case-control study on three antithrombotic agents for the prevention of venous thromboembolism after unilateral total knee arthroplasty].
Topics: Aged; Arthroplasty, Replacement, Knee; Aspirin; Case-Control Studies; Female; Fibrinolytic Agents; H | 2015 |
Late Major Hemoptysis After Lung Volume Reduction With Coils Induced by Dual Antiaggregation Therapy.
Topics: Aspirin; Clopidogrel; Hemoptysis; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Pneumo | 2016 |
What is the appropriate duration of dual antiplatelet therapy?
Topics: Aspirin; Drug Therapy, Combination; Drug-Eluting Stents; Humans; Percutaneous Coronary Intervention; | 2016 |
Taking aspirin before coronary artery surgery does not increase deaths or bleeding, study shows.
Topics: Aspirin; Coronary Artery Bypass; Female; Humans; Male; Platelet Aggregation Inhibitors; Postoperativ | 2016 |
[Mechanic valve prosthesis and pregnancy: Is Phenprocoumon replaceable?].
Topics: Abortion, Missed; Adult; Aortic Valve; Aspirin; Drug Substitution; Drug Therapy, Combination; Female | 2016 |
Antiplatelet therapy: Safe to continue aspirin therapy before CABG surgery.
Topics: Aspirin; Coronary Artery Bypass; Female; Humans; Male; Platelet Aggregation Inhibitors; Postoperativ | 2016 |
[Acetylsalicylic acid-renaissance with venous thrombosis? ].
Topics: Aspirin; Humans; Platelet Aggregation Inhibitors; Postoperative Complications; Venous Thrombosis | 2016 |
Association between Postprocedural Infarction and Antiplatelet Drug Resistance after Coiling for Unruptured Intracranial Aneurysms.
Topics: Aged; Aspirin; Cerebral Infarction; Drug Resistance; Female; Humans; Intracranial Aneurysm; Magnetic | 2016 |
Aspirin Can Be Used as Prophylaxis for Prevention of Venous Thromboembolism After Revision Hip and Knee Arthroplasty.
Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Fema | 2016 |
Is preoperative withdrawal of aspirin necessary in patients undergoing elective inguinal hernia repair?
Topics: Adult; Aged; Aspirin; Blood Loss, Surgical; Drug Administration Schedule; Elective Surgical Procedur | 2016 |
Antiplatelet and Anticoagulant Medications Significantly Increase the Risk of Postoperative Hematoma: Review of over 4500 Thyroid and Parathyroid Procedures.
Topics: Anticoagulants; Aspirin; Clopidogrel; Female; Hematoma; Humans; Male; Middle Aged; Parathyroidectomy | 2016 |
Aspirin - have we had the answer all along?
Topics: Arthroplasty, Replacement; Aspirin; Chemoprevention; Humans; Platelet Aggregation Inhibitors; Postop | 2016 |
Fatal pulmonary embolism following elective total hip arthroplasty: a 12-year study.
Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Aspirin; Chemoprevention; Clinical Audit; Elec | 2016 |
Complication of Stenting in Intracranial Arterial Stenosis.
Topics: Age Factors; Aged; Angioplasty; Aspirin; China; Clopidogrel; Computed Tomography Angiography; Constr | 2016 |
Associations between antithrombotic therapy and the risk of perioperative complications among patients undergoing laparoscopic gastrectomy.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Blood Loss, Surgical; Female; Fibrinolytic Agents; Gastrect | 2017 |
Contemporary imaging following atrial redirection surgery for transposition of the great arteries.
Topics: Adult; Arterial Switch Operation; Aspirin; Echocardiography, Doppler, Color; Fibrinolytic Agents; Hu | 2016 |
Ticagrelor for left ventricular assist device thrombosis: A new therapeutic option to be evaluated with caution.
Topics: Adenosine; Aged; Aspirin; Blood Coagulation; Cardiomyopathies; Clopidogrel; Drug Substitution; Drug | 2016 |
Aspirin before Coronary Artery Surgery.
Topics: Aspirin; Coronary Artery Bypass; Female; Humans; Male; Platelet Aggregation Inhibitors; Postoperativ | 2016 |
Aspirin before Coronary Artery Surgery.
Topics: Aspirin; Coronary Artery Bypass; Female; Humans; Male; Platelet Aggregation Inhibitors; Postoperativ | 2016 |
Aspirin before Coronary Artery Surgery.
Topics: Aspirin; Coronary Artery Bypass; Female; Humans; Male; Platelet Aggregation Inhibitors; Postoperativ | 2016 |
The Effect of Antiplatelet Agents on Bleeding-Related Complications After Ureteroscopy.
Topics: Adenosine; Adult; Aged; Anticoagulants; Aspirin; Blood Platelets; Clopidogrel; Female; Hemorrhage; H | 2016 |
CASE 11-2016 Perioperative Coronary Thrombosis in a Patient With Multiple Second-Generation Drug-Eluting Stents: Is It Time for a Paradigm Shift?
Topics: Analgesics, Opioid; Anti-Arrhythmia Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clopid | 2016 |
Clopidogrel use After Myocardial Revascularization: Prevalence, Predictors, and One-Year Survival Rate.
Topics: Aspirin; Cardiopulmonary Bypass; Clopidogrel; Coronary Artery Bypass; Drug Therapy, Combination; Fem | 2016 |
Efficacy and Safety of Dual Antiplatelet Therapy After Complex PCI.
Topics: Aspirin; Clopidogrel; Drug Therapy, Combination; Drug-Eluting Stents; Female; Humans; Male; Middle A | 2016 |
Impact of Anticoagulant and Antiplatelet Drugs on Perioperative Outcomes of Robotic-assisted Partial Nephrectomy.
Topics: Administration, Oral; Aged; Anticoagulants; Aspirin; Clopidogrel; Dose-Response Relationship, Drug; | 2017 |
Prasugrel versus clopidogrel in stent-assisted coil embolization of unruptured intracranial aneurysms.
Topics: Adult; Aged; Aspirin; Clopidogrel; Combined Modality Therapy; Drug Therapy, Combination; Embolizatio | 2017 |
Impact of different antithrombotics on the microcirculation and viability of perforator-based ischaemic skin flaps in a small animal model.
Topics: Animals; Aspirin; Clopidogrel; Disease Models, Animal; Fibrinolytic Agents; Graft Survival; Heparin; | 2016 |
Do Antiplatelet and Anticoagulation Agents Matter after Repair of Traumatic Arterial Injuries?
Topics: Anticoagulants; Arteries; Aspirin; Case-Control Studies; Chi-Square Distribution; Female; Follow-Up | 2016 |
Can TAVI patients receive aspirin monotherapy as patients after surgical aortic bioprosthesis implantation? Data from the Polish Registry - POL-TAVI.
Topics: Adult; Aged; Aged, 80 and over; Aortic Valve Stenosis; Aspirin; Bioprosthesis; Female; Heart Valve P | 2017 |
Transcatheter left atrial appendage occlusion in patients with atrial fibrillation and a high bleeding risk using aspirin alone for post-implant antithrombotic therapy.
Topics: Aged; Aged, 80 and over; Aspirin; Atrial Fibrillation; Cardiac Surgical Procedures; Endovascular Pro | 2017 |
Dual Antiplatelet Therapy Versus Aspirin Monotherapy in Diabetics With Multivessel Disease Undergoing CABG: FREEDOM Insights.
Topics: Acute Coronary Syndrome; Aged; Aspirin; Cause of Death; Clopidogrel; Diabetic Angiopathies; Drug The | 2017 |
Low-Dose Aspirin Is Effective Chemoprophylaxis Against Clinically Important Venous Thromboembolism Following Total Joint Arthroplasty: A Preliminary Analysis.
Topics: Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Chemoprevention; Cross-Ove | 2017 |
The CYP2C19*2 and CYP2C19*17 Polymorphisms play a Vital Role in Clopidogrel Responsiveness after Percutaneous Coronary Intervention: A Pharmacogenomics Study.
Topics: Aged; Aspirin; Clopidogrel; Coronary Artery Disease; Cytochrome P-450 CYP2C19; Female; Gene Frequenc | 2017 |
Reversible thrombotic mitral valve stenosis after transcatheter mitral valve replacement (TMVR): Is life-long anticoagulation therapy necessary?
Topics: Aged; Anticoagulants; Aspirin; Bioprosthesis; Cardiac Catheterization; Clopidogrel; Female; Heart Va | 2017 |
Intermittent Pneumatic Compression for the Prevention of Venous Thromboembolism after Total Hip Arthroplasty.
Topics: Adult; Age Factors; Aged; Arthroplasty, Replacement, Hip; Asian People; Aspirin; Computed Tomography | 2017 |
Thromboprophylaxis for patients at high risk of VTE.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Heparin; Humans; Postoperative Com | 2008 |
Regional anesthesia, compression, and aspirin is the safest form of prophylaxis for hip and knee arthroplasty.
Topics: Anesthesia, Conduction; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Hu | 2008 |
VTE prevention in major orthopedic surgery.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Aspirin; Fondaparinux; Heparin, Low-Molecular-Weight | 2008 |
Evaluation of deep venous thrombosis prophylaxis in low-risk patients undergoing total knee arthroplasty.
Topics: Arthroplasty, Replacement, Knee; Aspirin; Female; Humans; Male; Middle Aged; Postoperative Complicat | 2008 |
Low incidence of neurologic events during long-term support with the HeartMate XVE left ventricular assist device.
Topics: Adult; Aged; Aspirin; Brain Diseases, Metabolic; Cardiomyopathy, Dilated; Cause of Death; Cognition | 2008 |
Short- and long-term efficacy of aspirin and clopidogrel for thromboprophylaxis for mechanical heart valves: an in vivo study in swine.
Topics: Administration, Oral; Animals; Aspirin; Bioprosthesis; Clopidogrel; Dalteparin; Disease Models, Anim | 2008 |
Risk factors for chemotherapy-associated liver injuries: A multivariate analysis of a group of 146 patients with colorectal metastases.
Topics: Aged; Antineoplastic Agents; Aspirin; Chemical and Drug Induced Liver Injury; Colorectal Neoplasms; | 2009 |
[Postoperative ischemic acute stroke and thrombolytic therapy].
Topics: Acute Disease; Aged; Anticoagulants; Aphasia, Broca; Aspirin; Cholesteatoma; Ear Diseases; Ear, Exte | 2009 |
[Do antiplatelet agents (aspirin and other antiplatelets such as clopidogrel) increase the risk of hemorrhagic complications after endoscopic polypectomy or endoscopic sphincterotomy and should these drugs therefore be withdrawn 7-10 days before these pro
Topics: Aspirin; Clopidogrel; Colonic Polyps; Colonoscopy; Hemorrhage; Humans; Platelet Aggregation Inhibito | 2009 |
Dual antiplatelet therapy after percutaneous coronary intervention with stent implantation in patients taking chronic oral anticoagulation.
Topics: Administration, Oral; Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Restenosi | 2008 |
Atrial septal defect closure and migraine with aura: is there a correlation?
Topics: Adult; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Brain; Cardiac Surgical Procedu | 2009 |
A very late stent thrombosis in a patient with diabetes: a call for lifelong dual anti-platelet therapy.
Topics: Aspirin; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Follow-Up Studies; Graft Occlusio | 2009 |
Incidence of thromboembolic complications in lumbar spinal surgery in 1,111 patients.
Topics: Anticoagulants; Aspirin; Female; Humans; Iatrogenic Disease; Incidence; Intermittent Pneumatic Compr | 2009 |
[Percutaneous endoscopic gastrostomy. Complications with and without anticoagulation].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Child; Child, Preschool; Clopid | 2010 |
New observations in postpartum ovarian vein thrombosis: experience of single center.
Topics: Adult; Anticoagulants; Aspirin; Cesarean Section; Early Diagnosis; Enoxaparin; Female; Humans; Incid | 2010 |
Does aspirin have a role in venous thromboembolism prophylaxis in total knee arthroplasty patients?
Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Knee; Aspirin; Cohort Studies; Female; Fondaparinux | 2010 |
SCIP: VTE prevention controversy.
Topics: Aspirin; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Postoperative Complications; Quality A | 2009 |
A comparison of methods used for the prevention of venous thromboembolic disease among orthopaedic surgeons at Wolverhampton, United Kingdom and Auckland, New Zealand.
Topics: Anticoagulants; Aspirin; Heparin, Low-Molecular-Weight; Humans; Intermittent Pneumatic Compression D | 2009 |
P2Y12 inhibitors: thienopyridines and direct oral inhibitors.
Topics: Acute Coronary Syndrome; Adenosine; Angioplasty, Balloon, Coronary; Aspirin; Atherosclerosis; Corona | 2009 |
[Paraplegia following a transurethral prostate resection: the anterior spinal artery syndrome].
Topics: Aged; Anesthesia, Spinal; Anterior Spinal Artery Syndrome; Aspirin; Humans; Male; Paraplegia; Platel | 2009 |
Aspirin and clopidogrel use in the early postoperative period following on-pump and off-pump coronary artery bypass grafting.
Topics: Adult; Aspirin; Clopidogrel; Coronary Artery Bypass; Coronary Artery Bypass, Off-Pump; Female; Human | 2009 |
Safety of carotid endarterectomy while on clopidogrel (Plavix). Clinical article.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Blood Loss, Surgical; Clopidogrel; Cohort Studies; Edema; E | 2010 |
Lack of complications in skin surgery of patients receiving clopidogrel as compared with patients taking aspirin, warfarin, and controls.
Topics: Aged; Anticoagulants; Aspirin; Case-Control Studies; Clopidogrel; Dermatologic Surgical Procedures; | 2010 |
Strategy to prevent recurrent portal vein stenosis following interventional radiology in pediatric liver transplantation.
Topics: Adolescent; Adult; Anticoagulants; Aspirin; Catheterization; Child; Child, Preschool; Constriction, | 2010 |
Letter by Doraiswamy regarding article, "Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: results from the double-blind, prospective, randomized Tailoring
Topics: Anticoagulants; Aspirin; Clopidogrel; Confounding Factors, Epidemiologic; Double-Blind Method; Drug | 2010 |
[Comment about patients with dual antiplatelet therapy].
Topics: Anticoagulants; Aspirin; Blood Loss, Surgical; Clopidogrel; Contraindications; Drug Therapy, Combina | 2010 |
I had two stents put in during the past year, but I'm going to have a hip replacement soon. Are there any heart-related or stent related precautions my doctor and I should take before the surgery?
Topics: Angioplasty, Balloon, Coronary; Arthroplasty, Replacement, Hip; Aspirin; Clopidogrel; Drug-Eluting S | 2009 |
Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy.
Topics: Anticoagulants; Aspirin; Drug Administration Schedule; Female; Heart Failure; Heart Transplantation; | 2010 |
Dual antiplatelet therapy prior to carotid endarterectomy reduces post-operative embolisation and thromboembolic events: post-operative transcranial Doppler monitoring is now unnecessary.
Topics: Aged; Angioscopy; Anticoagulants; Aspirin; Clopidogrel; Dextrans; Drug Therapy, Combination; Endarte | 2010 |
Clinical pharmacology: antiplatelet therapy during surgery.
Topics: Aspirin; Blood Loss, Surgical; Clopidogrel; Humans; Perioperative Care; Platelet Aggregation Inhibit | 2010 |
Steps to preventing DVT for outpatients.
Topics: Age Factors; Ambulatory Surgical Procedures; Anticoagulants; Aspirin; Humans; Outpatients; Postopera | 2010 |
[Thrombotic microangiopathy after extracorporeal circulation: important differential diagnosis].
Topics: ADAM Proteins; ADAMTS13 Protein; Aged, 80 and over; Aortic Diseases; Aspirin; Coma; Critical Care; D | 2011 |
Long-term anticoagulation with fondaparinux in a patient with a mechanical heart valve.
Topics: Anticoagulants; Aortic Valve Stenosis; Aspirin; Drug Therapy, Combination; Fondaparinux; Heart Valve | 2011 |
Variation in anticoagulation prophylaxis practice after Fontan: a call for a national Fontan registry.
Topics: Anticoagulants; Aspirin; Fontan Procedure; Health Care Surveys; Humans; Platelet Aggregation Inhibit | 2011 |
Page kidney Doppler ultrasound.
Topics: Aspirin; Diagnosis, Differential; Diastole; Hematoma; Humans; Hypertension, Renal; Kidney Diseases; | 2011 |
Effect of timing of chronic preoperative aspirin discontinuation on morbidity and mortality in coronary artery bypass surgery.
Topics: Aged; Aspirin; Blood Loss, Surgical; Blood Transfusion; Coronary Artery Bypass; Female; Hospital Mor | 2011 |
Immortal person-time bias in observational studies in cardiac surgery.
Topics: Aspirin; Bias; Clopidogrel; Coronary Artery Bypass; Data Interpretation, Statistical; Drug Therapy, | 2011 |
[Preoperative analysis of platelet aggregability in carotid surgery].
Topics: Aged; Aged, 80 and over; Aspirin; Carotid Arteries; Clopidogrel; Endarterectomy, Carotid; Female; Hu | 2011 |
Complications of cutaneous surgery in patients taking clopidogrel-containing anticoagulation.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Clopidogrel; Dermatologic Surgical Procedures; Fem | 2011 |
Thromboembolic events are uncommon after open treatment of proximal humerus fractures using aspirin and compression devices.
Topics: Aspirin; Comorbidity; Early Ambulation; Female; Fracture Fixation, Internal; Humans; Incidence; Male | 2011 |
Long-term follow-up of liver transplantation for Budd-Chiari syndrome with antithrombotic therapy based on the etiology.
Topics: Adolescent; Adult; Anticoagulants; Aspirin; Budd-Chiari Syndrome; Child; Female; Fibrinolytic Agents | 2011 |
Risk assessment of simple phacoemulsification in patients on combined anticoagulant and antiplatelet therapy.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Blood Loss, Surgical; Clopidogrel; Drug Therapy, C | 2011 |
Low-dose versus high-dose aspirin after percutaneous coronary intervention: analysis from the guthrie health off-label StenT (GHOST) registry.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Cohort Studies; Coronary Artery Disease; Delivery of | 2011 |
Emergency surgery following trancutaneous aortic valve insertion.
Topics: Aged, 80 and over; Aortic Valve; Aspirin; Blood Loss, Surgical; Clopidogrel; Emergency Medical Servi | 2011 |
Anticoagulation and clinically significant postoperative vitreous hemorrhage in diabetic vitrectomy.
Topics: Anticoagulants; Aspirin; Clopidogrel; Diabetic Retinopathy; Female; Humans; Incidence; Intraoperativ | 2011 |
Experience with distal finger replantation: a 20-year retrospective study from a major trauma center.
Topics: Adult; Amputation, Traumatic; Anastomosis, Surgical; Animals; Anticoagulants; Aspirin; Dipyridamole; | 2011 |
Thrombus formation on a left atrial appendage closure device.
Topics: Aged; Anticoagulants; Aspirin; Atrial Appendage; Atrial Fibrillation; Clopidogrel; Equipment Design; | 2011 |
Preoperative aspirin use and outcomes in cardiac surgery patients.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiovascular Surgical Procedures; Female; | 2012 |
Illustration of the impact of antiplatelet drugs on the genesis and management of chronic subdural hematoma.
Topics: Aged; Aged, 80 and over; Aspirin; Cerebral Hemorrhage; Clopidogrel; Drug Therapy, Combination; Hemat | 2012 |
Pre-operative risk factors and clinical outcomes associated with vasoplegia in recipients of orthotopic heart transplantation in the contemporary era.
Topics: Adult; Aged; Aspirin; Body Mass Index; Cohort Studies; Female; Heart Transplantation; Heart-Assist D | 2012 |
Timing of preoperative aspirin discontinuation and outcome after elective coronary artery bypass graft surgery.
Topics: Aged; Aspirin; Coronary Artery Bypass; Elective Surgical Procedures; Female; Humans; Male; Middle Ag | 2012 |
Little impact of antiplatelet agents on venous thromboembolism after hip fracture surgery.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Female; Hip Fractures; Humans; | 2011 |
[Thyrotoxicosis induced by subacute thyroiditis after surgery for a thyrotropinoma].
Topics: Adenoma; Adult; Aspirin; Female; Humans; Magnetic Resonance Imaging; Octreotide; Pituitary Gland, An | 2012 |
Effect of timing of chronic preoperative aspirin discontinuation on morbidity and mortality in patients having combined coronary artery bypass grafting and valve surgery.
Topics: Aged; Aspirin; Coronary Artery Bypass; Coronary Artery Disease; Female; Fibrinolytic Agents; Follow- | 2012 |
[Use of a percutaneous suture-mediated closure system after 6 - 8F transfemoral approaches: results for 2200 patients].
Topics: Aged; Aged, 80 and over; Aneurysm, False; Angiography; Angioplasty; Anticoagulants; Aspirin; Female; | 2012 |
Successful use of glycoprotein IIb/IIIa inhibitor, heparin, and IABP during PCI in a post-neurosurgical patient with STEMI and cardiogenic shock due to very late bare-metal stent thrombosis.
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Heparin; Humans; Intra-Aortic | 2012 |
Catastrophic pulmonary and paradoxical embolism.
Topics: Angiography; Aspirin; Cardiac Surgical Procedures; Critical Illness; Echocardiography, Transesophage | 2011 |
Anatomical and visual results of transconjunctival sutureless vitrectomy using subconjunctival anesthesia performed on select patients taking anticoagulant and antiplatelet agents.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Local; Anesthetics, Local; Anticoagulants; Aspirin; Bupi | 2012 |
Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Atrial Fibrillation; Drug Administration Schedule; Elective | 2012 |
Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Atrial Fibrillation; Drug Administration Schedule; Elective | 2012 |
Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Atrial Fibrillation; Drug Administration Schedule; Elective | 2012 |
Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Atrial Fibrillation; Drug Administration Schedule; Elective | 2012 |
Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Topics: Aspirin; Catheterization; Combined Modality Therapy; Ductus Arteriosus, Patent; Evidence-Based Medic | 2012 |
Effects of preoperative aspirin on cardiocerebral and renal complications in non-emergent cardiac surgery patients: a sub-group and cohort study.
Topics: Aged; Aspirin; Cardiac Surgical Procedures; Cardiovascular Diseases; Case-Control Studies; Cohort St | 2012 |
Incidence of venous thromboembolism in elective foot and ankle surgery with and without aspirin prophylaxis.
Topics: Ankle; Aspirin; Female; Foot; Humans; Male; Platelet Aggregation Inhibitors; Postoperative Care; Pos | 2012 |
Initial experience with aspirin use during robotic radical prostatectomy.
Topics: Adult; Aged; Aspirin; Blood Loss, Surgical; Chi-Square Distribution; Hematocrit; Humans; Laparoscopy | 2012 |
Cardiology patient page: Aspirin.
Topics: Aspirin; Blood Coagulation; Cardiovascular Diseases; Coronary Artery Disease; Drug Therapy, Combinat | 2012 |
Bead-like coronary spasm.
Topics: Aspirin; Bradycardia; Calcium Channel Blockers; Chest Pain; Coronary Angiography; Coronary Stenosis; | 2012 |
Safety of withholding anticoagulation in patients with mechanical prosthetic valves and intracranial haemorrhage.
Topics: Adult; Anticoagulants; Aspirin; Atrial Fibrillation; Combined Modality Therapy; Comorbidity; Contrai | 2011 |
Safety of withholding anticoagulation in patients with mechanical prosthetic valves and intracranial haemorrhage.
Topics: Adult; Anticoagulants; Aspirin; Atrial Fibrillation; Combined Modality Therapy; Comorbidity; Contrai | 2011 |
Safety of withholding anticoagulation in patients with mechanical prosthetic valves and intracranial haemorrhage.
Topics: Adult; Anticoagulants; Aspirin; Atrial Fibrillation; Combined Modality Therapy; Comorbidity; Contrai | 2011 |
Safety of withholding anticoagulation in patients with mechanical prosthetic valves and intracranial haemorrhage.
Topics: Adult; Anticoagulants; Aspirin; Atrial Fibrillation; Combined Modality Therapy; Comorbidity; Contrai | 2011 |
Comparison of additional versus no additional heparin during therapeutic oral anticoagulation in patients undergoing percutaneous coronary intervention.
Topics: Administration, Oral; Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Atrial Fibrilla | 2012 |
Inpatient enoxaparin and outpatient aspirin chemoprophylaxis regimen after primary hip and knee arthroplasty: a preliminary study.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Body Mass | 2012 |
Timing of preoperative aspirin discontinuation and outcome after elective coronary artery bypass graft surgery: a role of platelet function assessment.
Topics: Aspirin; Coronary Artery Bypass; Elective Surgical Procedures; Female; Humans; Male; Postoperative C | 2012 |
Hemimandibulectomy and vascularized fibula flap in bisphosphonate-induced mandibular osteonecrosis with polycythaemia rubra vera.
Topics: Aged, 80 and over; Alendronate; Aspirin; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone De | 2013 |
Postoperative anticoagulation in patients with mechanical heart valves following surgical treatment of subdural hematomas.
Topics: Aged; Anticoagulants; Aspirin; Enoxaparin; Female; Follow-Up Studies; Heart Valve Prosthesis Implant | 2013 |
[Low-dose aspirin doesn't increase surgical bleeding nor transfusion rate in total knee arthroplasty].
Topics: Aged; Arthroplasty, Replacement, Knee; Aspirin; Blood Loss, Surgical; Blood Transfusion; Comorbidity | 2012 |
Utility of VasoCT in the treatment of intracranial aneurysm with flow-diverter stents.
Topics: Adult; Aged; Angiography, Digital Subtraction; Angioplasty, Balloon; Aspirin; Catheterization; Cereb | 2012 |
Aspirin for elective hip and knee arthroplasty: a multimodal thromboprophylaxis protocol.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arthroplasty, Replacement; Arthroplasty, Replacement, Hi | 2012 |
Combined clopidogrel and aspirin treatment up to surgery increases the risk of postoperative myocardial infarction, blood loss and reoperation for bleeding in patients undergoing coronary artery bypass grafting.
Topics: Aged; Aspirin; Blood Transfusion; Chi-Square Distribution; Clopidogrel; Coronary Artery Bypass; Fema | 2013 |
Perioperative management of a neurosurgical patient requiring antiplatelet therapy.
Topics: Aged; Aspirin; Cerebral Angiography; Clopidogrel; Humans; Intracranial Aneurysm; Intracranial Thromb | 2012 |
Long-term risk of vascular events after peripheral bypass surgery. A cohort study.
Topics: Administration, Oral; Aged; Aged, 80 and over; Amputation, Surgical; Anticoagulants; Aspirin; Blood | 2012 |
Early postmarket results after treatment of intracranial aneurysms with the pipeline embolization device: a U.S. multicenter experience.
Topics: Aged; Aspirin; Blood Vessel Prosthesis; Embolization, Therapeutic; Female; Fibrinolytic Agents; Foll | 2012 |
[Postoperative cortical blindness after right upper lung lobectomy].
Topics: Anticoagulants; Aspirin; Blindness, Cortical; Brain Ischemia; Cerebellum; Cerebral Angiography; Colo | 2012 |
Successful resection of complicated bleeding arteriovenous malformation of the jejunum in patients starting dual-antiplatelet therapy just after implanting a drug-eluting coronary stent.
Topics: Arteriovenous Malformations; Aspirin; Clopidogrel; Drug-Eluting Stents; Gastrointestinal Hemorrhage; | 2012 |
Effect of postoperative aspirin on outcomes in microvascular free tissue transfer surgery.
Topics: Adult; Analysis of Variance; Aspirin; Chi-Square Distribution; Cohort Studies; Databases, Factual; F | 2013 |
Ketorolac-associated renal morbidity: risk factors in cardiac surgical infants.
Topics: Acute Kidney Injury; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiac Surgical Procedures; | 2013 |
Bleeding risk after invasive procedures in aspirin/NSAID users: polypectomy study in veterans.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cohort Studies; Colonic Polyps; Colonoscopy; | 2012 |
Clopidogrel and aspirin administration management prior to coronary artery surgery requires an individual approach.
Topics: Aspirin; Coronary Artery Bypass; Female; Humans; Male; Myocardial Infarction; Platelet Aggregation I | 2013 |
Continued concern about parent vessel steno-occlusive progression with Onyx HD-500 and the utility of quantitative magnetic resonance imaging in serial assessment.
Topics: Angioplasty; Aspirin; Carotid Artery Diseases; Carotid Stenosis; Clopidogrel; Constriction, Patholog | 2013 |
Friend or foe? Discussion about dual platelet inhibition as a salvage procedure from imminent flap failure.
Topics: Aspirin; Clopidogrel; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Mamma | 2013 |
Reversible cerebral vasoconstriction syndrome and bilateral vertebral artery dissection presenting in a patient after cesarean section.
Topics: Aspirin; Cerebral Angiography; Cesarean Section; Clopidogrel; Female; Headache; Humans; Magnetic Res | 2013 |
Thromboembolism after total knee arthroplasty: intermittent pneumatic compression and aspirin prophylaxis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Arthroplasty, Replacement, | 2001 |
[Long-term anticoagulation after bypass operation].
Topics: Arterial Occlusive Diseases; Aspirin; Clopidogrel; Humans; Long-Term Care; Platelet Aggregation Inhi | 2002 |
Aspirin with bypass surgery--from taboo to new standard of care.
Topics: Aspirin; Coronary Artery Bypass; Coronary Disease; Drug Administration Schedule; Humans; Inflammatio | 2002 |
Need for emergency CABG decreases, but morbidity and mortality remain high.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Coronary Artery Bypass; Emergencies; Homocysteine; Humans; | 2002 |
Early bioprosthetic mitral valve "pseudostenosis" after complete preservation of the native mitral apparatus.
Topics: Aged; Aspirin; Bioprosthesis; Combined Modality Therapy; Coronary Artery Bypass; Drug Therapy, Combi | 2002 |
Serious adverse vascular events associated with perioperative interruption of antiplatelet and anticoagulant therapy.
Topics: Aged; Anticoagulants; Aspirin; Carcinoma, Basal Cell; Clopidogrel; Drug Administration Schedule; Fem | 2002 |
[Staphylococcus epidermidis infective endocarditis after mitral surgery, successfully treated with aspirin and antibiotics: a case report].
Topics: Adult; Anti-Bacterial Agents; Aspirin; Endocarditis, Bacterial; Female; Humans; Mitral Valve; Platel | 2000 |
Thrombotic complications related to discontinuation of warfarin and aspirin therapy perioperatively for cutaneous operation.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Female; Humans; Ischemic Attack, Transient; Male; | 2003 |
A multimodality regimen for deep venous thrombosis prophylaxis in total knee arthroplasty.
Topics: Aged; Arthroplasty, Replacement, Knee; Aspirin; Bandages; Chemoprevention; Combined Modality Therapy | 2003 |
The effects of aspirin and warfarin therapy on haemorrhage in vitreoretinal surgery.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Child; Choroid Hemorrhage; Cont | 2003 |
Aspirin and mortality from coronary bypass surgery.
Topics: Aspirin; Coronary Artery Bypass; Humans; Platelet Aggregation Inhibitors; Postoperative Care; Postop | 2003 |
Aspirin and mortality from coronary bypass surgery.
Topics: Aspirin; Coronary Artery Bypass; Platelet Aggregation Inhibitors; Postoperative Care; Postoperative | 2003 |
Successful control of postsurgical bleeding by recombinant factor VIIa in a renal failure patient given low molecular weight heparin and aspirin.
Topics: Adult; Anticoagulants; Arteriovenous Shunt, Surgical; Aspirin; Factor VIIa; Female; Hemorrhage; Hepa | 2003 |
Outcome of aspirin use during excision of cutaneous lesions.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Hemostasis, Surgical; Humans; Incidence; Mi | 2003 |
Effect of preoperative aspirin use in off-pump coronary artery bypass operations.
Topics: Aged; Aspirin; Blood Transfusion; Case-Control Studies; Coronary Artery Bypass; Coronary Disease; Fe | 2003 |
["How must deep leg venous thrombosis be diagnosed and treated?"].
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Aspirin; Blood Coagulation Tests; Blood Viscosity; F | 2003 |
Veterans Affairs (VA) Cooperative Study #362.
Topics: Aspirin; Cohort Studies; Female; Graft Rejection; Graft Survival; Hospitals, Veterans; Humans; Male; | 2003 |
PRIMARY STAPHYLOCOCCAL PERICARDITIS COMPLICATING CARDIOTOMY: A REPORT OF A CASE WITH A NOTE ON INTRAPERICARDIAL METHICILLIN THERAPY.
Topics: Aspirin; Bacterial Infections; Cardiac Surgical Procedures; Methicillin; Penicillins; Pericarditis; | 1964 |
METHYLPREDNISOLONE-ASPIRIN IN OROFACIAL SURGERY: CONTROLLED CLINICAL TRIAL.
Topics: Aspirin; Face; Humans; Methylprednisolone; Pain; Postoperative Complications; Surgical Procedures, O | 1964 |
[POSTCOMMISSUROTOMY SYNDROME].
Topics: Adrenal Cortex Hormones; Aspirin; Cardiac Surgical Procedures; Mitral Valve; Postoperative Complicat | 1964 |
[CLINICAL EXPERIMENTATION WITH TH-2152 IN GYNECOLOGY AND OBSTETRICS].
Topics: Analgesia; Aspirin; Bicarbonates; Biomedical Research; Dysmenorrhea; Female; Gynecology; Headache; H | 1964 |
A CASE OF THE BEMUSED MEDIC.
Topics: Aspirin; Colon; Depression; Diagnosis, Differential; Diverticulitis; Diverticulitis, Colonic; Gastro | 1964 |
Aspirin and microvascular surgery: an update.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Humans; Microcirculation; Postoperative Complicati | 2003 |
Clinical significance of PlA polymorphism of platelet GP IIb/IIIa receptors during long-term VAD support.
Topics: Anticoagulants; Aspirin; Female; Genotype; Heart-Assist Devices; Humans; Male; Middle Aged; Phenproc | 2004 |
If there's smoke, is there fire?
Topics: Aspirin; Clopidogrel; Drug Therapy, Combination; Endarterectomy, Carotid; Endpoint Determination; Hu | 2004 |
Thrombosis and neointima formation in vein grafts are inhibited by locally applied aspirin through endothelial protection.
Topics: Animals; Arteriosclerosis; Aspirin; Blood Vessel Prosthesis Implantation; Carotid Arteries; Disease | 2004 |
Clinical application of bidirectional Glenn shunt with off-pump technique.
Topics: Adolescent; Adult; Arteriovenous Shunt, Surgical; Aspirin; Blood Pressure; Cardiopulmonary Bypass; C | 2004 |
Late incidence and determinants of stroke after aortic and mitral valve replacement.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aortic Valve; Aspirin; Atrial Fibrillation; Cerebral | 2004 |
Low-dose aspirin therapy is associated with improved allograft function and prolonged allograft survival after kidney transplantation.
Topics: Adult; Aspirin; Female; Graft Survival; Humans; Kidney Transplantation; Male; Middle Aged; Platelet | 2004 |
Multivessel distal sutureless off-pump coronary artery bypass grafting procedure using magnetic connectors.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Artery Bypass, Off-Pump; Corona | 2004 |
Anticoagulation interruptus: not without risk.
Topics: Anticoagulants; Aspirin; Atrial Appendage; Atrial Fibrillation; Blood Loss, Surgical; Carotid Arteri | 2004 |
[Interventional radiologic management for early post-transplant perfusion failure of renal allografts].
Topics: Aged; Angiography; Angiography, Digital Subtraction; Angioplasty, Balloon; Aspirin; Fibrinolytic Age | 2004 |
Does clopidogrel increase blood loss following coronary artery bypass surgery?
Topics: Aged; Aspirin; Blood Loss, Surgical; Blood Transfusion; Clopidogrel; Coronary Artery Bypass; Critica | 2004 |
[The use of thromboprophylaxis in Danish surgical departments. The results of the fifth survey].
Topics: Aspirin; Denmark; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Postoperative Complica | 2005 |
Effects of clopidogrel and high dose aspirin on survival of skin flaps in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clopidogrel; Dose-Response Relationship, | 2005 |
Reversible ischaemia after raising a radial forearm flap with ulceration of three fingers in a cigarette smoker.
Topics: Anticoagulants; Aspirin; Carcinoma, Squamous Cell; Fascia; Fibrinolytic Agents; Fingers; Forearm; He | 2006 |
Deep vein thrombosis prophylaxis: better living through chemistry--in the affirmative.
Topics: Anticoagulants; Arthroplasty, Replacement; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement | 2005 |
Deep venous thrombosis prophylaxis: better living through chemistry--in opposition.
Topics: Anticoagulants; Arthroplasty, Replacement; Aspirin; Humans; Postoperative Complications; Pulmonary E | 2005 |
Thromboembolic disease prophylaxis in total hip arthroplasty.
Topics: Arthroplasty, Replacement, Hip; Aspirin; California; Cause of Death; Evidence-Based Medicine; Exerci | 2005 |
Clopidogrel reduces migraine with aura after transcatheter closure of persistent foramen ovale and atrial septal defects.
Topics: Adult; Aspirin; Cardiac Catheterization; Clopidogrel; Drug Therapy, Combination; Female; Heart Septa | 2005 |
Preoperative aspirin therapy is associated with improved postoperative outcomes in patients undergoing coronary artery bypass grafting.
Topics: Aged; Aspirin; Cohort Studies; Coronary Artery Bypass; Coronary Disease; Drug Administration Schedul | 2005 |
Overestimation of platelet aspirin resistance detection by thrombelastograph platelet mapping and validation by conventional aggregometry using arachidonic acid stimulation.
Topics: Adult; Aged; Arachidonic Acid; Aspirin; Blood Platelets; Drug Resistance; Female; Humans; Male; Midd | 2005 |
The splenectomy controversy.
Topics: Anticoagulants; Aspirin; Gaucher Disease; Humans; Hypertension, Pulmonary; Postoperative Complicatio | 2005 |
Venous thromboembolism and fractured neck of femur.
Topics: Aged; Aged, 80 and over; Anesthesia; Anticoagulants; Aspirin; Blood Loss, Surgical; Blood Transfusio | 2005 |
Endothelial injury and acquired aspirin resistance as promoters of regional thrombin formation and early vein graft failure after coronary artery bypass grafting.
Topics: Aged; Aspirin; Coronary Artery Bypass, Off-Pump; Drug Resistance; Endothelium, Vascular; Female; Fib | 2006 |
Clopidogrel-aspirin inhibit the thrombogenicity of St. Jude mechanical aortic prostheses.
Topics: Aspirin; Clopidogrel; Heart Valve Diseases; Heart Valve Prosthesis Implantation; Humans; Patient Sel | 2006 |
Upper gastrointestinal bleeding after hip and knee arthroplasty.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Arthroplast | 2006 |
[Aspirin and risk of perioperative hemorrhage].
Topics: Anesthesia, Spinal; Aspirin; Germany; Humans; Platelet Aggregation Inhibitors; Postoperative Complic | 2006 |
Compatibility of carotid stenting and cardiac surgery.
Topics: Aspirin; Blood Loss, Surgical; Carotid Arteries; Carotid Stenosis; Humans; Platelet Aggregation Inhi | 2006 |
[Percutaneous closure of patent foramen ovale-- Against].
Topics: Aspirin; Evidence-Based Medicine; Heart Septal Defects, Atrial; Humans; Platelet Aggregation Inhibit | 2006 |
[Postoperative antithrombotic treatment in diabetic patients].
Topics: Anticoagulants; Aspirin; Clopidogrel; Coronary Artery Bypass; Coronary Artery Disease; Diabetes Mell | 2006 |
Absence epilepsy associated with moyamoya disease. Case report.
Topics: Anticonvulsants; Aspirin; Carotid Artery, Internal; Carotid Stenosis; Cerebral Angiography; Cerebral | 2006 |
Influence of cardiac risk factors and medication on length of hospitalization in patients undergoing major vascular surgery.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Age Factors; Aged; Aspirin; Cardiovascular Diseases; | 2006 |
Flexible versus nonflexible mitral valve rings for congestive heart failure: differential durability of repair.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Cardiomyopathy, Dilated; Combined Modality | 2006 |
Leaflet movement of the ATS valve in the aortic position: unique behavior observed in 19-mm valves.
Topics: Adolescent; Adult; Aged; Anticoagulants; Aortic Valve; Aortic Valve Insufficiency; Aortic Valve Sten | 2006 |
Ventricular assist device support in children and adolescents as a bridge to heart transplantation.
Topics: Adolescent; Anticoagulants; Aprotinin; Aspirin; Cardiomyopathy, Dilated; Child; Child, Preschool; Da | 2006 |
Impact of PlA polymorphism of platelet GP IIb/IIIa receptors on clinical course during long-term LVAD support is independent of type of LVAD.
Topics: Anticoagulants; Antigens, Human Platelet; Aspirin; Clopidogrel; Equipment Design; Genetic Predisposi | 2006 |
Surgical revascularisation in patients with severe limb ischaemia induces a pro-thrombotic state.
Topics: Aged; Aged, 80 and over; Antithrombin III; Arterial Occlusive Diseases; Aspirin; Blood Coagulation; | 2006 |
[Constrictive pericarditis after inferoposterior myocardial infarction].
Topics: Abciximab; Angioplasty, Balloon; Antibodies, Monoclonal; Anticoagulants; Aspirin; Heart Failure; Hep | 2006 |
Premature discontinuation of antiplatelet therapy in patients with drug-eluting coronary stents.
Topics: Aspirin; Clopidogrel; Coronary Restenosis; Coronary Vessels; Delayed-Action Preparations; Humans; Pa | 2006 |
Factors associated with prolonged wound drainage after primary total hip and knee arthroplasty.
Topics: Aged; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Body Mass Index; Dra | 2007 |
Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions,
Topics: Aspirin; Coronary Disease; Coronary Thrombosis; Drug Administration Schedule; Education, Professiona | 2007 |
Perioperative thrombotic risk of coronary artery stents: possible role for intravenous platelet blockade.
Topics: Aspirin; Clopidogrel; Coronary Thrombosis; Humans; Injections, Intravenous; Perioperative Care; Plat | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma | 2007 |
Symptomatic thromboembolism after one-stage bilateral THA with a multimodal prophylaxis protocol.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Aspirin; Clinical Protocols; Female; Humans; Inciden | 2007 |
[Postoperative nausea and vomiting after laparoscopic cholecystectomy under total intravenous anesthesia using propofol combined with fentanyl or pentazocine].
Topics: Acetaminophen; Anesthetics, Intravenous; Aspirin; Chlorpheniramine; Cholecystectomy, Laparoscopic; D | 2007 |
Hemorrhagic foreign body granuloma after cutaneous surgery occurring in the setting of aspirin therapy or thrombocytopenia: a presentation of six cases.
Topics: Aged; Aged, 80 and over; Aspirin; Biopsy; Diagnosis, Differential; Female; Fibrinolytic Agents; Gran | 2008 |
Ninety-day mortality after elective total hip replacement: 1549 patients using aspirin as a thromboprophylactic agent.
Topics: Arthroplasty, Replacement, Hip; Aspirin; England; Follow-Up Studies; Humans; Platelet Aggregation In | 2008 |
[Stents, antiplatelet therapy, and surgery].
Topics: Adult; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Cesarean Section; Enoxaparin; Female | 2008 |
Multimodal thromboprophylaxis following primary hip arthroplasty: the role of adjuvant intermittent pneumatic calf compression.
Topics: Adult; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Aspirin; Early Ambulation; Epidemiol | 2008 |
Sinonasal outcomes after endoscopic sinus surgery in asthmatic patients with nasal polyps: a difference between aspirin-tolerant and aspirin-induced asthma?
Topics: Adult; Aspirin; Asthma; Bleeding Time; Drug Hypersensitivity; Endoscopy; Female; Humans; Male; Middl | 2008 |
[The use of mefenamic acid in the treatment of postoperative pain. (Clinico-statistical data)].
Topics: Anti-Inflammatory Agents; Aspirin; Humans; ortho-Aminobenzoates; Pain; Postoperative Complications | 1966 |
[Prevention of postoperative thrombosis of the deep veins of the lower limbs].
Topics: Aspirin; Clothing; Dextrans; Dihydroergotamine; Early Ambulation; Heparin; Humans; Postoperative Com | 1984 |
Postoperative venous thrombosis. Evaluation of five methods of treatment.
Topics: Adult; Age Factors; Aged; Aspirin; Clothing; Dextrans; Female; Fibrinogen; Heparin; Humans; Iodine R | 1981 |
["Low-dose heparin" and other methods to prevent thrombo-embolism in gynaecological surgery (author's transl)].
Topics: Aspirin; Dextrans; Dose-Response Relationship, Drug; Escin; Female; Genital Diseases, Female; Hepari | 1980 |
[Prophylaxis of thrombosis in surgical gynecology and obstetrics (author's transl)].
Topics: Adult; Aged; Aspirin; Bandages; Dextrans; Dose-Response Relationship, Drug; Early Ambulation; Female | 1980 |
[Prevention of thrombosis].
Topics: Administration, Oral; Anticoagulants; Aspirin; Dextrans; Dose-Response Relationship, Drug; Heparin; | 1981 |
[Prevention of deep vein thrombosis and pulmonary thromboembolism].
Topics: Anticoagulants; Aspirin; Constriction; Dextrans; Electric Stimulation Therapy; Heparin; Humans; Phys | 1981 |
Preliminary experience with aspirin for anticoagulation in children with prosthetic cardiac valves.
Topics: Adolescent; Anticoagulants; Aortic Valve; Aspirin; Bioprosthesis; Child; Child, Preschool; Dicumarol | 1982 |
[Fatal pulmonary embolism after hip surgery].
Topics: Aspirin; Bandages; Dextrans; Early Ambulation; Hip Joint; Humans; Postoperative Complications; Pulmo | 1982 |
Prevention of postoperative deep venous thrombosis and pulmonary emboli with combined modalities.
Topics: Adult; Aged; Aspirin; Clothing; Combined Modality Therapy; Dextrans; Heparin; Humans; Middle Aged; M | 1983 |
Thromboembolism in orthopaedic surgery.
Topics: Adult; Anticoagulants; Aspirin; Dextrans; Dihydroergotamine; Heparin; Humans; Joint Prosthesis; Midd | 1984 |
Aspirin as an antithrombotic medication.
Topics: Arachidonic Acids; Aspirin; Epoprostenol; Humans; Platelet Aggregation; Postoperative Complications; | 1983 |
Salicylates and post-tonsillectomy haemorrhage.
Topics: Acetaminophen; Aspirin; Hemorrhage; Humans; Pain, Postoperative; Postoperative Complications; Prospe | 1984 |
Antithrombotic potential of low-dose aspirin.
Topics: Antifibrinolytic Agents; Aspirin; Humans; Postoperative Complications; Thromboembolism | 1984 |
Aspirin and postoperative hemorrhage.
Topics: Aspirin; Hemorrhage; Humans; Male; Middle Aged; Postoperative Complications | 1984 |
[Optimizing therapeutic success in aortocoronary bypass operations].
Topics: Aspirin; Coronary Artery Bypass; Coronary Disease; Humans; Myocardial Contraction; Postoperative Com | 1983 |
Dipyridamole and aspirin and patency of coronary bypass grafts.
Topics: Aspirin; Coronary Artery Bypass; Dipyridamole; Humans; Postoperative Complications | 1984 |
[Intimal hyperplasia in aorta adjacent to small diameter Gore-Tex graft in monkey and its reduction by antiplatelet therapy].
Topics: Animals; Aorta; Aspirin; Blood Platelets; Blood Vessel Prosthesis; Hyperplasia; Macaca fascicularis; | 1983 |
The incidence and natural history of pericardial effusion after cardiac surgery--an echocardiographic study.
Topics: Adult; Aged; Aspirin; Cardiac Surgical Procedures; Echocardiography; Female; Humans; Indomethacin; M | 1984 |
[Treatment of thrombotic occlusion of the pelvic and extremity veins. Comparison of three different types of treatment].
Topics: Adult; Aspirin; Drug Therapy, Combination; Female; Heparin; Humans; Male; Pelvis; Postoperative Comp | 1984 |
Acute bleeding emergencies.
Topics: Acute Disease; Aspirin; Blood Coagulation Disorders; Blood Platelet Disorders; Blood Vessels; Child; | 1980 |
[Prophylaxis of thromboembolism in abdominal surgery. Comparison of low dose heparin, acetylsalicylic acid and their combination (author's transl)].
Topics: Abdomen; Adult; Aspirin; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combin | 1980 |
Antiplatelet and anticoagulant therapy after coronary bypass.
Topics: Aspirin; Coronary Artery Bypass; Dipyridamole; Embolism; Humans; Postoperative Care; Postoperative C | 1980 |
Assessment of the interaction of warfarin with aspirin and dipyridamole.
Topics: Aspirin; Coronary Artery Bypass; Dipyridamole; Drug Interactions; Heart Valve Prosthesis; Humans; Po | 1982 |
Risk-benefit analysis of warfarin therapy in Hancock mitral valve replacement.
Topics: Adult; Aged; Aspirin; Bioprosthesis; Cerebral Hemorrhage; Female; Gastrointestinal Hemorrhage; Heart | 1982 |
[Problems of the operated patient and suggestions for their treatment].
Topics: Angina Pectoris; Anti-Arrhythmia Agents; Anticoagulants; Anxiety Disorders; Arrhythmias, Cardiac; As | 1982 |
[Gastrointestinal hemorrhage during treatment of spinal cord injuries].
Topics: Anticoagulants; Aspirin; Gastrointestinal Hemorrhage; Humans; Middle Aged; Postoperative Care; Posto | 1982 |
Aspirin or Coumadin as the drug of choice for valve replacement with porcine bioprosthesis.
Topics: Adolescent; Adult; Aged; Aortic Valve; Aspirin; Bioprosthesis; Child; Female; Follow-Up Studies; Hea | 1982 |
Aspirin prophylaxis for pulmonary embolism following total hip arthroplasty. An incidence study.
Topics: Adolescent; Adult; Aged; Aspirin; Female; Hip Prosthesis; Humans; Lung; Male; Middle Aged; Postopera | 1982 |
The detection and prevention of pulmonary embolism in total hip replacement. A study comparing aspirin and low-dose warfarin.
Topics: Aspirin; Female; Hip Joint; Hip Prosthesis; Humans; Male; Middle Aged; Postoperative Complications; | 1982 |
Salicylate-induced bleeding problem in ophthalmic plastic surgery.
Topics: Aspirin; Bleeding Time; Blood Platelets; Eyelid Diseases; Eyelids; Female; Hemorrhage; Humans; Middl | 1982 |
Effect of platelet aggregation inhibitors on the rate of thrombectomy following arterial reconstructions with Gore-Tex prostheses: a retrospective study.
Topics: Aspirin; Blood Vessel Prosthesis; Dipyridamole; Humans; Ischemia; Leg; Platelet Aggregation; Postope | 1982 |
Testing and treatment of arterial graft thrombosis.
Topics: Animals; Arteries; Aspirin; Blood Vessel Prosthesis; Constriction, Pathologic; Disease Models, Anima | 1981 |
Bioavailability of rectal aspirin in neurosurgical patients.
Topics: Administration, Oral; Adult; Aged; Aspirin; Biological Availability; Brain Diseases; Female; Fever; | 1981 |
Delayed thrombosis of synthetic microvascular bypass grafts.
Topics: Animals; Aspirin; Blood Vessel Prosthesis; Carotid Arteries; Cerebral Revascularization; Cerebrovasc | 1981 |
[The meaning of specialist and adequate documentation for retrospective analysis of sicknesses (author's transl)].
Topics: Aspirin; Documentation; Duodenal Ulcer; Humans; Postoperative Complications; Prospective Studies; Ra | 1981 |
Current concepts review. The use of aspirin in thromboembolic disease.
Topics: Adult; Aspirin; Female; Hip Prosthesis; Humans; Male; Platelet Aggregation; Postoperative Complicati | 1980 |
Aspirin and postoperative bleeding.
Topics: Aspirin; Hemorrhage; Humans; Postoperative Complications | 1980 |
[Current aspects of postoperative thrombophlebitis and pulmonary artery thromboembolism].
Topics: Adult; Age Factors; Aspirin; Bandages; Dextrans; Heparin; Humans; Iodine Radioisotopes; Middle Aged; | 1994 |
Performance of aortic and pulmonary homografts in the right ventricular outflow tract in children.
Topics: Age Factors; Aortic Valve; Aortic Valve Stenosis; Aspirin; Calcinosis; Cardiac Catheterization; Chil | 1995 |
Intracranial haemorrhage from a meningioma in a patient receiving aspirin prophylaxis: a case report.
Topics: Aged; Aspirin; Craniotomy; Female; Hematoma, Subdural; Humans; Ischemic Attack, Transient; Meningeal | 1995 |
Systemic thromboembolism leading to myocardial infarction and stroke after fenestrated total cavopulmonary connection.
Topics: Aspirin; Cerebrovascular Disorders; Child, Preschool; Drug Administration Schedule; Female; Fontan P | 1995 |
CarboMedics valve in congenital heart disease. Midterm follow-up study of 14 patients.
Topics: Aortic Valve; Aspirin; Child; Dipyridamole; Female; Follow-Up Studies; Heart Defects, Congenital; He | 1994 |
Power and temperature guided radiofrequency catheter ablation of the right atrium in pigs.
Topics: Animals; Aspirin; Catheter Ablation; Heart Atria; Heart Diseases; Heparin; Lung Injury; Postoperativ | 1994 |
Platelet response to vascular surgery--a preliminary study on the effect of aspirin and heparin.
Topics: Adult; Aged; Aspirin; Female; Fibrinogen; Heparin; Humans; Male; Middle Aged; Platelet Aggregation; | 1994 |
Monitoring combined antithrombotic treatments in patients with prosthetic heart valves using transcranial Doppler and coagulation markers.
Topics: Administration, Oral; Adult; Antithrombin III; Aspirin; beta-Thromboglobulin; Biomarkers; Coumarins; | 1995 |
Low-molecular-weight heparin versus aspirin and dipyridamole after femoropopliteal bypass grafting.
Topics: Anastomosis, Surgical; Aspirin; Dipyridamole; Drug Combinations; Femoral Artery; Graft Occlusion, Va | 1994 |
Inhibition of platelet deposition by combined hirulog and aspirin in a rat carotid endarterectomy model.
Topics: Animals; Aspirin; Blood Platelets; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Th | 1995 |
High risk of thromboemboli early after bioprosthetic cardiac valve replacement.
Topics: Adult; Age Factors; Aged; Aortic Valve; Aspirin; Bioprosthesis; Dipyridamole; Female; Follow-Up Stud | 1995 |
High risk of thromboemboli early after bioprosthetic cardiac valve replacement.
Topics: Adult; Age Factors; Aged; Aortic Valve; Aspirin; Bioprosthesis; Dipyridamole; Female; Follow-Up Stud | 1995 |
High risk of thromboemboli early after bioprosthetic cardiac valve replacement.
Topics: Adult; Age Factors; Aged; Aortic Valve; Aspirin; Bioprosthesis; Dipyridamole; Female; Follow-Up Stud | 1995 |
High risk of thromboemboli early after bioprosthetic cardiac valve replacement.
Topics: Adult; Age Factors; Aged; Aortic Valve; Aspirin; Bioprosthesis; Dipyridamole; Female; Follow-Up Stud | 1995 |
High risk of thromboemboli early after bioprosthetic cardiac valve replacement.
Topics: Adult; Age Factors; Aged; Aortic Valve; Aspirin; Bioprosthesis; Dipyridamole; Female; Follow-Up Stud | 1995 |
High risk of thromboemboli early after bioprosthetic cardiac valve replacement.
Topics: Adult; Age Factors; Aged; Aortic Valve; Aspirin; Bioprosthesis; Dipyridamole; Female; Follow-Up Stud | 1995 |
High risk of thromboemboli early after bioprosthetic cardiac valve replacement.
Topics: Adult; Age Factors; Aged; Aortic Valve; Aspirin; Bioprosthesis; Dipyridamole; Female; Follow-Up Stud | 1995 |
High risk of thromboemboli early after bioprosthetic cardiac valve replacement.
Topics: Adult; Age Factors; Aged; Aortic Valve; Aspirin; Bioprosthesis; Dipyridamole; Female; Follow-Up Stud | 1995 |
High risk of thromboemboli early after bioprosthetic cardiac valve replacement.
Topics: Adult; Age Factors; Aged; Aortic Valve; Aspirin; Bioprosthesis; Dipyridamole; Female; Follow-Up Stud | 1995 |
High risk of thromboemboli early after bioprosthetic cardiac valve replacement.
Topics: Adult; Age Factors; Aged; Aortic Valve; Aspirin; Bioprosthesis; Dipyridamole; Female; Follow-Up Stud | 1995 |
High risk of thromboemboli early after bioprosthetic cardiac valve replacement.
Topics: Adult; Age Factors; Aged; Aortic Valve; Aspirin; Bioprosthesis; Dipyridamole; Female; Follow-Up Stud | 1995 |
High risk of thromboemboli early after bioprosthetic cardiac valve replacement.
Topics: Adult; Age Factors; Aged; Aortic Valve; Aspirin; Bioprosthesis; Dipyridamole; Female; Follow-Up Stud | 1995 |
High risk of thromboemboli early after bioprosthetic cardiac valve replacement.
Topics: Adult; Age Factors; Aged; Aortic Valve; Aspirin; Bioprosthesis; Dipyridamole; Female; Follow-Up Stud | 1995 |
High risk of thromboemboli early after bioprosthetic cardiac valve replacement.
Topics: Adult; Age Factors; Aged; Aortic Valve; Aspirin; Bioprosthesis; Dipyridamole; Female; Follow-Up Stud | 1995 |
High risk of thromboemboli early after bioprosthetic cardiac valve replacement.
Topics: Adult; Age Factors; Aged; Aortic Valve; Aspirin; Bioprosthesis; Dipyridamole; Female; Follow-Up Stud | 1995 |
High risk of thromboemboli early after bioprosthetic cardiac valve replacement.
Topics: Adult; Age Factors; Aged; Aortic Valve; Aspirin; Bioprosthesis; Dipyridamole; Female; Follow-Up Stud | 1995 |
Anticoagulation after intracoronary stent insertion.
Topics: Anticoagulants; Aspirin; Blood Coagulation Tests; Clinical Protocols; Coronary Disease; Drug Adminis | 1994 |
Effect of aspirin and nonsteroidal antiinflammatory drug therapy on bleeding complications in dermatologic surgical patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bandages; Blood Co | 1994 |
Is this the end of the aspirin and vein graft story?
Topics: Aspirin; Coronary Artery Bypass; Graft Occlusion, Vascular; Humans; Postoperative Complications; Tim | 1994 |
[Emergency intracoronary stent implantation: complications and experiences with 124 patients].
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Aspirin; Blood Coagulation Tests; Co | 1994 |
The role of various antithrombotic agents in microvascular surgery.
Topics: Administration, Oral; Anastomosis, Surgical; Animals; Aspirin; Bleeding Time; Disease Models, Animal | 1994 |
Experience with moderate intensity anticoagulation and aspirin after mechanical valve replacement. A retrospective, non-randomized study.
Topics: Acenocoumarol; Adult; Aged; Aspirin; Blood Coagulation Tests; Dose-Response Relationship, Drug; Drug | 1993 |
[No benefit in the addition of dipyridamole to, nor of anticoagulants in comparison to, a low dose of acetylsalicylic acid (50 mg) in the prevention of venous transplant stenosis following coronary bypass surgery].
Topics: Anticoagulants; Aspirin; Coronary Artery Bypass; Dipyridamole; Humans; Postoperative Complications; | 1993 |
The role of anticoagulation in the development of pericardial effusion and late tamponade after cardiac surgery.
Topics: Adult; Anticoagulants; Aspirin; Cardiac Surgical Procedures; Cardiac Tamponade; Coronary Artery Bypa | 1993 |
Anticoagulants, antiaggregants or nothing following carotid endarterectomy?
Topics: Aged; Aspirin; Carotid Stenosis; Cause of Death; Endarterectomy, Carotid; Female; Follow-Up Studies; | 1993 |
Low-dose anticoagulant management of patients with St. Jude Medical mechanical valve prostheses.
Topics: Adolescent; Adult; Aged; Anticoagulants; Aortic Valve; Aspirin; Child; Dipyridamole; Drug Therapy, C | 1993 |
[Anti-inflammatory agents in acute tissue trauma. Choice and effects].
Topics: Acetaminophen; Adolescent; Analgesics; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Stero | 1993 |
Antiplatelet therapy in children with left-sided mechanical prostheses.
Topics: Adolescent; Aortic Valve; Aspirin; Child; Child, Preschool; Dipyridamole; Female; Follow-Up Studies; | 1993 |
Inhibition of perioperative platelet aggregation using toradol (ketorolac).
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Carcinoma, Squamous Cell; Contraindications; Drug | 1993 |
The antiplatelet effects of aspirin and related component drugs on the surgical patient.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Female; Hemorrhage; Humans; Male; Nur | 1993 |
Prevention of post-surgical adhesion formation using aspirin in a rodent model: a preliminary report.
Topics: Animals; Aspirin; Female; Postoperative Complications; Rats; Rats, Wistar; Tissue Adhesions; Uterine | 1995 |
Low molecular weight heparin-induced thrombocytopenia and thrombosis.
Topics: Adenocarcinoma; Aged; Arterial Occlusive Diseases; Aspirin; Dextrans; Embolism; Female; Femoral Arte | 1996 |
Reduction of haemorrhagic complications during mechanically assisted circulation with the use of a multi-system anticoagulation protocol.
Topics: Adolescent; Adult; Antifibrinolytic Agents; Antithrombin III; Aprotinin; Aspirin; Assisted Circulati | 1995 |
[Comprehensive prevention of postoperative thrombosis].
Topics: Anticoagulants; Aspirin; Dextrans; Drug Therapy, Combination; Female; Hemodilution; Heparin; Humans; | 1996 |
Pathogenetic factors in chronic subdural haematoma and causes of recurrence after drainage.
Topics: Adult; Aged; Aspirin; Chronic Disease; Drainage; Female; Hematoma, Subdural; Humans; Male; Middle Ag | 1995 |
Spinal haematoma and central neural blockade.
Topics: Aspirin; Hematoma, Epidural, Cranial; Humans; Nerve Block; Postoperative Complications | 1996 |
Comparison of aspirin alone versus aspirin plus ticlopidine after coronary artery stenting.
Topics: Aged; Aspirin; Coronary Disease; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Plate | 1996 |
Pneumatic compression or aspirin prophylaxis against thromboembolism in total hip arthroplasty.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Cohort Studies; Female; Gravity Suits; Hip Prosthesis; Huma | 1996 |
Enhanced response to chemotactic activation of polymorphonuclear leukocytes from patients with heart valve replacement.
Topics: Anticoagulants; Aspirin; Cells, Cultured; Chemotaxis; Female; Heart Valve Prosthesis; Humans; Male; | 1997 |
Antiplatelet therapy alone is safe and effective after coronary stenting: observations of a transition in practice.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Coronary Ar | 1997 |
Predictors of hospital readmission two years after coronary artery bypass grafting.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Anti-Arrhythmia Agents; Aspirin; Coronary Artery | 1997 |
Our experience with pancreatic graft extraperitoneal placement.
Topics: Adult; Anticoagulants; Aspirin; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Drug Therapy, Com | 1997 |
Thromboprophylaxis in elective orthopaedic surgery -- what is the purpose?
Topics: Anticoagulants; Aspirin; Bone and Bones; Chemoprevention; Elective Surgical Procedures; Femoral Neck | 1997 |
Low-dose aspirin therapy is associated with few side effects but does not prevent hepatic artery thrombosis in liver transplant recipients.
Topics: Adolescent; Adult; Aged; Aspirin; Child; Child, Preschool; Female; Hepatic Artery; Humans; Infant; L | 1997 |
New stent delivery balloon: a technical note.
Topics: Angioplasty, Balloon; Aspirin; Coronary Angiography; Coronary Disease; Female; Follow-Up Studies; Hu | 1997 |
[Comparative study of 2 antithrombotic regimens in 75 patients with coronary endoprostheses].
Topics: Acenocoumarol; Adult; Aged; Anticoagulants; Aspirin; Coronary Disease; Dipyridamole; Drug Evaluation | 1997 |
Coronary artery disease and diabetes.
Topics: Aspirin; Coronary Angiography; Coronary Disease; Diabetic Angiopathies; Female; Humans; Hypolipidemi | 1997 |
Intractable upper gastrointestinal ulceration due to aspirin in patients who have undergone surgery for peptic ulcer.
Topics: Aspirin; Female; Humans; Intestinal Diseases; Male; Middle Aged; Peptic Ulcer; Postoperative Complic | 1998 |
Clinical and angiographic outcome of Micro Stent II implantation in native coronary arteries.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Aspirin; Blood Vessel Prosthesis Implantation; Coro | 1998 |
Possibility of checking compliance and efficacy of antiaggregatory treatment following femoro-popliteal vein bypass surgery.
Topics: Anastomosis, Surgical; Arteriosclerosis Obliterans; Aspirin; Blood Coagulation; Female; Femoral Vein | 1998 |
Micro stent implantation in patients with acute myocardial infarction without anticoagulation: clinical experience with two different antithrombotic protocols.
Topics: Abciximab; Antibodies, Monoclonal; Aspirin; Blood Vessel Prosthesis Implantation; Coronary Angiograp | 1998 |
[Importance of the urinary leukotriene E4 level. Preliminary study].
Topics: Acetaminophen; Anaphylaxis; Anesthetics; Aspirin; Biomarkers; Chymases; Drug Hypersensitivity; Hista | 1998 |
Postoperative adhesion prevention with low-dose aspirin: effect through the selective inhibition of thromboxane production.
Topics: Abdominal Muscles; Animals; Aspirin; Female; Ovary; Platelet Aggregation Inhibitors; Postoperative C | 1998 |
DVT prophylaxis options: facts & fictions.
Topics: Arthroplasty, Replacement, Knee; Aspirin; Fibrinolytic Agents; Hemorrhage; Humans; Postoperative Com | 1998 |
Emergency coronary artery bypass grafting (CABG) after failed coronary artery intervention--caution regarding the combined use of aspirin, ticlopidine and abciximab.
Topics: Abciximab; Adult; Angina Pectoris; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Aspirin; | 1998 |
Coronary stenting in unstable angina: early and late clinical outcomes.
Topics: Angina, Unstable; Angioplasty, Balloon, Coronary; Aspirin; Coronary Artery Bypass; Coronary Disease; | 1998 |
[Reduction of in-hospital complications after elective percutaneous transluminal coronary angioplasty using a combined pretreatment with ticlopidine and aspirin].
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Aspirin; Case-Control Studies; Coron | 1998 |
Delayed neurological deterioration following resection of arteriovenous malformations of the brain.
Topics: Adolescent; Adult; Aged; Anesthesia, General; Aneurysm; Anticoagulants; Antihypertensive Agents; Asp | 1999 |
Alabama coronary artery bypass grafting Cooperative Project: baseline data. Alabama CABG Cooperative Project Study Group.
Topics: Aged; Aged, 80 and over; Alabama; Aspirin; Benchmarking; Coronary Artery Bypass; Female; Hospital Mo | 1999 |
The Canadian Study of Cardiac Transplantation. Atherosclerosis. Investigators of the CASCADE Study.
Topics: Adult; Antihypertensive Agents; Arteriosclerosis; Aspirin; Cardiovascular Agents; Cyclosporine; Cyto | 1999 |
Studies published on clopidogrel-aspirin for coronary stent placement.
Topics: Aspirin; Clopidogrel; Coronary Thrombosis; Coronary Vessels; Drug Combinations; Humans; Platelet Agg | 2000 |
Saphenous vein graft disease treated with the Wiktor Hepamed stent: procedural outcome, in-hospital complications and six-month angiographic follow-up.
Topics: Aged; Aspirin; Coronary Angiography; Coronary Artery Bypass; Female; Fibrinolytic Agents; Follow-Up | 2000 |
Hazards of aspirin withdrawal before transurethral prostatectomy.
Topics: Aged; Aspirin; Humans; Platelet Aggregation Inhibitors; Postoperative Complications; Prostatectomy; | 2000 |
Ten year audit of secondary prevention in coronary bypass patients.
Topics: Anticholesteremic Agents; Aspirin; Blood Pressure; Cholesterol; Coronary Artery Bypass; Humans; Medi | 2000 |
Peri-operative aspirin can prevent post-operative ischemia and thrombosis.
Topics: Aspirin; Humans; Intraoperative Period; Platelet Activation; Postoperative Complications; Thrombosis | 2000 |
Can low-dose aspirin prevent thromboembolic phenomena in patients undergoing surgery for hip fracture or elective arthroplasty?
Topics: Anticoagulants; Arthroplasty, Replacement; Aspirin; Cause of Death; Double-Blind Method; Follow-Up S | 2000 |
Clopidogrel for prevention of major cardiac events after coronary stent implantation: 30-day and 6-month results in patients with smaller stents.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clopidogrel; Coron | 2000 |
[Prevention of early thrombotic complications after reconstructive operations in occlusions of the aorto-iliac segment].
Topics: Adult; Aged; Anticoagulants; Aorta, Abdominal; Aortic Diseases; Arterial Occlusive Diseases; Aspirin | 2000 |
Low dose aspirin as prophylaxis against renal-vein thrombosis in renal-transplant recipients.
Topics: Adult; Aged; Aspirin; Cadaver; Cyclosporine; Databases as Topic; Drug Therapy, Combination; Fibrinol | 2000 |
[Undertreatment in secondary prevention of patients with coronary heart disease after revascularization].
Topics: Adrenergic beta-Antagonists; Aftercare; Angiotensin-Converting Enzyme Inhibitors; Anticholesteremic | 2000 |
Antiphospholipid antibody syndrome manifested as a postoperative cerebrovascular event in a child.
Topics: Anticoagulants; Antiphospholipid Syndrome; Aspirin; Brain Infarction; Child; Drug Therapy, Combinati | 2000 |
Aspirin-related hepatotoxicity in a child after liver transplant.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Chemical and Drug Induced Liver Injury; Child, Pre | 2001 |
Efficacy of oral anticoagulants compared with aspirin after infrainguinal bypass surgery (the Dutch Bypass Oral anticoagulants or Aspirin study). Lancet 2000; 355: 346-51.
Topics: Administration, Oral; Anticoagulants; Aspirin; Graft Occlusion, Vascular; Humans; Leg; Platelet Aggr | 2001 |
Effect of cilostazol on restenosis after coronary angioplasty and stenting in comparison to conventional coronary artery stenting with ticlopidine.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Angioplasty, Balloon, Coronary; Aspirin; Cilos | 2001 |
[Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery].
Topics: Aspirin; Clopidogrel; Coronary Disease; Humans; Platelet Aggregation Inhibitors; Postoperative Compl | 2001 |
Failure of oral iron therapy in treatment of iron deficiency anemia: pharmaceutical iatrogenic cause.
Topics: Anemia, Iron-Deficiency; Aspirin; Coronary Artery Bypass; Ferric Compounds; Ferrous Compounds; Hemog | 2001 |
Emergency coronary artery bypass grafting: does excessive preoperative anticoagulation increase bleeding complications and transfusion requirements?
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Blood Transfusion, Autologous; Cardiopulmon | 2001 |
Prophylactic low-dose aspirin therapy in patients having hip-fracture surgery or elective arthroplasty.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Hip Fractu | 2001 |
Venous thromboembolic disease management patterns in total hip arthroplasty and total knee arthroplasty patients: a survey of the AAHKS membership.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Bandages; | 2001 |
Aspirin plus clopidogrel for everyone: panacea comes true in the 21st century.
Topics: Aspirin; Clopidogrel; Coronary Thrombosis; Humans; Platelet Aggregation Inhibitors; Postoperative Co | 2001 |
Treatment of acute coronary syndromes.
Topics: Acute Disease; Aspirin; Clopidogrel; Coronary Artery Bypass; Drug Therapy, Combination; Hemorrhage; | 2002 |
OPCAB therapy survey: off-pump clopidogrel, aspirin or both therapy survey.
Topics: Anticoagulants; Aspirin; Canada; Cardiology; Clopidogrel; Combined Modality Therapy; Coronary Artery | 2001 |
Lowering cardiac risk in noncardiac surgery.
Topics: Aspirin; Cardiovascular Diseases; Humans; Intraoperative Complications; Platelet Aggregation Inhibit | 2002 |
Oral buprenorphine and aspirin analgesia in rats undergoing liver transplantation.
Topics: Activity Cycles; Administration, Oral; Analgesics, Opioid; Animals; Aspirin; Body Weight; Buprenorph | 2002 |
Changing patterns of pharmacological thromboprophylaxis use by orthopaedic surgeons in New Zealand.
Topics: Anticoagulants; Arthroplasty, Replacement; Aspirin; Drug Utilization; Elective Surgical Procedures; | 2002 |
[Is it worthwhile preventing postoperative thromboembolism?].
Topics: Anticoagulants; Aspirin; Dihydroergotamine; Dipyridamole; Dose-Response Relationship, Drug; Drug The | 1979 |
Management of thrombo-embolism after aortic valve replacement with the Björk-Shiley tilting disc valve. Medicamental prevention with dicumarol in comparison with dipyridamole - acetylsalicylic acid. Surgical treatment of prosthetic thrombosis.
Topics: Adult; Aortic Valve; Aspirin; Cerebral Hemorrhage; Dicumarol; Dipyridamole; Drug Therapy, Combinatio | 1975 |
Anti-platelet drugs and portacaval anastomosis for homozygous hypercholesterolaemia.
Topics: Adolescent; Adult; Aspirin; Child; Dipyridamole; Female; Homozygote; Humans; Hypercholesterolemia; M | 1976 |
Fibrinogen catabolism in the surgically treated patient and in those with postoperative venous thrombosis. Correlation of plasma fibrinogen chromatographic findings with 125I-labeled fibrinogen scan findings.
Topics: Adolescent; Adult; Aged; alpha 1-Antitrypsin; alpha-Macroglobulins; Antithrombins; Aspirin; Chromato | 1977 |
[Iron substitution in postoperative anemia during thromboembolic prophylaxis (author's transl)].
Topics: Anemia, Hypochromic; Aspirin; Heparin; Humans; Iron; Postoperative Care; Postoperative Complications | 1979 |
Pulmonary embolism prophylaxis in the orthopaedic and trauma patient.
Topics: Arthroplasty; Aspirin; Dextrans; Femoral Neck Fractures; Heparin; Hip Joint; Humans; Postoperative C | 1976 |
Prevention of postoperative ocular hypertension by prostaglandin inhibitors.
Topics: Aspirin; Cataract Extraction; Depression, Chemical; Humans; Indomethacin; Intraocular Pressure; Post | 1977 |
The prevention of postoperative venous thromboembolism.
Topics: Anticoagulants; Aspirin; Dextrans; Heparin; Humans; Hydroxychloroquine; Leg; Postoperative Complicat | 1978 |
Aspirin- and coumadin-related bleeding after coronary- artery bypass graft surgery.
Topics: Aged; Aspirin; Coronary Artery Bypass; Female; Hemorrhage; Humans; Male; Middle Aged; Postoperative | 1978 |
Postoperative bleeding caused by aspirin.
Topics: Adult; Aspirin; Humans; Male; Oral Hemorrhage; Periodontium; Postoperative Complications | 1978 |
Relation of preoperative use of aspirin to increased mediastinal blood loss after coronary artery bypass graft surgery.
Topics: Adult; Aged; Aspirin; Coronary Artery Bypass; Drainage; Hemorrhage; Humans; Male; Mediastinal Diseas | 1978 |
Aspirin and postsurgery bleeding.
Topics: Aspirin; Coronary Artery Bypass; Hemorrhage; Humans; Postoperative Complications | 1978 |
Aspirin and postoperative bleeding.
Topics: Aspirin; Blood Coagulation Tests; Coronary Artery Bypass; Hemorrhage; Humans; Postoperative Complica | 1979 |
Effect of acetylsalicylate on surgical bleeding, postoperative mortality and allograft survival in rats undergoing heart transplantation.
Topics: Animals; Aspirin; Blood Coagulation; Female; Graft Rejection; Heart Transplantation; Hemorrhage; Myo | 1979 |
[Informative value of control methods for postoperative supervision of medication with aspirin and heparin (author's transl)].
Topics: Aged; Antithrombins; Aspirin; Blood Coagulation Tests; Collagen; Female; Heparin; Humans; Lysine; Ma | 1977 |
[The effect of Aspisol on platelet function after vascular surgery (author's transl)].
Topics: Aged; Aspirin; Blood Coagulation Disorders; Drug Therapy, Combination; Female; Humans; Male; Middle | 1977 |
Surgical postoperative bleeding associated with aspirin ingestion. Report of two cases.
Topics: Aged; Aspirin; Blood Platelet Disorders; Hematoma; Humans; Male; Middle Aged; Neurosurgery; Postoper | 1979 |
Our experience with the Carpentier-Edwards bioprosthesis.
Topics: Adolescent; Adult; Aged; Aortic Valve; Aspirin; Bioprosthesis; Child; Female; Follow-Up Studies; Hea | 1979 |
[Thromboembolism and total arthroplasty of the hip: preventive aspects].
Topics: Arthroplasty; Ascorbic Acid; Aspirin; Female; Hip; Hip Joint; Humans; Joint Prosthesis; Male; Middle | 1979 |
[Preliminary experience with the catheter dilatation of coronary artery stenoses (author's transl)].
Topics: Adult; Angiocardiography; Arteries; Aspirin; Cardiac Catheterization; Coronary Disease; Coronary Ves | 1979 |
Rectal aspirin--absorption and antipyretic effect.
Topics: Adolescent; Aspirin; Child; Child, Preschool; Fever; Humans; Intestinal Absorption; Postoperative Co | 1979 |
Thromboembolic complications after mitral valve replacement with Hancock xenograft.
Topics: Adolescent; Adult; Aged; Animals; Aortic Valve; Aspirin; Atrial Fibrillation; Blood Vessel Prosthesi | 1978 |
[Dental surgery in drug-induced increase of bleeding tendency].
Topics: Anticoagulants; Aspirin; Disseminated Intravascular Coagulation; Humans; Phenylbutazone; Postoperati | 1977 |
Femoral vein thrombosis and total hip replacement.
Topics: Aspirin; Femoral Vein; Hip; Humans; Postoperative Complications; Thrombosis | 1977 |
[Dextran for the prophylaxis of postoperative thromboembolism (author's transl)].
Topics: Anaphylaxis; Aspirin; Dextrans; Heparin; Humans; Postoperative Complications; Thromboembolism | 1977 |
Hemostatic effects of uniform, low-dose subcutaneous heparin in surgical patients.
Topics: Adult; Aged; Aspirin; Blood Coagulation; Dose-Response Relationship, Drug; Drug Therapy, Combination | 1978 |
Incidence of emboli with cloth-covered Starr-Edwards valve without anticoagulation and with varying forms of anticoagulation. Analysis of 183 patients followed for 3 1/2 years.
Topics: Anticoagulants; Aortic Valve; Aspirin; Connecticut; Dipyridamole; Embolism; Female; Follow-Up Studie | 1978 |
[Thrombocyte-aggregation inhibitors following open or semi-open endarterectomy-preliminary results of a prospective study].
Topics: Arterial Occlusive Diseases; Aspirin; Dipyridamole; Endarterectomy; Humans; Platelet Aggregation; Po | 1978 |
Failure of aspirin to prevent postoperative deep vein thrombosis in patients undergoing total hip replacement.
Topics: Aged; Aspirin; Female; Hip Joint; Humans; Male; Middle Aged; Postoperative Complications; Thrombophl | 1978 |
Modified "low-dose" heparin prophylaxis to reduce thrombosis after hip joint operations.
Topics: Adult; Aged; Aspirin; Evaluation Studies as Topic; Female; Hematoma; Heparin; Hip Joint; Humans; Leg | 1978 |
[Deep-vein thrombosis after hip replacement].
Topics: Aspirin; Hip Joint; Humans; Postoperative Complications; Thrombophlebitis | 1978 |
[Concerning: "The value of acetylsalicylic acid in the prevention of postoperative thromboembolic complications" by M. Pfenninger and U. F. Gruber, Schweiz. med. Wschr. 107, 1335-1338 (1977)].
Topics: Aspirin; Postoperative Complications; Thromboembolism | 1978 |
Thromboembolic risk of postsplenectomy thrombocytosis.
Topics: Aspirin; Humans; Postoperative Complications; Retrospective Studies; Risk; Splenectomy; Thrombocytos | 1978 |
[Prevention of thromboembolism in surgical gynecology].
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Female; Heparin; Humans; Hysterectomy; Po | 1978 |
Prevention of thromboembolic complications of valve prostheses by agents affecting platelet function.
Topics: Aspirin; Blood Cell Count; Blood Platelets; Child; Child, Preschool; Dipyridamole; Drug Therapy, Com | 1978 |
[Correction of disorders of rheologic properties of blood in reconstructive operations on the abdominal aorta].
Topics: Adult; Aged; Aorta, Abdominal; Aortic Diseases; Arteriosclerosis; Aspirin; Blood Viscosity; Dipyrida | 1978 |
[Clinical and in-vitro studies of the therapeutical range of acetylsalicylic-acid to prevent deep vein thrombosis (author's transl)].
Topics: Aged; Aspirin; Hip Joint; Humans; Male; Middle Aged; Platelet Aggregation; Postoperative Complicatio | 1978 |
[Early diagnosis of postoperative venous thrombosis and evaluation of the effects of pharmacological prevention of thrombosis].
Topics: Aspirin; Dipyridamole; Heparin; Humans; Postoperative Complications; Thrombophlebitis | 1978 |
[Thrombosis prevention with heparin and acetylsalicylic acid in elective hip joint surgery].
Topics: Aspirin; Drug Therapy, Combination; Heparin; Hip Joint; Humans; Postoperative Complications; Thrombo | 1979 |
[Prevention of thromboembolism following thoracic surgery using acetylsalicylic acid (Micristine)].
Topics: Adult; Age Factors; Aged; Aspirin; Bronchiectasis; Humans; Middle Aged; Postoperative Complications; | 1977 |
A multifaceted approach to prevention of thromboembolism: a report of 529 cases.
Topics: Aspirin; Bandages; Dextrans; Exercise Therapy; Heparin; Hip Joint; Humans; Joint Prosthesis; Phenylb | 1977 |
Selecting and preparing patients for total hip replacement.
Topics: Aged; Anticoagulants; Arthritis, Rheumatoid; Arthroplasty; Aspirin; Blood Coagulation; Blood Platele | 1977 |
The prevention of acute pulmonary embolism.
Topics: Adult; Anticoagulants; Aspirin; Dextrans; Early Ambulation; Female; Heparin; Humans; Leg; Postoperat | 1977 |
[Lysine acetylsalicylate in the prevention of thromboembolic disease].
Topics: Adult; Aged; Aspirin; Female; Genital Diseases, Female; Humans; Lysine; Middle Aged; Postoperative C | 1977 |
The present status of acute deep venous thrombosis.
Topics: Acute Disease; Aspirin; Dextrans; Fibrinogen; Heparin; Humans; Iodine Radioisotopes; Plethysmography | 1977 |
Patency of venous grafts in small veins: influence of aspirin and warfarin sodium.
Topics: Animals; Aspirin; Drug Therapy, Combination; Female; Jugular Veins; Male; Platelet Aggregation; Post | 1977 |
Thrombus formation and endothelial alterations in microarterial anastomoses.
Topics: Animals; Aspirin; Carotid Arteries; Endothelium; Heparin; Intracranial Embolism and Thrombosis; Micr | 1977 |
[The value of acetylsalicylic acid for the prevention of postoperative thromboembolic complications].
Topics: Aspirin; Coumarins; Dextrans; Heparin; Humans; Postoperative Complications; Thromboembolism | 1977 |
Surgical grand rounds carotid artery surgery.
Topics: Anticoagulants; Arteriovenous Shunt, Surgical; Aspirin; Carotid Arteries; Carotid Artery Diseases; C | 1976 |
[Postoperative prophylaxis of thromboembolism. Present position.(author's transl)].
Topics: Aged; Aspirin; Coumarins; Dextrans; Heparin; Humans; Male; Middle Aged; Postoperative Complications; | 1976 |
[Drug prophylaxis of thromboembolism in surgical medicine].
Topics: Anticoagulants; Aspirin; Coumarins; Dextrans; Humans; Postoperative Complications; Thromboembolism | 1976 |
Thromboembolism following total hip-replacement arthroplasty. The efficicy of dextran-aspirin and dextran-warfarin in prophylaxis.
Topics: Arthroplasty; Aspirin; Dextrans; Drug Therapy, Combination; Female; Hip Joint; Humans; Joint Prosthe | 1976 |
A clinical evaluation of aspirin prophylaxis of thromboembolic disease after total hip arthroplasty.
Topics: Adolescent; Adult; Aged; Arthroplasty; Aspirin; Female; Hip Joint; Humans; Joint Prosthesis; Male; M | 1976 |
Thromboembolic disease in patients undergoing total knee replacement.
Topics: Aged; Aspirin; Fibrinogen; Humans; Joint Prosthesis; Knee Joint; Middle Aged; Phlebography; Postoper | 1976 |
[Role of drugs with disaggregative effect in the prevention of thrombosis in reconstructive operations on the veins of the limbs].
Topics: Aspirin; Humans; Leg; Platelet Aggregation; Postoperative Complications; Thrombophlebitis; Varicose | 1976 |
[A comparative investigation of acetylsalicyclic acid and indirect anticoagulants for the prophylaxis of venous thromboses in patients with an orthopedic-traumatologic case history (author's transl)].
Topics: Aspirin; Female; Fractures, Bone; Humans; Male; Middle Aged; Osteotomy; Phenindione; Postoperative C | 1976 |
[Intraoperative tendency to bleeding under micristine therapy in major surgery of the hip joint].
Topics: Adult; Aged; Aspirin; Female; Hemorrhage; Hip Joint; Humans; Joint Prosthesis; Male; Middle Aged; Po | 1976 |
Management of small arterial injuries: clinical and experimental studies.
Topics: Aspirin; Brachial Artery; Femoral Artery; Follow-Up Studies; Heparin; Humans; Postoperative Complica | 1976 |
Analgesic requirements after orthognathic surgery.
Topics: Acetaminophen; Adolescent; Adult; Analgesics; Aspirin; Female; Humans; Male; Malocclusion; Meperidin | 1976 |
[Inhibition of aggregation in the prevention of venous thromboses (proceedings)].
Topics: Aspirin; Humans; Platelet Aggregation; Postoperative Complications; Thrombophlebitis | 1976 |
Drugs affecting platelet function tests: their effects on haemostasis and surgical bleeding.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Coagulation Disorders; Blood Donors; Blood P | 1975 |
Aspirin and prophylaxis of thromboembolic complications in patients with substitute heart valves.
Topics: Acenocoumarol; Anticoagulants; Aspirin; Blindness; Drug Therapy, Combination; Female; Gastrointestin | 1976 |
Gastric devascularization: an alternate approach to the surgical treatment of massive, diffuse hemorrhage from gastritis.
Topics: Adult; Age Factors; Alcoholism; Aspirin; Burns; Child, Preschool; Female; Gastrectomy; Gastritis; Ga | 1976 |
[Circulatory dynamics and excitomotor currents. A preventive association in the prophylaxis of postoperative thrombosis].
Topics: Anticoagulants; Aspirin; Bandages; Dextrans; Electric Stimulation Therapy; Female; Humans; Male; Pos | 1976 |
Civilian vascular injuries.
Topics: Adolescent; Adult; Age Factors; Aged; Aneurysm; Arteries; Arteriovenous Fistula; Aspirin; Blood Vess | 1975 |
Results of emergency surgical management of hemorrhagic duodenal ulcer.
Topics: Adolescent; Adult; Aged; Aspirin; Duodenal Ulcer; Emergencies; Female; Gastrectomy; Gastroscopy; Hum | 1975 |
[Susceptibility of platelet adhesiveness following bone surgery].
Topics: Aspirin; Blood Cell Count; Blood Platelets; Dextrans; Dipyridamole; Humans; Phenylbutazone; Platelet | 1975 |
Prophylaxis of venous thromboembolism.
Topics: Aspirin; Blood Coagulation; Dextrans; Dipyridamole; Ethylestrenol; Fibrinolysis; Heparin; Humans; Ph | 1975 |
[Prevention of thromboembolism in urology].
Topics: Adult; Aged; Anticoagulants; Aspirin; Breathing Exercises; Dextrans; Gymnastics; Humans; Middle Aged | 1975 |
Prophylactic administrations of aspirin for the prevention of thrombo-embolic complications in postoperative reactive thrombocytosis.
Topics: Adult; Aged; Aspirin; Female; Humans; Male; Platelet Aggregation; Postoperative Complications; Throm | 1975 |
[Prevention of thrombosis using acetylsalicylic acid following vascular prosthesis and endarterectomy].
Topics: Animals; Aspirin; Blood Vessel Prosthesis; Dogs; Endarterectomy; Platelet Adhesiveness; Postoperativ | 1975 |
[Proceedings: Anticoagulant prevention following gynecologist and obstetrical surgery at the University Gynecological Hospital Freiburg from 1953 to 1973].
Topics: Aspirin; Coumarins; Dextrans; Female; Germany, West; Heparin; Humans; Postoperative Complications; R | 1975 |
Dangers of aspirin before cardiac surgery.
Topics: Aspirin; Cardiac Surgical Procedures; Humans; Postoperative Complications; Thrombolytic Therapy | 1992 |
Venous thromboembolism associated with hip and knee arthroplasty: current prophylactic practices and outcomes.
Topics: Aspirin; Bandages; Hip Prosthesis; Humans; Knee Prosthesis; Postoperative Complications; Pulmonary E | 1992 |
Renal function after hip arthroplasty and isoxazolylpenicillin prophylaxis.
Topics: Age Factors; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; beta 2-Micro | 1992 |
The significance of calf thrombi after total knee arthroplasty.
Topics: Aspirin; Humans; Knee Prosthesis; Leg; Phlebography; Postoperative Complications; Pulmonary Embolism | 1992 |
Gastric changes in coronary-operated patients with low-dose aspirin.
Topics: Adult; Aged; Aspirin; Coronary Artery Bypass; Coronary Disease; Dose-Response Relationship, Drug; Fe | 1992 |
[Prevention of thrombosis after surgical interventions on the venous system].
Topics: Anticoagulants; Aspirin; Coumarins; Dipyridamole; Drug Administration Schedule; Drug Therapy, Combin | 1992 |
High-dose aspirin inhibits shear-induced platelet reaction involving thrombin generation.
Topics: Aspirin; Coronary Artery Bypass; Dose-Response Relationship, Drug; Female; Hemostasis; Humans; Male; | 1992 |
Short-term treatment with nonsteroidal antiinflammatory medications to prevent heterotopic bone formation after total hip arthroplasty. A preliminary report.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Hip Prosthesis; Humans; Indomethacin; Male; Middle Aged; Os | 1992 |
[Heparin-associated thrombocytopenia, thrombosis and embolism. Side effects of thromboembolism prevention with low molecular weight heparin enoxaparin?].
Topics: Aged; Aspirin; Blood Coagulation Tests; Carcinoma, Renal Cell; Heparin, Low-Molecular-Weight; Humans | 1991 |
Myocardial infarction in patients with previous bypass surgery.
Topics: Adrenergic beta-Antagonists; Aspirin; Coronary Angiography; Coronary Disease; Diltiazem; Electrocard | 1991 |
[Prevention of thrombosis in orthopedic surgery].
Topics: Aspirin; Bandages; Combined Modality Therapy; Dextrans; Drug Therapy, Combination; Heparin; Humans; | 1991 |
[The level of vasoactive prostanoids in patients with ischemic heart disease in the early period following aortocoronary bypass].
Topics: Aspirin; Combined Modality Therapy; Coronary Artery Bypass; Coronary Disease; Dipyridamole; Drug The | 1991 |
[Treatment of acute manifestation of hemichorea with aspirin. A case report].
Topics: Aged; Aged, 80 and over; Anesthesia, General; Aspirin; Brain Ischemia; Carotid Stenosis; Chorea; Cor | 1991 |
Effect of low and ultra low oral doses of acetylsalicylic acid in microvascular surgery. An experimental study in the rabbit.
Topics: Administration, Oral; Animals; Aspirin; Blood Platelets; Ear, External; Female; Male; Microscopy, El | 1991 |
Anticoagulant drugs and central nerve blockade.
Topics: Anesthesia, Epidural; Anticoagulants; Aspirin; Hematoma, Epidural, Cranial; Humans; Postoperative Co | 1991 |
[Carotid endarterectomy for prevention of stroke: comparison of surgical and conservative therapy].
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Carotid Artery Diseases; Carotid Artery, Internal; Cerebral | 1991 |
[Effect of postoperative aggregation inhibiting therapy following carotid thrombendarterectomy on patient survival. Analysis after more than 15 years follow-up].
Topics: Aspirin; Carotid Artery Thrombosis; Carotid Artery, Internal; Combined Modality Therapy; Endarterect | 1991 |
Case 4--1990. A 66-year-old woman who is taking aspirin continues to bleed after routine care.
Topics: Aged; Algorithms; Antifibrinolytic Agents; Aspirin; Blood Coagulation Tests; Blood Platelet Disorder | 1990 |
Aspirin prophylaxis and surveillance of pulmonary embolism and deep vein thrombosis in total hip arthroplasty.
Topics: Aspirin; Female; Hip Prosthesis; Humans; Lung; Male; Middle Aged; Postoperative Complications; Preme | 1990 |
Surgery for sinusitis and aspirin triad.
Topics: Adolescent; Adult; Aspirin; Asthma; Chronic Disease; Drug Hypersensitivity; Female; Follow-Up Studie | 1990 |
Perioperative stroke risk in 173 consecutive patients with a past history of stroke.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anesthesia, General; Aspirin; Cerebrovascular Disorders | 1990 |
Identifiable factors in post-prostatectomy haemorrhage: the role of aspirin.
Topics: Aged; Aspirin; Blood Transfusion; Female; Hemorrhage; Humans; Male; Platelet Aggregation; Postoperat | 1990 |
The role of antiplatelet drugs in carotid reconstructive surgery.
Topics: Adult; Aged; Aspirin; Carotid Artery Thrombosis; Carotid Artery, Internal; Dextrans; Dipyridamole; D | 1985 |
Prophylaxis of venous thromboembolic disease following hip and knee surgery.
Topics: Anticoagulants; Aspirin; Combined Modality Therapy; Dextrans; Heparin; Hip; Humans; Knee; Leg; Posto | 1986 |
Prophylaxis of venous thromboembolism. An overview.
Topics: Abdomen; Anticoagulants; Aspirin; Combined Modality Therapy; Cost-Benefit Analysis; Dextrans; Drug T | 1986 |
[Fibrinolytic hemorrhages in patients with prostatic adenoma treated with acetylsalicylic acid in the preoperative period].
Topics: Aged; Aspirin; Hemorrhage; Humans; Male; Middle Aged; Postoperative Complications; Premedication; Pr | 1987 |
Heterotopic ossification with total hip endoprostheses in various models of thrombosis prophylaxis.
Topics: Aspirin; Bone and Bones; Choristoma; Dextrans; Heparin; Hip Prosthesis; Humans; Indomethacin; Oxyphe | 1988 |
Plasmapheresis in the management of heparin-associated thrombocytopenia with thrombosis.
Topics: Amputation, Surgical; Aspirin; Dextrans; Female; Heparin; Humans; Intermittent Claudication; Ischemi | 1988 |
Hepatic artery thrombosis after pediatric liver transplantation--a medical or surgical event?
Topics: Anastomosis, Surgical; Aspirin; Blood Coagulation Tests; Celiac Artery; Child; Child, Preschool; Dex | 1989 |
[Reevaluation of postoperative thrombosis prevention].
Topics: Anticoagulants; Aspirin; Coumarins; Dextrans; Dihydroergotamine; Heparin; Humans; Postoperative Comp | 1985 |
Inhibition of accelerated cardiac allograft arteriosclerosis by fish oil.
Topics: Animals; Aspirin; Coronary Disease; Dipyridamole; Fish Oils; Heart Transplantation; Postoperative Co | 1989 |
Late perforation of a mediastinal oesophagocoloplasty.
Topics: Adult; Aspirin; Colon; Esophageal Perforation; Esophagoplasty; Humans; Male; Postoperative Complicat | 1989 |
Clinical application of a new in vitro bleeding time device on surgical patients.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Aspirin; Bleeding Time; Epoprostenol; Hemorrhage; Hemostasis; H | 1988 |
Percutaneous transluminal angioplasty of stenotic deep vein arterial bypass grafts.
Topics: Aged; Angioplasty, Balloon; Aspirin; Female; Femoral Vein; Graft Occlusion, Vascular; Humans; Male; | 1985 |
[Effect of aggregation inhibitors on patient survival following thrombendarterectomy of the internal carotid artery].
Topics: Aged; Aspirin; Carotid Artery Thrombosis; Carotid Artery, Internal; Combined Modality Therapy; Endar | 1988 |
[Current topics of anticoagulant therapy and antiplatelet therapy after cardiac valve replacement].
Topics: Adolescent; Adult; Aspirin; Drug Evaluation; Female; Heart Valve Prosthesis; Humans; Male; Middle Ag | 1988 |
[Prevention of thromboses in vascular microanastomoses. Experimental study on the role of anti-aggregant drugs. Preliminary remarks].
Topics: Animals; Aspirin; Isoindoles; Male; Microsurgery; Phenylbutyrates; Platelet Aggregation Inhibitors; | 1988 |
Thrombotic microangiopathy of the miscellaneous secondary type responding to plasma exchange in a liver transplant recipient.
Topics: Aspirin; Dipyridamole; Humans; Liver Transplantation; Male; Middle Aged; Plasma Exchange; Postoperat | 1988 |
Indications and results for splenectomy for beta thalassemia in two hundred and twenty-one pediatric patients.
Topics: Aspirin; Blood Transfusion; Cerebrovascular Disorders; Child; Dipyridamole; Female; Follow-Up Studie | 1988 |
[Mortality and morbidity of thromboembolism in drug prevention--5-year analysis].
Topics: Adenocarcinoma; Adult; Aspirin; Cesarean Section; Dihydroergotamine; Female; Genital Diseases, Femal | 1988 |
[Retrospective study of the use of dipyridamole and acetylsalicylic acid in the pre-, trans- and postoperative periods, in the prevention of thromboembolic complications, in high risk vascular surgery].
Topics: Aspirin; Dipyridamole; Humans; Platelet Aggregation; Postoperative Complications; Retrospective Stud | 1987 |
Oral acetylsalicylic acid improves patency rates in small-vessel anastomoses.
Topics: Administration, Oral; Animals; Aspirin; Femoral Artery; Male; Platelet Aggregation; Postoperative Co | 1986 |
Prevention of postoperative neurologic deficits after carotid endarterectomy. Is platelet inhibition beneficial?
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Carotid Artery Diseases; Cerebrovascular Disorders; Dipyrid | 1987 |
Persistent hemorrhage after extracapsular surgery associated with excessive aspirin ingestion.
Topics: Aged; Aspirin; Cataract Extraction; Eye Diseases; Hemorrhage; Humans; Male; Postoperative Complicati | 1987 |
Activity, air boots, and aspirin as thromboembolism prophylaxis in knee arthroplasty. A multiple regimen approach.
Topics: Adult; Aged; Aged, 80 and over; Arthritis; Aspirin; Clothing; Combined Modality Therapy; Female; Fol | 1987 |
[Prevention of thromboembolic complications in fractures of the upper part of the femur].
Topics: Aged; Aspirin; Femoral Neck Fractures; Fracture Fixation, Internal; Heparin; Humans; Middle Aged; Po | 1986 |
Antithrombotic therapy in children and adolescents.
Topics: Acenocoumarol; Adolescent; Age Factors; Aspirin; Child; Child, Preschool; Drug Therapy, Combination; | 1986 |
Oral anticoagulation is not necessary for patients with bioprosthetic mitral valve replacement in atrial fibrillation.
Topics: Anticoagulants; Aortic Valve; Aspirin; Atrial Fibrillation; Bioprosthesis; Dipyridamole; Drug Therap | 1986 |
Do all patients with mechanical heart valve prostheses need anticoagulant therapy?
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Bioprosthesis; Dipyridamole; Drug Therapy, Combination | 1986 |
Etiology and prevention of thromboembolic disease. Taming a complex circulatory malfunction.
Topics: Antithrombin III Deficiency; Aspirin; Blood Coagulation Disorders; Catheters, Indwelling; Contracept | 1986 |
Comparative study of warfarin versus antiplatelet therapy in patients with a St. Jude Medical valve in the aortic position.
Topics: Adolescent; Adult; Aged; Anticoagulants; Aortic Valve; Aspirin; Cineradiography; Dipyridamole; Echoc | 1986 |
Platelet antagonists eliminate thromboembolic complications of small-diameter arterial prostheses.
Topics: Animals; Aspirin; Blood Vessel Prosthesis; Dipyridamole; Graft Occlusion, Vascular; Male; Platelet A | 1987 |
Aspirin and post-surgical haemorrhage.
Topics: Aspirin; Humans; Oral Hemorrhage; Postoperative Complications; Tooth Extraction | 1985 |
Postoperative changes in the plasmatic levels of tissue-type plasminogen activator and its fast-acting inhibitor--relationship to deep vein thrombosis and influence of prophylaxis.
Topics: alpha-2-Antiplasmin; Aspirin; Dihydroergotamine; Drug Therapy, Combination; Fibrinogen; Glycoprotein | 1985 |
Antiplatelet drugs and the incidence of thromboembolic complications of the St. Jude Medical aortic prosthesis in patients with rheumatic heart disease.
Topics: Adolescent; Adult; Aortic Valve; Aspirin; Blood Platelets; Dipyridamole; Female; Follow-Up Studies; | 1986 |
Anesthetic management of patients with coagulation disorders.
Topics: Anesthetics; Anticoagulants; Aspirin; Blood Coagulation; Blood Coagulation Disorders; Cardiopulmonar | 1985 |
Postimplantation bleeding after aspirin ingestion.
Topics: Aged; Aspirin; Female; Humans; Hyphema; Lenses, Intraocular; Postoperative Complications | 1985 |
Thromboembolism in patients with aortic porcine bioprostheses.
Topics: Adolescent; Adult; Aged; Aorta; Aortic Valve; Aspirin; Bioprosthesis; Blood Vessel Prosthesis; Femal | 1985 |
[Effect of various drugs on platelet aggregation during the postoperative phase].
Topics: Arthrodesis; Aspirin; Fracture Fixation; Humans; Intervertebral Disc Displacement; Leg; Phenylbutazo | 1971 |
Aspirin and emboli.
Topics: Aspirin; Craniotomy; Humans; Neurosurgery; Postoperative Complications; Thromboembolism | 1971 |
Rate of fibrinogen turnover in thrombosis.
Topics: Age Factors; Analysis of Variance; Aspirin; Fibrin; Fibrinogen; Humans; Iodine Radioisotopes; Method | 1972 |
Should we stand all day?
Topics: Adult; Aspirin; Blood Coagulation; Blood Vessels; Child; Dextrans; Heparin; Humans; Leg; Plasminogen | 1973 |
Complications revisited. The debit side of total hip replacement.
Topics: Anti-Bacterial Agents; Arthritis, Rheumatoid; Arthroplasty; Aspirin; Bone Cements; Dextrans; Female; | 1973 |
Malignant melanoma metastatic to the bladder. Regression following intratumor injection of BCG vaccine.
Topics: Aspirin; BCG Vaccine; Biopsy; Cystoscopy; Diphenhydramine; Humans; Immunotherapy; Male; Melanoma; Mi | 1974 |
[Comparison of the prevention of thrombo-embolism by heparin and sintrom and by Macrodex and Colfarit in gynecologic surgery of the elderly (author's transl)].
Topics: Acenocoumarol; Aged; Anticoagulants; Aspirin; Blood Coagulation Disorders; Dextrans; Drug Therapy, C | 1974 |
Comparison of warfarin, low-molecular-weight dextran, aspirin, and subcutaneous heparin in prevention of venous thromboembolism following total hip replacement.
Topics: Aspirin; Dextrans; Female; Hemorrhage; Heparin; Hip Joint; Humans; Injections, Subcutaneous; Joint P | 1974 |
Aspirin prophylaxis of thromboembolic disease in patients undergoing hip surgery.
Topics: Adult; Aged; Aspirin; Female; Hip Dislocation; Humans; Male; Middle Aged; Postoperative Complication | 1974 |
A clinical trial of Apernyl cones and tamponade with Ward's Wondr Pak in the treatment of dry socket.
Topics: Adolescent; Adult; Aspirin; Drug Combinations; Dry Socket; Female; Humans; Male; Mandible; Middle Ag | 1973 |
Acute "stress" ulcers of the stomach: a review.
Topics: Acute Disease; Age Factors; Antacids; Aspirin; Bacteria; Gastric Juice; Gastric Mucosa; Gastrointest | 1973 |
Disseminated intravascular coagulation after excision of giant hemangioma.
Topics: Adolescent; Afibrinogenemia; Anemia, Hemolytic, Congenital; Aspirin; Blood Platelet Disorders; Disse | 1974 |
[Upper digestive hemorrhages due to gastritis or of unknown cause. (Apropos of 140 cases)].
Topics: Alcoholism; Aspirin; Endoscopy; Esophageal and Gastric Varices; Fiber Optic Technology; Gastrectomy; | 1973 |
Clinical replantation of digits.
Topics: Adolescent; Adult; Amputation, Traumatic; Anesthesia, General; Aspirin; Child; Debridement; Dipyrida | 1973 |
Successful treatment of systemic candidiasis following cardiac surgery.
Topics: Administration, Oral; Anti-Bacterial Agents; Antibodies; Antifungal Agents; Aspirin; Candida albican | 1974 |
[Postoperative thromboembolic complications].
Topics: Aspirin; Blood Coagulation Tests; Heparin; Humans; Injections, Subcutaneous; Postoperative Complicat | 1972 |
Lysozymuria and acute disorders of renal function.
Topics: Acetaminophen; Acute Disease; Aspirin; Electroshock; Glomerulonephritis; Heart Failure; Humans; Hypo | 1973 |
The treatment of pulmonary embolism.
Topics: Adult; Aspirin; Blood Coagulation Tests; Cholelithiasis; Diabetes Complications; Female; Heparin; Hu | 1973 |
Dipyridamole and aspirin tested against an experimental model of thrombosis.
Topics: Animals; Aspirin; Blood Vessels; Dipyridamole; Disease Models, Animal; Dogs; Hematoma; Hemorrhagic D | 1973 |
Aspirin in the prevention of thrombosis.
Topics: Aspirin; Fibrinogen; Humans; Iodine Radioisotopes; Platelet Adhesiveness; Postoperative Complication | 1973 |
[Prevention of postoperative thromboembolism in patients with fractures in the region of the hip joint by the use of acetylsalicylic acid micropellets (author's transl)].
Topics: Aspirin; Coumarins; Drug Synergism; Female; Femoral Fractures; Fractures, Bone; Hip; Hip Joint; Huma | 1973 |
[Prophylaxis of thrombo-embolic complications in major surgery of the hip joint. A comparative controlled study with subcutaneous calcium heparinate and acetylsalicylic acid (author's transl)].
Topics: Aspirin; Calcium; Heparin; Hip; Hip Joint; Humans; Injections, Subcutaneous; Joint Prosthesis; Posto | 1973 |
Dipyridamole ("Persantin") and aspirin and the prevention of post-operative deep-vein thrombosis.
Topics: Adult; Aspirin; Dextrans; Dipyridamole; Drug Therapy, Combination; Female; Fibrinogen; Heparin; Huma | 1973 |
Postoperative deep vein thrombosis and pulmonary embolism: a selective review and personal viewpoint.
Topics: Adult; Age Factors; Aged; Aspirin; Clothing; Dextrans; Dipyridamole; Exercise Therapy; Heparin; Huma | 1974 |
Inhibition of platelet-induced thrombus formation.
Topics: Adenosine; Adenosine Diphosphate; Aspirin; Blood Platelets; Brain Diseases; Dipyridamole; Epinephrin | 1974 |
The effect of acetylsalicylic acid on thrombosis at microvenous anastomotic sites.
Topics: Animals; Aspirin; Collagen; Platelet Adhesiveness; Postoperative Complications; Rabbits; Surgical Wo | 1972 |
[Acetylsalicylic acid in thromboembolic diseases].
Topics: Anticoagulants; Aspirin; Blood Platelets; Humans; Postoperative Complications; Thromboembolism; Thro | 1972 |
[Behavior of thrombocyte function with and without the action of thrombocyte inhibitors in the postoperative course].
Topics: Aspirin; Blood Platelet Disorders; Blood Platelets; Humans; Phenylbutazone; Platelet Adhesiveness; P | 1971 |
Anaesthetics and platelets.
Topics: Aspirin; Blood Platelets; Hemorrhagic Disorders; Hemostasis; Humans; Postoperative Complications | 1971 |
Unusual causes of occult bleeding from the gastrointestinal tract.
Topics: Adolescent; Adult; Aged; Anemia; Aspirin; Child; Diagnosis, Differential; Esophagitis, Peptic; Femal | 1970 |
[Congenital factor 13 deficiency: severe abdominal hemorrhage after combined antiinflammatory therapy].
Topics: Appendectomy; Appendicitis; Aspirin; Blood Coagulation Disorders; Blood Platelets; Blood Transfusion | 1971 |
Perforated peptic ulcer.
Topics: Adult; Age Factors; Aspirin; Australia; Duodenal Ulcer; Female; Follow-Up Studies; Gastrectomy; Huma | 1969 |
Studies of platelet and fibrinogen kinetics in patients with prosthetic heart valves.
Topics: Aortic Valve; Aspirin; Blood Cell Count; Blood Platelets; Chromium Isotopes; Dipyridamole; Drug Syne | 1970 |
Polyarthritis in obese patients with intestinal bypass.
Topics: Adolescent; Adult; Arthritis; Aspirin; Body Height; Body Weight; Colon; Dehydration; Female; Humans; | 1971 |
Thrombosis prevention.
Topics: Animals; Arteries; Arthroplasty; Aspirin; Blood Platelets; Dextrans; Dipyridamole; Hemorrhage; Hip; | 1971 |
Secondary post-tonsillectomy haemorrhage.
Topics: Aspirin; Child; Child, Preschool; Hemorrhage; Humans; Neomycin; Postoperative Care; Postoperative Co | 1966 |